Contrast,Database,Pathway,pvalue,p.adjust,GeneRatio
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,3.3328017724565106e-16,3.9604794396024865e-14,70/435
Female_OUD_vs_Control,GO_BP,immune response,4.1022898824388537e-17,8.346108765821848e-14,88/287
Pooled_OUD_vs_Control,GO_BP,immune response,9.589641451612784e-16,1.39529283120966e-12,103/380
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,9.880510407294027e-14,4.69653594693376e-12,56/435
Female_OUD_vs_Control,Reactome,Immune System,7.41356318006257e-15,5.938264107230119e-12,89/206
Female_OUD_vs_Control,GO_BP,response to cytokine,1.6186637297921766e-14,2.1954475721747888e-11,59/287
Female_OUD_vs_Control,GO_BP,cellular response to cytokine stimulus,1.3094863955901876e-13,7.805979444394777e-11,54/287
Pooled_OUD_vs_Control,GO_BP,response to cytokine,1.774144992151465e-13,1.290690481790191e-10,68/380
Female_OUD_vs_Control,GO_BP,positive regulation of immune system process,5.40725447100915e-13,2.7502648053170287e-10,60/287
Female_OUD_vs_Control,DO,bone inflammation disease,1.5658025409077823e-12,4.0345512137390527e-10,29/160
Pooled_OUD_vs_Control,GO_BP,cellular response to cytokine stimulus,4.547367553246763e-12,1.5268661053786246e-9,61/380
Female_OUD_vs_Control,GO_BP,regulation of immune system process,5.115501964412231e-12,1.6011521148610283e-9,73/287
Pooled_OUD_vs_Control,GO_MF,immune receptor activity,7.451345615602396e-12,1.9646714606471653e-9,24/376
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,9.367464861553005e-12,2.140349238186923e-9,24/410
Pooled_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,7.582124495029641e-11,2.1624219059824538e-9,40/435
Pooled_OUD_vs_Control,Reactome,Immune System,2.8477849051704873e-12,2.261141214705367e-9,101/267
Pooled_OUD_vs_Control,DO,bone inflammation disease,1.5395509381723886e-11,3.121439527144518e-9,31/199
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,1.4761570881700544e-10,3.7589285852330314e-9,43/435
Female_OUD_vs_Control,DO,immune system disease,3.365994324195424e-11,6.504784031507657e-9,41/160
Female_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,1.3667105744521486e-10,8.324509862572178e-9,50/334
Female_OUD_vs_Control,GO_BP,cytokine production,4.521353797217703e-11,8.76066123851373e-9,48/287
Female_OUD_vs_Control,GO_BP,regulation of immune response,5.4804654575331315e-11,1.0136369975773778e-8,51/287
DLPFC_OUD_vs_Control,DO,bone inflammation disease,5.2201818784797824e-11,1.3816081371709825e-8,25/136
Pooled_OUD_vs_Control,GO_BP,positive regulation of immune system process,8.269266323761057e-11,1.8047673751608507e-8,67/380
Female_OUD_vs_Control,GO_BP,regulation of cytokine production,1.1721922267913582e-10,2.07376094383219e-8,47/287
Female_OUD_vs_Control,GO_BP,innate immune response,2.646297766790414e-10,4.486577338779247e-8,49/287
Female_OUD_vs_Control,GO_BP,positive regulation of cytokine production,3.0661839286671987e-10,4.9905209622987326e-8,36/287
Pooled_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM,1.0749995967289994e-10,5.020248116724427e-8,20/254
Male_OUD_vs_Control,GO_BP,response to cytokine,2.5165264955203296e-11,5.3089358248658104e-8,29/101
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,3.900090280599656e-9,7.515579378560958e-8,23/435
Female_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,2.784511156774283e-9,9.328112375193849e-8,32/334
Female_OUD_vs_Control,C8_CellType,HU_FETAL_RETINA_MICROGLIA,3.4927028254675558e-9,1.1143385205063155e-7,32/334
Female_OUD_vs_Control,GO_BP,cytokine-mediated signaling pathway,7.825959114202682e-10,1.1372795584175256e-7,36/287
Pooled_OUD_vs_Control,DO,immune system disease,3.8825568144285214e-9,1.9679709853134567e-7,43/199
Female_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,7.427143435300066e-9,2.1635591746308887e-7,34/334
Pooled_OUD_vs_Control,GO_BP,regulation of immune system process,1.8235918397471274e-9,2.74482013120559e-7,82/380
Female_OUD_vs_Control,Reactome,Cytokine Signaling in Immune system,9.650209522862885e-10,3.8649089139065855e-7,44/206
Pooled_OUD_vs_Control,KEGG,Cytokine-cytokine receptor interaction,2.334340434609216e-9,6.302719173444883e-7,31/225
DLPFC_OUD_vs_Control,GO_BP,response to cytokine,3.908493399660232e-10,6.834748293000522e-7,47/253
OUD_DLPFC_vs_NAC,GO_CC,synapse,1.1233713125677939e-9,7.593990072958287e-7,745/5358
Pooled_OUD_vs_Control,C8_CellType,HU_FETAL_RETINA_MICROGLIA,5.689548698734223e-8,8.45135046291146e-7,35/435
Female_OUD_vs_Control,GO_MF,immune receptor activity,1.3323917682019017e-9,9.180179282911103e-7,19/292
Male_OUD_vs_Control,GO_BP,cellular response to cytokine stimulus,2.0671234485584736e-9,1.4518373468726042e-6,25/101
Pooled_OUD_vs_Control,GO_MF,cytokine binding,9.340372308513428e-9,1.4776468992068243e-6,19/376
Female_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,1.092137410086905e-8,1.5171073493648388e-6,18/319
Female_OUD_vs_Control,Reactome,Innate Immune System,6.613153085231057e-9,1.765711873756692e-6,49/206
Pooled_OUD_vs_Control,GO_BP,cytokine-mediated signaling pathway,1.512893993691581e-8,1.8343839673510417e-6,40/380
Male_OUD_vs_Control,Reactome,Cytokine Signaling in Immune system,1.0850263525629673e-8,2.0072987522414895e-6,23/75
Male_OUD_vs_Control,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,1.279622942292808e-7,2.0318861265497924e-6,19/118
Pooled_OUD_vs_Control,GO_BP,positive regulation of cytokine production,1.876719096039021e-8,2.214021311948737e-6,39/380
DLPFC_OUD_vs_Control,GO_BP,cellular response to cytokine stimulus,4.939278267307288e-9,2.4931007054233537e-6,42/253
Female_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,1.360011976158355e-7,3.2543143715217774e-6,37/334
Pooled_OUD_vs_Control,GO_BP,cytokine production,3.106880909074213e-8,3.390383792027235e-6,51/380
Male_OUD_vs_Control,DO,bone inflammation disease,7.453450429415188e-8,3.612056746562745e-6,14/61
Female_OUD_vs_Control,GO_BP,positive regulation of immune response,3.1630262227586977e-8,3.6772439144014686e-6,39/287
Pooled_OUD_vs_Control,Reactome,Cytokine Signaling in Immune system,2.2081013178560844e-8,3.89407598897643e-6,49/267
Pooled_OUD_vs_Control,Reactome,Innate Immune System,2.4521889099347793e-8,3.89407598897643e-6,57/267
Female_OUD_vs_Control,GO_BP,regulation of response to stress,4.7908172053502674e-8,5.268604110424389e-6,54/287
Female_OUD_vs_Control,DO,autoimmune disease,1.5584388810238994e-7,5.736539309673687e-6,24/160
Pooled_OUD_vs_Control,GO_BP,regulation of cytokine production,6.325200384434572e-8,5.8743616336291296e-6,50/380
Pooled_OUD_vs_Control,GO_BP,innate immune response,7.494666630670663e-8,6.6763713965056e-6,53/380
Pooled_OUD_vs_Control,GO_BP,adaptive immune response,8.953202123868951e-8,7.5383327717714495e-6,35/380
Female_OUD_vs_Control,GO_MF,cytokine binding,5.7584384764932345e-8,8.083768148538867e-6,16/292
Female_OUD_vs_Control,GO_MF,chemokine binding,5.8663048973431534e-8,8.083768148538867e-6,9/292
Pooled_OUD_vs_Control,GO_BP,regulation of response to stress,2.0385837824725222e-7,1.6039691375198682e-5,64/380
Pooled_OUD_vs_Control,DO,adult respiratory distress syndrome,8.531270297251601e-7,1.779690224190479e-5,10/199
Male_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,1.5670322845538448e-7,2.237373872946323e-5,10/110
Pooled_OUD_vs_Control,GO_BP,immune effector process,3.362465165267058e-7,2.5749404291913526e-5,42/380
Female_OUD_vs_Control,GO_BP,programmed cell death,2.8490188189684617e-7,2.5761461276405933e-5,67/287
DLPFC_OUD_vs_Control,C8_CellType,HU_FETAL_RETINA_MICROGLIA,1.1944198000029214e-6,2.659229697167085e-5,25/286
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,6.356130589254343e-7,2.8590594952419534e-5,17/410
Female_OUD_vs_Control,GO_BP,cell death,3.2998855992877567e-7,2.9189640225004093e-5,67/287
Female_OUD_vs_Control,GO_BP,regulation of programmed cell death,3.40742331525974e-7,2.9499586105940176e-5,55/287
NAC_OUD_vs_Control,DO,bone inflammation disease,1.8197242234776606e-7,2.9843477265033635e-5,29/257
Pooled_OUD_vs_Control,KEGG,Viral protein interaction with cytokine and cytokine receptor,2.2161893577677228e-7,2.9918556329864257e-5,14/225
Female_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM,7.781945708952929e-8,3.3462366548497595e-5,15/198
Male_OUD_vs_Control,DO,immune system disease,1.7504065067209065e-6,3.715638515622539e-5,18/61
Male_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,3.7450817186949273e-7,4.1249400073054124e-5,10/110
Male_OUD_vs_Control,GO_BP,cytokine-mediated signaling pathway,8.996993491891227e-8,4.25257892383392e-5,18/101
Female_OUD_vs_Control,GO_BP,adaptive immune response,6.34803706356479e-7,4.453476346835368e-5,28/287
Pooled_OUD_vs_Control,GO_BP,humoral immune response,7.032877668969372e-7,4.514486915448721e-5,21/380
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,3.937414439497659e-7,4.7839585439896553e-5,15/278
DLPFC_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM,3.3497906993687615e-7,4.8236986070910164e-5,13/161
Pooled_OUD_vs_Control,GO_BP,regulation of immune response,9.318575453345959e-7,5.419355805522829e-5,51/380
Female_OUD_vs_Control,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,8.818120954884746e-7,5.980155694237672e-5,14/287
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,2.670640333018842e-7,6.000441466995387e-5,22/580
Control_DLPFC_vs_NAC,GO_CC,neuron projection,8.923667414877426e-8,6.03239917245714e-5,599/5212
Female_OUD_vs_Control,GO_BP,regulation of innate immune response,9.261552662012286e-7,6.0535157224567555e-5,26/287
Female_OUD_vs_Control,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,9.805794689288288e-7,6.0535157224567555e-5,22/287
DLPFC_OUD_vs_Control,GO_BP,regulation of response to stress,2.1581260109395153e-7,6.22465202298126e-5,48/253
DLPFC_OUD_vs_Control,DO,immune system disease,2.3706679770120908e-6,6.498288759619467e-5,29/136
Pooled_OUD_vs_Control,GO_MF,chemokine binding,5.172115806546274e-7,6.818572671630172e-5,9/376
Female_OUD_vs_Control,GO_BP,immune response-regulating signaling pathway,1.143295039574256e-6,6.841275758864188e-5,30/287
Female_OUD_vs_Control,GO_BP,positive regulation of innate immune response,1.2916638634439149e-6,7.031190588349953e-5,23/287
Female_OUD_vs_Control,GO_BP,tumor necrosis factor superfamily cytokine production,1.3287942115199797e-6,7.031190588349953e-5,17/287
Female_OUD_vs_Control,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,1.3287942115199797e-6,7.031190588349953e-5,17/287
DLPFC_OUD_vs_Control,DO,autoimmune disease,2.6645824466182556e-6,7.052261542049649e-5,20/136
Male_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,6.369929627860507e-6,7.101793882976396e-5,9/118
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,4.525476652533301e-6,7.919796296261794e-5,36/286
Male_OUD_vs_Control,GO_BP,immune response,2.520151156755065e-7,7.941276311730405e-5,32/101
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,7.372885683279596e-7,8.302588585293144e-5,14/278
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,2.185744535278013e-6,8.404540277585134e-5,18/410
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,6.262021619848042e-7,8.516349402993336e-5,136/6250
Pooled_OUD_vs_Control,GO_BP,programmed cell death,1.8598883750215719e-6,9.551073831728425e-5,80/380
DLPFC_OUD_vs_Control,GO_BP,positive regulation of cytokine production,5.097324033708356e-7,9.908615578399377e-5,28/253
Pooled_OUD_vs_Control,GO_BP,regulation of programmed cell death,2.0448557731703973e-6,1.0142949374873619e-4,65/380
Pooled_OUD_vs_Control,GO_BP,cell death,2.1737157524750987e-6,1.0660976696127872e-4,80/380
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,2.7505050404500915e-6,1.1200201790909595e-4,60/581
Male_OUD_vs_Control,GO_BP,regulation of response to stress,3.9777384237157224e-7,1.128086616965779e-4,26/101
Female_OUD_vs_Control,DO,glucose metabolism disease,7.29834663591414e-6,1.175337906158673e-4,36/160
Pooled_OUD_vs_Control,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2.843327511307231e-6,1.279497380088254e-4,25/380
Male_OUD_vs_Control,GO_BP,positive regulation of immune system process,5.859344333512576e-7,1.2900761386961914e-4,24/101
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,1.0194646684229895e-6,1.2998174522393116e-4,20/580
Female_OUD_vs_Control,GO_BP,immune effector process,2.9049208717118587e-6,1.3546829201070275e-4,33/287
Female_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,3.791496074142472e-6,1.4353893223069885e-4,14/319
NAC_OUD_vs_Control,GO_BP,immune response,9.656550603411691e-8,1.5147909046551807e-4,104/513
Pooled_OUD_vs_Control,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,1.308865201433374e-6,1.5281001226734642e-4,24/254
Female_OUD_vs_Control,GO_BP,regulation of T-helper 1 type immune response,3.7603503806241786e-6,1.6452543762107293e-4,7/287
Male_OUD_vs_Control,Reactome,Immune System,1.9134409834710578e-6,1.6784502190968952e-4,33/75
DLPFC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,1.1404542175174239e-5,1.798204556922822e-4,23/286
OUD_DLPFC_vs_NAC,GO_CC,neuron projection,5.35154638760111e-7,1.8088226790091754e-4,609/5358
Male_OUD_vs_Control,KEGG,Cytokine-cytokine receptor interaction,2.186093589121974e-6,1.8363186148624583e-4,13/64
Female_OUD_vs_Control,GO_BP,regulation of immune effector process,4.419151328469091e-6,1.8730757037021593e-4,24/287
NAC_OUD_vs_Control,GO_MF,immune receptor activity,9.057244750696798e-7,1.9699507332765536e-4,21/528
Male_OUD_vs_Control,GO_MF,cytokine receptor binding,4.978198542463757e-7,2.0012358140704303e-4,11/99
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,1.3172811937017908e-5,2.0298105666586685e-4,25/286
DLPFC_OUD_vs_Control,GO_MF,immune receptor activity,3.257028689846223e-7,2.1952373369563545e-4,15/253
Pooled_OUD_vs_Control,GO_MF,cytokine activity,2.338732493568703e-6,2.3124217530160553e-4,19/376
Female_OUD_vs_Control,GO_BP,chemokine-mediated signaling pathway,5.944745767013765e-6,2.394967378809803e-4,9/287
Female_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,2.087225716834e-5,2.4534056671557543e-4,15/334
Female_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,7.646612266613056e-6,2.5613439528520185e-4,15/319
Female_OUD_vs_Control,DO,disease of metabolism,2.047090010526804e-5,2.7761413651530164e-4,58/160
Female_OUD_vs_Control,GO_BP,positive regulation of T cell cytokine production,7.480183859811593e-6,2.8987493452927024e-4,6/287
Pooled_OUD_vs_Control,GO_BP,positive regulation of immune response,7.28242289927488e-6,2.9433125884569303e-4,41/380
Pooled_OUD_vs_Control,DO,autoimmune disease,2.92850209784781e-5,3.0063483561450303e-4,23/199
Male_OUD_vs_Control,KEGG,Fluid shear stress and atherosclerosis,9.24919730165494e-6,3.1077302933560597e-4,9/64
DLPFC_OUD_vs_Control,DO,glucose metabolism disease,2.5111520713077895e-5,3.215894749384492e-4,31/136
Male_OUD_vs_Control,GO_BP,regulation of immune system process,3.854566459482105e-6,3.5263066061584674e-4,28/101
Male_OUD_vs_Control,GO_BP,programmed cell death,4.460940425638206e-6,3.833705165790894e-4,30/101
DLPFC_OUD_vs_Control,GO_BP,cytokine-mediated signaling pathway,3.2193400418117796e-6,3.8647135047727355e-4,27/253
DLPFC_OUD_vs_Control,GO_BP,programmed cell death,3.453417313894707e-6,3.87358308708523e-4,58/253
Male_OUD_vs_Control,GO_BP,cell death,4.830659489450312e-6,3.9142143748803097e-4,30/101
DLPFC_OUD_vs_Control,GO_BP,cell death,3.909355667662088e-6,4.047686714363977e-4,58/253
Female_OUD_vs_Control,GO_BP,stress response to metal ion,1.1089845648773686e-5,4.0652776526901017e-4,5/287
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,1.502047661733002e-5,4.3143152115318996e-4,15/410
Female_OUD_vs_Control,KEGG,Viral protein interaction with cytokine and cytokine receptor,5.823446948934989e-6,4.5617001099990746e-4,11/175
NAC_OUD_vs_Control,DO,immune system disease,8.168510360452688e-6,4.7844132111222884e-4,43/257
Female_OUD_vs_Control,GO_BP,response to chemokine,1.4143201737971265e-5,4.930119722288281e-4,9/287
Female_OUD_vs_Control,GO_BP,cellular response to chemokine,1.4143201737971265e-5,4.930119722288281e-4,9/287
DLPFC_OUD_vs_Control,GO_BP,stress response to metal ion,5.9611789892367894e-6,5.084332552725871e-4,5/253
DLPFC_OUD_vs_Control,GO_BP,regulation of cytokine production,6.043783123596875e-6,5.084332552725871e-4,34/253
NAC_OUD_vs_Control,GO_BP,response to cytokine,6.520650000216344e-7,5.114363150169687e-4,66/513
DLPFC_OUD_vs_Control,GO_BP,regulation of programmed cell death,6.210492980357732e-6,5.117953194833576e-4,47/253
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,7.840877381972505e-6,5.323829358197958e-4,163/6250
Pooled_OUD_vs_Control,GO_MF,cytokine receptor binding,8.30897981288944e-6,5.477002526662956e-4,19/376
NAC_OUD_vs_Control,GO_BP,positive regulation of immune system process,8.354219971089186e-7,5.616422740563673e-4,71/513
DLPFC_OUD_vs_Control,GO_BP,cytokine production,7.231901526701311e-6,5.840483672963979e-4,34/253
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,6.588758398316716e-5,6.101019140259506e-4,18/435
Female_OUD_vs_Control,KEGG,Cytokine-cytokine receptor interaction,1.3278644727232223e-5,6.240963021799144e-4,21/175
Pooled_OUD_vs_Control,GO_BP,immune response-regulating signaling pathway,1.9108972123655944e-5,6.526763070369305e-4,33/380
Female_OUD_vs_Control,GO_BP,immune response-activating signaling pathway,2.086662904836514e-5,6.53874935777396e-4,26/287
Female_OUD_vs_Control,GO_BP,innate immune response-activating signaling pathway,2.317729819437181e-5,0.00071502520163089665,18/287
Pooled_OUD_vs_Control,GO_BP,regulation of immune effector process,2.2516923234719115e-5,7.176294262395825e-4,27/380
Pooled_OUD_vs_Control,DO,glucose metabolism disease,8.98916283928092e-5,7.755543683677475e-4,39/199
Pooled_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,8.960151191480114e-5,8.086819999399141e-4,15/435
Female_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,8.346108620792463e-5,8.441617810227683e-4,13/334
DLPFC_OUD_vs_Control,GO_MF,cytokine binding,2.537475081958077e-6,8.551291026198718e-4,13/253
Female_OUD_vs_Control,GO_BP,activation of immune response,2.8858512439160113e-5,8.698169415921666e-4,27/287
Male_OUD_vs_Control,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1.8741763668186822e-5,9.277173015752477e-4,6/75
NAC_OUD_vs_Control,GO_BP,cellular response to cytokine stimulus,1.5973080310336085e-6,9.396164492555203e-4,60/513
Male_OUD_vs_Control,Hallmark,HALLMARK_APOPTOSIS,1.2187962601535094e-4,9.750370081228075e-4,10/57
Female_OUD_vs_Control,GO_MF,C-C chemokine binding,1.3031646628999883e-5,9.97644947486769e-4,6/292
Female_OUD_vs_Control,GO_BP,negative regulation of immune response,3.513561448368445e-5,0.0010162255370214405,14/287
Female_OUD_vs_Control,GO_BP,regulation of adaptive immune response,3.521450005407302e-5,0.0010162255370214405,15/287
Female_OUD_vs_Control,GO_BP,activation of innate immune response,3.554244042994166e-5,0.0010184661275312156,18/287
Pooled_OUD_vs_Control,GO_MF,cytokine receptor activity,1.994893944961624e-5,0.0011271150789033176,13/376
Female_OUD_vs_Control,GO_BP,negative regulation of programmed cell death,4.222164391586089e-5,0.0011848266834043998,34/287
Female_OUD_vs_Control,DO,adult respiratory distress syndrome,1.454399373612867e-4,0.001208871737422308,7/160
Male_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,3.708510716551122e-5,0.0012622831341148855,8/110
Male_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,3.732821719561529e-5,0.0012622831341148855,7/110
Pooled_OUD_vs_Control,GO_BP,stress response to metal ion,4.3739655589495427e-5,0.0012813664204573661,5/380
Male_OUD_vs_Control,DO,glucose metabolism disease,1.4320320404070483e-4,0.0013267355668477067,17/61
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C3_MICROGLIA,2.7968746349488543e-5,0.00134249982477545,221/6250
DLPFC_OUD_vs_Control,GO_BP,regulation of T-helper 1 type immune response,2.703157834866409e-5,0.0014132417871087846,6/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of immune system process,2.7645893559595993e-5,0.0014132417871087846,39/253
Pooled_OUD_vs_Control,GO_BP,immunoglobulin mediated immune response,5.055943573151921e-5,0.0014362102335359025,13/380
Male_OUD_vs_Control,GO_BP,positive regulation of T cell cytokine production,3.163518787308163e-5,0.001481807820101206,4/101
NAC_OUD_vs_Control,Reactome,Immune System,2.1803418980206103e-6,0.0016629969778203606,105/349
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,1.0648436989933758e-4,0.001767640540329004,45/581
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,1.1035410662177437e-5,0.0018009790200673576,160/6081
Pooled_OUD_vs_Control,Hallmark,HALLMARK_COMPLEMENT,2.7124665925859005e-4,0.001821227569307676,18/151
Pooled_OUD_vs_Control,DO,disease of metabolism,2.5769268825210777e-4,0.0018971487559599216,65/199
Female_OUD_vs_Control,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7.655470671875319e-5,0.0019347894511714703,14/287
Female_OUD_vs_Control,GO_BP,negative regulation of cytokine production,7.898368846922642e-5,0.0019716848366949837,18/287
Female_OUD_vs_Control,GO_BP,T cell cytokine production,8.199700493354517e-5,0.0020129173510514296,6/287
Female_OUD_vs_Control,GO_BP,regulation of T cell cytokine production,8.199700493354517e-5,0.0020129173510514296,6/287
Female_OUD_vs_Control,GO_BP,T-helper 1 type immune response,8.211950854621217e-5,0.0020129173510514296,7/287
Male_OUD_vs_Control,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,4.780389261105607e-5,0.0020282508722119503,4/75
Male_OUD_vs_Control,GO_MF,cytokine activity,1.5521371648683666e-5,0.0020798638009236112,9/99
NAC_OUD_vs_Control,DO,adult respiratory distress syndrome,7.10949445035236e-5,0.002114244018076766,9/257
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,4.901313671747645e-5,0.0022219288645255993,107/6250
Female_OUD_vs_Control,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,2.589582534363099e-4,0.0022829214447674688,27/334
Pooled_OUD_vs_Control,GO_MF,C-C chemokine binding,5.524330985282992e-5,0.002299866215452024,6/376
NAC_OUD_vs_Control,GO_BP,regulation of cytokine production,5.133032486203366e-6,0.002415605088007304,56/513
OUD_DLPFC_vs_NAC,GO_CC,presynapse,1.09787418187674e-5,0.0024738764898289208,310/5358
NAC_OUD_vs_Control,KEGG,Cytokine-cytokine receptor interaction,1.271775199779033e-5,0.002511463830346278,28/278
NAC_OUD_vs_Control,KEGG,Viral protein interaction with cytokine and cytokine receptor,1.7875187404599845e-5,0.002511463830346278,13/278
Male_OUD_vs_Control,KEGG,Viral protein interaction with cytokine and cytokine receptor,1.2079518136532486e-4,0.0025366988086718218,6/64
Female_OUD_vs_Control,GO_MF,cytokine receptor activity,4.445953176540152e-5,0.002596709729139901,11/292
Pooled_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway,9.978438215143053e-5,0.002608136695155654,24/380
NAC_OUD_vs_Control,GO_BP,cytokine production,6.621716349075005e-6,0.002740941357084668,56/513
NAC_OUD_vs_Control,GO_BP,positive regulation of cytokine production,6.989225729922656e-6,0.002740941357084668,41/513
Male_OUD_vs_Control,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,8.369501930451169e-5,0.0027619356370488855,5/75
Pooled_OUD_vs_Control,GO_BP,positive regulation of programmed cell death,1.0829132636925489e-4,0.002780539056481162,30/380
Female_OUD_vs_Control,GO_BP,regulation of cytokine production involved in immune response,1.2237947810934757e-4,0.002781911153223102,11/287
DLPFC_OUD_vs_Control,GO_BP,regulation of immune system process,8.502816532631224e-5,0.0028325852927532,49/253
DLPFC_OUD_vs_Control,GO_BP,stress response to copper ion,9.158062119895241e-5,0.002866686421716045,4/253
Pooled_OUD_vs_Control,GO_MF,complement receptor activity,8.004357337027984e-5,0.0028779302970859703,5/376
Male_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM,9.823669785477226e-5,0.002917629926286736,7/75
Male_OUD_vs_Control,DO,autoimmune disease,4.0908380119043054e-4,0.0029623309741376004,10/61
DLPFC_OUD_vs_Control,DO,adult respiratory distress syndrome,4.6253428329841214e-4,0.0030351423218094153,6/136
Female_OUD_vs_Control,GO_BP,cytokine production involved in immune response,1.421727699171778e-4,0.0030981096233769667,11/287
Female_OUD_vs_Control,GO_BP,chemokine production,1.461632496534242e-4,0.0030981096233769667,10/287
Female_OUD_vs_Control,GO_BP,regulation of chemokine production,1.461632496534242e-4,0.0030981096233769667,10/287
Female_OUD_vs_Control,GO_BP,stress response to copper ion,1.4999449393100577e-4,0.0030981096233769667,4/287
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,2.841433600744385e-4,0.003321537898801195,12/286
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,7.796097367397671e-5,0.0033957152401202875,12/278
Male_OUD_vs_Control,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,1.362299741488311e-4,0.0036782093020184398,10/75
Male_OUD_vs_Control,GO_BP,regulation of T-helper 1 type immune response,1.1052782190885251e-4,0.0037588201280431663,4/101
Female_OUD_vs_Control,DO,autoimmune disease of endocrine system,6.496004593994979e-4,0.003953867363116629,6/160
DLPFC_OUD_vs_Control,Hallmark,HALLMARK_APOPTOSIS,6.504840773819751e-4,0.004367535948136119,13/109
DLPFC_OUD_vs_Control,Reactome,Cytokine Signaling in Immune system,1.609300954055888e-5,0.004377298595032016,31/172
Male_OUD_vs_Control,GO_BP,T cell cytokine production,1.4270585776911282e-4,0.00444983291034836,4/101
Male_OUD_vs_Control,GO_BP,regulation of T cell cytokine production,1.4270585776911282e-4,0.00444983291034836,4/101
Male_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,1.8535981690786087e-4,0.004494101221256626,8/110
NAC_OUD_vs_Control,GO_BP,regulation of immune system process,1.244235433776886e-5,0.004504132270272327,89/513
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,2.5843750949666966e-4,0.00453470076550948,16/410
DLPFC_OUD_vs_Control,GO_BP,positive regulation of T-helper 1 type immune response,1.7720006340866853e-4,0.004594548192447542,4/253
Male_OUD_vs_Control,GO_BP,regulation of adaptive immune response,1.703059782146195e-4,0.0047163914973584265,8/101
Pooled_OUD_vs_Control,KEGG,Complement and coagulation cascades,1.41537715036231e-4,0.004776897882472797,11/225
OUD_DLPFC_vs_NAC,GO_BP,generation of neurons,6.281059552592253e-6,0.004897656186133809,656/5050
Female_OUD_vs_Control,GO_BP,positive regulation of T-helper 1 type immune response,2.8889914221323773e-4,0.00496004476652179,4/287
DLPFC_OUD_vs_Control,KEGG,Cytokine-cytokine receptor interaction,1.0013016157940778e-4,0.004973143586598544,17/142
Female_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,2.8514972299303084e-4,0.00500655071262485,12/319
Male_OUD_vs_Control,DO,autoimmune disease of endocrine system,7.720935129306079e-4,0.005014627970580237,4/61
NAC_OUD_vs_Control,GO_MF,cytokine binding,3.468824790446789e-5,0.005029795946147844,17/528
Male_OUD_vs_Control,GO_BP,regulation of programmed cell death,1.9212682257831095e-4,0.005092258587215793,22/101
Female_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway,3.09373464671956e-4,0.005159182900615528,19/287
NAC_OUD_vs_Control,Reactome,Innate Immune System,2.444643146271409e-5,0.005399539752075866,60/349
Female_OUD_vs_Control,GO_BP,regulation of production of molecular mediator of immune response,3.300150869017679e-4,0.005436564326329124,13/287
Female_OUD_vs_Control,GO_MF,cytokine activity,1.0539161439869478e-4,0.005585755563130824,14/292
Female_OUD_vs_Control,GO_BP,negative regulation of immune system process,3.4365350169129454e-4,0.0056384116870236995,24/287
Pooled_OUD_vs_Control,GO_BP,regulation of T-helper 1 type immune response,2.6311859798566984e-4,0.005685706337660638,6/380
Pooled_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,2.1961571847009485e-4,0.005700242764761234,9/254
Pooled_OUD_vs_Control,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,2.1961571847009485e-4,0.005700242764761234,9/254
Pooled_OUD_vs_Control,GO_BP,activation of immune response,2.6676768595527707e-4,0.005736162311304357,30/380
DLPFC_OUD_vs_Control,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,2.3059879834874637e-4,0.005747888566248382,10/253
Male_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,2.6905658691470964e-4,0.005819376976972891,7/110
NAC_OUD_vs_Control,Reactome,Cytokine Signaling in Immune system,3.564485073718223e-5,0.0058398147124416894,50/349
Pooled_OUD_vs_Control,GO_BP,negative regulation of programmed cell death,2.732488451121965e-4,0.0058467216123271465,39/380
Male_OUD_vs_Control,GO_BP,positive regulation of T-helper 1 type immune response,2.321984725547257e-4,0.005879597037189305,3/101
Male_OUD_vs_Control,GO_BP,stress response to metal ion,2.321984725547257e-4,0.005879597037189305,3/101
Male_OUD_vs_Control,GO_BP,humoral immune response,2.4249591178913293e-4,0.006086003591451159,8/101
Female_OUD_vs_Control,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,3.735289171586219e-4,0.006103972545857159,8/287
DLPFC_OUD_vs_Control,GO_BP,immune response,2.529855593728936e-4,0.0061257697724907125,51/253
NAC_OUD_vs_Control,Hallmark,HALLMARK_COMPLEMENT,7.704084569590825e-4,0.00616326765567266,18/164
Female_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3.879384560159944e-4,0.006180519428263628,9/287
Male_OUD_vs_Control,DO,adult respiratory distress syndrome,0.0011073614476566724,0.0062289081430687825,4/61
DLPFC_OUD_vs_Control,GO_BP,negative regulation of programmed cell death,2.797363862368124e-4,0.00641804277059232,29/253
Control_DLPFC_vs_NAC,GO_BP,neuron development,3.1028437520803644e-6,0.006451846441825772,502/4916
Control_DLPFC_vs_NAC,GO_CC,axon,2.8934481405269253e-5,0.006519903143320672,305/5212
Female_OUD_vs_Control,GO_BP,positive regulation of immune effector process,4.189359233885657e-4,0.0065563472010310535,15/287
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,1.8132538687645386e-4,0.006737225090801155,13/278
OUD_DLPFC_vs_NAC,GO_CC,postsynapse,8.84135458852825e-5,0.006926486871382491,352/5358
Female_OUD_vs_Control,GO_BP,positive regulation of chemokine production,4.481703931394241e-4,0.0069700821287383505,8/287
Female_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response,4.5393751882911353e-4,0.0069700821287383505,9/287
Pooled_OUD_vs_Control,GO_BP,regulation of innate immune response,3.468082319540779e-4,0.0072086568213311905,25/380
OUD_DLPFC_vs_NAC,GO_CC,glutamatergic synapse,1.1784884075206321e-4,0.007242346940763157,266/5358
OUD_DLPFC_vs_NAC,GO_CC,axon,1.4084648149829295e-4,0.0073240170379112336,309/5358
Pooled_OUD_vs_Control,GO_BP,chemokine-mediated signaling pathway,3.6530968703144857e-4,0.007486275980714896,8/380
DLPFC_OUD_vs_Control,GO_BP,T-helper 1 type immune response,3.432695095736327e-4,0.007533273259012656,6/253
Pooled_OUD_vs_Control,GO_BP,immune response-activating signaling pathway,3.8037423891801325e-4,0.0076162089581519625,28/380
Pooled_OUD_vs_Control,KEGG,Fluid shear stress and atherosclerosis,3.6751757169054466e-4,0.007633057258188236,14/225
Female_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in immune response,5.344801858270977e-4,0.007995587779891398,8/287
Male_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,4.13974006164433e-4,0.008142192825325965,7/110
DLPFC_OUD_vs_Control,GO_MF,cytokine receptor binding,5.5616362088467856e-5,0.008227641214518359,14/253
DLPFC_OUD_vs_Control,DO,disease of metabolism,0.0017381374954925778,0.008268450843980677,45/136
OUD_DLPFC_vs_NAC,GO_CC,neuronal cell body,1.7879028274376282e-4,0.008329218250752567,242/5358
Male_OUD_vs_Control,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,4.146281054527276e-4,0.008422011163105553,5/101
Pooled_OUD_vs_Control,GO_BP,regulation of complement activation,4.460322134764805e-4,0.008428271046860768,4/380
Pooled_OUD_vs_Control,GO_BP,stress response to copper ion,4.460322134764805e-4,0.008428271046860768,4/380
Control_DLPFC_vs_NAC,GO_BP,neuron projection development,7.3022332331821704e-6,0.008440427088504268,446/4916
Control_DLPFC_vs_NAC,GO_BP,generation of neurons,9.252445373817382e-6,0.008440427088504268,641/4916
Control_DLPFC_vs_NAC,GO_BP,neuron differentiation,9.471463549139128e-6,0.008440427088504268,611/4916
OUD_DLPFC_vs_NAC,GO_BP,neuron differentiation,1.2253230856006135e-5,0.008492850453307364,624/5050
Female_OUD_vs_Control,GO_BP,positive regulation of programmed cell death,5.837403506704776e-4,0.008668757251380194,23/287
Pooled_OUD_vs_Control,GO_BP,T-helper 1 type immune response,4.7155068803098385e-4,0.008724260318339923,7/380
NAC_OUD_vs_Control,DO,autoimmune disease,5.851821618881307e-4,0.008724534049968494,24/257
Pooled_OUD_vs_Control,GO_BP,complement receptor mediated signaling pathway,5.018835962396111e-4,0.009052569824735134,5/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of T cell cytokine production,5.018835962396111e-4,0.009052569824735134,5/380
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,6.348335581292595e-4,0.009228312210854602,12/410
Male_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",4.8569082433637655e-4,0.009306886336607863,3/101
DLPFC_OUD_vs_Control,GO_BP,tumor necrosis factor superfamily cytokine production,4.5905579836476155e-4,0.009314911124607573,12/253
DLPFC_OUD_vs_Control,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,4.5905579836476155e-4,0.009314911124607573,12/253
Female_OUD_vs_Control,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,1.9568465370559658e-4,0.009349377899267392,17/198
DLPFC_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",4.976262627982972e-4,0.009660648313363097,4/253
Female_OUD_vs_Control,GO_BP,production of molecular mediator of immune response,6.804308357583587e-4,0.009783297069613997,13/287
Female_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,0.001305090140355977,0.009824835888073084,13/334
NAC_OUD_vs_Control,GO_BP,adaptive immune response,3.624228125257856e-5,0.009856223241470024,36/513
Female_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,6.852625563127251e-4,0.009958446318353848,13/319
Pooled_OUD_vs_Control,Hallmark,HALLMARK_APOPTOSIS,0.0017190927734400047,0.010099670043960028,15/151
NAC_OUD_vs_Control,GO_MF,chemokine binding,8.191630690019912e-5,0.010181026714739035,8/528
Male_OUD_vs_Control,GO_BP,T-helper 1 type immune response,5.828460899768791e-4,0.010349187353177733,4/101
Female_OUD_vs_Control,GO_MF,cytokine receptor binding,0.00025642423673766734,0.010392723477191342,14/292
DLPFC_OUD_vs_Control,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,2.959017981195099e-4,0.010735803738463709,12/161
Male_OUD_vs_Control,GO_BP,negative regulation of programmed cell death,6.27884487355823e-4,0.010792002461461296,15/101
DLPFC_OUD_vs_Control,KEGG,Fluid shear stress and atherosclerosis,2.655468034766061e-4,0.010843161141961417,11/142
Pooled_OUD_vs_Control,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,4.890001849493401e-4,0.01087443268434961,5/254
Male_OUD_vs_Control,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,6.455410837792563e-4,0.010942887152465138,9/101
Female_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",8.039438155902285e-4,0.011164666845176245,4/287
Female_OUD_vs_Control,GO_BP,positive regulation of production of molecular mediator of immune response,8.140685165557191e-4,0.011190691871166288,10/287
Female_OUD_vs_Control,Reactome,Diseases of Immune System,2.6450428450907866e-4,0.011231054355518034,6/206
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,8.100932835875975e-4,0.011261005178267246,13/410
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,8.100932835875975e-4,0.011261005178267246,13/410
Female_OUD_vs_Control,GO_BP,humoral immune response,8.250417581135319e-4,0.011265419173704569,13/287
Male_OUD_vs_Control,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7.176940058103222e-4,0.011370839108816056,7/101
Female_OUD_vs_Control,GO_BP,negative regulation of cytokine-mediated signaling pathway,8.512186421833889e-4,0.011492648686710303,7/287
DLPFC_OUD_vs_Control,GO_BP,positive regulation of programmed cell death,6.42314402930587e-4,0.011629062901500968,21/253
Male_OUD_vs_Control,GO_BP,adaptive immune response,7.578328629389208e-4,0.011874110493341323,11/101
DLPFC_OUD_vs_Control,Reactome,Immune System,1.1930596049453602e-4,0.011936230879346116,55/172
DLPFC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.0013439742884645263,0.011989665362880906,10/286
Pooled_OUD_vs_Control,GO_BP,response to chemokine,7.349095550781176e-4,0.012226934122252672,8/380
Pooled_OUD_vs_Control,GO_BP,cellular response to chemokine,7.349095550781176e-4,0.012226934122252672,8/380
Pooled_OUD_vs_Control,GO_BP,regulation of humoral immune response,7.595808888457093e-4,0.012226934122252672,6/380
Pooled_OUD_vs_Control,GO_BP,regulation of adaptive immune response,7.826429412702987e-4,0.012288620282895159,15/380
NAC_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM,9.66141750342143e-5,0.012300204463857347,14/307
NAC_OUD_vs_Control,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,1.0790691164984969e-4,0.012300204463857347,23/307
Female_OUD_vs_Control,GO_BP,negative regulation of T-helper 1 type immune response,9.599691568274392e-4,0.012361121832692565,3/287
Male_OUD_vs_Control,GO_BP,positive regulation of immune response,7.960682816579254e-4,0.012404668388911409,14/101
DLPFC_OUD_vs_Control,DO,autoimmune disease of blood,0.0030561276456676435,0.012508068817835612,4/136
DLPFC_OUD_vs_Control,DO,autoimmune thrombocytopenic purpura,0.0030561276456676435,0.012508068817835612,4/136
Female_OUD_vs_Control,DO,newborn respiratory distress syndrome,0.0028045085460056142,0.012904078012275833,3/160
Pooled_OUD_vs_Control,GO_BP,positive regulation of T-helper 1 type immune response,8.483247713634686e-4,0.012947334360145245,4/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of innate immune response,8.593685726991225e-4,0.013070187525545887,21/380
OUD_DLPFC_vs_NAC,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,3.684572376753379e-4,0.013072221997525032,140/6250
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,0.0016213996046064482,0.013915302935736352,24/286
Female_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.00107507250131164,0.014424907453678625,11/319
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,4.3161930025004195e-4,0.014675056208501427,100/6250
Pooled_OUD_vs_Control,GO_BP,positive regulation of immune effector process,0.001022811547930333,0.015032230325642774,17/380
NAC_OUD_vs_Control,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,6.639242840507987e-5,0.015456560980362348,27/513
NAC_OUD_vs_Control,GO_BP,regulation of immune response,7.542137852739055e-5,0.015456560980362348,57/513
NAC_OUD_vs_Control,GO_BP,humoral immune response,7.561336373364933e-5,0.015456560980362348,21/513
NAC_OUD_vs_Control,GO_BP,cytokine-mediated signaling pathway,8.135317482554786e-5,0.015456560980362348,39/513
Male_OUD_vs_Control,DO,autoimmune disease of the nervous system,0.003930719256412457,0.015638151037089428,3/61
DLPFC_OUD_vs_Control,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,9.871397247412255e-4,0.015755218215435053,15/253
Male_OUD_vs_Control,DO,lipid metabolism disorder,0.004358391635456011,0.01643326164840799,5/61
Male_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.0012049240417647093,0.016508041461085584,5/101
Male_OUD_vs_Control,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.0013514846621418125,0.01672462269400493,4/75
DLPFC_OUD_vs_Control,GO_BP,positive regulation of T cell cytokine production,0.0010982095784808146,0.016727940885496388,4/253
DLPFC_OUD_vs_Control,GO_BP,response to toxic substance,0.0011192835796317482,0.01686442945728731,13/253
Male_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response,0.0013214418024146426,0.01727008733478307,5/101
Female_OUD_vs_Control,GO_BP,negative regulation of response to cytokine stimulus,0.0014433897279986824,0.017427753125301596,7/287
DLPFC_OUD_vs_Control,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,7.536794201280036e-4,0.018088306083072086,5/161
DLPFC_OUD_vs_Control,GO_MF,cytokine activity,3.783657206854917e-4,0.018215606838715818,12/253
Female_OUD_vs_Control,Hallmark,HALLMARK_COMPLEMENT,0.0028687484172655233,0.01844195411099265,14/126
Female_OUD_vs_Control,GO_BP,immunoglobulin mediated immune response,0.0015706853443950845,0.01852498164157565,9/287
NAC_OUD_vs_Control,GO_BP,stress response to metal ion,1.8638583475388327e-4,0.018816993879648455,5/513
Female_OUD_vs_Control,GO_BP,regulation of response to cytokine stimulus,0.001613957115050235,0.018980322257628343,11/287
Pooled_OUD_vs_Control,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.001357092522587079,0.01898640284621088,14/380
Pooled_OUD_vs_Control,GO_BP,chemokine production,0.00136008362972305,0.01898640284621088,10/380
Pooled_OUD_vs_Control,GO_BP,regulation of chemokine production,0.00136008362972305,0.01898640284621088,10/380
OUD_DLPFC_vs_NAC,GO_CC,axoneme,5.729521578233724e-4,0.019469725779866685,97/5358
OUD_DLPFC_vs_NAC,GO_CC,dendrite,6.048287594337284e-4,0.019469725779866685,292/5358
Male_OUD_vs_Control,GO_MF,cytokine binding,6.809732967328687e-4,0.01955366180618666,6/99
Pooled_OUD_vs_Control,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,0.003308431582752194,0.01965759765418595,29/435
Pooled_OUD_vs_Control,DO,newborn respiratory distress syndrome,0.005250013865408063,0.02008377945682047,3/199
Pooled_OUD_vs_Control,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,0.001543940284115226,0.02073630566203988,11/380
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,6.900669067480993e-4,0.022488982000631416,163/6250
Pooled_OUD_vs_Control,GO_BP,tumor necrosis factor superfamily cytokine production,0.0018672011878143806,0.024113411789378023,14/380
Pooled_OUD_vs_Control,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,0.0018672011878143806,0.024113411789378023,14/380
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,8.864166153304335e-4,0.024541077150148288,16/580
DLPFC_OUD_vs_Control,GO_BP,regulation of adaptive immune response,0.001941496486479685,0.025453775364951192,11/253
OUD_DLPFC_vs_NAC,GO_CC,neuron to neuron synapse,9.376001492736724e-4,0.026409070871208442,192/5358
Female_OUD_vs_Control,KEGG,Fluid shear stress and atherosclerosis,0.001579150566571378,0.026507170224590985,11/175
Female_OUD_vs_Control,DO,autoimmune disease of skin and connective tissue,0.007240791693367975,0.02652669184347604,3/160
Control_DLPFC_vs_NAC,GO_CC,synapse,2.505859426715308e-4,0.026529191527157076,705/5212
Control_DLPFC_vs_NAC,GO_CC,axoneme,2.747105631510348e-4,0.026529191527157076,96/5212
DLPFC_OUD_vs_Control,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.0012908782388727507,0.0265552094853823,8/161
DLPFC_OUD_vs_Control,GO_MF,chemokine binding,7.704370881180312e-4,0.027330241967976475,5/253
Male_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,0.0021383083695323594,0.02756915974764965,6/110
Male_OUD_vs_Control,DO,disease of metabolism,0.008665153969739051,0.027731327057196633,22/61
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.0013378391373725452,0.027823438275896582,10/278
Pooled_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",0.0023022791552678177,0.027992892793158843,4/380
Male_OUD_vs_Control,GO_BP,regulation of cytokine production,0.0026241553715756713,0.028245768521172568,14/101
NAC_OUD_vs_Control,GO_BP,programmed cell death,4.0800354291079373e-4,0.02834926519053676,91/513
Pooled_OUD_vs_Control,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,0.002344918248203834,0.02841237235066528,8/380
Pooled_OUD_vs_Control,GO_BP,immune response-activating cell surface receptor signaling pathway,0.002462571545920077,0.029449656980660648,19/380
Pooled_OUD_vs_Control,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.0017057148036985338,0.029502548641748717,6/254
Male_OUD_vs_Control,WikiPathways,WP_FOLATE_METABOLISM,0.0034097266964194383,0.02961647763252725,4/75
Female_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.0027312179386671178,0.029791090818302075,11/319
Male_OUD_vs_Control,GO_BP,regulation of immune response,0.0028282190209616624,0.029823575141229526,15/101
Male_OUD_vs_Control,GO_BP,cytokine production,0.0028288228889248035,0.029823575141229526,14/101
DLPFC_OUD_vs_Control,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,0.004035015805626024,0.030215224760941763,21/286
DLPFC_OUD_vs_Control,WikiPathways,WP_FOLATE_METABOLISM,0.0019522228463402737,0.030293658167930528,6/161
Male_OUD_vs_Control,Hallmark,HALLMARK_COMPLEMENT,0.0060857799322119,0.0304288996610595,8/57
Female_OUD_vs_Control,Reactome,Chemokine receptors bind chemokines,8.84104156966421e-4,0.030789888249134926,6/206
NAC_OUD_vs_Control,GO_BP,cell death,4.6597726840143076e-4,0.03088576091686103,91/513
Male_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.003887548058602802,0.03120545333527114,4/75
Male_OUD_vs_Control,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.003887548058602802,0.03120545333527114,4/75
Pooled_OUD_vs_Control,GO_BP,positive regulation of chemokine production,0.0027754663318514177,0.032654745386877196,8/380
Male_OUD_vs_Control,GO_MF,immune receptor activity,0.001315221313039672,0.03304493549012176,6/99
Female_OUD_vs_Control,GO_BP,negative regulation of chemokine production,0.003299657600718569,0.03315137475882434,4/287
Pooled_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.0028451583931660327,0.033295218193484535,9/380
Female_OUD_vs_Control,Hallmark,HALLMARK_APOPTOSIS,0.007402686215041495,0.033312087967686727,12/126
Female_OUD_vs_Control,GO_BP,regulation of cytokine-mediated signaling pathway,0.003338534291252876,0.033459349830315156,10/287
Male_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.0029304140076904734,0.033924162161101425,5/110
Female_OUD_vs_Control,GO_BP,response to toxic substance,0.0034397227627015184,0.034304490003510976,13/287
Pooled_OUD_vs_Control,GO_BP,T cell cytokine production,0.0030249469665288254,0.03447491777780241,5/380
Pooled_OUD_vs_Control,GO_BP,regulation of T cell cytokine production,0.0030249469665288254,0.03447491777780241,5/380
DLPFC_OUD_vs_Control,GO_BP,regulation of immune response,0.0030048416813598035,0.034568520539404235,29/253
Female_OUD_vs_Control,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.0019277489204646034,0.03492147431694997,5/198
NAC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.003619472055159678,0.03571505783318039,29/581
Pooled_OUD_vs_Control,DO,autoimmune disease of endocrine system,0.011271050487883539,0.035987487975092713,5/199
DLPFC_OUD_vs_Control,DO,autoimmune disease of gastrointestinal tract,0.01216519733651269,0.0360416667357876,3/136
Pooled_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in immune response,0.0032653121014506086,0.0364529087540458,8/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response,0.0032837843391250897,0.03647256651470997,9/380
Male_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.003333077132825602,0.03702885402605964,6/110
DLPFC_OUD_vs_Control,Hallmark,HALLMARK_COMPLEMENT,0.006312093864880724,0.03708355145617425,12/109
Male_OUD_vs_Control,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.005195723857909592,0.037637316726808506,3/75
Pooled_OUD_vs_Control,GO_BP,negative regulation of immune effector process,0.0035634608097054135,0.0383855278196958,10/380
Pooled_OUD_vs_Control,GO_MF,complement binding,0.0020439678503102097,0.038494727847508944,4/376
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.002161959400968813,0.038689017652220964,9/278
NAC_OUD_vs_Control,GO_MF,complement receptor activity,4.0415142176147145e-4,0.03906797077027557,5/528
Male_OUD_vs_Control,DO,"autoimmune disease of eyes, ear, nose and throat",0.013890680802070829,0.039242730517061085,2/61
Male_OUD_vs_Control,GO_BP,positive regulation of production of molecular mediator of immune response,0.0042375503526078636,0.039662352475233996,5/101
DLPFC_OUD_vs_Control,GO_BP,positive regulation of immune response,0.00368632287308003,0.04078184044245797,24/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.0037496907926786276,0.04125681586058937,7/253
DLPFC_OUD_vs_Control,DO,autoimmune disease of endocrine system,0.014204213019352216,0.04146376888737375,4/136
Male_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in immune response,0.004479518479904602,0.04148179452384543,4/101
DLPFC_OUD_vs_Control,GO_BP,regulation of immune effector process,0.003855300329855321,0.04162487361485504,16/253
OUD_DLPFC_vs_NAC,GO_CC,GABA-ergic synapse,0.0017680897699092822,0.0424427201496583,55/5358
OUD_DLPFC_vs_NAC,GO_CC,asymmetric synapse,0.0018207675803847499,0.0424427201496583,172/5358
NAC_OUD_vs_Control,KEGG,Complement and coagulation cascades,9.071684851393328e-4,0.04248572405402542,11/278
Female_OUD_vs_Control,GO_MF,C-C chemokine receptor activity,0.0017310125817948474,0.0425952738877375,4/292
OUD_DLPFC_vs_NAC,KEGG,Cholinergic synapse,2.461762083670566e-4,0.04274468858512367,65/2402
Female_OUD_vs_Control,GO_BP,immune response-activating cell surface receptor signaling pathway,0.0047070838655365365,0.04323504345116967,15/287
DLPFC_OUD_vs_Control,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.003575122565065171,0.0441272270888044,5/161
Male_OUD_vs_Control,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.007296370568970509,0.04440688690417727,2/75
DLPFC_OUD_vs_Control,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.004190378434633198,0.04458827862915884,10/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response,0.004209510971032607,0.044614187141810153,7/253
DLPFC_OUD_vs_Control,GO_BP,innate immune response,0.004246817625249471,0.04481499278438086,28/253
NAC_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,9.088986142814803e-4,0.04503236405813234,9/307
NAC_OUD_vs_Control,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,9.088986142814803e-4,0.04503236405813234,9/307
Male_OUD_vs_Control,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.012608234288670703,0.04519437677329927,12/118
Male_OUD_vs_Control,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.007667453401143335,0.04554467320279141,6/75
DLPFC_OUD_vs_Control,GO_BP,T cell cytokine production,0.004482253459337702,0.04607178700771135,4/253
DLPFC_OUD_vs_Control,GO_BP,regulation of T cell cytokine production,0.004482253459337702,0.04607178700771135,4/253
Male_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.0045967760855966456,0.046510687165288896,5/110
Male_OUD_vs_Control,GO_BP,stress response to copper ion,0.005398120848785122,0.046816730052460565,2/101
Pooled_OUD_vs_Control,GO_BP,positive regulation of humoral immune response,0.004911482331126571,0.04774748413222156,4/380
NAC_OUD_vs_Control,GO_BP,positive regulation of immune response,7.960256470107626e-4,0.04802688070298268,44/513
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.0022006409160477084,0.04802750107320336,14/580
OUD_Male_vs_Female,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,1.8489161238537512e-4,0.04807181922019753,3/43
NAC_OUD_vs_Control,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.0011819391669180073,0.0484595058436383,5/307
Male_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.004880342757528136,0.048614267003284146,5/110
Pooled_OUD_vs_Control,GO_BP,innate immune response-activating signaling pathway,0.005206869807251093,0.049301489606618266,16/380
NAC_OUD_vs_Control,GO_BP,T-helper 17 type immune response,8.381254052259851e-4,0.049885689460047275,7/513
NAC_OUD_vs_Control,GO_BP,regulation of adaptive immune response,9.07908169284838e-4,0.049885689460047275,18/513
Male_OUD_vs_Control,GO_BP,positive regulation of cytokine production,0.006091570989647351,0.05010230604702922,10/101
Female_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.005409400741874439,0.050391715392254385,8/319
Pooled_OUD_vs_Control,GO_BP,negative regulation of cytokine production,0.005471051184812861,0.050595632249381656,17/380
NAC_OUD_vs_Control,GO_BP,immune effector process,9.819963691975507e-4,0.05134749903826304,41/513
OUD_DLPFC_vs_NAC,GO_BP,neuron development,1.2237631811422067e-4,0.05139244360976648,506/5050
DLPFC_OUD_vs_Control,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.006486610724954529,0.05189288579963623,4/12
Control_DLPFC_vs_NAC,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,9.604349317614292e-4,0.05224766028782175,95/6081
Male_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.005484417576095463,0.05246260485322087,5/110
Male_OUD_vs_Control,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.010064229645332962,0.05337636079756946,2/75
Pooled_OUD_vs_Control,GO_BP,negative regulation of immune response,0.0060132382570369704,0.05423096072720326,12/380
Pooled_OUD_vs_Control,WikiPathways,WP_FOLATE_METABOLISM,0.004431002545814847,0.05445468918146141,7/254
DLPFC_OUD_vs_Control,GO_BP,positive regulation of chemokine production,0.00561604391947176,0.05490940761943576,6/253
Male_OUD_vs_Control,GO_BP,ectopic germ cell programmed cell death,0.007120094974195254,0.055020679419121914,2/101
DLPFC_OUD_vs_Control,GO_MF,cytokine receptor activity,0.001725020289804712,0.05536493692039885,8/253
DLPFC_OUD_vs_Control,GO_BP,immune effector process,0.005791283982846864,0.05621443442965298,22/253
DLPFC_OUD_vs_Control,GO_BP,chemokine production,0.005846858643462252,0.05634753031575316,7/253
DLPFC_OUD_vs_Control,GO_BP,regulation of chemokine production,0.005846858643462252,0.05634753031575316,7/253
Female_OUD_vs_Control,DO,autoimmune disease of gastrointestinal tract,0.018905939854220472,0.05664454072601715,3/160
Pooled_OUD_vs_Control,GO_BP,positive regulation of production of molecular mediator of immune response,0.006414377628283216,0.05749231693522842,10/380
OUD_DLPFC_vs_NAC,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.001974379209149509,0.057539051238071404,96/6250
Pooled_OUD_vs_Control,GO_BP,complement activation,0.006492822061265504,0.05783911897433453,5/380
Male_OUD_vs_Control,GO_BP,negative regulation of cytokine production,0.0079415197646241,0.05895850799076949,7/101
Pooled_OUD_vs_Control,GO_BP,negative regulation of humoral immune response,0.006948872658471946,0.05935778699457935,3/380
DLPFC_OUD_vs_Control,GO_BP,immune response-regulating signaling pathway,0.006306793834432771,0.05968492708921987,19/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in immune response,0.006355750036742087,0.05968492708921987,6/253
Pooled_OUD_vs_Control,GO_BP,activation of innate immune response,0.007028857644537962,0.0598069466245774,16/380
Pooled_OUD_vs_Control,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.00526670352614596,0.059989037724638136,6/254
Female_OUD_vs_Control,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.012638556140869193,0.060055550456612476,26/334
NAC_OUD_vs_Control,GO_BP,immune response-regulating signaling pathway,0.0012649711979570676,0.06137066451119546,35/513
NAC_OUD_vs_Control,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.0013044228241330235,0.06181639574425215,17/513
NAC_OUD_vs_Control,GO_BP,regulation of T-helper 1 type immune response,0.0013218582080360647,0.06181639574425215,6/513
NAC_OUD_vs_Control,GO_BP,stress response to copper ion,0.0014075987754837965,0.06181639574425215,4/513
NAC_OUD_vs_Control,GO_MF,cytokine activity,7.649259961324853e-4,0.06218821393810933,18/528
NAC_OUD_vs_Control,GO_MF,cytokine receptor binding,7.862877624358651e-4,0.06218821393810933,19/528
Male_OUD_vs_Control,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.013221354151088069,0.06232924099798661,2/75
Control_DLPFC_vs_NAC,GO_BP,neuron projection morphogenesis,1.4338687010521773e-4,0.0630805258566481,304/4916
Male_OUD_vs_Control,GO_BP,astrocyte activation,0.009056089517386897,0.06338628135404469,2/101
Male_OUD_vs_Control,GO_BP,regulation of cytokine-mediated signaling pathway,0.009151050805246398,0.06360877471489898,5/101
DLPFC_OUD_vs_Control,DO,opiate dependence,0.026059639077723448,0.06366570285449974,5/136
DLPFC_OUD_vs_Control,GO_BP,mast cell activation involved in immune response,0.0071717761663552555,0.0636877629140564,5/253
DLPFC_OUD_vs_Control,GO_BP,chemokine-mediated signaling pathway,0.0071717761663552555,0.0636877629140564,5/253
Female_OUD_vs_Control,WikiPathways,WP_FOLATE_METABOLISM,0.0055252397462755,0.06390333337507853,6/198
Female_OUD_vs_Control,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.005987663094817371,0.06390333337507853,4/198
Female_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.006623827045614198,0.06390333337507853,6/198
Female_OUD_vs_Control,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.006623827045614198,0.06390333337507853,6/198
Pooled_OUD_vs_Control,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.005753376961938321,0.0639720724101237,5/254
Male_OUD_vs_Control,KEGG,Complement and coagulation cascades,0.010693361122765383,0.0641601667365923,4/64
NAC_OUD_vs_Control,GO_BP,regulation of response to stress,0.001576441675077362,0.06507661862205322,65/513
Female_OUD_vs_Control,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.007012277297231008,0.06554954864802899,5/198
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.008179265193120223,0.06569796880925599,31/581
NAC_OUD_vs_Control,GO_BP,regulation of cytokine production involved in immune response,0.0016085856066442683,0.06582612056406892,13/513
Pooled_OUD_vs_Control,GO_BP,astrocyte development,0.008095015489366435,0.0662940761934043,5/380
DLPFC_OUD_vs_Control,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.0076180519620103115,0.06641498727842392,5/161
Pooled_OUD_vs_Control,GO_MF,lipopolysaccharide immune receptor activity,0.00379634371700051,0.06673128622549786,3/376
Male_OUD_vs_Control,GO_BP,immune effector process,0.009853281082215778,0.06701176294763536,11/101
DLPFC_OUD_vs_Control,DO,autoimmune disease of peripheral nervous system,0.028206868549075306,0.0674585952649572,2/136
Pooled_OUD_vs_Control,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.006479827406292457,0.06774255781403384,9/254
Pooled_OUD_vs_Control,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.006665974312046464,0.06774255781403384,7/254
DLPFC_OUD_vs_Control,Reactome,Innate Immune System,0.0011716701944550906,0.06829163419109671,31/172
DLPFC_OUD_vs_Control,GO_BP,cellular response to toxic substance,0.00791934511622053,0.06877057113827634,7/253
DLPFC_OUD_vs_Control,DO,mineral metabolism disease,0.02929931232774258,0.06903161420839053,3/136
NAC_OUD_vs_Control,GO_BP,cytokine production involved in immune response,0.0018752721244540867,0.07004072014615578,13/513
NAC_OUD_vs_Control,GO_BP,T cell cytokine production,0.0018994992264522385,0.07004072014615578,6/513
NAC_OUD_vs_Control,GO_BP,regulation of T cell cytokine production,0.0018994992264522385,0.07004072014615578,6/513
NAC_OUD_vs_Control,GO_BP,complement receptor mediated signaling pathway,0.0019820674982283805,0.07004072014615578,5/513
NAC_OUD_vs_Control,GO_BP,positive regulation of T cell cytokine production,0.0019820674982283805,0.07004072014615578,5/513
DLPFC_OUD_vs_Control,KEGG,Viral protein interaction with cytokine and cytokine receptor,0.008009932435485331,0.07008690881049665,6/142
DLPFC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.005137183787249751,0.0710131064243476,9/278
Female_OUD_vs_Control,DO,plasma protein metabolism disease,0.02641764334217407,0.07165206422280897,2/160
Pooled_OUD_vs_Control,GO_MF,C-C chemokine receptor activity,0.004374392104778876,0.0720863365600019,4/376
Female_OUD_vs_Control,GO_BP,T cell differentiation involved in immune response,0.009042843356564108,0.0722894491510007,6/287
Male_OUD_vs_Control,GO_BP,regulation of immune effector process,0.010886763501386771,0.07251023412027871,8/101
Pooled_OUD_vs_Control,GO_BP,mast cell activation involved in immune response,0.009289694943164015,0.07359259242633562,6/380
Male_OUD_vs_Control,DO,autoimmune disease of blood,0.03285296883061585,0.07365612228928109,2/61
Male_OUD_vs_Control,DO,autoimmune thrombocytopenic purpura,0.03285296883061585,0.07365612228928109,2/61
Male_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.009314383802105544,0.07430688272962506,5/110
DLPFC_OUD_vs_Control,GO_BP,programmed cell death involved in cell development,0.009077403499644943,0.07457152129199689,3/253
OUD_DLPFC_vs_NAC,GO_CC,Schaffer collateral - CA1 synapse,0.003843388183115337,0.07474230648468327,50/5358
DLPFC_OUD_vs_Control,WikiPathways,WP_APOPTOSIS,0.009529606327359198,0.07485072606216679,6/161
Female_OUD_vs_Control,KEGG,Complement and coagulation cascades,0.008607461462500028,0.0749167942106484,7/175
Male_OUD_vs_Control,GO_BP,regulation of response to cytokine stimulus,0.011798148984064697,0.07496806125880787,5/101
NAC_OUD_vs_Control,GO_BP,regulation of programmed cell death,0.002198914668888322,0.07498617704194524,69/513
Female_OUD_vs_Control,GO_BP,T cell activation involved in immune response,0.009719337060017355,0.07504361005163306,8/287
DLPFC_OUD_vs_Control,DO,lipid metabolism disorder,0.03372526454808913,0.07694787371029531,6/136
Female_OUD_vs_Control,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.008638549955945183,0.07738701002200894,5/198
Female_OUD_vs_Control,GO_BP,negative regulation of innate immune response,0.010229850568504626,0.0785382301193308,6/287
Female_OUD_vs_Control,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.009686523295633744,0.07858877390797188,3/198
DLPFC_OUD_vs_Control,DO,autoimmune disease of the nervous system,0.034867758171515696,0.07932664753061164,3/136
Male_OUD_vs_Control,C8_CellType,HU_FETAL_RETINA_MICROGLIA,0.024681199002951307,0.07934324096654286,8/118
Male_OUD_vs_Control,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.012930384993693981,0.07937353212579248,3/101
Male_OUD_vs_Control,GO_BP,mast cell activation involved in immune response,0.012930384993693981,0.07937353212579248,3/101
Male_OUD_vs_Control,GO_BP,chemokine-mediated signaling pathway,0.012930384993693981,0.07937353212579248,3/101
Male_OUD_vs_Control,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.01852481048462713,0.07973722773817764,4/75
Female_OUD_vs_Control,GO_BP,antiviral innate immune response,0.010612294240493864,0.07977035967033802,4/287
NAC_OUD_vs_Control,GO_BP,activation of immune response,0.0024261179812581552,0.07984133720140474,34/513
NAC_OUD_vs_Control,GO_BP,immune response-activating signaling pathway,0.002522211399149767,0.07993051318123058,32/513
NAC_OUD_vs_Control,GO_BP,chemokine-mediated signaling pathway,0.002627890423723512,0.07993051318123058,8/513
Male_OUD_vs_Control,DO,mineral metabolism disease,0.03740861069529495,0.08016130863277489,2/61
Male_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.010752073643051443,0.08032799204256456,5/110
Pooled_OUD_vs_Control,DO,autoimmune disease of gastrointestinal tract,0.03365035294388467,0.08074093561387713,3/199
Male_OUD_vs_Control,GO_BP,positive regulation of type 2 immune response,0.013540661361281903,0.08084487499072733,2/101
Male_OUD_vs_Control,GO_BP,programmed cell death involved in cell development,0.013540661361281903,0.08084487499072733,2/101
Female_OUD_vs_Control,GO_MF,chemokine receptor activity,0.004269893033971155,0.08172100834461461,4/292
Male_OUD_vs_Control,Reactome,IL-6-type cytokine receptor ligand interactions,0.005565538449353041,0.08236996905042501,2/75
NAC_OUD_vs_Control,GO_BP,T-helper 1 type immune response,0.002782826858373517,0.08288596959180869,7/513
DLPFC_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.012213835644053319,0.08380227858723102,5/161
DLPFC_OUD_vs_Control,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.012213835644053319,0.08380227858723102,5/161
DLPFC_OUD_vs_Control,GO_BP,response to chemokine,0.010798566941004291,0.08401659596873859,5/253
DLPFC_OUD_vs_Control,GO_BP,cellular response to chemokine,0.010798566941004291,0.08401659596873859,5/253
Male_OUD_vs_Control,GO_BP,innate immune response,0.0144074291950569,0.08424632824161107,13/101
NAC_OUD_vs_Control,GO_BP,regulation of immune effector process,0.002850681062087685,0.08437298791311099,27/513
DLPFC_OUD_vs_Control,DO,post-traumatic stress disorder,0.0383063143117309,0.08495869710478865,2/136
Male_OUD_vs_Control,GO_BP,positive regulation of programmed cell death,0.014967473181233823,0.08734105749378421,9/101
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.004967135900603488,0.08751190341245053,15/580
NAC_OUD_vs_Control,GO_BP,immunoglobulin mediated immune response,0.003149668967265168,0.08770616662692238,12/513
DLPFC_OUD_vs_Control,GO_BP,complement receptor mediated signaling pathway,0.01173713480669966,0.088093959757348,3/253
Male_OUD_vs_Control,GO_BP,positive regulation of response to cytokine stimulus,0.015425657019547097,0.08834993071721463,3/101
Male_OUD_vs_Control,GO_BP,complement receptor mediated signaling pathway,0.016074952133315498,0.08834993071721463,2/101
Pooled_OUD_vs_Control,Reactome,Chemokine receptors bind chemokines,0.003385599603268149,0.08960553616649701,6/267
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.007495827910930993,0.09071528564828554,9/278
Male_OUD_vs_Control,GO_BP,response to chemokine,0.01676797682670149,0.09127443815839813,3/101
Male_OUD_vs_Control,GO_BP,cellular response to chemokine,0.01676797682670149,0.09127443815839813,3/101
OUD_DLPFC_vs_NAC,GO_BP,neuron projection development,2.6361713125583737e-4,0.09135798137632853,449/5050
Female_OUD_vs_Control,GO_BP,microglial cell activation,0.012784407785682189,0.09155778661345537,4/287
Female_OUD_vs_Control,GO_BP,T-helper 17 type immune response,0.012784407785682189,0.09155778661345537,4/287
Female_OUD_vs_Control,GO_BP,programmed cell death involved in cell development,0.012825740567625844,0.09155778661345537,3/287
Pooled_OUD_vs_Control,DO,plasma protein metabolism disease,0.03981126952015897,0.09172426017286626,2/199
DLPFC_OUD_vs_Control,DO,drug dependence,0.04234866647219452,0.09176041887188784,5/136
DLPFC_OUD_vs_Control,Reactome,IL-6-type cytokine receptor ligand interactions,0.0016871810032585237,0.09178264657726369,3/172
Male_OUD_vs_Control,C8_CellType,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.03131483737922936,0.09323281128816013,14/118
Female_OUD_vs_Control,DO,autoimmune disease of blood,0.0369977970044652,0.09350416108297362,3/160
Female_OUD_vs_Control,DO,autoimmune thrombocytopenic purpura,0.0369977970044652,0.09350416108297362,3/160
Pooled_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.012766047534921622,0.09444711438971674,6/380
DLPFC_OUD_vs_Control,KEGG,Apoptosis,0.016023239763026248,0.09574862785223001,7/142
Male_OUD_vs_Control,GO_BP,regulation of production of molecular mediator of immune response,0.017794447504942967,0.0959411656350157,5/101
Male_OUD_vs_Control,GO_BP,regulation of cytokine production involved in immune response,0.018962688112866735,0.09724807140703447,4/101
DLPFC_OUD_vs_Control,GO_BP,regulation of cytokine production involved in immune response,0.013618950737771026,0.09806544335577187,7/253
NAC_OUD_vs_Control,GO_BP,positive regulation of programmed cell death,0.003806323975952564,0.09896442337476666,32/513
Male_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.024843760846284972,0.09971076988306266,2/75
Male_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,0.03483649141176825,0.10013058587195608,12/118
Female_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.014416947342161562,0.10028165286749494,8/319
NAC_OUD_vs_Control,C8_CellType,HU_FETAL_RETINA_MICROGLIA,0.013917578346251165,0.10093622354028757,27/581
Male_OUD_vs_Control,Reactome,Chemokine receptors bind chemokines,0.008881238309340976,0.1012403055994498,3/75
Male_OUD_vs_Control,GO_BP,cytokine production involved in immune response,0.019997383219113898,0.10145362935493205,4/101
DLPFC_OUD_vs_Control,DO,autoimmune disease of skin and connective tissue,0.049550501709830684,0.1019251252787709,2/136
DLPFC_OUD_vs_Control,GO_BP,cellular response to stress,0.014371590419683746,0.10216986287796297,36/253
DLPFC_OUD_vs_Control,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.015632606743016055,0.10232251686337782,11/161
OUD_DLPFC_vs_NAC,GO_BP,neuron projection morphogenesis,3.295948877186412e-4,0.10280064547944419,309/5050
Female_OUD_vs_Control,GO_BP,astrocyte development,0.015220909973790133,0.10284743733727947,4/287
NAC_OUD_vs_Control,GO_BP,postsynapse assembly,0.004131875125707833,0.10368562025965458,10/513
NAC_OUD_vs_Control,GO_BP,T cell differentiation involved in immune response,0.00420823490641607,0.10368562025965458,9/513
NAC_OUD_vs_Control,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,0.00420823490641607,0.10368562025965458,9/513
Female_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,0.01514443377707763,0.1039638964086303,9/319
Female_OUD_vs_Control,DO,mineral metabolism disease,0.0444467832991089,0.10411322269760963,3/160
DLPFC_OUD_vs_Control,GO_BP,cytokine production involved in immune response,0.014796816550055535,0.10428166437779998,7/253
NAC_OUD_vs_Control,GO_BP,innate immune response,0.004280909991199996,0.10444541905684433,49/513
Pooled_OUD_vs_Control,GO_BP,response to toxic substance,0.014400749406673633,0.10459113337792081,14/380
Male_OUD_vs_Control,Reactome,Response of endothelial cells to shear stress,0.010758604156839232,0.10475482994817147,4/75
Control_Male_vs_Female,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,3.851367224036809e-4,0.10514232521620488,3/55
Male_OUD_vs_Control,Reactome,Programmed Cell Death,0.011387689064111972,0.10536146777736723,5/75
DLPFC_OUD_vs_Control,GO_BP,positive regulation of innate immune response,0.015097223062723883,0.1054716033343928,13/253
Female_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.015761858452400936,0.10565898194863164,5/287
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter transport,3.2252672690049965e-4,0.10584716522707992,108/4916
Control_DLPFC_vs_NAC,GO_BP,axonogenesis,3.2993099292291076e-4,0.10584716522707992,220/4916
Control_DLPFC_vs_NAC,GO_BP,axon development,3.393625047357484e-4,0.10584716522707992,247/4916
Male_OUD_vs_Control,GO_BP,T cell activation involved in immune response,0.02106635966951552,0.10592168402338961,4/101
Pooled_OUD_vs_Control,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.012505661251121208,0.10605508030514062,6/254
DLPFC_OUD_vs_Control,GO_BP,adaptive immune response,0.015696786847442794,0.10662570077360124,16/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of T-helper 1 type immune response,0.015764126637404643,0.10662570077360124,2/253
Pooled_OUD_vs_Control,GO_BP,astrocyte activation,0.015187666084347662,0.10697845028608277,3/380
Pooled_OUD_vs_Control,GO_BP,cytokine production involved in immune response,0.015219614576782909,0.10697845028608277,9/380
Male_OUD_vs_Control,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.021693144614043158,0.1075555211982979,2/101
Pooled_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.016977029096106856,0.10807272994691254,11/410
Female_OUD_vs_Control,GO_BP,complement receptor mediated signaling pathway,0.01651491417839778,0.1083857835353235,3/287
Female_OUD_vs_Control,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.016133532111049467,0.10959146821599544,10/198
Female_OUD_vs_Control,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.01682101605175744,0.10959146821599544,7/198
Male_OUD_vs_Control,GO_BP,alpha-beta T cell activation involved in immune response,0.022774300759929075,0.11078544932274247,3/101
Male_OUD_vs_Control,GO_BP,alpha-beta T cell differentiation involved in immune response,0.022774300759929075,0.11078544932274247,3/101
Male_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.022774300759929075,0.11078544932274247,3/101
DLPFC_OUD_vs_Control,KEGG,Central carbon metabolism in cancer,0.020165972268111107,0.1110557357825784,5/142
Male_OUD_vs_Control,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.029376490508931926,0.11181580762352833,2/75
Female_OUD_vs_Control,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.017733406062437434,0.11213771480658966,5/198
Female_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.016818772109178214,0.11219641337803489,8/319
DLPFC_OUD_vs_Control,GO_MF,complement receptor activity,0.004625554293148314,0.11227249756376935,3/253
Pooled_OUD_vs_Control,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.014370274988917029,0.11374437999702124,4/254
NAC_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.004786096891168334,0.1137544038880716,6/513
Female_OUD_vs_Control,Reactome,Adaptive Immune System,0.005112979395762564,0.11376379155571706,25/206
NAC_OUD_vs_Control,GO_BP,response to chemokine,0.0049825216393609454,0.11382401376132334,8/513
NAC_OUD_vs_Control,GO_BP,cellular response to chemokine,0.0049825216393609454,0.11382401376132334,8/513
Male_OUD_vs_Control,GO_BP,production of molecular mediator of immune response,0.023653749153663858,0.1138913966040589,5/101
Female_OUD_vs_Control,GO_BP,leukocyte activation involved in immune response,0.01754114294041746,0.11401742911271348,13/287
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.011697204252269956,0.11417757300788665,7/278
DLPFC_OUD_vs_Control,GO_BP,positive regulation of production of molecular mediator of immune response,0.017367475647736642,0.11419134482695231,7/253
NAC_OUD_vs_Control,GO_BP,negative regulation of T-helper 1 type immune response,0.0051961092844352045,0.11420151158921281,3/513
NAC_OUD_vs_Control,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.0051961092844352045,0.11420151158921281,3/513
Control_DLPFC_vs_NAC,GO_BP,cell morphogenesis involved in neuron differentiation,4.007317168941189e-4,0.11451029048716235,272/4916
NAC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.007524286013299563,0.1157306848712266,15/580
Female_OUD_vs_Control,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.020209864242418215,0.11586988832319776,4/198
Female_OUD_vs_Control,GO_MF,complement receptor activity,0.0069206151216708025,0.11630009314222398,3/292
Pooled_OUD_vs_Control,GO_BP,leukocyte activation involved in immune response,0.016711946394814544,0.11634393303567063,16/380
DLPFC_OUD_vs_Control,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.018266348899786216,0.11721886036864516,3/253
Female_OUD_vs_Control,GO_BP,cell activation involved in immune response,0.01848306073784616,0.11769573418199691,13/287
Pooled_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response,0.01706538207567547,0.11786454550684086,6/380
Pooled_OUD_vs_Control,GO_BP,myeloid cell activation involved in immune response,0.01758159370729901,0.12009961898647917,8/380
DLPFC_OUD_vs_Control,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.02309832166941031,0.12022258989379823,3/161
Male_OUD_vs_Control,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.034210796725642624,0.12095960270852213,2/75
Male_OUD_vs_Control,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.034210796725642624,0.12095960270852213,2/75
Pooled_OUD_vs_Control,GO_BP,cell activation involved in immune response,0.017751650098289173,0.12107180106098787,16/380
NAC_OUD_vs_Control,DO,autoimmune disease of blood,0.02831486511965253,0.1215612010372517,4/257
NAC_OUD_vs_Control,DO,autoimmune thrombocytopenic purpura,0.02831486511965253,0.1215612010372517,4/257
Male_OUD_vs_Control,GO_BP,T cell differentiation involved in immune response,0.026161104425498696,0.1218274091144734,3/101
Pooled_OUD_vs_Control,Reactome,IL-6-type cytokine receptor ligand interactions,0.0059871925577282634,0.12189309976503182,3/267
Female_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response,0.020183380849389216,0.12331257759183892,5/287
Control_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.002626002560589721,0.1260481229083066,61/6081
NAC_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in immune response,0.005984221102106301,0.1262858498049877,9/513
Male_OUD_vs_Control,GO_BP,positive regulation of chemokine production,0.02795034671003888,0.12644706179181175,3/101
NAC_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.0038597070969448506,0.1276143625424784,7/307
Female_OUD_vs_Control,GO_BP,negative regulation of immune effector process,0.021609692932700524,0.12817761012122222,7/287
NAC_OUD_vs_Control,GO_BP,T cell activation involved in immune response,0.006287455445161534,0.1282287350499569,12/513
DLPFC_OUD_vs_Control,GO_BP,regulation of response to cytokine stimulus,0.02106535316487482,0.12907723229099322,8/253
Pooled_OUD_vs_Control,GO_BP,production of molecular mediator of immune response,0.019345232782780903,0.129910678610521,12/380
NAC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.009161737663804894,0.13017190317048305,11/580
NAC_OUD_vs_Control,GO_MF,cytokine receptor activity,0.0021090145954384717,0.1310601927165336,12/528
Control_DLPFC_vs_NAC,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.002903504690459721,0.13162554596750736,74/6081
Pooled_OUD_vs_Control,Reactome,Diseases of Immune System,0.00684085492724137,0.1324789954202353,5/267
DLPFC_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway,0.021791786657149467,0.1327228273326841,13/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of astrocyte differentiation,0.023004096924563452,0.1330810077097238,2/253
DLPFC_OUD_vs_Control,GO_BP,commissural neuron axon guidance,0.023004096924563452,0.1330810077097238,2/253
Pooled_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.022400399044432782,0.13317344469308667,8/410
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,0.0055531775900734956,0.1332762621617639,48/6250
Pooled_OUD_vs_Control,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.020709974768239048,0.1341232045450496,3/380
NAC_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway,0.006712033068714827,0.13498644282637598,24/513
Pooled_OUD_vs_Control,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.01919707190028365,0.13576448840115873,3/254
Female_OUD_vs_Control,DO,metal metabolism disorder,0.06246517287654902,0.13601571446076732,4/160
Pooled_OUD_vs_Control,DO,autoimmune disease of blood,0.06394409480504751,0.13647016022866718,3/199
Pooled_OUD_vs_Control,DO,autoimmune thrombocytopenic purpura,0.06394409480504751,0.13647016022866718,3/199
Male_OUD_vs_Control,GO_BP,regulation of astrocyte differentiation,0.03139633266360381,0.136984614513816,2/101
Male_OUD_vs_Control,GO_BP,leukocyte activation involved in immune response,0.031622917919305285,0.13754941927078185,6/101
Male_OUD_vs_Control,GO_MF,complement receptor activity,0.008358033701803744,0.1399970645052127,2/99
Male_OUD_vs_Control,GO_BP,cell activation involved in immune response,0.03255989689015231,0.14097689706942282,6/101
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.024201616759666318,0.14106761456001102,11/410
Male_OUD_vs_Control,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.01913330215903853,0.14158643597688514,2/75
Pooled_OUD_vs_Control,GO_MF,chemokine receptor activity,0.010444319538323804,0.14243890956576086,4/376
DLPFC_OUD_vs_Control,GO_BP,positive regulation of immune effector process,0.025336184958207844,0.14344610164761254,10/253
NAC_OUD_vs_Control,DO,disease of metabolism,0.0363254116529267,0.14604150866309437,69/257
Male_OUD_vs_Control,GO_BP,regulation of type 2 immune response,0.034945938055700024,0.1479204183969631,2/101
Pooled_OUD_vs_Control,KEGG,Apoptosis,0.023013859586804197,0.14794624020088412,9/225
DLPFC_OUD_vs_Control,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.031543659360823956,0.14879710135506605,2/161
Male_OUD_vs_Control,GO_BP,astrocyte differentiation,0.035742289641165756,0.1501705680331053,3/101
Pooled_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,0.026646220310901397,0.15042493270407914,10/410
OUD_DLPFC_vs_NAC,Reactome,Neuronal System,1.0354136649849483e-4,0.15158456055379643,214/3111
Female_OUD_vs_Control,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.02912144211695191,0.15271000134499174,4/198
Female_OUD_vs_Control,GO_BP,myeloid leukocyte cytokine production,0.02777881150108381,0.1542046166410778,4/287
Pooled_OUD_vs_Control,GO_BP,negative regulation of immune system process,0.02483198683411523,0.15462428321100283,23/380
Pooled_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.022895298118809276,0.15495803219541932,8/254
Female_OUD_vs_Control,GO_BP,alpha-beta T cell activation involved in immune response,0.028218182361781842,0.15537183224640097,5/287
Female_OUD_vs_Control,GO_BP,alpha-beta T cell differentiation involved in immune response,0.028218182361781842,0.15537183224640097,5/287
Female_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.028218182361781842,0.15537183224640097,5/287
DLPFC_OUD_vs_Control,GO_BP,negative regulation of cytokine production,0.028939786094987287,0.15557790328206478,11/253
DLPFC_OUD_vs_Control,GO_BP,regulation of innate immune response,0.02897339853098383,0.15557790328206478,14/253
Male_OUD_vs_Control,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.05036813221867762,0.1568836009889902,2/75
Female_OUD_vs_Control,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.03161363585145039,0.15704396666264714,5/198
Pooled_OUD_vs_Control,DO,mineral metabolism disease,0.07608090186863083,0.15733365205041253,3/199
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.011957502515686622,0.15742961871875458,14/580
Male_OUD_vs_Control,GO_BP,programmed necrotic cell death,0.038643176221789435,0.15768639966186307,2/101
DLPFC_OUD_vs_Control,DO,morphine dependence,0.08893693307482431,0.15895937501110802,2/136
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.029036173758407308,0.15911433456155988,8/410
DLPFC_OUD_vs_Control,GO_BP,execution phase of apoptosis,0.03033620826885358,0.1593549385044595,4/253
DLPFC_OUD_vs_Control,GO_BP,regulation of astrocyte differentiation,0.031145678829144784,0.1593549385044595,3/253
DLPFC_OUD_vs_Control,GO_BP,inhibitory synapse assembly,0.031145678829144784,0.1593549385044595,3/253
DLPFC_OUD_vs_Control,GO_BP,regulation of complement activation,0.03133427963658763,0.1593549385044595,2/253
Male_OUD_vs_Control,WikiPathways,WP_APOPTOSIS,0.054743009942804795,0.16097696983181212,3/75
Pooled_OUD_vs_Control,GO_BP,regulation of production of molecular mediator of immune response,0.02688983242635251,0.16180554415169712,11/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of type 2 immune response,0.027185609274017065,0.16180554415169712,3/380
Pooled_OUD_vs_Control,GO_BP,programmed cell death involved in cell development,0.027185609274017065,0.16180554415169712,3/380
Female_OUD_vs_Control,GO_BP,negative regulation of cytokine production involved in immune response,0.03077956248639701,0.16181142087487008,3/287
NAC_OUD_vs_Control,GO_BP,regulation of production of molecular mediator of immune response,0.009206269400974167,0.16226480824338738,15/513
Female_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.029333634195203254,0.16395592225318933,8/319
NAC_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.00974605441784581,0.16557737216744542,3/513
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.030628294979913668,0.16623873679376308,10/410
Female_OUD_vs_Control,DO,"autoimmune disease of eyes, ear, nose and throat",0.08242309702788089,0.16635262141658466,2/160
NAC_OUD_vs_Control,GO_BP,alpha-beta T cell activation involved in immune response,0.0102910615131726,0.16699908786548362,8/513
NAC_OUD_vs_Control,GO_BP,alpha-beta T cell differentiation involved in immune response,0.0102910615131726,0.16699908786548362,8/513
NAC_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.0102910615131726,0.16699908786548362,8/513
Male_OUD_vs_Control,GO_MF,cytokine receptor activity,0.011694733183666746,0.16764985052348352,4/99
Male_OUD_vs_Control,GO_MF,chemokine activity,0.014855489253689694,0.16764985052348352,2/99
NAC_OUD_vs_Control,GO_MF,C-C chemokine binding,0.0030991828210034035,0.16851806589206006,5/528
NAC_OUD_vs_Control,GO_BP,regulation of innate immune response,0.010470276868285288,0.16874357171969373,26/513
NAC_OUD_vs_Control,DO,autoimmune disease of the nervous system,0.044838759479626636,0.16889787957452038,4/257
Male_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.042482291123745484,0.16968982764358057,2/101
Male_OUD_vs_Control,GO_BP,T-helper 17 type immune response,0.042482291123745484,0.16968982764358057,2/101
Male_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor internalization,0.042482291123745484,0.16968982764358057,2/101
DLPFC_OUD_vs_Control,DO,heroin dependence,0.09657682965397839,0.1700266136258511,3/136
DLPFC_OUD_vs_Control,GO_BP,astrocyte differentiation,0.03424294179561272,0.17028694454517757,5/253
DLPFC_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.021357846531367825,0.17030946016463772,7/278
DLPFC_OUD_vs_Control,GO_BP,immunoglobulin mediated immune response,0.034413065290317756,0.17071247867604802,6/253
Male_OUD_vs_Control,Reactome,Regulation of necroptotic cell death,0.02644753238770262,0.17167696462192927,2/75
NAC_OUD_vs_Control,GO_BP,tumor necrosis factor superfamily cytokine production,0.011181677806848693,0.1717027536871161,15/513
NAC_OUD_vs_Control,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,0.011181677806848693,0.1717027536871161,15/513
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.004386532560621319,0.1726452049687293,96/6081
Male_OUD_vs_Control,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.062372621498029725,0.17312774378425072,2/75
Male_OUD_vs_Control,DO,autoimmune disease of central nervous system,0.09962243470654031,0.17337606040088507,1/61
Male_OUD_vs_Control,DO,autoimmune thyroiditis,0.09962243470654031,0.17337606040088507,1/61
OUD_Male_vs_Female,GO_MF,immune receptor activity,0.00694770575256782,0.17429556803225682,3/32
DLPFC_OUD_vs_Control,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.04061436931243511,0.17565146031813222,3/161
Male_OUD_vs_Control,GO_BP,negative regulation of immune system process,0.04460652406552081,0.17573366535995108,8/101
DLPFC_OUD_vs_Control,GO_BP,regulation of production of molecular mediator of immune response,0.03626236191450242,0.17663138409018186,8/253
NAC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.02917310160905397,0.1771732268452302,12/581
Male_OUD_vs_Control,GO_BP,response to toxic substance,0.0453835287163501,0.17806145742735394,5/101
Male_OUD_vs_Control,GO_BP,astrocyte development,0.04645767352163729,0.17901353547196105,2/101
Male_OUD_vs_Control,GO_BP,positive regulation of immune effector process,0.046774620790512034,0.17969347229459195,5/101
Female_OUD_vs_Control,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.03956346876510781,0.18098182520208891,3/198
NAC_OUD_vs_Control,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.008105442312179384,0.18126716443601168,7/307
DLPFC_OUD_vs_Control,KEGG,Complement and coagulation cascades,0.04264134739030495,0.18328298439692478,5/142
Pooled_OUD_vs_Control,GO_BP,microglial cell activation,0.03240489183861056,0.18441636620017615,4/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of T-helper 1 type immune response,0.03412022714066003,0.18478261968856205,2/380
Pooled_OUD_vs_Control,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.03412022714066003,0.18478261968856205,2/380
NAC_OUD_vs_Control,Hallmark,HALLMARK_APOPTOSIS,0.05047523482091989,0.1863700978003196,12/164
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.006111893562045254,0.18759929941901832,105/6081
Male_OUD_vs_Control,GO_BP,activation of immune response,0.050310851486066795,0.18843508624797684,8/101
Female_OUD_vs_Control,GO_BP,regulation of complement activation,0.03958778369987338,0.18884254616035734,2/287
DLPFC_OUD_vs_Control,GO_BP,ectopic germ cell programmed cell death,0.04065253811773033,0.1889009768922843,2/253
Control_Male_vs_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.038416407179917456,0.18909098089196796,1/16
Male_OUD_vs_Control,DO,metal metabolism disorder,0.11358998247294588,0.18970845504794223,2/61
Male_OUD_vs_Control,DO,autoimmune disease of peripheral nervous system,0.1183419410060973,0.18970845504794223,1/61
Female_OUD_vs_Control,GO_BP,myeloid cell activation involved in immune response,0.03994582246427135,0.18980851350240335,6/287
Female_OUD_vs_Control,GO_BP,lymphocyte activation involved in immune response,0.04019447141610802,0.18980851350240335,9/287
DLPFC_OUD_vs_Control,GO_BP,positive regulation of response to cytokine stimulus,0.04172901167353189,0.18996589741483183,4/253
DLPFC_OUD_vs_Control,GO_BP,regulation of cytokine-mediated signaling pathway,0.04203639283841706,0.1909369564471632,7/253
NAC_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,0.034769144965227074,0.19097464183106339,13/581
Pooled_OUD_vs_Control,DO,autoimmune disease of skin and connective tissue,0.09748742310296603,0.19236569376278698,2/199
NAC_OUD_vs_Control,DO,alcohol dependence,0.05517702974149209,0.19418525488422111,6/257
Pooled_OUD_vs_Control,GO_BP,regulation of cytokine production involved in immune response,0.03720915713587053,0.19663192602672502,8/380
NAC_OUD_vs_Control,GO_BP,regulation of excitatory synapse assembly,0.014050168232943258,0.19663652684674987,5/513
Female_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.03829881864535492,0.19704283274728898,7/319
Pooled_OUD_vs_Control,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.03303343592880342,0.19708794056736958,11/254
DLPFC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.02788133823022294,0.19804329016759895,8/278
OUD_DLPFC_vs_NAC,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.011340861963180439,0.19863333787285317,74/6250
OUD_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.01144089078434326,0.19863333787285317,196/6250
Male_OUD_vs_Control,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.07523681477391954,0.19951191060584023,2/75
NAC_OUD_vs_Control,GO_BP,immune response-activating cell surface receptor signaling pathway,0.014473362852974766,0.19996199562220524,21/513
Female_OUD_vs_Control,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.04631548354479438,0.20116826186122813,2/198
NAC_OUD_vs_Control,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,0.014785878392843857,0.20286397585050492,11/513
OUD_Male_vs_Female,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.030729768422997683,0.2033100349684273,1/17
OUD_Male_vs_Female,WikiPathways,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.03576416925917547,0.2033100349684273,1/17
OUD_Male_vs_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.060569152597168,0.2033100349684273,1/17
OUD_Male_vs_Female,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.060569152597168,0.2033100349684273,1/17
OUD_Male_vs_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.06545752860140719,0.2033100349684273,1/17
OUD_Male_vs_Female,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.06545752860140719,0.2033100349684273,1/17
OUD_Male_vs_Female,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.08954238267760928,0.2033100349684273,1/17
Female_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.0397954705228563,0.20363381070362982,8/319
NAC_OUD_vs_Control,DO,substance dependence,0.06317389941201361,0.2046259186031626,10/257
NAC_OUD_vs_Control,DO,plasma protein metabolism disease,0.06380204832309597,0.2046259186031626,2/257
NAC_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.015048380068423973,0.20526862783189337,7/513
NAC_OUD_vs_Control,GO_BP,regulation of complement activation,0.015999896149617308,0.2057254406560083,3/513
NAC_OUD_vs_Control,GO_BP,regulation of cellular response to osmotic stress,0.015999896149617308,0.2057254406560083,3/513
Male_OUD_vs_Control,GO_BP,chemokine production,0.05689279557794909,0.20632732513946753,3/101
Male_OUD_vs_Control,GO_BP,regulation of chemokine production,0.05689279557794909,0.20632732513946753,3/101
Female_OUD_vs_Control,KEGG,Apoptosis,0.04405189949893452,0.20704392764499224,7/175
DLPFC_OUD_vs_Control,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.05511118534276781,0.2073614085401329,3/161
DLPFC_OUD_vs_Control,WikiPathways,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.055200374958600196,0.2073614085401329,2/161
DLPFC_OUD_vs_Control,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.055200374958600196,0.2073614085401329,2/161
NAC_OUD_vs_Control,GO_BP,positive regulation of chemokine production,0.016418810568146116,0.20939545402085535,8/513
DLPFC_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.04768744149638174,0.20999115459366355,3/253
DLPFC_OUD_vs_Control,GO_BP,T-helper 17 type immune response,0.04768744149638174,0.20999115459366355,3/253
DLPFC_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor internalization,0.04768744149638174,0.20999115459366355,3/253
Female_OUD_vs_Control,GO_BP,cellular response to toxic substance,0.046494423171652345,0.21020645320605932,6/287
DLPFC_OUD_vs_Control,KEGG,Adipocytokine signaling pathway,0.04977078579279901,0.21023866412475448,4/142
DLPFC_OUD_vs_Control,Reactome,Diseases of Immune System,0.007751281568155528,0.21083485865383036,4/172
DLPFC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.030507798679922014,0.21086003967844302,6/278
Pooled_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.044481289060146964,0.21208678623878072,9/410
Male_OUD_vs_Control,GO_BP,type 2 immune response,0.059147468427030316,0.21233192463171896,2/101
DLPFC_OUD_vs_Control,GO_BP,activation of immune response,0.04860506335541072,0.21264056969571882,16/253
DLPFC_OUD_vs_Control,GO_BP,immune response-activating signaling pathway,0.050795845709391524,0.21282173829968531,15/253
DLPFC_OUD_vs_Control,GO_BP,astrocyte activation,0.05086327475637148,0.21282173829968531,2/253
Male_OUD_vs_Control,GO_BP,myeloid cell activation involved in immune response,0.05954056519447475,0.21347287344062,3/101
Female_OUD_vs_Control,DO,calcium metabolism disease,0.1173493301266767,0.2139411136507573,2/160
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.013767576716458712,0.2159855053658916,50/6250
Male_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.09045683760403855,0.21750342278665075,1/118
DLPFC_OUD_vs_Control,GO_BP,production of molecular mediator of immune response,0.05225550825187135,0.21753375497016136,8/253
Female_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.04459911614029969,0.21919003697256548,8/319
NAC_OUD_vs_Control,GO_BP,production of molecular mediator of immune response,0.017582579407664903,0.219340473110497,15/513
Female_OUD_vs_Control,GO_BP,regulation of type 2 immune response,0.04978440567662515,0.21987144982148235,3/287
Female_OUD_vs_Control,GO_BP,mast cell activation involved in immune response,0.050168226157878505,0.21987144982148235,4/287
Female_OUD_vs_Control,GO_BP,dendritic cell cytokine production,0.0511718513101361,0.21987144982148235,2/287
Female_OUD_vs_Control,GO_BP,regulation of dendritic cell cytokine production,0.0511718513101361,0.21987144982148235,2/287
Female_OUD_vs_Control,GO_BP,negative regulation of immunoglobulin mediated immune response,0.0511718513101361,0.21987144982148235,2/287
Female_OUD_vs_Control,GO_BP,ectopic germ cell programmed cell death,0.0511718513101361,0.21987144982148235,2/287
Female_OUD_vs_Control,GO_BP,regulation of axon extension involved in axon guidance,0.0511718513101361,0.21987144982148235,2/287
OUD_DLPFC_vs_NAC,GO_BP,axoneme assembly,0.0010255340518126141,0.22059591086920988,58/5050
Male_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.054820474170751254,0.2210595480420984,4/110
DLPFC_OUD_vs_Control,GO_BP,astrocyte development,0.053986144722026654,0.22154070364587766,3/253
Pooled_OUD_vs_Control,DO,"autoimmune disease of eyes, ear, nose and throat",0.11992932120550363,0.22155507858237689,2/199
NAC_OUD_vs_Control,GO_BP,response to toxic substance,0.019108494179186,0.22224866342044042,17/513
Control_Male_vs_Female,Reactome,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.03478594443207139,0.22258418336179808,1/19
Control_Male_vs_Female,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.0541456556194434,0.22258418336179808,1/19
Control_Male_vs_Female,Reactome,Cytokine Signaling in Immune system,0.06428583861081316,0.22258418336179808,4/19
Control_Male_vs_Female,Reactome,Selenoamino acid metabolism,0.10550588664733573,0.22258418336179808,1/19
Control_Male_vs_Female,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.1100416187406642,0.22258418336179808,1/19
Pooled_OUD_vs_Control,GO_BP,T cell activation involved in immune response,0.043784234967278554,0.22274846810276328,8/380
NAC_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.01927657969292016,0.2228884128621186,9/513
Male_OUD_vs_Control,GO_BP,response to pain,0.06361465357025524,0.2241132391617936,2/101
NAC_OUD_vs_Control,GO_BP,negative regulation of programmed cell death,0.019501661131694832,0.2249382776611664,41/513
Male_OUD_vs_Control,DO,complement deficiency,0.15463983194819209,0.22499559844656122,1/61
DLPFC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.05999986583088523,0.22726206163877197,7/286
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter secretion,0.0011665171589556485,0.22739793867391672,83/5050
OUD_DLPFC_vs_NAC,GO_BP,signal release from synapse,0.0011665171589556485,0.22739793867391672,83/5050
Pooled_OUD_vs_Control,GO_BP,positive regulation of response to cytokine stimulus,0.04580627999045705,0.22850789960953716,5/380
Female_OUD_vs_Control,GO_BP,astrocyte differentiation,0.054016901975830166,0.23001699036858986,5/287
NAC_OUD_vs_Control,Reactome,p75NTR regulates axonogenesis,0.006831883175413078,0.23157728142865708,3/349
DLPFC_OUD_vs_Control,GO_BP,humoral immune response,0.05754459225311537,0.23236506351807987,8/253
DLPFC_OUD_vs_Control,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.06873172259809467,0.23379609576674723,2/161
Pooled_OUD_vs_Control,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.0490993701913961,0.23397243546445845,2/380
Pooled_OUD_vs_Control,GO_BP,"complement activation, alternative pathway",0.0490993701913961,0.23397243546445845,2/380
Pooled_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.0490993701913961,0.23397243546445845,2/380
DLPFC_OUD_vs_Control,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.07172672221767576,0.2347419999851207,3/161
NAC_OUD_vs_Control,DO,substance-related disorder,0.07659707997123465,0.2352419684509828,22/257
NAC_OUD_vs_Control,DO,glucose metabolism disease,0.07690932791762517,0.2353195854195994,35/257
Male_OUD_vs_Control,GO_BP,neurotransmitter receptor internalization,0.06819215206176815,0.23555778714637574,2/101
NAC_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response,0.020794484106240695,0.235558686867373,7/513
DLPFC_OUD_vs_Control,GO_BP,axon extension,0.0588043230878111,0.23697790082692735,5/253
NAC_OUD_vs_Control,GO_BP,positive regulation of adaptive immune response,0.021820944509017302,0.23705430336392874,9/513
NAC_OUD_vs_Control,GO_BP,excitatory synapse assembly,0.022111772277687385,0.23705430336392874,6/513
Control_DLPFC_vs_NAC,GO_CC,presynapse,0.005435432690379379,0.2374981027017087,293/5212
Control_DLPFC_vs_NAC,GO_CC,axonemal doublet microtubule,0.005980188740514797,0.2378004463875296,33/5212
Pooled_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.05303006645186305,0.23786204782924084,8/410
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.009929375285889845,0.2383050068613563,150/6081
Female_OUD_vs_Control,GO_BP,regulation of humoral immune response,0.05712917657089972,0.23890916697532472,3/287
Female_OUD_vs_Control,GO_BP,programmed necrotic cell death,0.05712917657089972,0.23890916697532472,3/287
Male_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.062124742949552086,0.2390805884645863,3/110
Male_OUD_vs_Control,GO_BP,tumor necrosis factor superfamily cytokine production,0.06979245901937253,0.24020802643075304,4/101
Male_OUD_vs_Control,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,0.06979245901937253,0.24020802643075304,4/101
Pooled_OUD_vs_Control,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.05223430291315676,0.2410176873318491,3/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.05223430291315676,0.2410176873318491,3/380
NAC_OUD_vs_Control,GO_BP,positive regulation of T-helper 1 type immune response,0.02402254680965949,0.24156005403046488,3/513
NAC_OUD_vs_Control,GO_BP,negative regulation of immunoglobulin mediated immune response,0.02402254680965949,0.24156005403046488,3/513
NAC_OUD_vs_Control,GO_BP,neurotransmitter receptor transport to plasma membrane,0.02402254680965949,0.24156005403046488,3/513
NAC_OUD_vs_Control,GO_BP,neurotransmitter receptor transport to postsynaptic membrane,0.02402254680965949,0.24156005403046488,3/513
Female_OUD_vs_Control,C8_CellType,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.0784416883555929,0.24219323132832832,30/334
NAC_OUD_vs_Control,GO_BP,negative regulation of immune response,0.024257169569863558,0.2423656900122673,13/513
Female_OUD_vs_Control,KEGG,Chemokine signaling pathway,0.05474246846451568,0.24272603941813553,9/175
DLPFC_OUD_vs_Control,GO_MF,C-C chemokine binding,0.013963002012625163,0.24273151578019667,3/253
DLPFC_OUD_vs_Control,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.0832142991484849,0.24289579210909104,2/161
DLPFC_OUD_vs_Control,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.0832142991484849,0.24289579210909104,2/161
Control_Male_vs_Female,KEGG,Nitrogen metabolism,0.04379349461401816,0.24323900839615176,1/13
Male_OUD_vs_Control,GO_BP,negative regulation of immune effector process,0.07660470737428454,0.24374731064073754,3/101
Male_OUD_vs_Control,GO_BP,lymphocyte activation involved in immune response,0.07872455896899803,0.24374731064073754,4/101
Male_OUD_vs_Control,GO_BP,negative regulation of T-helper 1 type immune response,0.08010313593694196,0.24374731064073754,1/101
Male_OUD_vs_Control,GO_BP,noradrenergic neuron differentiation,0.08010313593694196,0.24374731064073754,1/101
Male_OUD_vs_Control,GO_BP,astrocyte cell migration,0.08010313593694196,0.24374731064073754,1/101
Male_OUD_vs_Control,GO_BP,stress-induced premature senescence,0.08010313593694196,0.24374731064073754,1/101
Male_OUD_vs_Control,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.08010313593694196,0.24374731064073754,1/101
Male_OUD_vs_Control,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.08010313593694196,0.24374731064073754,1/101
Pooled_OUD_vs_Control,GO_BP,astrocyte differentiation,0.053357910603013876,0.24465050397285248,6/380
Male_OUD_vs_Control,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.10931441963354593,0.2467989280467795,1/75
Male_OUD_vs_Control,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.10931441963354593,0.2467989280467795,1/75
OUD_Male_vs_Female,Reactome,MECP2 regulates neuronal receptors and channels,0.04679932240550555,0.2469566622104092,1/18
OUD_Male_vs_Female,Reactome,Immune System,0.05255108611858421,0.2469566622104092,7/18
OUD_Male_vs_Female,Reactome,Selenoamino acid metabolism,0.10022863524112557,0.2469566622104092,1/18
NAC_OUD_vs_Control,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.02503801923981174,0.24702079359026005,4/513
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.026159978970133058,0.24813367660515195,14/580
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.026968605203893766,0.24813367660515195,11/580
Male_OUD_vs_Control,GO_BP,execution phase of apoptosis,0.08253921791586917,0.24875794049883632,2/101
Male_OUD_vs_Control,GO_BP,immune response-activating signaling pathway,0.08289168532911906,0.24955501018405696,7/101
Female_OUD_vs_Control,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.062308272167059364,0.25039772926949094,2/198
Female_OUD_vs_Control,GO_BP,positive regulation of response to cytokine stimulus,0.0612383081904112,0.25043083017767154,4/287
Female_OUD_vs_Control,GO_BP,astrocyte activation,0.0637915347277172,0.25200752893891387,2/287
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.039958777691511974,0.25307225871290917,6/278
OUD_Male_vs_Female,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.18446325295028965,0.2545592890713997,1/17
Male_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.09534420930806531,0.25678649344508375,1/101
Male_OUD_vs_Control,GO_BP,T-helper 2 cell cytokine production,0.09534420930806531,0.25678649344508375,1/101
Male_OUD_vs_Control,GO_BP,positive regulation of astrocyte differentiation,0.09534420930806531,0.25678649344508375,1/101
Male_OUD_vs_Control,GO_BP,axonogenesis involved in innervation,0.09534420930806531,0.25678649344508375,1/101
Male_OUD_vs_Control,GO_BP,regulation of T-helper 2 cell cytokine production,0.09534420930806531,0.25678649344508375,1/101
NAC_OUD_vs_Control,GO_MF,lipopolysaccharide immune receptor activity,0.009947331905509959,0.25768161194623707,3/528
NAC_OUD_vs_Control,GO_BP,astrocyte development,0.027076159537191016,0.25839269287914557,5/513
Pooled_OUD_vs_Control,GO_BP,cellular response to toxic substance,0.057347049771139885,0.2591303025372936,7/380
Male_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.09771392883389081,0.25947256757763515,2/101
Pooled_OUD_vs_Control,DO,lipid metabolism disorder,0.14553990448208312,0.25998427871138635,6/199
Male_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.11876772370665101,0.26039450720621393,1/118
Pooled_OUD_vs_Control,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.058523267458952574,0.26146782237290483,4/380
Pooled_OUD_vs_Control,GO_BP,type 2 immune response,0.058523267458952574,0.26146782237290483,4/380
Male_OUD_vs_Control,DO,autoimmune disease of gastrointestinal tract,0.20634718268631314,0.2615668512925096,1/61
Male_OUD_vs_Control,DO,calcium metabolism disease,0.20634718268631314,0.2615668512925096,1/61
DLPFC_OUD_vs_Control,GO_BP,myeloid cell activation involved in immune response,0.0717592172287156,0.2628103432323913,5/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of immune system process,0.07256599786973508,0.2628103432323913,15/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of type 2 immune response,0.07361032644770543,0.2628103432323913,2/253
DLPFC_OUD_vs_Control,GO_BP,regulation of neurotransmitter uptake,0.07361032644770543,0.2628103432323913,2/253
Female_OUD_vs_Control,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.06820618571623892,0.2635621744343553,5/287
Male_OUD_vs_Control,KEGG,Intestinal immune network for IgA production,0.10316551639152219,0.26369680965561026,2/64
Male_OUD_vs_Control,KEGG,Chemokine signaling pathway,0.1038958020335651,0.26369680965561026,4/64
NAC_OUD_vs_Control,DO,substance abuse,0.0945766806515875,0.265592048405143,17/257
Pooled_OUD_vs_Control,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.08246451389105104,0.2657683398405503,28/435
Male_OUD_vs_Control,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.10293624831822547,0.26736092468549955,2/101
Male_OUD_vs_Control,GO_BP,immune response-activating cell surface receptor signaling pathway,0.10456685780051525,0.26736092468549955,5/101
Male_OUD_vs_Control,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.10823390006234325,0.26736092468549955,2/101
Male_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response,0.10823390006234325,0.26736092468549955,2/101
Male_OUD_vs_Control,GO_BP,regulation of complement activation,0.1103352240512786,0.26736092468549955,1/101
Male_OUD_vs_Control,GO_BP,G protein-coupled opioid receptor signaling pathway,0.1103352240512786,0.26736092468549955,1/101
Male_OUD_vs_Control,GO_BP,regulation of cellular response to osmotic stress,0.1103352240512786,0.26736092468549955,1/101
Male_OUD_vs_Control,GO_BP,regulation of microglial cell activation,0.1103352240512786,0.26736092468549955,1/101
DLPFC_OUD_vs_Control,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,0.07644900328259525,0.2682024980496261,4/253
OUD_Male_vs_Female,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.20982244541753237,0.26874176639482544,1/17
OUD_Male_vs_Female,WikiPathways,WP_COMPLEMENT_SYSTEM,0.22631422939769397,0.26923589359380834,1/17
Female_OUD_vs_Control,DO,lipid metabolism disorder,0.1589809599838476,0.26950061856911006,5/160
DLPFC_OUD_vs_Control,GO_BP,response to endoplasmic reticulum stress,0.07701881164281293,0.2697328373058791,6/253
Male_OUD_vs_Control,GO_BP,immune response-regulating signaling pathway,0.1122829636676444,0.27147014915723744,7/101
DLPFC_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.09852336854507684,0.27242308116733716,2/161
DLPFC_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.09852336854507684,0.27242308116733716,2/161
DLPFC_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.1002668284852005,0.27242308116733716,3/161
Male_OUD_vs_Control,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.12971802944646094,0.2732358492595666,1/75
Pooled_OUD_vs_Control,GO_BP,regulation of stress-activated MAPK cascade,0.062375067155723087,0.2736353448590264,3/380
Pooled_OUD_vs_Control,Reactome,Complement cascade,0.016656205236054957,0.2763418935037571,5/267
DLPFC_OUD_vs_Control,DO,cocaine dependence,0.16737064861183024,0.27685894791206916,2/136
NAC_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.032053128742193016,0.27731680134986636,12/580
Male_OUD_vs_Control,GO_BP,response to endoplasmic reticulum stress,0.11624192782520974,0.2781958711496159,3/101
Male_OUD_vs_Control,GO_MF,chemokine receptor binding,0.029077856358343764,0.27831662514414746,2/99
Female_OUD_vs_Control,GO_BP,negative regulation of production of molecular mediator of immune response,0.07324369300855113,0.27842631421088865,3/287
Female_OUD_vs_Control,GO_BP,macrophage cytokine production,0.07324369300855113,0.27842631421088865,3/287
Female_OUD_vs_Control,GO_BP,regulation of macrophage cytokine production,0.07324369300855113,0.27842631421088865,3/287
Female_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.06499784761605842,0.2791609612187152,6/319
Male_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.07822078809406839,0.27983701866596217,3/110
DLPFC_OUD_vs_Control,GO_BP,innate immune response-activating signaling pathway,0.08033275225342355,0.28036616560010746,9/253
Pooled_OUD_vs_Control,GO_BP,regulation of cellular response to osmotic stress,0.06595956920456572,0.28089123861261406,2/380
Male_OUD_vs_Control,GO_BP,cellular response to stress,0.11853614898195568,0.28108365111258743,14/101
Male_OUD_vs_Control,GO_BP,negative regulation of response to cytokine stimulus,0.12454074253674008,0.28108365111258743,2/101
Male_OUD_vs_Control,GO_BP,positive regulation of innate immune response,0.12526309740583796,0.28127168982023476,5/101
Control_Male_vs_Female,Reactome,Metabolism of nucleotides,0.1712978613447318,0.28232425295705793,1/19
OUD_Male_vs_Female,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.1425795229682959,0.2830926760385005,1/18
NAC_OUD_vs_Control,GO_BP,chemokine production,0.030887206824575898,0.2835345619739667,9/513
NAC_OUD_vs_Control,GO_BP,regulation of chemokine production,0.030887206824575898,0.2835345619739667,9/513
Female_OUD_vs_Control,WikiPathways,WP_APOPTOSIS,0.07571865929555417,0.2837603942430291,5/198
DLPFC_OUD_vs_Control,GO_BP,regulation of neuron apoptotic process,0.08201129396847856,0.2848075752266111,8/253
DLPFC_OUD_vs_Control,GO_BP,myeloid leukocyte cytokine production,0.08283184558883631,0.2849020378941406,3/253
Pooled_OUD_vs_Control,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.05989732564738753,0.28542909262581606,3/254
NAC_OUD_vs_Control,DO,autoimmune disease of endocrine system,0.10485606537327141,0.28565439736240056,4/257
Female_OUD_vs_Control,GO_BP,antifungal innate immune response,0.07732449833681594,0.2865513513046485,2/287
Control_Male_vs_Female,GO_CC,symmetric synapse,0.035209790112094796,0.2870422183757069,1/33
Control_Male_vs_Female,GO_CC,inhibitory synapse,0.035209790112094796,0.2870422183757069,1/33
Control_Male_vs_Female,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.04014057483043154,0.2870422183757069,1/33
Pooled_OUD_vs_Control,DO,morphine dependence,0.1678853084827788,0.2872468041762313,2/199
NAC_OUD_vs_Control,GO_BP,lymphocyte activation involved in immune response,0.0337228001206647,0.2873213355715086,14/513
NAC_OUD_vs_Control,GO_BP,regulation of response to osmotic stress,0.03382405862869013,0.2873213355715086,3/513
NAC_OUD_vs_Control,GO_BP,astrocyte activation,0.03382405862869013,0.2873213355715086,3/513
NAC_OUD_vs_Control,GO_BP,glutamatergic neuron differentiation,0.03382405862869013,0.2873213355715086,3/513
DLPFC_OUD_vs_Control,GO_MF,lipopolysaccharide immune receptor activity,0.022085474860586297,0.2880671411178816,2/253
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.034825133192303376,0.2892881068903682,12/580
Control_DLPFC_vs_NAC,GO_BP,"synaptic transmission, glutamatergic",0.0019914476526959016,0.2899697683260687,62/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neuron differentiation,0.001994197110322291,0.2899697683260687,101/4916
DLPFC_OUD_vs_Control,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.11454401922726933,0.2910765665069432,2/161
DLPFC_OUD_vs_Control,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.11454401922726933,0.2910765665069432,2/161
DLPFC_OUD_vs_Control,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.11454401922726933,0.2910765665069432,2/161
Male_OUD_vs_Control,KEGG,Porphyrin metabolism,0.12485178872731639,0.2913208403637383,1/64
OUD_Male_vs_Female,GO_MF,cytokine receptor activity,0.03309522489834515,0.29187330237852444,2/32
OUD_Male_vs_Female,GO_MF,complement receptor activity,0.04528944566442483,0.29187330237852444,1/32
OUD_Male_vs_Female,GO_MF,cytokine binding,0.04713479580031235,0.29187330237852444,2/32
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,0.05211605535129106,0.29379710324409136,7/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.05211605535129106,0.29379710324409136,7/278
Female_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.07084732786213577,0.2939290910571845,8/319
Pooled_OUD_vs_Control,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.06357357641067637,0.29394911073055313,4/254
Male_OUD_vs_Control,GO_BP,regulation of response to osmotic stress,0.13958326161254642,0.29497625181310105,1/101
Male_OUD_vs_Control,GO_BP,negative regulation of programmed necrotic cell death,0.13958326161254642,0.29497625181310105,1/101
Male_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.13958326161254642,0.29497625181310105,1/101
Male_OUD_vs_Control,GO_BP,neurotransmitter receptor diffusion trapping,0.13958326161254642,0.29497625181310105,1/101
Male_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,0.14567766314521624,0.29579623631812907,8/118
Male_OUD_vs_Control,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.14620462825647984,0.29579623631812907,1/118
Control_Male_vs_Female,Reactome,Protein-protein interactions at synapses,0.20040671374876506,0.29726995872733486,1/19
Control_Male_vs_Female,Reactome,Response of endothelial cells to shear stress,0.20040671374876506,0.29726995872733486,1/19
Male_OUD_vs_Control,KEGG,Adipocytokine signaling pathway,0.1321604358864024,0.29866231823725,2/64
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.07763543977877296,0.300459234468498,7/410
DLPFC_OUD_vs_Control,GO_BP,neurotransmitter receptor internalization,0.09089329312005619,0.3005955099252964,3/253
Pooled_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.07335113260116106,0.3026254194745445,3/380
Pooled_OUD_vs_Control,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.07335113260116106,0.3026254194745445,3/380
Pooled_OUD_vs_Control,WikiPathways,WP_APOPTOSIS,0.06910213017230742,0.3029314659277565,6/254
Pooled_OUD_vs_Control,WikiPathways,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.07281127625954792,0.3029314659277565,2/254
Pooled_OUD_vs_Control,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.07281127625954792,0.3029314659277565,2/254
Pooled_OUD_vs_Control,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.07355544084492871,0.3029314659277565,3/254
Pooled_OUD_vs_Control,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.07394900881319966,0.3029314659277565,4/254
Male_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway,0.14513545890231674,0.30444094781580644,5/101
DLPFC_OUD_vs_Control,GO_BP,activation of innate immune response,0.09321172267193245,0.3070056575442604,9/253
NAC_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.07240544938609242,0.3084779038835507,2/581
DLPFC_OUD_vs_Control,GO_BP,regulation of axonogenesis,0.09430395381315429,0.3093414829386816,6/253
NAC_OUD_vs_Control,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.021132641662380797,0.30939098198455006,9/307
Male_OUD_vs_Control,C8_CellType,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.15960373104484704,0.31322979426029907,1/118
OUD_DLPFC_vs_NAC,KEGG,Morphine addiction,0.010255622449597492,0.3132626493695234,50/2402
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.040892500417802506,0.31398441287520307,14/580
Male_OUD_vs_Control,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.16915161159363434,0.31398767902068375,1/75
DLPFC_OUD_vs_Control,GO_BP,behavioral response to pain,0.09892809116955918,0.31438485758045714,2/253
DLPFC_OUD_vs_Control,DO,substance dependence,0.1961742730729509,0.31559139032682676,5/136
DLPFC_OUD_vs_Control,DO,autoimmune disease of central nervous system,0.2110567106593766,0.31559139032682676,1/136
DLPFC_OUD_vs_Control,DO,plasma protein metabolism disease,0.2110567106593766,0.31559139032682676,1/136
DLPFC_OUD_vs_Control,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.13117050969233454,0.3164288748408208,2/161
Female_OUD_vs_Control,GO_BP,axon extension,0.09002423578473735,0.3179493553394148,5/287
Female_OUD_vs_Control,GO_BP,positive regulation of type 2 immune response,0.09165755561885809,0.3179493553394148,2/287
Female_OUD_vs_Control,GO_BP,axon extension involved in axon guidance,0.09165755561885809,0.3179493553394148,2/287
Female_OUD_vs_Control,GO_BP,chemokine (C-X-C motif) ligand 2 production,0.09165755561885809,0.3179493553394148,2/287
Female_OUD_vs_Control,GO_BP,neuron projection extension involved in neuron projection guidance,0.09165755561885809,0.3179493553394148,2/287
Female_OUD_vs_Control,GO_BP,regulation of chemokine (C-X-C motif) ligand 2 production,0.09165755561885809,0.3179493553394148,2/287
OUD_Male_vs_Female,Reactome,Cytokine Signaling in Immune system,0.17881345804051593,0.3181486201500089,3/18
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.1102338541989156,0.3182054171814851,2/435
OUD_Male_vs_Female,KEGG,Fluid shear stress and atherosclerosis,0.043883685388232806,0.3187147016736558,2/15
OUD_Male_vs_Female,KEGG,Autoimmune thyroid disease,0.06016203468669257,0.3187147016736558,1/15
OUD_Male_vs_Female,KEGG,Intestinal immune network for IgA production,0.1215156172209263,0.3187147016736558,1/15
OUD_Male_vs_Female,KEGG,Glycerolipid metabolism,0.12607680300897972,0.3187147016736558,1/15
OUD_Male_vs_Female,KEGG,Cytokine-cytokine receptor interaction,0.1368105221558748,0.3187147016736558,2/15
OUD_Male_vs_Female,KEGG,Cholesterol metabolism,0.13962809214912753,0.3187147016736558,1/15
Female_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.0805623019943907,0.31884347746558417,7/319
Control_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter transport,0.002253002598286357,0.31941432291159766,54/4916
Male_OUD_vs_Control,GO_BP,cellular component disassembly involved in execution phase of apoptosis,0.16787896937812652,0.3195333940646757,1/101
Male_OUD_vs_Control,GO_BP,regulation of neurotransmitter uptake,0.16787896937812652,0.3195333940646757,1/101
Male_OUD_vs_Control,GO_BP,regulation of receptor localization to synapse,0.16787896937812652,0.3195333940646757,1/101
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,0.015329299850085427,0.3207361199402489,124/6081
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter secretion,0.0023651807407630114,0.32073907523651446,81/4916
Control_DLPFC_vs_NAC,GO_BP,signal release from synapse,0.0023651807407630114,0.32073907523651446,81/4916
Male_OUD_vs_Control,KEGG,Central carbon metabolism in cancer,0.16275852421624593,0.3214623354253882,2/64
Control_DLPFC_vs_NAC,GO_CC,axonemal microtubule doublet inner sheath,0.008734148814309683,0.321677518327362,31/5212
OUD_Male_vs_Female,Reactome,Protein-protein interactions at synapses,0.19091599225023403,0.32290729553434644,1/18
Pooled_OUD_vs_Control,GO_BP,lymphocyte activation involved in immune response,0.08282864750661698,0.3242061141996914,10/380
Pooled_OUD_vs_Control,GO_BP,regulation of immunoglobulin mediated immune response,0.08366852154854695,0.3242061141996914,4/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of immunoglobulin mediated immune response,0.08440969180917522,0.3242061141996914,2/380
Pooled_OUD_vs_Control,GO_BP,ectopic germ cell programmed cell death,0.08440969180917522,0.3242061141996914,2/380
Female_OUD_vs_Control,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.09869404622983466,0.3264495375294531,2/198
Male_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.18820194150206482,0.3285986518833477,1/75
Male_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.18820194150206482,0.3285986518833477,1/75
Male_OUD_vs_Control,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.18820194150206482,0.3285986518833477,1/75
Female_OUD_vs_Control,KEGG,Cholesterol metabolism,0.09238590371000349,0.3302100570902482,4/175
Male_OUD_vs_Control,GO_BP,organ or tissue specific immune response,0.1816793345822003,0.3311327717706427,1/101
Male_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.1816793345822003,0.3311327717706427,1/101
Male_OUD_vs_Control,GO_BP,positive regulation of humoral immune response,0.1816793345822003,0.3311327717706427,1/101
Male_OUD_vs_Control,GO_BP,response to arsenic-containing substance,0.1816793345822003,0.3311327717706427,1/101
Male_OUD_vs_Control,GO_BP,regulation of programmed necrotic cell death,0.1816793345822003,0.3311327717706427,1/101
OUD_Male_vs_Female,KEGG,Apoptosis,0.24912600969590049,0.3334604550494296,1/15
Male_OUD_vs_Control,GO_MF,chemokine binding,0.03582045752645279,0.3348796261775354,2/99
NAC_OUD_vs_Control,GO_BP,cellular response to toxic substance,0.042293588160909626,0.33563849221794384,9/513
Male_OUD_vs_Control,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.07555134181364205,0.33593972592780774,2/75
Male_OUD_vs_Control,GO_CC,glycinergic synapse,0.07501742008424306,0.33826036692531414,1/100
Male_OUD_vs_Control,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.09967951253578737,0.339213481508848,2/75
Male_OUD_vs_Control,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.11368235596512744,0.339213481508848,1/75
Female_OUD_vs_Control,GO_BP,type 2 immune response,0.10069695527763536,0.34087846175099695,3/287
NAC_OUD_vs_Control,GO_BP,positive regulation of production of molecular mediator of immune response,0.04338699670818747,0.3420087211201511,10/513
Male_OUD_vs_Control,GO_BP,behavioral response to pain,0.19525305558847394,0.3428716195968496,1/101
Control_Male_vs_Female,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.02301334121787378,0.3452001182681067,2/8
Male_OUD_vs_Control,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.2686620595840127,0.3459543514605249,1/4
Pooled_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.09707199272772868,0.3460505389606816,4/254
DLPFC_OUD_vs_Control,KEGG,Apoptosis - multiple species,0.1130606013543025,0.3462480916475514,2/142
Male_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.22501890324534302,0.3462726127661496,1/75
Female_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.10668608390695021,0.3472845403339043,2/287
Female_OUD_vs_Control,GO_BP,positive regulation of humoral immune response,0.10668608390695021,0.3472845403339043,2/287
Female_OUD_vs_Control,GO_BP,regulation of axon regeneration,0.10668608390695021,0.3472845403339043,2/287
Female_OUD_vs_Control,GO_BP,regulation of neuron projection regeneration,0.10668608390695021,0.3472845403339043,2/287
Female_OUD_vs_Control,GO_BP,negative regulation of synapse organization,0.10668608390695021,0.3472845403339043,2/287
NAC_OUD_vs_Control,GO_BP,positive regulation of stress-activated MAPK cascade,0.04537101366959762,0.3477459125881538,3/513
NAC_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",0.04537101366959762,0.3477459125881538,3/513
NAC_OUD_vs_Control,GO_BP,positive regulation of stress-activated protein kinase signaling cascade,0.04537101366959762,0.3477459125881538,3/513
Female_OUD_vs_Control,DO,autoimmune disease of the nervous system,0.21530887978568733,0.3479305907672368,2/160
NAC_OUD_vs_Control,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.03187467511601057,0.34849644793504886,3/307
DLPFC_OUD_vs_Control,DO,combined oxidative phosphorylation deficiency,0.24762667908143676,0.3486091900543631,1/136
DLPFC_OUD_vs_Control,DO,newborn respiratory distress syndrome,0.24762667908143676,0.3486091900543631,1/136
DLPFC_OUD_vs_Control,DO,autoimmune hepatitis,0.24762667908143676,0.3486091900543631,1/136
DLPFC_OUD_vs_Control,DO,substance-induced psychosis,0.24762667908143676,0.3486091900543631,1/136
Pooled_OUD_vs_Control,GO_BP,T cell differentiation involved in immune response,0.09235327379760114,0.3487214879987275,5/380
NAC_OUD_vs_Control,GO_BP,positive regulation of innate immune response,0.04617607010433648,0.3504912675983991,20/513
OUD_Male_vs_Female,Reactome,Apoptosis,0.23667078721125567,0.3524336722602394,1/18
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,0.08957403977303675,0.3540307286267643,13/581
Male_OUD_vs_Control,GO_BP,negative regulation of chemokine production,0.20860381797112248,0.35425175315335533,1/101
Male_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.20860381797112248,0.35425175315335533,1/101
Female_OUD_vs_Control,GO_MF,lipopolysaccharide immune receptor activity,0.02893896924551999,0.35605267518148703,2/292
Control_DLPFC_vs_NAC,GO_CC,A axonemal microtubule,0.010542887878939186,0.35634961030814444,30/5212
Male_OUD_vs_Control,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.24280457713047143,0.3569948485532179,1/75
Male_OUD_vs_Control,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.24280457713047143,0.3569948485532179,1/75
Male_OUD_vs_Control,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.24280457713047143,0.3569948485532179,1/75
Female_OUD_vs_Control,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.11862413251150339,0.35921392239398914,2/198
Female_OUD_vs_Control,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.11862413251150339,0.35921392239398914,2/198
Pooled_OUD_vs_Control,Reactome,Diseases of metabolism,0.025438131375222047,0.36067636271296977,12/267
NAC_OUD_vs_Control,GO_BP,regulation of presynapse organization,0.048735825915061266,0.36175204535690586,4/513
NAC_OUD_vs_Control,GO_BP,regulation of presynapse assembly,0.048735825915061266,0.36175204535690586,4/513
Pooled_OUD_vs_Control,GO_BP,mature B cell differentiation involved in immune response,0.0976274851195787,0.36175209893629967,3/380
Pooled_OUD_vs_Control,GO_BP,regulation of type 2 immune response,0.0976274851195787,0.36175209893629967,3/380
Female_OUD_vs_Control,DO,autoimmune disease of central nervous system,0.2442822266502186,0.36243792936779073,1/160
Female_OUD_vs_Control,DO,glucose intolerance,0.2442822266502186,0.36243792936779073,1/160
Female_OUD_vs_Control,DO,autoimmune thyroiditis,0.2442822266502186,0.36243792936779073,1/160
Male_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,0.19446453308424214,0.36263137130299955,3/118
Control_DLPFC_vs_NAC,GO_CC,neuron projection membrane,0.011809959390194916,0.3628878430805347,37/5212
Male_OUD_vs_Control,GO_BP,regulation of innate immune response,0.2149076502634508,0.36343356955703426,5/101
Male_OUD_vs_Control,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.2601873921642074,0.3662353339941687,1/75
Pooled_OUD_vs_Control,GO_BP,microglia differentiation,0.10418741344484025,0.366756499747361,2/380
Pooled_OUD_vs_Control,GO_BP,regulation of response to osmotic stress,0.10418741344484025,0.366756499747361,2/380
DLPFC_OUD_vs_Control,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.12611420548171348,0.36889107349777983,3/253
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.028952729229728393,0.369147297679037,19/6250
Male_OUD_vs_Control,Reactome,Innate Immune System,0.14540997253859936,0.36916837895991456,11/75
Male_OUD_vs_Control,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.146021263057156,0.36916837895991456,2/75
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.019220933324147975,0.3702359660186553,27/6081
Control_DLPFC_vs_NAC,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.019509983503434043,0.3702359660186553,132/6081
Control_Male_vs_Female,Hallmark,HALLMARK_COMPLEMENT,0.05649793141339989,0.3711323521742784,2/8
Male_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.23465091342137756,0.37343994975478495,1/101
Male_OUD_vs_Control,GO_BP,neurotransmitter reuptake,0.23465091342137756,0.37343994975478495,1/101
Male_OUD_vs_Control,GO_BP,maintenance of synapse structure,0.23465091342137756,0.37343994975478495,1/101
Male_OUD_vs_Control,Reactome,Regulation of pyruvate metabolism,0.16564200297655884,0.37459498656230517,1/75
NAC_OUD_vs_Control,GO_BP,programmed cell death involved in cell development,0.05859617293804812,0.3746839510398216,3/513
NAC_OUD_vs_Control,GO_BP,mature B cell differentiation involved in immune response,0.05864601382423775,0.3746839510398216,4/513
NAC_OUD_vs_Control,GO_BP,astrocyte cell migration,0.059474906805513546,0.3746839510398216,2/513
NAC_OUD_vs_Control,GO_BP,phospholipase C-activating dopamine receptor signaling pathway,0.059474906805513546,0.3746839510398216,2/513
NAC_OUD_vs_Control,GO_BP,positive regulation of T-helper 17 type immune response,0.059474906805513546,0.3746839510398216,2/513
NAC_OUD_vs_Control,GO_BP,cell activation involved in immune response,0.05972969395412638,0.3752842987291305,18/513
OUD_Male_vs_Female,GO_CC,excitatory synapse,0.02146036267681607,0.3763036150626219,2/32
OUD_Male_vs_Female,GO_CC,symmetric synapse,0.03415865680949348,0.3763036150626219,1/32
OUD_Male_vs_Female,GO_CC,inhibitory synapse,0.03415865680949348,0.3763036150626219,1/32
OUD_Male_vs_Female,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.038945233080532216,0.3763036150626219,1/32
Male_OUD_vs_Control,GO_BP,cellular response to toxic substance,0.2370439945777418,0.3764035658580491,2/101
OUD_Male_vs_Female,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.33300305237950345,0.37667558383911043,1/17
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.021393399974460926,0.3783251991318666,99/6081
Female_OUD_vs_Control,GO_BP,regulation of T-helper 17 type immune response,0.12231347365909698,0.3789917772296994,2/287
Male_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.2152785341334989,0.3823930572405201,6/118
OUD_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.002502370631105309,0.383974871284048,4/42
DLPFC_OUD_vs_Control,DO,nicotine dependence,0.2884092416971593,0.3842230501804438,2/136
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,0.13328386647049859,0.38453813390211933,7/286
Pooled_OUD_vs_Control,DO,opiate dependence,0.23888532791727027,0.3859282887269047,4/199
Control_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.025144853111809334,0.38631061701186814,190/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.026373631610355736,0.38631061701186814,17/6081
Male_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.2836964900106309,0.3882850577564856,2/75
Control_Male_vs_Female,DO,calcium metabolism disease,0.06897164219927343,0.38846565451699516,1/19
Control_Male_vs_Female,DO,mineral metabolism disease,0.09291562237927775,0.38846565451699516,1/19
Pooled_OUD_vs_Control,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.08636563162212618,0.3886453422995678,3/15
Male_OUD_vs_Control,GO_BP,multicellular organismal response to stress,0.2493581421077654,0.38920181123699654,2/101
Pooled_OUD_vs_Control,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.11323194525453749,0.390100584874551,4/380
Pooled_OUD_vs_Control,GO_BP,cytokine production involved in inflammatory response,0.11323194525453749,0.390100584874551,4/380
Pooled_OUD_vs_Control,GO_BP,regulation of cytokine production involved in inflammatory response,0.11323194525453749,0.390100584874551,4/380
OUD_Male_vs_Female,Reactome,Cellular responses to stress,0.27970288331629445,0.39228494003052117,2/18
OUD_Male_vs_Female,Reactome,Innate Immune System,0.28229924795258554,0.39228494003052117,3/18
OUD_Male_vs_Female,Reactome,Programmed Cell Death,0.2834759785622014,0.39228494003052117,1/18
DLPFC_OUD_vs_Control,GO_BP,positive regulation of neuron apoptotic process,0.135587446214387,0.3930381247765217,3/253
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.09060126670704778,0.39314478231808236,6/278
OUD_Male_vs_Female,GO_CC,parallel fiber to Purkinje cell synapse,0.09010390086115405,0.3934537004270393,1/32
Female_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.12116319746176779,0.3943857902218672,7/319
DLPFC_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.1377800668559503,0.3958257852895521,7/286
Male_OUD_vs_Control,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.2555242446244153,0.39642601627726576,2/101
Female_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.13944094878000837,0.3970834965258516,2/198
DLPFC_OUD_vs_Control,GO_BP,negative regulation of immune response,0.14003833379259206,0.3978855440503442,6/253
DLPFC_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.14051133873595614,0.3978855440503442,2/253
DLPFC_OUD_vs_Control,GO_BP,neurotransmitter reuptake,0.14051133873595614,0.3978855440503442,2/253
DLPFC_OUD_vs_Control,GO_BP,maintenance of synapse structure,0.14051133873595614,0.3978855440503442,2/253
Male_OUD_vs_Control,GO_BP,mature B cell differentiation involved in immune response,0.25984893569891754,0.3983413954822325,1/101
NAC_OUD_vs_Control,GO_BP,innate immune response-activating signaling pathway,0.06554424593617272,0.3990313342504901,16/513
Female_OUD_vs_Control,DO,autoimmune disease of peripheral nervous system,0.2854938298322113,0.3997948015585132,1/160
Female_OUD_vs_Control,DO,autoimmune hepatitis,0.2854938298322113,0.3997948015585132,1/160
OUD_Male_vs_Female,GO_CC,immunological synapse,0.09462161617107534,0.39985263607776994,1/32
Female_OUD_vs_Control,GO_BP,regulation of immunoglobulin mediated immune response,0.13158281294577465,0.3998584509905579,3/287
Female_OUD_vs_Control,Reactome,Programmed Cell Death,0.032862944288105114,0.40094044040981225,8/206
Female_OUD_vs_Control,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.033853076040543384,0.40094044040981225,4/206
Female_OUD_vs_Control,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.03854233946511304,0.40094044040981225,2/206
Female_OUD_vs_Control,Reactome,IL-6-type cytokine receptor ligand interactions,0.03854233946511304,0.40094044040981225,2/206
Pooled_OUD_vs_Control,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.12159721053882148,0.4021401331596336,3/254
Pooled_OUD_vs_Control,WikiPathways,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.12273267801655723,0.4021401331596336,2/254
DLPFC_OUD_vs_Control,GO_BP,leukocyte activation involved in immune response,0.14286231262379515,0.4034112016607586,9/253
NAC_OUD_vs_Control,GO_BP,synapse assembly,0.0665207769486088,0.4044531993800427,18/513
DLPFC_OUD_vs_Control,DO,complement deficiency,0.3157938215192295,0.4057286315311784,1/136
Pooled_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.12466787082425787,0.40691579371153946,3/380
Pooled_OUD_vs_Control,GO_BP,T-helper 17 type immune response,0.12466787082425787,0.40691579371153946,3/380
Pooled_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor internalization,0.12466787082425787,0.40691579371153946,3/380
Pooled_OUD_vs_Control,GO_BP,regulation of immune response to tumor cell,0.1250567731139907,0.40691579371153946,2/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of stress-activated MAPK cascade,0.1250567731139907,0.40691579371153946,2/380
Pooled_OUD_vs_Control,GO_BP,antifungal innate immune response,0.1250567731139907,0.40691579371153946,2/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of stress-activated protein kinase signaling cascade,0.1250567731139907,0.40691579371153946,2/380
DLPFC_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.14529693944275135,0.4071540884592852,3/253
Male_OUD_vs_Control,GO_BP,regulation of humoral immune response,0.2721381445587576,0.4074887951259961,1/101
OUD_Male_vs_Female,Reactome,Metabolism of RNA,0.3007454316448025,0.4079418231221579,1/18
Pooled_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.1252283989190473,0.40812645662748975,8/410
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.10985295222098429,0.4082594791496282,8/581
Control_Male_vs_Female,Reactome,Metabolism of RNA,0.3145403764750573,0.40867289790189926,1/19
Male_OUD_vs_Control,GO_CC,cholinergic synapse,0.11732464244845087,0.40981001869318046,1/100
NAC_OUD_vs_Control,GO_MF,neurotransmitter receptor regulator activity,0.024495115863044654,0.4098221307855548,3/528
NAC_OUD_vs_Control,DO,"autoimmune disease of eyes, ear, nose and throat",0.1824772163761871,0.40994881487252993,2/257
DLPFC_OUD_vs_Control,GO_BP,cell activation involved in immune response,0.14715665200747438,0.41150869861923933,9/253
DLPFC_OUD_vs_Control,GO_BP,axon guidance,0.14715665200747438,0.41150869861923933,9/253
Female_OUD_vs_Control,GO_BP,negative regulation of stress fiber assembly,0.1384506103147063,0.41203095273561313,2/287
Female_OUD_vs_Control,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.1384506103147063,0.41203095273561313,2/287
Female_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.1384506103147063,0.41203095273561313,2/287
Female_OUD_vs_Control,WikiPathways,WP_CHEMOKINE_SIGNALING,0.1487726293288952,0.41272406846080606,7/198
Male_OUD_vs_Control,Reactome,Activation of ATR in response to replication stress,0.1985999301738518,0.4128200795748605,1/75
DLPFC_OUD_vs_Control,DO,withdrawal disorder,0.3232095679025505,0.4139167692171373,2/136
Male_OUD_vs_Control,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,0.28020642196343404,0.4142152805145721,2/101
Male_OUD_vs_Control,GO_BP,microglial cell activation,0.2842252947395477,0.4142152805145721,1/101
Male_OUD_vs_Control,GO_BP,complement activation,0.2842252947395477,0.4142152805145721,1/101
Male_OUD_vs_Control,GO_BP,integrated stress response signaling,0.2842252947395477,0.4142152805145721,1/101
Male_OUD_vs_Control,KEGG,Autoimmune thyroid disease,0.23432886916199047,0.4143921054654147,1/64
Male_OUD_vs_Control,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.22553083143992736,0.4144169249119371,1/25
Control_Male_vs_Female,Reactome,Metabolism of proteins,0.32376720494068034,0.4146083631614468,4/19
NAC_OUD_vs_Control,GO_BP,astrocyte differentiation,0.0721287848022981,0.4157058069734332,7/513
NAC_OUD_vs_Control,GO_BP,positive regulation of immune effector process,0.07268474741774338,0.4157058069734332,15/513
NAC_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.07340661402357054,0.4157058069734332,3/513
Female_OUD_vs_Control,KEGG,Central carbon metabolism in cancer,0.1327304987968093,0.4158888962300024,4/175
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.14783341374583858,0.4158964917828986,2/286
Female_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.15848337402924875,0.41696037265979635,3/198
Female_OUD_vs_Control,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.1609660973523865,0.41696037265979635,2/198
Female_OUD_vs_Control,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.1609660973523865,0.41696037265979635,2/198
Pooled_OUD_vs_Control,KEGG,Starch and sucrose metabolism,0.10367472757846018,0.4177936783012574,3/225
Control_Male_vs_Female,Reactome,Immune System,0.33216063117367556,0.41932334999229964,5/19
Control_Male_vs_Female,Hallmark,HALLMARK_HEME_METABOLISM,0.25057411330885127,0.4204141625175081,1/8
Control_Male_vs_Female,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.29279644307977903,0.4204141625175081,1/8
Pooled_OUD_vs_Control,KEGG,Central carbon metabolism in cancer,0.10597020014503872,0.4207640299876537,5/225
DLPFC_OUD_vs_Control,GO_BP,neuron projection guidance,0.15151555605214578,0.4210735136535201,9/253
Male_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.1647861783212781,0.4218132253841481,3/110
Male_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.24773553283092042,0.42185222653157667,1/118
Male_OUD_vs_Control,GO_BP,neurotransmitter uptake,0.29611367580044345,0.4224237346931879,1/101
Male_OUD_vs_Control,GO_BP,regulation of neurotransmitter receptor activity,0.29611367580044345,0.4224237346931879,1/101
Male_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,0.2564000350373826,0.4236953436810867,3/118
Pooled_OUD_vs_Control,DO,metal metabolism disorder,0.2938167735201489,0.42395348052900417,3/199
Pooled_OUD_vs_Control,DO,autoimmune disease of the nervous system,0.29584131519112855,0.42395348052900417,2/199
Pooled_OUD_vs_Control,DO,autoimmune disease of central nervous system,0.2958787545985405,0.42395348052900417,1/199
Pooled_OUD_vs_Control,DO,glucose intolerance,0.2958787545985405,0.42395348052900417,1/199
Male_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.26063610070036,0.4241407353012069,3/118
Male_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.32586720108586564,0.42448490667764077,1/75
DLPFC_OUD_vs_Control,DO,"autoimmune disease of eyes, ear, nose and throat",0.34754136170120986,0.4245351402934779,1/136
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.0721811987850352,0.4262458800563514,9/580
Female_OUD_vs_Control,DO,glycogen metabolism disorder,0.32447132292012304,0.4272850640839099,1/160
Female_OUD_vs_Control,DO,post-traumatic stress disorder,0.32447132292012304,0.4272850640839099,1/160
Female_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.20303230496723046,0.42912190639761644,1/334
Female_OUD_vs_Control,DO,opiate dependence,0.32715687254893067,0.4293586799326374,3/160
Female_OUD_vs_Control,GO_BP,regulation of axonogenesis,0.14646654074143925,0.43030494893640164,6/287
Pooled_OUD_vs_Control,Reactome,Response of endothelial cells to shear stress,0.03301290193658823,0.4306909991476564,7/267
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.036402683988835255,0.43176869035677967,27/6250
OUD_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.03683662149149642,0.43176869035677967,35/6250
NAC_OUD_vs_Control,GO_BP,postsynapse organization,0.07697247924896587,0.4329504101211898,15/513
NAC_OUD_vs_Control,GO_BP,response to endoplasmic reticulum stress,0.07733614396583059,0.4337829481563752,10/513
Male_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.17234301836729868,0.4342368207881937,3/110
Female_OUD_vs_Control,Reactome,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.05204658257939269,0.4342930493208138,2/206
DLPFC_OUD_vs_Control,DO,mitochondrial metabolism disease,0.35757985923702296,0.4347908242483863,2/136
NAC_OUD_vs_Control,GO_BP,complement activation,0.08140052190554559,0.43615483636805374,4/513
NAC_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor internalization,0.08140052190554559,0.43615483636805374,4/513
NAC_OUD_vs_Control,GO_BP,activation of innate immune response,0.08178159648925079,0.43615483636805374,16/513
NAC_OUD_vs_Control,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.0843393329993474,0.43615483636805374,2/513
NAC_OUD_vs_Control,GO_BP,"complement activation, alternative pathway",0.0843393329993474,0.43615483636805374,2/513
NAC_OUD_vs_Control,GO_BP,positive regulation of astrocyte differentiation,0.0843393329993474,0.43615483636805374,2/513
NAC_OUD_vs_Control,GO_BP,regulation of response to drug,0.0843393329993474,0.43615483636805374,2/513
DLPFC_OUD_vs_Control,GO_MF,complement binding,0.059543746912420446,0.43620647359852177,2/253
DLPFC_OUD_vs_Control,GO_BP,neuron apoptotic process,0.16106617787370744,0.43620739520726404,8/253
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_STOMACH_ENS_NEURONS,0.039404867226901605,0.43671630592726657,42/6250
OUD_DLPFC_vs_NAC,KEGG,Serotonergic synapse,0.02098993050615884,0.436932180410036,59/2402
OUD_DLPFC_vs_NAC,KEGG,Dopaminergic synapse,0.028739538436467857,0.436932180410036,63/2402
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,0.032670254623017723,0.437031602825942,16/6081
Female_OUD_vs_Control,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.1465802328100899,0.43705709568311524,6/319
NAC_OUD_vs_Control,KEGG,2-Oxocarboxylic acid metabolism,0.033469433757943715,0.43706557773140087,3/278
NAC_OUD_vs_Control,KEGG,Chemokine signaling pathway,0.044255384349963824,0.43706557773140087,13/278
NAC_OUD_vs_Control,KEGG,Fluid shear stress and atherosclerosis,0.04510641193669261,0.43706557773140087,11/278
Male_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.27134242212537973,0.4374874744421507,5/118
Male_OUD_vs_Control,GO_BP,cellular response to chemical stress,0.3149966372213254,0.43873775270098403,3/101
Control_DLPFC_vs_NAC,GO_BP,axoneme assembly,0.005128819373531174,0.43878044996672755,56/4916
Control_DLPFC_vs_NAC,GO_BP,dopamine metabolic process,0.005550228333886704,0.43878044996672755,24/4916
Male_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.17615857712543817,0.44068222895429215,3/110
Female_OUD_vs_Control,GO_BP,neuron projection regeneration,0.1537808124329338,0.44139790714559946,3/287
Female_OUD_vs_Control,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.15501538690367697,0.44139790714559946,2/287
Female_OUD_vs_Control,GO_BP,positive regulation of macrophage cytokine production,0.15501538690367697,0.44139790714559946,2/287
Pooled_OUD_vs_Control,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.03789359031826033,0.4424633928338044,3/267
DLPFC_OUD_vs_Control,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.22267073810917848,0.44328921135099125,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.22267073810917848,0.44328921135099125,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.22267073810917848,0.44328921135099125,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_PURINE_METABOLISM,0.22267073810917848,0.44328921135099125,1/161
NAC_OUD_vs_Control,DO,mitochondrial metabolism disease,0.20609235018722005,0.443558338985618,4/257
Male_OUD_vs_Control,Reactome,Pyruvate metabolism,0.2302726678659055,0.4437546203665887,1/75
Female_OUD_vs_Control,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.21314805336962706,0.444888460304206,3/334
DLPFC_OUD_vs_Control,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.16536241214501143,0.4454525818822923,3/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of adaptive immune response,0.16536241214501143,0.4454525818822923,3/253
NAC_OUD_vs_Control,GO_BP,regulation of T-helper 17 type immune response,0.08969055900293599,0.4457061992268392,3/513
Male_OUD_vs_Control,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.3306183095808072,0.44649215522436625,1/101
Male_OUD_vs_Control,GO_BP,cellular response to osmotic stress,0.3306183095808072,0.44649215522436625,1/101
Female_OUD_vs_Control,GO_CC,immunological synapse,0.0654491886437891,0.44652656706685206,3/305
DLPFC_OUD_vs_Control,DO,metal metabolism disorder,0.3745377503243106,0.447752161523603,2/136
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,0.039510819200755595,0.4478591485806329,98/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.042465411753513795,0.4478591485806329,48/6081
Pooled_OUD_vs_Control,DO,drug dependence,0.31611066612602456,0.4481918710283321,4/199
DLPFC_OUD_vs_Control,GO_BP,regulation of type 2 immune response,0.169947700504513,0.4485286370177931,2/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of axon extension,0.169947700504513,0.4485286370177931,2/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.169947700504513,0.4485286370177931,2/253
Pooled_OUD_vs_Control,GO_BP,regulation of response to cytokine stimulus,0.14358296979235693,0.44937436435297573,8/380
Pooled_OUD_vs_Control,GO_BP,natural killer cell activation involved in immune response,0.14680592063398473,0.44937436435297573,2/380
Pooled_OUD_vs_Control,GO_BP,immune response to tumor cell,0.14680592063398473,0.44937436435297573,2/380
Pooled_OUD_vs_Control,GO_BP,response to morphine,0.14680592063398473,0.44937436435297573,2/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.14680592063398473,0.44937436435297573,2/380
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.044028303269943246,0.4494952020784493,81/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_STOMACH_ENS_NEURONS,0.048950521176639214,0.4494952020784493,41/6081
Female_OUD_vs_Control,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.05667980641784659,0.44951014792767446,4/206
Control_Male_vs_Female,Reactome,Diseases of metabolism,0.3721772772207804,0.45066364180475454,1/19
OUD_DLPFC_vs_NAC,GO_BP,axonemal dynein complex assembly,0.0033903391545061943,0.4522695766135545,30/5050
DLPFC_OUD_vs_Control,GO_BP,immune response-activating cell surface receptor signaling pathway,0.17424814620747694,0.4523850441685863,9/253
DLPFC_OUD_vs_Control,GO_BP,regulation of humoral immune response,0.1850267756941191,0.4523850441685863,2/253
DLPFC_OUD_vs_Control,GO_BP,regulation of tolerance induction,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of natural killer cell mediated immune response to tumor cell,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,noradrenergic neuron differentiation,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,astrocyte cell migration,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of stress-activated protein kinase signaling cascade,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,stress-induced premature senescence,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,motor neuron migration,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of synapse pruning,0.19090245548867535,0.4523850441685863,1/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of T-helper 17 type immune response,0.19090245548867535,0.4523850441685863,1/253
OUD_Male_vs_Female,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.08524783091481831,0.45740116231747013,2/42
OUD_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.08524783091481831,0.45740116231747013,2/42
OUD_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.0887854852006629,0.45740116231747013,2/42
OUD_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.282206852558596,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.29489659932705736,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.34740073554174167,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.3551319046802347,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.38517228543970106,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.3888299007387851,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.41033365675591527,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.4138450684128345,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.4173360648857021,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.4242572748962212,0.45740116231747013,1/42
OUD_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.4276877181441089,0.45740116231747013,1/42
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.08210041523913614,0.45932622613581364,12/580
Female_OUD_vs_Control,DO,complement deficiency,0.3613350979313036,0.45939478733700273,1/160
OUD_Male_vs_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.4511483592447617,0.459805080529163,1/42
NAC_OUD_vs_Control,GO_BP,leukocyte activation involved in immune response,0.0950571731555598,0.460252859643029,17/513
DLPFC_OUD_vs_Control,GO_BP,alpha-beta T cell activation involved in immune response,0.19684572223821686,0.46132502983048157,3/253
DLPFC_OUD_vs_Control,GO_BP,alpha-beta T cell differentiation involved in immune response,0.19684572223821686,0.46132502983048157,3/253
DLPFC_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.19684572223821686,0.46132502983048157,3/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of axonogenesis,0.19684572223821686,0.46132502983048157,3/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of response to cytokine stimulus,0.19684572223821686,0.46132502983048157,3/253
OUD_Male_vs_Female,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.26853853855838694,0.46146487609674935,1/10
OUD_Male_vs_Female,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.4349115414181475,0.46167532858234117,1/17
Control_Male_vs_Female,GO_CC,excitatory synapse,0.21042947422429936,0.46202993253596164,1/33
Male_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.1916510005681945,0.462337050807503,3/110
DLPFC_OUD_vs_Control,GO_BP,microglial cell activation,0.2002867017160899,0.46347146219459656,2/253
DLPFC_OUD_vs_Control,GO_BP,complement activation,0.2002867017160899,0.46347146219459656,2/253
DLPFC_OUD_vs_Control,GO_BP,integrated stress response signaling,0.2002867017160899,0.46347146219459656,2/253
DLPFC_OUD_vs_Control,GO_BP,regulation of response to endoplasmic reticulum stress,0.2002867017160899,0.46347146219459656,2/253
Control_DLPFC_vs_NAC,GO_CC,AMPA glutamate receptor complex,0.025606656705403325,0.4638907851018123,17/5212
Control_DLPFC_vs_NAC,GO_CC,glutamatergic synapse,0.02742074493715812,0.4638907851018123,250/5212
Pooled_OUD_vs_Control,WikiPathways,WP_RETINOL_METABOLISM,0.15003529363126913,0.4640164379192231,2/254
Pooled_OUD_vs_Control,KEGG,Galactose metabolism,0.12204285928877823,0.4641066479995791,2/225
Male_OUD_vs_Control,GO_BP,innate immune response-activating signaling pathway,0.3514919369429609,0.46413741001366676,3/101
Female_OUD_vs_Control,GO_MF,chemokine receptor binding,0.04247954252301799,0.4645778539422126,3/292
Female_OUD_vs_Control,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.16529332201905103,0.46545226802458034,3/287
Female_OUD_vs_Control,GO_BP,cytokine production involved in inflammatory response,0.16529332201905103,0.46545226802458034,3/287
Female_OUD_vs_Control,GO_BP,regulation of cytokine production involved in inflammatory response,0.16529332201905103,0.46545226802458034,3/287
OUD_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.4609130685976234,0.46563346578882064,1/42
Female_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.1637566000446004,0.4658857218444506,5/319
NAC_OUD_vs_Control,DO,metal metabolism disorder,0.2251602693273976,0.46624096173855056,4/257
Pooled_OUD_vs_Control,GO_BP,stress-activated protein kinase signaling cascade,0.15404532143897565,0.46662583489321907,3/380
Pooled_OUD_vs_Control,GO_BP,stress-activated MAPK cascade,0.15404532143897565,0.46662583489321907,3/380
DLPFC_OUD_vs_Control,DO,calcium metabolism disease,0.40671505107903594,0.4673397258419023,1/136
DLPFC_OUD_vs_Control,DO,opioid abuse,0.40671505107903594,0.4673397258419023,1/136
Pooled_OUD_vs_Control,DO,autoimmune disease of peripheral nervous system,0.3436361260487414,0.4675988225260558,1/199
Pooled_OUD_vs_Control,DO,autoimmune hepatitis,0.3436361260487414,0.4675988225260558,1/199
DLPFC_OUD_vs_Control,GO_BP,regulation of axon extension,0.20764908634410392,0.4686963958839956,3/253
DLPFC_OUD_vs_Control,GO_BP,regulation of synapse organization,0.20851917419369675,0.4686963958839956,9/253
DLPFC_OUD_vs_Control,GO_BP,neurotransmitter uptake,0.2156867603470439,0.4686963958839956,2/253
DLPFC_OUD_vs_Control,GO_BP,macrophage cytokine production,0.2156867603470439,0.4686963958839956,2/253
DLPFC_OUD_vs_Control,GO_BP,regulation of macrophage cytokine production,0.2156867603470439,0.4686963958839956,2/253
DLPFC_OUD_vs_Control,GO_BP,T cell differentiation involved in immune response,0.21858242659922958,0.4686963958839956,3/253
DLPFC_OUD_vs_Control,GO_BP,regulation of synapse structure or activity,0.22399572766009568,0.4686963958839956,9/253
DLPFC_OUD_vs_Control,GO_BP,natural killer cell mediated immune response to tumor cell,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of immune response to tumor cell,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,"complement activation, alternative pathway",0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of macrophage cytokine production,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,T-helper 2 cell cytokine production,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,dopamine uptake involved in synaptic transmission,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of dopamine uptake involved in synaptic transmission,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,axonogenesis involved in innervation,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of execution phase of apoptosis,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.22448212720149763,0.4686963958839956,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of T-helper 2 cell cytokine production,0.22448212720149763,0.4686963958839956,1/253
OUD_Male_vs_Female,DO,substance abuse,0.04326487283253079,0.469027072001299,3/17
Control_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.05593912726614633,0.4729249836528734,34/6081
DLPFC_OUD_vs_Control,GO_BP,ensheathment of neurons,0.2292890442244346,0.4755691758987148,5/253
DLPFC_OUD_vs_Control,GO_BP,axon ensheathment,0.2292890442244346,0.4755691758987148,5/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of innate immune response,0.22963148885211565,0.4755691758987148,3/253
DLPFC_OUD_vs_Control,GO_BP,synapse organization,0.22970488242270357,0.4755691758987148,15/253
Female_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.23519130691999374,0.4760669958803498,7/334
Female_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.1719322456766135,0.4765615174782972,2/287
Female_OUD_vs_Control,GO_BP,dopaminergic neuron differentiation,0.1719322456766135,0.4765615174782972,2/287
Female_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.23841072205135416,0.4768214441027083,1/334
Female_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.17205641175345401,0.47717112901442355,6/319
Pooled_OUD_vs_Control,GO_BP,response to endoplasmic reticulum stress,0.1594397335828668,0.4786481685620451,7/380
Male_OUD_vs_Control,GO_BP,activation of innate immune response,0.36968631785062045,0.47873534128966194,3/101
Male_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.38578690375490265,0.4794088301891468,1/75
Control_DLPFC_vs_NAC,KEGG,Dopaminergic synapse,0.003804299077190859,0.47944994574134375,64/2345
Control_DLPFC_vs_NAC,KEGG,Axon guidance,0.0042808030869762835,0.47944994574134375,88/2345
Male_OUD_vs_Control,KEGG,Fatty acid metabolism,0.29970352693961777,0.47952564310338847,1/64
Female_OUD_vs_Control,DO,heroin dependence,0.37888018191949013,0.4801219354487965,2/160
Control_DLPFC_vs_NAC,GO_CC,dendrite,0.0301203628541091,0.48072267412465663,277/5212
Control_DLPFC_vs_NAC,GO_CC,axonemal dynein complex,0.03177669792849127,0.48072267412465663,16/5212
Male_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.203491389923221,0.4812633792355932,3/110
NAC_OUD_vs_Control,DO,autoimmune disease of gastrointestinal tract,0.2492115446095349,0.4819657230656099,2/257
NAC_OUD_vs_Control,DO,morphine dependence,0.2492115446095349,0.4819657230656099,2/257
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,0.06172744553257973,0.48323995526991265,45/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.06274805711877407,0.48323995526991265,56/6081
DLPFC_OUD_vs_Control,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.2608961538588489,0.48372162432198595,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.2608961538588489,0.48372162432198595,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.2608961538588489,0.48372162432198595,1/161
Male_OUD_vs_Control,Reactome,Cellular response to chemical stress,0.2697316521286114,0.484469472269836,2/75
Male_OUD_vs_Control,Reactome,Diseases of metabolism,0.271047623806486,0.48448125994396046,3/75
NAC_OUD_vs_Control,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.05194053112401931,0.48485108399615073,12/307
DLPFC_OUD_vs_Control,GO_BP,negative regulation of immune effector process,0.23691801873408866,0.48531439115815184,4/253
DLPFC_OUD_vs_Control,GO_BP,regulation of neuron projection development,0.2541426288428633,0.4868235467594326,11/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of humoral immune response,0.25667343512898266,0.4868235467594326,1/253
DLPFC_OUD_vs_Control,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.25667343512898266,0.4868235467594326,1/253
DLPFC_OUD_vs_Control,GO_BP,G protein-coupled opioid receptor signaling pathway,0.25667343512898266,0.4868235467594326,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of cellular response to osmotic stress,0.25667343512898266,0.4868235467594326,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of execution phase of apoptosis,0.25667343512898266,0.4868235467594326,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.25667343512898266,0.4868235467594326,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of microglial cell activation,0.25667343512898266,0.4868235467594326,1/253
Female_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.178697168847387,0.4870730831530035,6/319
OUD_DLPFC_vs_NAC,GO_CC,distal axon,0.04628395098395591,0.4888742322680343,134/5358
Female_OUD_vs_Control,DO,drug dependence,0.40292848039905105,0.48895402723464126,3/160
NAC_OUD_vs_Control,GO_BP,presynapse organization,0.10236297406366424,0.48951270793965707,5/513
Male_OUD_vs_Control,GO_BP,neuron projection regeneration,0.3844426704183317,0.489573153707404,1/101
Pooled_OUD_vs_Control,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.17838367456883816,0.490030447197926,2/254
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.14191559098654755,0.4904167939664454,5/278
Pooled_OUD_vs_Control,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.1661681697267788,0.4908791131182609,5/380
Pooled_OUD_vs_Control,GO_BP,organ or tissue specific immune response,0.16924504110978558,0.4908791131182609,2/380
Pooled_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.16924504110978558,0.4908791131182609,2/380
Pooled_OUD_vs_Control,GO_BP,response to arsenic-containing substance,0.16924504110978558,0.4908791131182609,2/380
Pooled_OUD_vs_Control,GO_BP,regulation of axon regeneration,0.16924504110978558,0.4908791131182609,2/380
Pooled_OUD_vs_Control,GO_BP,regulation of neuron projection regeneration,0.16924504110978558,0.4908791131182609,2/380
OUD_Male_vs_Female,DO,substance-related disorder,0.08586805833339357,0.4909706311118282,3/17
OUD_Male_vs_Female,DO,heroin dependence,0.1304462033404571,0.4909706311118282,1/17
OUD_DLPFC_vs_NAC,GO_CC,axonemal dynein complex,0.049471445555399576,0.4918043705213252,16/5358
DLPFC_OUD_vs_Control,GO_BP,neuron projection extension,0.26057809858566777,0.49376553828668535,5/253
DLPFC_OUD_vs_Control,GO_BP,type 2 immune response,0.2623650997072301,0.494137254019494,2/253
DLPFC_OUD_vs_Control,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.2623650997072301,0.494137254019494,2/253
Control_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.026282386754601542,0.49432855989862573,3/47
Control_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.052142469995383835,0.49432855989862573,2/47
Control_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.10318965353235429,0.49432855989862573,2/47
Control_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.11589339975818527,0.49432855989862573,2/47
Control_Male_vs_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.14239220987751364,0.49432855989862573,2/47
Control_Male_vs_Female,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.29147353545268473,0.49432855989862573,1/47
Control_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.3326641936648709,0.49432855989862573,1/47
Control_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.3756851493881984,0.49432855989862573,1/47
Control_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.3880535363790787,0.49432855989862573,1/47
Control_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.3880535363790787,0.49432855989862573,1/47
Control_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,0.41598794522997795,0.49432855989862573,1/47
Control_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.427574166695151,0.49432855989862573,1/47
Control_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.4389353244646723,0.49432855989862573,1/47
Control_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.4463865104652017,0.49432855989862573,1/47
Control_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.4609994839771373,0.49432855989862573,1/47
OUD_DLPFC_vs_NAC,WikiPathways,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.004000954947576013,0.4945751757851005,27/2675
Control_Male_vs_Female,Reactome,Metabolism of amino acids and derivatives,0.425202289934419,0.49467978828971626,1/19
NAC_OUD_vs_Control,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.05557230672087444,0.49506093147181407,6/307
NAC_OUD_vs_Control,WikiPathways,WP_APOPTOSIS,0.05911728732578539,0.49506093147181407,7/307
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.17783713172378626,0.495284721997087,8/410
DLPFC_OUD_vs_Control,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.27587626300605883,0.4965772734109059,2/161
Male_OUD_vs_Control,GO_BP,cytokine production involved in inflammatory response,0.39468168397033243,0.49659150653942447,1/101
Male_OUD_vs_Control,GO_BP,regulation of cytokine production involved in inflammatory response,0.39468168397033243,0.49659150653942447,1/101
DLPFC_OUD_vs_Control,DO,alcohol dependence,0.440370436475614,0.4973742909838371,2/136
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.09504531904034072,0.49891069420417206,8/580
OUD_Male_vs_Female,Reactome,Metabolism of amino acids and derivatives,0.4081618966631909,0.4992694628826532,1/18
Pooled_OUD_vs_Control,DO,alcohol dependence,0.369996915412672,0.49928036339380527,3/199
OUD_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.050231528460828734,0.500021470853203,67/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.05147279847018267,0.500021470853203,104/6250
Control_Male_vs_Female,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,0.019889846531396714,0.5001358029929611,6/55
Control_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.029641520279685057,0.5001358029929611,2/55
NAC_OUD_vs_Control,GO_BP,"complement activation, classical pathway",0.10732306984742442,0.5005171971627248,3/513
NAC_OUD_vs_Control,GO_BP,regulation of glutamate secretion,0.10732306984742442,0.5005171971627248,3/513
NAC_OUD_vs_Control,GO_BP,negative regulation of humoral immune response,0.1116751077392395,0.5005171971627248,2/513
NAC_OUD_vs_Control,KEGG,Apoptosis,0.07314259089632387,0.5012943424845612,9/278
Pooled_OUD_vs_Control,DO,glycogen metabolism disorder,0.3881695085636754,0.5036887543122253,1/199
Pooled_OUD_vs_Control,DO,post-traumatic stress disorder,0.3881695085636754,0.5036887543122253,1/199
Male_OUD_vs_Control,GO_BP,positive regulation of neuron apoptotic process,0.4047520430411605,0.5038967489309619,1/101
Male_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.4137443413678018,0.5056875283384245,1/75
Male_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.4137443413678018,0.5056875283384245,1/75
Male_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.32350396789533675,0.5060181467974819,2/118
Male_OUD_vs_Control,GO_MF,CXCR chemokine receptor binding,0.09161544392776522,0.5061821183471455,1/99
Male_OUD_vs_Control,GO_MF,CCR chemokine receptor binding,0.1060550828248672,0.5061821183471455,1/99
Male_OUD_vs_Control,GO_MF,complement binding,0.14802460806302054,0.5061821183471455,1/99
Pooled_OUD_vs_Control,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.18687167030294893,0.507378314136495,6/254
DLPFC_OUD_vs_Control,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.2972529272254011,0.5075623105192619,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.2972529272254011,0.5075623105192619,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.2972529272254011,0.5075623105192619,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_ESTROGEN_METABOLISM_WP697,0.2972529272254011,0.5075623105192619,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.2972529272254011,0.5075623105192619,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.2972529272254011,0.5075623105192619,1/161
Female_OUD_vs_Control,GO_BP,regulation of astrocyte differentiation,0.1891317471187226,0.5078156797711423,2/287
Female_OUD_vs_Control,GO_BP,regulation of presynapse organization,0.1891317471187226,0.5078156797711423,2/287
Female_OUD_vs_Control,GO_BP,regulation of presynapse assembly,0.1891317471187226,0.5078156797711423,2/287
Female_OUD_vs_Control,GO_BP,mature B cell differentiation involved in immune response,0.20655016479898478,0.5078156797711423,2/287
Female_OUD_vs_Control,GO_BP,positive regulation of axon extension,0.20655016479898478,0.5078156797711423,2/287
Female_OUD_vs_Control,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.20655016479898478,0.5078156797711423,2/287
Female_OUD_vs_Control,GO_BP,regulation of tolerance induction,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,noradrenergic neuron differentiation,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,astrocyte cell migration,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of stress-activated protein kinase signaling cascade,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,chemokine (C-C motif) ligand 5 production,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,regulation of chemokine (C-C motif) ligand 5 production,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,stress-induced premature senescence,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,motor neuron migration,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of T-helper 17 type immune response,0.21415868923255843,0.5078156797711423,1/287
Female_OUD_vs_Control,GO_BP,positive regulation of T-helper 17 type immune response,0.21415868923255843,0.5078156797711423,1/287
DLPFC_OUD_vs_Control,GO_BP,regulation of cellular response to stress,0.27091775710841304,0.5081123563417427,8/253
NAC_OUD_vs_Control,GO_BP,negative regulation of innate immune response,0.1150692860232241,0.5085589239527095,6/513
DLPFC_OUD_vs_Control,GO_BP,T cell activation involved in immune response,0.2736719586960055,0.50879076621304975,4/253
DLPFC_OUD_vs_Control,GO_BP,response to pain,0.27797668702187306,0.50879076621304975,2/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of axonogenesis,0.27797668702187306,0.50879076621304975,2/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of neuron projection development,0.28301508302110634,0.50879076621304975,4/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of immunoglobulin mediated immune response,0.28753356327344715,0.50879076621304975,1/253
DLPFC_OUD_vs_Control,GO_BP,neuron remodeling,0.28753356327344715,0.50879076621304975,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of axon extension involved in axon guidance,0.28753356327344715,0.50879076621304975,1/253
DLPFC_OUD_vs_Control,GO_BP,peripheral nervous system neuron development,0.28753356327344715,0.50879076621304975,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of synapse assembly,0.28753356327344715,0.50879076621304975,1/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of dendrite development,0.28753356327344715,0.50879076621304975,1/253
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.15349975345655367,0.5098767295612868,6/278
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.20276676024637894,0.5100402600507379,2/286
Male_OUD_vs_Control,GO_BP,negative regulation of immune response,0.4127529000288541,0.5104921039621322,2/101
Control_Male_vs_Female,DO,substance abuse,0.225835747772249,0.51073622957724,2/19
Male_OUD_vs_Control,GO_MF,C-C chemokine binding,0.18804269438086796,0.5110160490825093,1/99
Male_OUD_vs_Control,GO_BP,response to oxidative stress,0.419185643380641,0.5155292647994354,3/101
OUD_Male_vs_Female,GO_BP,immunoglobulin mediated immune response,0.04007673338289368,0.5162958763698835,2/33
OUD_Male_vs_Female,GO_BP,neuron cell-cell adhesion,0.04248512700398477,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.04340596198701992,0.5162958763698835,3/33
OUD_Male_vs_Female,GO_BP,complement receptor mediated signaling pathway,0.06306603497490493,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,negative regulation of cytokine production involved in inflammatory response,0.06814385084710539,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,negative regulation of stress fiber assembly,0.07319497649133111,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,somatic recombination of immunoglobulin genes involved in immune response,0.08818956799463085,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,somatic diversification of immunoglobulins involved in immune response,0.08818956799463085,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,positive regulation of immunoglobulin mediated immune response,0.08818956799463085,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,immunoglobulin production involved in immunoglobulin-mediated immune response,0.09805498540758817,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,somatic diversification of immune receptors via germline recombination within a single locus,0.10294880084355484,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,adaptive immune response,0.10771087757624566,0.5162958763698835,3/33
OUD_Male_vs_Female,GO_BP,somatic diversification of immune receptors,0.10781686359181386,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,presynapse assembly,0.122267845521697,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,immune response-activating signaling pathway,0.12401578345851229,0.5162958763698835,3/33
OUD_Male_vs_Female,GO_BP,regulation of immunoglobulin mediated immune response,0.13649174152283328,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,activation of immune response,0.14623830316537745,0.5162958763698835,3/33
OUD_Male_vs_Female,GO_BP,immune response-regulating signaling pathway,0.14623830316537745,0.5162958763698835,3/33
OUD_Male_vs_Female,GO_BP,cytokine production involved in inflammatory response,0.15049201025936343,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,presynapse organization,0.15049201025936343,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,regulation of cytokine production involved in inflammatory response,0.15049201025936343,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,regulation of response to stress,0.1635154414587616,0.5162958763698835,5/33
OUD_Male_vs_Female,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.1688170531361911,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,negative regulation of cytokine production,0.1727076915916357,0.5162958763698835,2/33
OUD_Male_vs_Female,GO_BP,neuron cellular homeostasis,0.1778352463051821,0.5162958763698835,1/33
OUD_Male_vs_Female,GO_BP,negative regulation of response to cytokine stimulus,0.18230869014226847,0.5166665989923304,1/33
OUD_Male_vs_Female,DO,alcohol dependence,0.17024377616392938,0.5211544168283553,1/17
Male_OUD_vs_Control,KEGG,Apoptosis,0.3417155753454063,0.5218928787093479,2/64
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.055652225335411205,0.5219794928010981,32/6250
Female_OUD_vs_Control,GO_BP,regulation of dopamine secretion,0.2241291045905242,0.5220270901996812,2/287
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.07317472124238533,0.5233625244416563,26/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.07317472124238533,0.5233625244416563,26/6081
NAC_OUD_vs_Control,Reactome,Diseases of metabolism,0.018563867853217213,0.5234247822516775,15/349
NAC_OUD_vs_Control,Reactome,Diseases of Immune System,0.020590480916587217,0.5234247822516775,5/349
OUD_Male_vs_Female,GO_BP,regulation of stress fiber assembly,0.19558786447308496,0.524435016471984,1/33
OUD_Male_vs_Female,GO_BP,immune response-activating cell surface receptor signaling pathway,0.1961775431987792,0.524435016471984,2/33
DLPFC_OUD_vs_Control,WikiPathways,WP_OPIOID_RECEPTOR_PATHWAYS,0.3129258243164931,0.5260076113024319,2/161
Female_OUD_vs_Control,GO_BP,positive regulation of neuron differentiation,0.2377571559379634,0.5261851131272126,4/287
Female_OUD_vs_Control,GO_BP,complement activation,0.24181514687796188,0.5261851131272126,2/287
Female_OUD_vs_Control,GO_BP,synapse maturation,0.24181514687796188,0.5261851131272126,2/287
Female_OUD_vs_Control,GO_BP,detection of stimulus involved in sensory perception of pain,0.24181514687796188,0.5261851131272126,2/287
Female_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.24181514687796188,0.5261851131272126,2/287
Female_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor internalization,0.24181514687796188,0.5261851131272126,2/287
Female_OUD_vs_Control,GO_BP,negative regulation of type 2 immune response,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,"complement activation, alternative pathway",0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of macrophage cytokine production,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,pyramidal neuron differentiation,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,T-helper 2 cell cytokine production,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,positive regulation of astrocyte differentiation,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,axonogenesis involved in innervation,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,commissural neuron axon guidance,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,regulation of T-helper 2 cell cytokine production,0.2511561393950018,0.5261851131272126,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of neuron migration,0.2511561393950018,0.5261851131272126,1/287
DLPFC_OUD_vs_Control,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.30909229654328446,0.5269629039618,3/253
DLPFC_OUD_vs_Control,GO_BP,regulation of immunoglobulin mediated immune response,0.30911095658951493,0.5269629039618,2/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of neuron projection development,0.3113056929082834,0.5269629039618,4/253
DLPFC_OUD_vs_Control,GO_BP,microglia differentiation,0.3171173493380818,0.5269629039618,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of response to osmotic stress,0.3171173493380818,0.5269629039618,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of axon regeneration,0.3171173493380818,0.5269629039618,1/253
DLPFC_OUD_vs_Control,GO_BP,peripheral nervous system neuron differentiation,0.3171173493380818,0.5269629039618,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of programmed necrotic cell death,0.3171173493380818,0.5269629039618,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of neuron projection regeneration,0.3171173493380818,0.5269629039618,1/253
DLPFC_OUD_vs_Control,GO_BP,dopamine uptake,0.3171173493380818,0.5269629039618,1/253
DLPFC_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.3171173493380818,0.5269629039618,1/253
DLPFC_OUD_vs_Control,GO_BP,neurotransmitter receptor diffusion trapping,0.3171173493380818,0.5269629039618,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.3171173493380818,0.5269629039618,1/253
OUD_Male_vs_Female,GO_BP,B cell activation involved in immune response,0.1999676038679682,0.527601821280307,1/33
OUD_Male_vs_Female,DO,opiate dependence,0.19423986571948593,0.5276178912435594,1/17
Female_OUD_vs_Control,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.09425917368128589,0.5279672288779966,4/206
Female_OUD_vs_Control,Reactome,MECP2 regulates neuronal receptors and channels,0.10018853781455118,0.5279672288779966,2/206
Female_OUD_vs_Control,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.2511852074166758,0.5281080176730639,2/198
Female_OUD_vs_Control,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.2677384833784371,0.5281080176730639,1/198
Female_OUD_vs_Control,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.2677384833784371,0.5281080176730639,1/198
Female_OUD_vs_Control,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.2677384833784371,0.5281080176730639,1/198
Female_OUD_vs_Control,WikiPathways,WP_NAD_METABOLISM,0.2677384833784371,0.5281080176730639,1/198
OUD_DLPFC_vs_NAC,KEGG,Inositol phosphate metabolism,0.05352507488496683,0.5289536812161428,31/2402
Female_OUD_vs_Control,KEGG,Intestinal immune network for IgA production,0.18683884041398574,0.5290015361118874,3/175
DLPFC_OUD_vs_Control,GO_BP,sensory perception of pain,0.3205976310505369,0.5307803338179861,3/253
DLPFC_OUD_vs_Control,GO_BP,neuron projection organization,0.3205976310505369,0.5307803338179861,3/253
NAC_OUD_vs_Control,GO_BP,negative regulation of cytokine production,0.12153034653971424,0.5331014599354702,16/513
NAC_OUD_vs_Control,GO_BP,protein localization to postsynapse,0.12234372646202885,0.5331014599354702,4/513
DLPFC_OUD_vs_Control,DO,substance-related disorder,0.482673668336823,0.5333210589521687,9/136
Control_Male_vs_Female,GO_CC,GABA-ergic synapse,0.2539898286732897,0.5344369311667136,1/33
Male_OUD_vs_Control,GO_BP,regulation of cellular response to stress,0.4456816913637115,0.5344411318002055,3/101
DLPFC_OUD_vs_Control,WikiPathways,WP_PYRIMIDINE_METABOLISM,0.33131439116062755,0.5348931527232792,2/161
DLPFC_OUD_vs_Control,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.33183186326351577,0.5348931527232792,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.33183186326351577,0.5348931527232792,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.33183186326351577,0.5348931527232792,1/161
Male_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.24169921889176285,0.5351812112738344,2/110
Pooled_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.20745374876368058,0.5352535948764576,2/254
Pooled_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.20745374876368058,0.5352535948764576,2/254
Female_OUD_vs_Control,GO_BP,dopamine secretion,0.2595595104431631,0.5361155573569699,2/287
NAC_OUD_vs_Control,GO_BP,regulation of stress-activated MAPK cascade,0.12617076687546172,0.5369349960426297,3/513
NAC_OUD_vs_Control,GO_BP,neurotransmitter receptor transport,0.12617076687546172,0.5369349960426297,3/513
NAC_OUD_vs_Control,GO_BP,positive regulation of response to cytokine stimulus,0.1264181843636281,0.5369349960426297,5/513
Pooled_OUD_vs_Control,DO,complement deficiency,0.42969552077234807,0.5377825113369973,1/199
Male_OUD_vs_Control,GO_BP,cellular response to oxidative stress,0.45259115862112687,0.5380421594564484,2/101
Male_OUD_vs_Control,GO_BP,neuron cellular homeostasis,0.4526687561576467,0.5380421594564484,1/101
Male_OUD_vs_Control,GO_BP,receptor localization to synapse,0.4526687561576467,0.5380421594564484,1/101
OUD_Male_vs_Female,GO_BP,positive regulation of innate immune response,0.21405382764070374,0.5381582245511124,2/33
OUD_Male_vs_Female,GO_BP,immune effector process,0.21678176897425294,0.5381582245511124,3/33
OUD_DLPFC_vs_NAC,GO_CC,main axon,0.05507700455142178,0.5388410215657441,39/5358
Pooled_OUD_vs_Control,GO_BP,alpha-beta T cell activation involved in immune response,0.19638903757487405,0.5394827872966175,4/380
Pooled_OUD_vs_Control,GO_BP,alpha-beta T cell differentiation involved in immune response,0.19638903757487405,0.5394827872966175,4/380
Pooled_OUD_vs_Control,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.19638903757487405,0.5394827872966175,4/380
NAC_OUD_vs_Control,GO_BP,negative regulation of immune effector process,0.12776761934576306,0.5397436415091211,8/513
Control_DLPFC_vs_NAC,GO_BP,neuron projection guidance,0.007985662682543755,0.5411090669900285,129/4916
NAC_OUD_vs_Control,GO_BP,regulation of synapse structure or activity,0.12869401072931305,0.5417119986512945,18/513
Male_OUD_vs_Control,GO_CC,cytoplasmic stress granule,0.2907657656442785,0.5418517379272259,1/100
OUD_Male_vs_Female,GO_BP,stress fiber assembly,0.22576448718444142,0.5426386783958385,1/33
Pooled_OUD_vs_Control,GO_CC,stress fiber,0.08822198808204793,0.5447357676812166,5/397
Pooled_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.20625707760174086,0.5448162954748599,7/410
Female_OUD_vs_Control,GO_BP,regulation of axon extension,0.26438843445444393,0.5452592700431488,3/287
DLPFC_OUD_vs_Control,GO_BP,cellular response to oxidative stress,0.33394833594721984,0.5453626516713798,5/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of neuron apoptotic process,0.33985067778201605,0.5453626516713798,4/253
DLPFC_OUD_vs_Control,GO_BP,neuron projection regeneration,0.3399704134054481,0.5453626516713798,2/253
DLPFC_OUD_vs_Control,GO_BP,tolerance induction,0.34547738062788247,0.5453626516713798,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of immune response to tumor cell,0.34547738062788247,0.5453626516713798,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.34547738062788247,0.5453626516713798,1/253
DLPFC_OUD_vs_Control,GO_BP,antifungal innate immune response,0.34547738062788247,0.5453626516713798,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of cellular response to oxidative stress,0.34547738062788247,0.5453626516713798,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.34547738062788247,0.5453626516713798,1/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of response to endoplasmic reticulum stress,0.34547738062788247,0.5453626516713798,1/253
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.08489777794940041,0.5454849354859114,31/6081
DLPFC_OUD_vs_Control,Reactome,Cellular response to chemical stress,0.0809246120430941,0.5457395324559073,5/172
OUD_Male_vs_Female,GO_BP,immune response-regulating cell surface receptor signaling pathway,0.23008685725243136,0.5466514950120558,2/33
OUD_Male_vs_Female,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.23418280094960908,0.5466514950120558,1/33
OUD_Male_vs_Female,GO_BP,positive regulation of adaptive immune response,0.23835860524053132,0.5469418420533438,1/33
DLPFC_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.23307438967101088,0.5471720235332234,4/286
DLPFC_OUD_vs_Control,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.3647193808466931,0.548985270124639,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.3647193808466931,0.548985270124639,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.3647193808466931,0.548985270124639,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.3647193808466931,0.548985270124639,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_RETINOL_METABOLISM,0.3647193808466931,0.548985270124639,1/161
DLPFC_OUD_vs_Control,DO,motor neuron disease,0.5080149920854583,0.5519514228429816,3/136
DLPFC_OUD_vs_Control,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.08470392837265123,0.5529472444166672,3/172
Pooled_OUD_vs_Control,Reactome,Regulation of necroptotic cell death,0.05916161903955412,0.5532265789024148,3/267
Female_OUD_vs_Control,GO_BP,negative regulation of humoral immune response,0.2864175320108566,0.5533869599962847,1/287
Female_OUD_vs_Control,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.2864175320108566,0.5533869599962847,1/287
Female_OUD_vs_Control,GO_BP,G protein-coupled opioid receptor signaling pathway,0.2864175320108566,0.5533869599962847,1/287
Female_OUD_vs_Control,GO_BP,regulation of cellular response to osmotic stress,0.2864175320108566,0.5533869599962847,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.2864175320108566,0.5533869599962847,1/287
Female_OUD_vs_Control,GO_BP,regulation of microglial cell activation,0.2864175320108566,0.5533869599962847,1/287
Female_OUD_vs_Control,GO_BP,regulation of dopaminergic neuron differentiation,0.2864175320108566,0.5533869599962847,1/287
Female_OUD_vs_Control,GO_BP,protein localization to presynapse,0.2864175320108566,0.5533869599962847,1/287
Male_OUD_vs_Control,Reactome,Metabolism of proteins,0.34660579460498686,0.5551694545621001,13/75
NAC_OUD_vs_Control,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.1376189850312923,0.5562422043616295,4/513
NAC_OUD_vs_Control,GO_BP,type 2 immune response,0.1376189850312923,0.5562422043616295,4/513
NAC_OUD_vs_Control,GO_BP,presynapse assembly,0.1376189850312923,0.5562422043616295,4/513
NAC_OUD_vs_Control,GO_BP,ectopic germ cell programmed cell death,0.14089262804909952,0.5562422043616295,2/513
OUD_Male_vs_Female,DO,drug dependence,0.21758170677879785,0.5562542411147207,1/17
OUD_Male_vs_Female,GO_BP,positive regulation of immune response,0.2530995543516114,0.5563938439600096,3/33
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.21457833615769326,0.5575528647410798,7/410
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.18179664866492268,0.5577110477647494,6/278
OUD_Male_vs_Female,GO_BP,positive regulation of immune system process,0.2578706227069828,0.5577552990407192,4/33
Female_OUD_vs_Control,GO_CC,stress fiber,0.10995347453750699,0.5588046445673301,4/305
Female_OUD_vs_Control,GO_BP,immune system development,0.2903219550627704,0.558853266838864,4/287
Female_OUD_vs_Control,GO_BP,regulation of stress fiber assembly,0.2903454917909459,0.558853266838864,3/287
Female_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.2263903612200188,0.5603992012799521,5/319
OUD_Male_vs_Female,GO_MF,cytokine receptor binding,0.41094694893917383,0.560629612460065,1/32
Female_OUD_vs_Control,C8_CellType,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.30453867707912885,0.5624616413610884,1/334
Control_DLPFC_vs_NAC,GO_BP,axon guidance,0.008840747059602675,0.5627406138551172,128/4916
NAC_OUD_vs_Control,GO_BP,synapse organization,0.14304690438220288,0.5628073201328859,30/513
DLPFC_OUD_vs_Control,GO_BP,cellular response to chemical stress,0.3721283626674387,0.5629695396383634,6/253
DLPFC_OUD_vs_Control,GO_BP,natural killer cell activation involved in immune response,0.3726640860459003,0.5629695396383634,1/253
DLPFC_OUD_vs_Control,GO_BP,immune response to tumor cell,0.3726640860459003,0.5629695396383634,1/253
DLPFC_OUD_vs_Control,GO_BP,cellular component disassembly involved in execution phase of apoptosis,0.3726640860459003,0.5629695396383634,1/253
DLPFC_OUD_vs_Control,GO_BP,response to morphine,0.3726640860459003,0.5629695396383634,1/253
DLPFC_OUD_vs_Control,GO_BP,axon extension involved in axon guidance,0.3726640860459003,0.5629695396383634,1/253
DLPFC_OUD_vs_Control,GO_BP,neuronal stem cell population maintenance,0.3726640860459003,0.5629695396383634,1/253
DLPFC_OUD_vs_Control,GO_BP,neuron projection extension involved in neuron projection guidance,0.3726640860459003,0.5629695396383634,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of receptor localization to synapse,0.3726640860459003,0.5629695396383634,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.3726640860459003,0.5629695396383634,1/253
NAC_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.12722482945103677,0.5634408580349846,9/580
Male_OUD_vs_Control,WikiPathways,WP_CHEMOKINE_SIGNALING,0.5020469973570632,0.5648190319245516,2/75
Male_OUD_vs_Control,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.5020613617107126,0.5648190319245516,1/75
NAC_OUD_vs_Control,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.14609570657850104,0.5649354109765209,3/513
NAC_OUD_vs_Control,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.14609570657850104,0.5649354109765209,3/513
NAC_OUD_vs_Control,GO_BP,neurotransmitter reuptake,0.14609570657850104,0.5649354109765209,3/513
Male_OUD_vs_Control,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.3710254821455794,0.5649359193163143,1/75
OUD_Male_vs_Female,GO_BP,immune system development,0.27097947716888615,0.5657045786257675,1/33
DLPFC_OUD_vs_Control,GO_BP,response to oxidative stress,0.3750898552637973,0.5664221524140663,7/253
Pooled_OUD_vs_Control,GO_BP,regulation of cytokine-mediated signaling pathway,0.2109389117287711,0.569417655965421,7/380
NAC_OUD_vs_Control,GO_BP,regulation of synapse assembly,0.1477814968175809,0.569727744689837,11/513
DLPFC_OUD_vs_Control,GO_BP,positive regulation of neuron differentiation,0.3779907184460868,0.5697795188830874,3/253
Pooled_OUD_vs_Control,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.236965033386939,0.5704261370706212,2/254
Pooled_OUD_vs_Control,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.236965033386939,0.5704261370706212,2/254
Pooled_OUD_vs_Control,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.236965033386939,0.5704261370706212,2/254
DLPFC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.2665243748599101,0.57184660175638935,1/286
Pooled_OUD_vs_Control,GO_BP,"complement activation, classical pathway",0.2155328001208315,0.5719153024482854,2/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of chemokine production,0.2155328001208315,0.5719153024482854,2/380
Male_OUD_vs_Control,GO_BP,B cell activation involved in immune response,0.49676335838408703,0.5734105060871286,1/101
Male_OUD_vs_Control,GO_BP,response to osmotic stress,0.49676335838408703,0.5734105060871286,1/101
OUD_Male_vs_Female,GO_BP,regulation of innate immune response,0.28063886750268097,0.5740340471645747,2/33
Pooled_OUD_vs_Control,GO_BP,neurotransmitter receptor internalization,0.21807752588036933,0.5748239133259735,3/380
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.09516818973475914,0.575724785466705,18/6081
Control_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.0952485858308887,0.575724785466705,11/6081
Female_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.30099878549308123,0.5758365915812071,4/198
Female_OUD_vs_Control,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.3120230833451657,0.5758365915812071,1/198
Female_OUD_vs_Control,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.3120230833451657,0.5758365915812071,1/198
Pooled_OUD_vs_Control,DO,substance dependence,0.47942762566865693,0.576023413951527,5/199
DLPFC_OUD_vs_Control,GO_BP,lymphocyte activation involved in immune response,0.3839204677671184,0.5771671067921162,5/253
DLPFC_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.39506720486291935,0.5779426231327213,3/161
Female_OUD_vs_Control,GO_BP,presynapse assembly,0.31271779725376125,0.5779750960012967,2/287
Female_OUD_vs_Control,GO_BP,response to axon injury,0.3164754144357162,0.5779750960012967,3/287
Female_OUD_vs_Control,GO_BP,peripheral nervous system neuron development,0.3200240578252449,0.5779750960012967,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of synapse assembly,0.3200240578252449,0.5779750960012967,1/287
NAC_OUD_vs_Control,DO,lipid metabolism disorder,0.3163728065392853,0.5781367405150909,6/257
Pooled_OUD_vs_Control,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.07175640814920203,0.5782428090384186,5/267
Pooled_OUD_vs_Control,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.0750646327525117,0.5782428090384186,4/267
OUD_Male_vs_Female,GO_CC,GABA-ergic synapse,0.24731962008260422,0.5785512541218063,1/32
DLPFC_OUD_vs_Control,Reactome,Programmed Cell Death,0.09292999600058457,0.5788616544769237,6/172
DLPFC_OUD_vs_Control,GO_BP,organ or tissue specific immune response,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of humoral immune response,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,response to arsenic-containing substance,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of axon regeneration,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of sensory perception of pain,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of programmed necrotic cell death,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of neuron projection regeneration,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,synapse pruning,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of synapse organization,0.39872582434317216,0.5809958905706827,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.40025117453664316,0.5809958905706827,2/253
DLPFC_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.19642336883459868,0.5835821711128327,4/278
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.2792760030028155,0.5839407335513416,2/435
DLPFC_OUD_vs_Control,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.33920940254499243,0.5844913160993429,1/40
DLPFC_OUD_vs_Control,BioCarta,BIOCARTA_STRESS_PATHWAY,0.49989388876917484,0.5844913160993429,1/40
DLPFC_OUD_vs_Control,WikiPathways,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.40320000492745656,0.585738562327601,2/161
Pooled_OUD_vs_Control,DO,heroin dependence,0.49089074290454393,0.5863216384323787,2/199
NAC_OUD_vs_Control,GO_MF,complement binding,0.04622008562253788,0.5867212562320958,3/528
NAC_OUD_vs_Control,GO_MF,neurotransmitter transmembrane transporter activity,0.04622008562253788,0.5867212562320958,3/528
NAC_OUD_vs_Control,DO,nicotine dependence,0.3262310604051172,0.5892279064585817,3/257
Female_OUD_vs_Control,GO_BP,axon regeneration,0.33028975018714124,0.5894513129436306,2/287
Female_OUD_vs_Control,GO_BP,response to pain,0.33028975018714124,0.5894513129436306,2/287
Female_OUD_vs_Control,GO_BP,negative regulation of axonogenesis,0.33028975018714124,0.5894513129436306,2/287
Male_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.4246310439366594,0.5897642766138462,2/118
OUD_Male_vs_Female,GO_BP,positive regulation of production of molecular mediator of immune response,0.2984080362155975,0.5909792404269779,1/33
Male_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.3104216716474335,0.5915351182406604,2/110
Control_Male_vs_Female,DO,substance-related disorder,0.33588135832236177,0.5918669402681038,2/19
DLPFC_OUD_vs_Control,GO_BP,synapse assembly,0.40950270158777413,0.5924657502728169,7/253
Control_Male_vs_Female,GO_BP,neuron cell-cell adhesion,0.04752591181235133,0.5927701115381654,1/37
Pooled_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.24058779807477063,0.5928282280209335,6/410
Control_Male_vs_Female,Reactome,Metabolism,0.5373431745136096,0.5932266409498929,4/19
OUD_Male_vs_Female,DO,substance dependence,0.3250496448627299,0.5946030088952377,1/17
Male_OUD_vs_Control,GO_BP,"regulation of synaptic transmission, glutamatergic",0.5215121723601277,0.5949350445749486,1/101
NAC_OUD_vs_Control,DO,autoimmune disease of central nervous system,0.3673635845090213,0.595332291101576,1/257
NAC_OUD_vs_Control,DO,autoimmune thyroiditis,0.3673635845090213,0.595332291101576,1/257
Male_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.3218033676645219,0.5967061002148782,2/110
Male_OUD_vs_Control,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.43448761376195344,0.5972739932364041,1/118
Pooled_OUD_vs_Control,DO,withdrawal disorder,0.5129324999225318,0.597684277926973,2/199
Female_OUD_vs_Control,GO_BP,neurotransmitter receptor internalization,0.34773529746283005,0.5983726643071856,2/287
Female_OUD_vs_Control,GO_BP,neuron projection extension,0.35180928057266747,0.5983726643071856,5/287
Female_OUD_vs_Control,GO_BP,microglia differentiation,0.3520531232124361,0.5983726643071856,1/287
Female_OUD_vs_Control,GO_BP,regulation of response to osmotic stress,0.3520531232124361,0.5983726643071856,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of axon regeneration,0.3520531232124361,0.5983726643071856,1/287
Female_OUD_vs_Control,GO_BP,peripheral nervous system neuron differentiation,0.3520531232124361,0.5983726643071856,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of programmed necrotic cell death,0.3520531232124361,0.5983726643071856,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of neuron projection regeneration,0.3520531232124361,0.5983726643071856,1/287
Female_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.3520531232124361,0.5983726643071856,1/287
Female_OUD_vs_Control,GO_BP,neurotransmitter receptor diffusion trapping,0.3520531232124361,0.5983726643071856,1/287
Female_OUD_vs_Control,GO_BP,regulation of protein localization to synapse,0.3520531232124361,0.5983726643071856,1/287
Female_OUD_vs_Control,GO_BP,glutamatergic neuron differentiation,0.3520531232124361,0.5983726643071856,1/287
DLPFC_OUD_vs_Control,GO_BP,regulation of T-helper 17 type immune response,0.42370896877430664,0.5984389002835433,1/253
DLPFC_OUD_vs_Control,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.4377883206810701,0.5984954257412097,2/161
NAC_OUD_vs_Control,WikiPathways,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.09474915777816821,0.5989025607089196,3/307
Male_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.443393320631844,0.6003568475738663,1/118
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter transport,0.005391894969640919,0.600618586082501,107/5050
DLPFC_OUD_vs_Control,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.44837719087836103,0.6016675645689402,3/161
DLPFC_OUD_vs_Control,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.45403617141082064,0.6016675645689402,1/161
DLPFC_OUD_vs_Control,GO_BP,regulation of neuronal synaptic plasticity,0.4294313761232075,0.6037667810103416,2/253
NAC_OUD_vs_Control,GO_BP,regulation of postsynapse organization,0.16643636964655092,0.6044959153106824,9/513
NAC_OUD_vs_Control,GO_BP,regulation of astrocyte differentiation,0.16695853814923806,0.6044959153106824,3/513
NAC_OUD_vs_Control,GO_BP,neurotransmitter receptor internalization,0.1702679369744441,0.6044959153106824,4/513
NAC_OUD_vs_Control,GO_BP,microglia differentiation,0.17148364788350212,0.6044959153106824,2/513
NAC_OUD_vs_Control,GO_BP,cerebral cortex GABAergic interneuron differentiation,0.17148364788350212,0.6044959153106824,2/513
Female_OUD_vs_Control,KEGG,Starch and sucrose metabolism,0.2263914290544513,0.6045680207704097,2/175
NAC_OUD_vs_Control,DO,mineral metabolism disease,0.3824708900456918,0.6054558491070796,2/257
Pooled_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.24940742945596023,0.6057262379274722,5/410
Pooled_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.26161430322361673,0.6061942517634478,3/254
Pooled_OUD_vs_Control,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.26667586839457746,0.6061942517634478,2/254
DLPFC_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.2141442237095307,0.6076852371646609,5/278
NAC_OUD_vs_Control,GO_BP,regulation of synapse organization,0.17356106538805732,0.6095360997882073,17/513
OUD_DLPFC_vs_NAC,Reactome,Transmission across Chemical Synapses,8.331098977564553e-4,0.6098364451577253,135/3111
Pooled_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.30036707541167407,0.610562700728741,1/435
Pooled_OUD_vs_Control,C8_CellType,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.30142786908347385,0.610562700728741,33/435
NAC_OUD_vs_Control,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.10179369826636547,0.6107621895981928,2/307
Pooled_OUD_vs_Control,GO_BP,negative regulation of innate immune response,0.23654174844185163,0.6113954193881296,4/380
Pooled_OUD_vs_Control,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.23909552826930977,0.6113954193881296,2/380
OUD_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.02629849245224854,0.6118194152426278,3/43
OUD_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.02823933981486826,0.6118194152426278,1/43
OUD_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.03379299590045526,0.6118194152426278,1/43
OUD_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.04480746089939136,0.6118194152426278,1/43
OUD_Male_vs_Female,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.09806614585747453,0.6118194152426278,1/43
OUD_Male_vs_Female,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.18671732216667847,0.6118194152426278,1/43
OUD_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.19138449888452613,0.6118194152426278,1/43
OUD_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.21309998047154208,0.6118194152426278,2/43
DLPFC_OUD_vs_Control,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.14828929859124712,0.6123555576105174,3/253
DLPFC_OUD_vs_Control,GO_MF,toxic substance binding,0.1871591170144905,0.6123555576105174,1/253
OUD_Male_vs_Female,GO_CC,axon terminus,0.3053322438720496,0.6129420012529209,1/32
Female_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.26942220234950814,0.6129484882932211,4/319
Male_OUD_vs_Control,GO_BP,regulation of neuron apoptotic process,0.5426109534012692,0.6130855234446213,2/101
OUD_Male_vs_Female,GO_BP,regulation of cytokine production,0.3175010158708318,0.6137847800844242,3/33
Male_OUD_vs_Control,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.5450553191209311,0.6141346384691937,1/101
Male_OUD_vs_Control,GO_BP,stress fiber assembly,0.5450553191209311,0.6141346384691937,1/101
NAC_OUD_vs_Control,DO,opiate dependence,0.4078829975623228,0.614201382720746,4/257
NAC_OUD_vs_Control,DO,autoimmune disease of peripheral nervous system,0.422778567052028,0.614201382720746,1/257
NAC_OUD_vs_Control,DO,combined oxidative phosphorylation deficiency,0.422778567052028,0.614201382720746,1/257
NAC_OUD_vs_Control,DO,autosomal dominant distal hereditary motor neuronopathy,0.422778567052028,0.614201382720746,1/257
NAC_OUD_vs_Control,DO,newborn respiratory distress syndrome,0.422778567052028,0.614201382720746,1/257
Female_OUD_vs_Control,GO_BP,dopamine transport,0.3650274962241947,0.6145208449053572,2/287
Female_OUD_vs_Control,GO_BP,negative regulation of neuron projection development,0.3659756282407718,0.6145913459808917,4/287
Female_OUD_vs_Control,GO_BP,axon guidance,0.3735358806721036,0.6150580885807768,8/287
Female_OUD_vs_Control,GO_BP,neuron projection guidance,0.38078681439164025,0.6150580885807768,8/287
Female_OUD_vs_Control,GO_BP,stress fiber assembly,0.38172434856454474,0.6150580885807768,3/287
Female_OUD_vs_Control,GO_BP,tolerance induction,0.38257852597639375,0.6150580885807768,1/287
Female_OUD_vs_Control,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.38257852597639375,0.6150580885807768,1/287
Female_OUD_vs_Control,GO_BP,regulation of cellular response to oxidative stress,0.38257852597639375,0.6150580885807768,1/287
Female_OUD_vs_Control,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.38257852597639375,0.6150580885807768,1/287
OUD_Male_vs_Female,GO_BP,cytokine production,0.3220417795510284,0.615203351377944,3/33
DLPFC_OUD_vs_Control,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.4453938215639742,0.6158919784578395,3/253
DLPFC_OUD_vs_Control,GO_BP,"complement activation, classical pathway",0.4476579883045465,0.6158919784578395,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of chemokine production,0.4476579883045465,0.6158919784578395,1/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.4476579883045465,0.6158919784578395,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of response to oxidative stress,0.4476579883045465,0.6158919784578395,1/253
Male_OUD_vs_Control,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.36123555085766246,0.615905815372087,2/110
Pooled_OUD_vs_Control,DO,calcium metabolism disease,0.5381839585602737,0.6164790824751157,1/199
Pooled_OUD_vs_Control,DO,opioid abuse,0.5381839585602737,0.6164790824751157,1/199
DLPFC_OUD_vs_Control,KEGG,Porphyrin metabolism,0.25918903292134743,0.6165176025799041,1/142
Pooled_OUD_vs_Control,GO_CC,immunological synapse,0.12084764498377465,0.6171651468432742,3/397
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.11279712944322519,0.6176273231179593,17/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.1179664168773599,0.6176273231179593,10/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.1179664168773599,0.6176273231179593,10/6081
DLPFC_OUD_vs_Control,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.48094164322069466,0.6183535412837503,1/161
Male_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.3668053170140949,0.6185627721300682,2/110
Female_OUD_vs_Control,Reactome,Cellular response to chemical stress,0.14365430249829475,0.6186403026942694,5/206
Female_OUD_vs_Control,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.35705941721444734,0.6190949572669853,4/198
OUD_DLPFC_vs_NAC,WikiPathways,WP_PHOSPHOINOSITIDES_METABOLISM,0.009094725223473425,0.6196737138836544,23/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.00995042020244149,0.6196737138836544,32/2675
Male_OUD_vs_Control,GO_BP,sensory perception of pain,0.5526452452472587,0.6207136299093964,1/101
Female_OUD_vs_Control,GO_MF,complement binding,0.07674770893372046,0.6217101912169586,2/292
Female_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.3649405092513496,0.6221632091562448,1/334
Female_OUD_vs_Control,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.3649405092513496,0.6221632091562448,1/334
OUD_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.27039631327494085,0.622302729380593,2/43
Male_OUD_vs_Control,KEGG,Platinum drug resistance,0.4524655362461977,0.6230672958144361,1/64
OUD_Male_vs_Female,GO_BP,regulation of cytokine-mediated signaling pathway,0.34671577555811217,0.6231076934044946,1/33
Pooled_OUD_vs_Control,GO_BP,B cell activation involved in immune response,0.2503413979248071,0.6243362909612413,4/380
Pooled_OUD_vs_Control,GO_BP,retinal ganglion cell axon guidance,0.26277329907904523,0.6243362909612413,2/380
Pooled_OUD_vs_Control,GO_BP,dopaminergic neuron differentiation,0.26277329907904523,0.6243362909612413,2/380
Pooled_OUD_vs_Control,GO_BP,response to axon injury,0.2643066815538926,0.6243362909612413,4/380
Pooled_OUD_vs_Control,GO_BP,neuron projection regeneration,0.26908799187667737,0.6243362909612413,3/380
Pooled_OUD_vs_Control,GO_BP,execution phase of apoptosis,0.26908799187667737,0.6243362909612413,3/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of dendritic cell cytokine production,0.2750512457086981,0.6243362909612413,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of natural killer cell mediated immune response to tumor cell,0.2750512457086981,0.6243362909612413,1/380
Pooled_OUD_vs_Control,GO_BP,noradrenergic neuron differentiation,0.2750512457086981,0.6243362909612413,1/380
Pooled_OUD_vs_Control,GO_BP,astrocyte cell migration,0.2750512457086981,0.6243362909612413,1/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of stress-activated protein kinase signaling cascade,0.2750512457086981,0.6243362909612413,1/380
Pooled_OUD_vs_Control,GO_BP,stress-induced premature senescence,0.2750512457086981,0.6243362909612413,1/380
Pooled_OUD_vs_Control,GO_BP,motor neuron migration,0.2750512457086981,0.6243362909612413,1/380
Pooled_OUD_vs_Control,GO_BP,antibacterial innate immune response,0.2750512457086981,0.6243362909612413,1/380
Pooled_OUD_vs_Control,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.2750512457086981,0.6243362909612413,1/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of T-helper 17 type immune response,0.2750512457086981,0.6243362909612413,1/380
Control_DLPFC_vs_NAC,GO_CC,axonemal microtubule,0.053689543231354074,0.6257608831792302,34/5212
DLPFC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.22838415447072247,0.6262064933324277,5/278
Female_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.36499895104834823,0.627798195803159,2/198
OUD_Male_vs_Female,GO_BP,regulation of response to cytokine stimulus,0.36442326364709654,0.6280486033066983,1/33
NAC_OUD_vs_Control,GO_BP,receptor localization to synapse,0.18124772876487272,0.6285569724152477,5/513
NAC_OUD_vs_Control,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.11036350013088593,0.6286338775035815,4/307
NAC_OUD_vs_Control,WikiPathways,WP_FOLATE_METABOLISM,0.11477998733098889,0.6286338775035815,5/307
NAC_OUD_vs_Control,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.11499400198236247,0.6286338775035815,3/307
NAC_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,0.16625600406388977,0.629470621428596,10/580
NAC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.16625600406388977,0.629470621428596,10/580
Female_OUD_vs_Control,WikiPathways,WP_AXON_GUIDANCE,0.3718310619417947,0.6301674968440361,3/198
Female_OUD_vs_Control,WikiPathways,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.39275555617256197,0.6301674968440361,1/198
Female_OUD_vs_Control,WikiPathways,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.39275555617256197,0.6301674968440361,1/198
OUD_DLPFC_vs_NAC,KEGG,GABAergic synapse,0.07315979925975348,0.6302998090071069,42/2402
OUD_Male_vs_Female,GO_CC,neuron projection terminus,0.3360354591878043,0.6306613709382672,1/32
Female_OUD_vs_Control,GO_BP,sensory perception of pain,0.3946487358972278,0.6322148450259134,3/287
Female_OUD_vs_Control,GO_BP,neuron apoptotic process,0.3971215279875112,0.6330641591218545,7/287
Female_OUD_vs_Control,GO_BP,execution phase of apoptosis,0.3990578587729475,0.6330641591218545,2/287
Female_OUD_vs_Control,GO_BP,regulation of neuron apoptotic process,0.4070411548360755,0.6330641591218545,6/287
Female_OUD_vs_Control,GO_BP,macrophage activation involved in immune response,0.4116706230121473,0.6330641591218545,1/287
Female_OUD_vs_Control,GO_BP,natural killer cell activation involved in immune response,0.4116706230121473,0.6330641591218545,1/287
Female_OUD_vs_Control,GO_BP,cellular component disassembly involved in execution phase of apoptosis,0.4116706230121473,0.6330641591218545,1/287
Female_OUD_vs_Control,GO_BP,detection of mechanical stimulus involved in sensory perception of pain,0.4116706230121473,0.6330641591218545,1/287
Female_OUD_vs_Control,GO_BP,regulation of neurotransmitter uptake,0.4116706230121473,0.6330641591218545,1/287
Female_OUD_vs_Control,GO_BP,regulation of synapse maturation,0.4116706230121473,0.6330641591218545,1/287
Female_OUD_vs_Control,GO_BP,regulation of receptor localization to synapse,0.4116706230121473,0.6330641591218545,1/287
Female_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.28852152518880225,0.6337633543097076,6/319
OUD_Male_vs_Female,GO_BP,positive regulation of cytokine production,0.3748771514881989,0.6339258720364115,2/33
DLPFC_OUD_vs_Control,GO_BP,negative regulation of cytokine production involved in immune response,0.47061552550825114,0.634717933200507,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of stress-activated MAPK cascade,0.47061552550825114,0.634717933200507,1/253
DLPFC_OUD_vs_Control,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.47061552550825114,0.634717933200507,1/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of macrophage cytokine production,0.47061552550825114,0.634717933200507,1/253
Female_OUD_vs_Control,GO_BP,presynapse organization,0.41575532568394036,0.6352641457784278,2/287
Male_OUD_vs_Control,KEGG,Cholesterol metabolism,0.47647643225126723,0.6353019096683563,1/64
Female_OUD_vs_Control,Reactome,Regulation of necroptotic cell death,0.1562520411974889,0.6353192131938508,2/206
Pooled_OUD_vs_Control,Reactome,Programmed Cell Death,0.1121301456172489,0.6353208299772357,8/267
Pooled_OUD_vs_Control,Reactome,Arachidonate metabolism,0.11969443956883394,0.6355481462259702,4/267
Male_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.5046907194057288,0.6357161946360623,3/118
Male_OUD_vs_Control,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.4111824810257806,0.6357513745090916,1/99
Pooled_OUD_vs_Control,GO_BP,positive regulation of immunoglobulin mediated immune response,0.28646066810866533,0.6382852558929679,2/380
Pooled_OUD_vs_Control,GO_BP,regulation of astrocyte differentiation,0.28646066810866533,0.6382852558929679,2/380
Pooled_OUD_vs_Control,GO_BP,inhibitory synapse assembly,0.28646066810866533,0.6382852558929679,2/380
NAC_OUD_vs_Control,GO_BP,regulation of immunoglobulin mediated immune response,0.18751653190702786,0.6385975744064782,4/513
NAC_OUD_vs_Control,GO_BP,dopamine transport,0.18751653190702786,0.6385975744064782,4/513
NAC_OUD_vs_Control,GO_BP,regulation of type 2 immune response,0.18862104301423815,0.6385975744064782,3/513
Male_OUD_vs_Control,GO_BP,axon extension,0.5746708482324396,0.6401282504270223,1/101
Female_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.38741376916633863,0.6409067292381404,5/334
DLPFC_OUD_vs_Control,WikiPathways,WP_ONECARBON_METABOLISM,0.50652902700559,0.641702462364853,1/161
Male_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.39981348330964395,0.6419329355096532,2/110
Control_Male_vs_Female,GO_BP,positive regulation of axon extension,0.10385056312452823,0.6429537016803389,1/37
Control_Male_vs_Female,GO_BP,astrocyte development,0.12010651057889521,0.6429537016803389,1/37
Control_Male_vs_Female,GO_BP,presynapse assembly,0.1360754076180556,0.6429537016803389,1/37
Control_Male_vs_Female,GO_BP,response to pain,0.141335438870011,0.6429537016803389,1/37
NAC_OUD_vs_Control,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.12681326498382064,0.6432177976498944,4/307
Control_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.1323805119208311,0.6441872060692164,64/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.13341622282560978,0.6441872060692164,16/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.13341622282560978,0.6441872060692164,16/6081
Male_OUD_vs_Control,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.5965619854965807,0.6442869443363072,1/75
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.3212508533937285,0.6444025994110885,1/286
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.3212508533937285,0.6444025994110885,1/286
NAC_OUD_vs_Control,DO,glycogen metabolism disorder,0.47335678330420294,0.6447505971931555,1/257
NAC_OUD_vs_Control,DO,neuronal ceroid lipofuscinosis,0.47335678330420294,0.6447505971931555,1/257
OUD_Male_vs_Female,GO_BP,regulation of immune response,0.38409672934085093,0.6451232824976144,3/33
Male_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.40524000790718573,0.6452706445610082,2/110
Female_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.2963520603221779,0.6459025292577971,6/319
Pooled_OUD_vs_Control,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.3258983278196259,0.6459207960380412,2/254
Pooled_OUD_vs_Control,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.33195073029792266,0.6459207960380412,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_BENZOAPYRENE_METABOLISM,0.33195073029792266,0.6459207960380412,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.33195073029792266,0.6459207960380412,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.33195073029792266,0.6459207960380412,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_NAD_METABOLISM,0.33195073029792266,0.6459207960380412,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_PURINE_METABOLISM,0.33195073029792266,0.6459207960380412,1/254
Pooled_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.32871299424762884,0.6470146749731699,8/435
Female_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.4088888543651096,0.6487904331254506,2/198
DLPFC_OUD_vs_Control,GO_MF,neurotransmitter receptor activity,0.23425197305321738,0.6489622682871024,4/253
DLPFC_OUD_vs_Control,GO_MF,postsynaptic neurotransmitter receptor activity,0.24198641925484832,0.6489622682871024,3/253
DLPFC_OUD_vs_Control,GO_MF,CCR chemokine receptor binding,0.25185271781237895,0.6489622682871024,1/253
Pooled_OUD_vs_Control,GO_BP,axon guidance,0.292396039164573,0.6490629228413332,11/380
DLPFC_OUD_vs_Control,GO_BP,L-glutamate transmembrane transport,0.4926224712930708,0.649431779001443,1/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of axon extension,0.4926224712930708,0.649431779001443,1/253
DLPFC_OUD_vs_Control,GO_BP,retinal ganglion cell axon guidance,0.4926224712930708,0.649431779001443,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.4926224712930708,0.649431779001443,1/253
DLPFC_OUD_vs_Control,GO_BP,dopaminergic neuron differentiation,0.4926224712930708,0.649431779001443,1/253
OUD_Male_vs_Female,GO_BP,cytokine-mediated signaling pathway,0.3905407881319216,0.64956476054796,2/33
Female_OUD_vs_Control,GO_BP,negative regulation of neuron apoptotic process,0.43063986564321,0.6496745343888665,4/287
Female_OUD_vs_Control,GO_BP,positive regulation of neuron apoptotic process,0.43221768379349523,0.6496745343888665,2/287
Female_OUD_vs_Control,GO_BP,organ or tissue specific immune response,0.4393964902035292,0.6496745343888665,1/287
Female_OUD_vs_Control,GO_BP,neutrophil activation involved in immune response,0.4393964902035292,0.6496745343888665,1/287
Female_OUD_vs_Control,GO_BP,response to arsenic-containing substance,0.4393964902035292,0.6496745343888665,1/287
Female_OUD_vs_Control,GO_BP,regulation of programmed necrotic cell death,0.4393964902035292,0.6496745343888665,1/287
Female_OUD_vs_Control,GO_BP,synapse pruning,0.4393964902035292,0.6496745343888665,1/287
Pooled_OUD_vs_Control,GO_BP,neuron projection guidance,0.3001211396578013,0.6502748394199903,11/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of axon extension,0.31006481598230085,0.6502748394199903,2/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.31006481598230085,0.6502748394199903,2/380
Pooled_OUD_vs_Control,GO_BP,natural killer cell mediated immune response to tumor cell,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of immune response to tumor cell,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of macrophage cytokine production,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,T-helper 2 cell cytokine production,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of astrocyte differentiation,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,axonogenesis involved in innervation,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,commissural neuron axon guidance,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of execution phase of apoptosis,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of T-helper 2 cell cytokine production,0.32024162081215846,0.6502748394199903,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of response to drug,0.32024162081215846,0.6502748394199903,1/380
OUD_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.3119483837790812,0.6503018589914484,1/43
OUD_Male_vs_Female,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.3531099351217518,0.6503018589914484,3/43
OUD_Male_vs_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.36911880020318066,0.6503018589914484,1/43
OUD_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.38712364505292185,0.6503018589914484,1/43
OUD_Male_vs_Female,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.3917913217391312,0.6503093660014269,1/33
OUD_Male_vs_Female,GO_BP,immune response,0.39286527615916245,0.6505203899084786,5/33
OUD_Male_vs_Female,GO_BP,regulation of production of molecular mediator of immune response,0.3951309034999648,0.6505203899084786,1/33
NAC_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.13333678641102031,0.6529399599671619,7/307
NAC_OUD_vs_Control,WikiPathways,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.1366927151963774,0.6529399599671619,3/307
DLPFC_OUD_vs_Control,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.5308625114319605,0.653369244839336,1/161
NAC_OUD_vs_Control,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.20301180643697825,0.655263073451591,2/513
Female_OUD_vs_Control,KEGG,Adipocytokine signaling pathway,0.25109899508527384,0.6556473760559928,3/175
DLPFC_OUD_vs_Control,DO,substance abuse,0.6311171410067079,0.6576207479781182,6/136
Male_OUD_vs_Control,Reactome,Regulation of lipid metabolism by PPARalpha,0.49663240123204755,0.6578732217745261,1/75
OUD_Male_vs_Female,GO_BP,regulation of adaptive immune response,0.4083123016317316,0.6600449362445878,1/33
OUD_Male_vs_Female,GO_BP,lymphocyte activation involved in immune response,0.4147981168583478,0.6600449362445878,1/33
OUD_Male_vs_Female,GO_BP,response to cytokine,0.4155838487465924,0.6600449362445878,3/33
DLPFC_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.3470684163581377,0.6608248323289835,1/286
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.3470684163581377,0.6608248323289835,1/286
OUD_Male_vs_Female,GO_BP,production of molecular mediator of immune response,0.41801511871469854,0.6608885529491468,1/33
DLPFC_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.3500186640537744,0.662884509018042,7/286
Control_Male_vs_Female,GO_BP,presynapse organization,0.16717168978237618,0.6644266638661939,1/37
DLPFC_OUD_vs_Control,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.12284300937180881,0.6650734512894872,3/172
Female_OUD_vs_Control,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.42184462439832526,0.6655451313950415,3/198
Female_OUD_vs_Control,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.4295132449154031,0.6655451313950415,1/198
Female_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.4295132449154031,0.6655451313950415,1/198
Female_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.4295132449154031,0.6655451313950415,1/198
Female_OUD_vs_Control,WikiPathways,WP_PYRIMIDINE_METABOLISM,0.430282666343771,0.6655451313950415,2/198
DLPFC_OUD_vs_Control,GO_BP,"synaptic transmission, dopaminergic",0.5137180365786669,0.665723180906501,1/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of immunoglobulin mediated immune response,0.5137180365786669,0.665723180906501,1/253
DLPFC_OUD_vs_Control,GO_BP,axon ensheathment in central nervous system,0.5137180365786669,0.665723180906501,1/253
Pooled_OUD_vs_Control,GO_BP,programmed necrotic cell death,0.33350439151240574,0.6659002386998719,2/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.33870828020070987,0.6659002386998719,3/380
Pooled_OUD_vs_Control,GO_BP,sensory perception of pain,0.3502340259379276,0.6659002386998719,4/380
Pooled_OUD_vs_Control,GO_BP,detection of stimulus involved in sensory perception of pain,0.35670844936664425,0.6659002386998719,2/380
Pooled_OUD_vs_Control,GO_BP,integrated stress response signaling,0.35670844936664425,0.6659002386998719,2/380
Pooled_OUD_vs_Control,GO_BP,regulation of response to endoplasmic reticulum stress,0.35670844936664425,0.6659002386998719,2/380
Pooled_OUD_vs_Control,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.3626219627467573,0.6659002386998719,1/380
Pooled_OUD_vs_Control,GO_BP,G protein-coupled opioid receptor signaling pathway,0.3626219627467573,0.6659002386998719,1/380
Pooled_OUD_vs_Control,GO_BP,L-glutamate import across plasma membrane,0.3626219627467573,0.6659002386998719,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of execution phase of apoptosis,0.3626219627467573,0.6659002386998719,1/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.3626219627467573,0.6659002386998719,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of microglial cell activation,0.3626219627467573,0.6659002386998719,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of dopaminergic neuron differentiation,0.3626219627467573,0.6659002386998719,1/380
Female_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.4175193892231326,0.6670003890016013,4/334
Female_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.4201106927741429,0.6670003890016013,1/334
Female_OUD_vs_Control,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.46437956020392535,0.6671671541117333,2/287
Female_OUD_vs_Control,GO_BP,behavioral response to pain,0.4658200749155651,0.6671671541117333,1/287
Female_OUD_vs_Control,GO_BP,negative regulation of cytokine production involved in inflammatory response,0.4658200749155651,0.6671671541117333,1/287
OUD_Male_vs_Female,GO_BP,humoral immune response,0.4243977561512925,0.6674993834612561,1/33
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,0.13936819774695042,0.6689673491853619,83/6081
OUD_Male_vs_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.44787979767111785,0.6692456746809807,1/43
NAC_OUD_vs_Control,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.14421982248243745,0.6693976666165965,4/307
NAC_OUD_vs_Control,GO_BP,regulation of humoral immune response,0.21094814840043338,0.6707580989002969,3/513
NAC_OUD_vs_Control,GO_BP,regulation of dopamine secretion,0.21094814840043338,0.6707580989002969,3/513
NAC_OUD_vs_Control,GO_BP,immune system development,0.21194361975118048,0.6708059262003131,7/513
NAC_OUD_vs_Control,GO_BP,sensory perception of pain,0.21293551686308834,0.6729849176344485,6/513
NAC_OUD_vs_Control,DO,drug dependence,0.5075167339819525,0.6729944590161452,4/257
NAC_OUD_vs_Control,DO,complement deficiency,0.5195188933624633,0.6729944590161452,1/257
Female_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.33023966870909416,0.6735179081175953,5/319
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.2650945820800909,0.6736057707560703,5/278
OUD_DLPFC_vs_NAC,KEGG,Drug metabolism - other enzymes,0.08029186379959141,0.6744516559165679,21/2402
Female_OUD_vs_Control,GO_BP,cellular response to stress,0.4717396967438514,0.6749327799053204,29/287
NAC_OUD_vs_Control,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.19307094042439893,0.6757482914853963,3/21
DLPFC_OUD_vs_Control,GO_BP,response to axon injury,0.5251380537636094,0.6768297035101996,2/253
DLPFC_OUD_vs_Control,GO_BP,positive regulation of synapse assembly,0.5251380537636094,0.6768297035101996,2/253
DLPFC_OUD_vs_Control,GO_BP,cell morphogenesis involved in neuron differentiation,0.525330166211665,0.6768612671227515,13/253
Male_OUD_vs_Control,GO_BP,regulation of neurotransmitter transport,0.6155512762392452,0.6771541580351045,1/101
DLPFC_OUD_vs_Control,GO_BP,dendrite morphogenesis,0.5303357664680055,0.6799271515025246,3/253
DLPFC_OUD_vs_Control,GO_BP,mature B cell differentiation involved in immune response,0.533939821053617,0.6799271515025246,1/253
DLPFC_OUD_vs_Control,GO_BP,sperm axoneme assembly,0.533939821053617,0.6799271515025246,1/253
DLPFC_OUD_vs_Control,GO_BP,motor neuron axon guidance,0.533939821053617,0.6799271515025246,1/253
DLPFC_OUD_vs_Control,GO_BP,response to fluid shear stress,0.533939821053617,0.6799271515025246,1/253
DLPFC_OUD_vs_Control,GO_BP,dendrite extension,0.533939821053617,0.6799271515025246,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of excitatory synapse assembly,0.533939821053617,0.6799271515025246,1/253
Pooled_OUD_vs_Control,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.3103274204962213,0.6799821419696614,6/410
DLPFC_OUD_vs_Control,GO_BP,regulation of synapse assembly,0.5343524060389154,0.680238025089893,4/253
Female_OUD_vs_Control,GO_BP,"complement activation, classical pathway",0.49100234142332333,0.6811757679002737,1/287
Female_OUD_vs_Control,GO_BP,regulation of response to oxidative stress,0.49100234142332333,0.6811757679002737,1/287
Control_Male_vs_Female,GO_BP,neuron cellular homeostasis,0.1971778732038887,0.6814437198752944,1/37
Control_Male_vs_Female,GO_BP,positive regulation of axonogenesis,0.20207555147123502,0.6814437198752944,1/37
Control_Male_vs_Female,GO_BP,regulation of axon extension,0.20694415381219233,0.6814437198752944,1/37
Pooled_OUD_vs_Control,Reactome,Regulation of Complement cascade,0.14725659564259497,0.681654182072754,3/267
Male_OUD_vs_Control,GO_BP,immune system development,0.6219757171889204,0.6823990696704891,1/101
DLPFC_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.5760091505174068,0.6827905030158072,1/161
Male_OUD_vs_Control,GO_MF,postsynaptic neurotransmitter receptor activity,0.4906292214923097,0.6834493334992412,1/99
Pooled_OUD_vs_Control,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.38377862110559746,0.6841220629164403,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_ESTROGEN_METABOLISM_WP5276,0.38377862110559746,0.6841220629164403,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.38377862110559746,0.6841220629164403,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.38377862110559746,0.6841220629164403,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_TAMOXIFEN_METABOLISM,0.38377862110559746,0.6841220629164403,1/254
Pooled_OUD_vs_Control,KEGG,Apoptosis - multiple species,0.23581244339738905,0.6846167711537101,2/225
Pooled_OUD_vs_Control,GO_BP,negative regulation of production of molecular mediator of immune response,0.37961547503637005,0.6847290801653978,2/380
Pooled_OUD_vs_Control,GO_BP,dopamine secretion,0.37961547503637005,0.6847290801653978,2/380
Pooled_OUD_vs_Control,GO_BP,axon extension,0.3935739933179956,0.6847290801653978,4/380
Pooled_OUD_vs_Control,GO_BP,innate immune response in mucosa,0.40236657288069766,0.6847290801653978,1/380
Pooled_OUD_vs_Control,GO_BP,dendritic cell cytokine production,0.40236657288069766,0.6847290801653978,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of dendritic cell cytokine production,0.40236657288069766,0.6847290801653978,1/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of glutamate secretion,0.40236657288069766,0.6847290801653978,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of axon extension involved in axon guidance,0.40236657288069766,0.6847290801653978,1/380
Pooled_OUD_vs_Control,GO_BP,peripheral nervous system neuron development,0.40236657288069766,0.6847290801653978,1/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of synapse assembly,0.40236657288069766,0.6847290801653978,1/380
Pooled_OUD_vs_Control,GO_BP,ventral spinal cord interneuron fate commitment,0.40236657288069766,0.6847290801653978,1/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of dendrite development,0.40236657288069766,0.6847290801653978,1/380
Control_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,0.22017646402755633,0.6858205354914328,4/55
Female_OUD_vs_Control,GO_MF,chemokine activity,0.10591678854393757,0.6860825495972659,2/292
Male_OUD_vs_Control,GO_BP,immunoglobulin mediated immune response,0.6282938460262395,0.6871736781066006,1/101
Control_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter secretion,0.011575968715005994,0.6877227889924514,44/4916
OUD_DLPFC_vs_NAC,KEGG,Purine metabolism,0.08482428994544633,0.6879005775815611,53/2402
Female_OUD_vs_Control,WikiPathways,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.4640564796269475,0.6880837456537497,1/198
Male_OUD_vs_Control,GO_BP,neuron apoptotic process,0.630621805178464,0.6886781607054168,2/101
Male_OUD_vs_Control,GO_CC,stress fiber,0.4565761881809043,0.6904322845662455,1/100
DLPFC_OUD_vs_Control,GO_BP,"regulation of synaptic transmission, glutamatergic",0.5504420972947027,0.6928129686584455,2/253
DLPFC_OUD_vs_Control,GO_BP,regulation of dopamine secretion,0.5533238791291448,0.6928129686584455,1/253
DLPFC_OUD_vs_Control,GO_BP,cerebral cortex neuron differentiation,0.5533238791291448,0.6928129686584455,1/253
DLPFC_OUD_vs_Control,GO_BP,programmed necrotic cell death,0.5533238791291448,0.6928129686584455,1/253
Female_OUD_vs_Control,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.40047561925879527,0.6946019463618953,1/49
OUD_DLPFC_vs_NAC,KEGG,Cocaine addiction,0.09331902810311306,0.6963728967665551,27/2402
OUD_DLPFC_vs_NAC,KEGG,Glutamatergic synapse,0.10233300915250992,0.6963728967665551,57/2402
OUD_DLPFC_vs_NAC,KEGG,Arginine and proline metabolism,0.10955740637768509,0.6963728967665551,19/2402
OUD_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.4910284184774085,0.6976360043941323,1/43
Male_OUD_vs_Control,Reactome,Diseases of programmed cell death,0.5543515953649942,0.6976533683164894,1/75
DLPFC_OUD_vs_Control,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.31189803667154564,0.6980575106458402,6/109
DLPFC_OUD_vs_Control,GO_BP,postsynapse organization,0.5606526313392933,0.69960300536096,5/253
Female_OUD_vs_Control,GO_BP,neuron cellular homeostasis,0.5105466658720167,0.6996797114109584,2/287
Female_OUD_vs_Control,GO_BP,regulation of stress-activated MAPK cascade,0.5150014096032982,0.6996797114109584,1/287
NAC_OUD_vs_Control,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.22446477390707945,0.7000206931787382,7/513
Control_Male_vs_Female,GO_BP,astrocyte differentiation,0.23555450723342453,0.7018604570570197,1/37
NAC_OUD_vs_Control,GO_BP,microglial cell activation,0.23380949425247266,0.7024763310281273,3/513
NAC_OUD_vs_Control,GO_BP,natural killer cell activation involved in immune response,0.23510416943674045,0.7024763310281273,2/513
NAC_OUD_vs_Control,GO_BP,positive regulation of type 2 immune response,0.23510416943674045,0.7024763310281273,2/513
NAC_OUD_vs_Control,GO_BP,response to morphine,0.23510416943674045,0.7024763310281273,2/513
NAC_OUD_vs_Control,GO_BP,regulation of receptor localization to synapse,0.23510416943674045,0.7024763310281273,2/513
NAC_OUD_vs_Control,GO_BP,interneuron migration,0.23510416943674045,0.7024763310281273,2/513
OUD_DLPFC_vs_NAC,GO_CC,neuron projection cytoplasm,0.07960634746098315,0.7030090400924686,36/5358
OUD_DLPFC_vs_NAC,GO_CC,hippocampal mossy fiber to CA3 synapse,0.08046696434614425,0.7030090400924686,29/5358
OUD_DLPFC_vs_NAC,GO_CC,neuron projection terminus,0.0855911299030795,0.7030090400924686,73/5358
OUD_DLPFC_vs_NAC,GO_CC,neuronal cell body membrane,0.08888411103649752,0.7030090400924686,21/5358
OUD_Male_vs_Female,DO,bone inflammation disease,0.5086798649327742,0.70328503350549,1/17
Pooled_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.378942243924988,0.7036089060378032,1/435
OUD_Male_vs_Female,GO_BP,positive regulation of immune effector process,0.47886854662081324,0.7039628362302336,1/33
Female_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.4965180327116415,0.7046295513729567,1/198
DLPFC_OUD_vs_Control,GO_BP,detection of stimulus involved in sensory perception of pain,0.5719047832035162,0.7051455006338315,1/253
Female_OUD_vs_Control,KEGG,Nicotinate and nicotinamide metabolism,0.2948529439165304,0.7060835261363893,2/175
Control_Male_vs_Female,GO_BP,axon extension,0.26766517564625836,0.706887561186595,1/37
Male_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.4632930418938228,0.708114325379437,2/110
DLPFC_OUD_vs_Control,Reactome,Response of endothelial cells to shear stress,0.1389282727029233,0.7085341907849088,4/172
Pooled_OUD_vs_Control,GO_BP,ventral spinal cord interneuron differentiation,0.43963896781017975,0.7086499610381959,1/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of axon regeneration,0.43963896781017975,0.7086499610381959,1/380
Pooled_OUD_vs_Control,GO_BP,peripheral nervous system neuron differentiation,0.43963896781017975,0.7086499610381959,1/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of programmed necrotic cell death,0.43963896781017975,0.7086499610381959,1/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of neuron projection regeneration,0.43963896781017975,0.7086499610381959,1/380
Pooled_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.43963896781017975,0.7086499610381959,1/380
Pooled_OUD_vs_Control,GO_BP,neurotransmitter receptor diffusion trapping,0.43963896781017975,0.7086499610381959,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.43963896781017975,0.7086499610381959,1/380
Pooled_OUD_vs_Control,GO_BP,glutamatergic neuron differentiation,0.43963896781017975,0.7086499610381959,1/380
Female_OUD_vs_Control,GO_BP,positive regulation of axonogenesis,0.5253482575358273,0.7090023415964448,2/287
Control_Male_vs_Female,Reactome,Cellular responses to stress,0.6785211428520235,0.7104515495744717,1/19
Pooled_OUD_vs_Control,GO_BP,regulation of cellular response to stress,0.4424587520641249,0.7108327025248087,10/380
NAC_OUD_vs_Control,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.16798698366290873,0.7124965169150956,2/307
Female_OUD_vs_Control,Reactome,Metabolism of water-soluble vitamins and cofactors,0.18347229193128461,0.7134043972667912,4/206
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.29811017126391665,0.7137445446607235,16/581
OUD_Male_vs_Female,GO_BP,innate immune response-activating signaling pathway,0.5014410898315499,0.7138265074930675,1/33
Pooled_OUD_vs_Control,GO_BP,cellular response to osmotic stress,0.44606240781964146,0.7142562032768655,2/380
NAC_OUD_vs_Control,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.24218052801982334,0.7145464356497108,4/513
NAC_OUD_vs_Control,GO_BP,mast cell activation involved in immune response,0.24218052801982334,0.7145464356497108,4/513
Female_OUD_vs_Control,GO_BP,negative regulation of axon extension,0.5378726871984103,0.7147628883769862,1/287
Female_OUD_vs_Control,GO_BP,retinal ganglion cell axon guidance,0.5378726871984103,0.7147628883769862,1/287
Female_OUD_vs_Control,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.5378726871984103,0.7147628883769862,1/287
Female_OUD_vs_Control,GO_BP,neurotransmitter reuptake,0.5378726871984103,0.7147628883769862,1/287
Female_OUD_vs_Control,GO_BP,maintenance of synapse structure,0.5378726871984103,0.7147628883769862,1/287
Control_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,0.38024996835271385,0.7148642863910072,4/55
Control_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.3803609875240852,0.7148642863910072,1/55
DLPFC_OUD_vs_Control,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.39964831208499774,0.7151392056476045,2/286
DLPFC_OUD_vs_Control,GO_BP,axonogenesis,0.5835950176228802,0.7155264222928247,10/253
DLPFC_OUD_vs_Control,GO_BP,negative regulation of production of molecular mediator of immune response,0.5897156843463399,0.7155264222928247,1/253
DLPFC_OUD_vs_Control,GO_BP,dopamine secretion,0.5897156843463399,0.7155264222928247,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of neurotransmitter receptor activity,0.5897156843463399,0.7155264222928247,1/253
DLPFC_OUD_vs_Control,GO_MF,chemokine activity,0.3920199703969989,0.7160473172021063,1/253
DLPFC_OUD_vs_Control,GO_MF,C-C chemokine receptor activity,0.3920199703969989,0.7160473172021063,1/253
OUD_Male_vs_Female,GO_BP,activation of innate immune response,0.5123689013374033,0.7167855096429995,1/33
Female_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.3750693639213839,0.7174123544436747,5/319
Male_OUD_vs_Control,GO_BP,"synaptic transmission, glutamatergic",0.6696868290242246,0.7188614107163895,1/101
OUD_Male_vs_Female,GO_BP,regulation of immune system process,0.5208492516387522,0.7192887398371761,4/33
Control_Male_vs_Female,DO,bone inflammation disease,0.5482126841058337,0.7195291478889068,1/19
Pooled_OUD_vs_Control,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.431600261875282,0.7198475796277025,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.431600261875282,0.7198475796277025,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_ESTROGEN_METABOLISM_WP697,0.431600261875282,0.7198475796277025,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.431600261875282,0.7198475796277025,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,0.431600261875282,0.7198475796277025,1/254
Pooled_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.35163193623518746,0.7214204268370799,6/410
Control_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.44548563425982013,0.7222343309911747,1/55
Control_Male_vs_Female,GO_BP,multicellular organismal response to stress,0.29846198733574325,0.7227371816407075,1/37
Male_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.6138672494735455,0.7228459297171637,1/118
Male_OUD_vs_Control,Reactome,Adaptive Immune System,0.6260426551280128,0.7238618199917648,5/75
OUD_Male_vs_Female,DO,glucose metabolism disease,0.5598966626906304,0.7240043052034014,2/17
Female_OUD_vs_Control,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.5270227541079371,0.7240248698607443,1/198
Female_OUD_vs_Control,WikiPathways,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.5270227541079371,0.7240248698607443,1/198
Female_OUD_vs_Control,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.5270227541079371,0.7240248698607443,1/198
DLPFC_OUD_vs_Control,GO_BP,regulation of postsynapse organization,0.5983784707987798,0.7245134228142348,3/253
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.2276413198504863,0.725030719645283,8/580
Female_OUD_vs_Control,GO_BP,somatic recombination of immunoglobulin genes involved in immune response,0.5596689959533909,0.7252525938007477,1/287
Female_OUD_vs_Control,GO_BP,somatic diversification of immunoglobulins involved in immune response,0.5596689959533909,0.7252525938007477,1/287
Female_OUD_vs_Control,GO_BP,positive regulation of immunoglobulin mediated immune response,0.5596689959533909,0.7252525938007477,1/287
Female_OUD_vs_Control,GO_BP,axon ensheathment in central nervous system,0.5596689959533909,0.7252525938007477,1/287
Female_OUD_vs_Control,GO_BP,inhibitory synapse assembly,0.5596689959533909,0.7252525938007477,1/287
Control_Male_vs_Female,Reactome,Axon guidance,0.7050193032600075,0.7270268755985466,1/19
Control_Male_vs_Female,Reactome,Neuronal System,0.7066047723513964,0.7270268755985466,1/19
Female_OUD_vs_Control,Reactome,Apoptosis,0.18911852960444026,0.7276259844728771,5/206
DLPFC_OUD_vs_Control,GO_MF,ionotropic glutamate receptor binding,0.4167417555930063,0.7295686838173668,1/253
OUD_Male_vs_Female,Reactome,Axon guidance,0.6853930641251884,0.7295993655787101,1/18
OUD_Male_vs_Female,Reactome,Neuronal System,0.6869950230631648,0.7295993655787101,1/18
DLPFC_OUD_vs_Control,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.6537528419189336,0.7297706142350886,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.6537528419189336,0.7297706142350886,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.6537528419189336,0.7297706142350886,1/161
DLPFC_OUD_vs_Control,GO_BP,stress-activated protein kinase signaling cascade,0.6067883705075859,0.7298812749805279,1/253
DLPFC_OUD_vs_Control,GO_BP,stress-activated MAPK cascade,0.6067883705075859,0.7298812749805279,1/253
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,0.16779442318398483,0.7307288223930664,353/6081
Female_OUD_vs_Control,GO_CC,glycinergic synapse,0.21474448670873358,0.7309193079719281,1/305
Pooled_OUD_vs_Control,GO_BP,cellular response to chemical stress,0.4648760520699726,0.7310769063854743,8/380
Pooled_OUD_vs_Control,GO_BP,axon regeneration,0.4673249927044901,0.7310769063854743,2/380
Pooled_OUD_vs_Control,GO_BP,response to pain,0.4673249927044901,0.7310769063854743,2/380
Pooled_OUD_vs_Control,GO_BP,myeloid leukocyte cytokine production,0.4673249927044901,0.7310769063854743,2/380
Pooled_OUD_vs_Control,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.4745925449986451,0.7310769063854743,1/380
OUD_Male_vs_Female,GO_BP,leukocyte activation involved in immune response,0.5463037989034296,0.7311544138723827,1/33
OUD_Male_vs_Female,GO_BP,cell activation involved in immune response,0.5488171402893934,0.7311544138723827,1/33
OUD_Male_vs_Female,GO_BP,synapse assembly,0.5538033828172229,0.7317793476051395,1/33
OUD_DLPFC_vs_NAC,KEGG,Platinum drug resistance,0.12196358453803882,0.731781507228233,25/2402
Male_OUD_vs_Control,Reactome,Cellular responses to stress,0.6390915500922136,0.7319860356406727,4/75
Pooled_OUD_vs_Control,DO,cocaine dependence,0.6752695183441912,0.7346098410430815,1/199
Male_OUD_vs_Control,GO_BP,vesicle-mediated transport in synapse,0.6904792123658594,0.7356119632868435,2/101
Control_Male_vs_Female,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.5101765689912174,0.7370999872157133,3/55
Control_DLPFC_vs_NAC,GO_CC,axonemal A tubule inner sheath,0.06545188789252959,0.7374246035891668,20/5212
OUD_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,0.5682736009946235,0.7387556812930106,2/43
Female_OUD_vs_Control,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.44469710321919065,0.7391285622831902,6/126
OUD_DLPFC_vs_NAC,GO_CC,axonemal microtubule,0.10101185153975188,0.7392226547238412,34/5358
OUD_DLPFC_vs_NAC,GO_CC,neuronal dense core vesicle,0.10328798640520873,0.7392226547238412,20/5358
Male_OUD_vs_Control,GO_BP,negative regulation of neuron apoptotic process,0.6964257195245753,0.7397240975923953,1/101
Pooled_OUD_vs_Control,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.4757242024265286,0.7405440084439628,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.4757242024265286,0.7405440084439628,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.4757242024265286,0.7405440084439628,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.4757242024265286,0.7405440084439628,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.4757242024265286,0.7405440084439628,1/254
Control_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.5276241619581087,0.74062443868947,2/55
NAC_OUD_vs_Control,DO,heroin dependence,0.634080801059784,0.7409008964260866,2/257
NAC_OUD_vs_Control,DO,opioid abuse,0.635186988033584,0.7409008964260866,1/257
OUD_Male_vs_Female,C8_CellType,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.5758061007508578,0.7411365653228863,3/43
DLPFC_OUD_vs_Control,KEGG,Galactose metabolism,0.32978324528661496,0.7412559183047768,1/142
DLPFC_OUD_vs_Control,KEGG,alpha-Linolenic acid metabolism,0.32978324528661496,0.7412559183047768,1/142
Female_OUD_vs_Control,GO_BP,sperm axoneme assembly,0.58044069190365,0.7417009626696408,1/287
Female_OUD_vs_Control,GO_BP,regulation of excitatory synapse assembly,0.58044069190365,0.7417009626696408,1/287
Female_OUD_vs_Control,GO_BP,B cell activation involved in immune response,0.5814791172316254,0.7417009626696408,2/287
Female_OUD_vs_Control,GO_BP,response to osmotic stress,0.5814791172316254,0.7417009626696408,2/287
DLPFC_OUD_vs_Control,GO_BP,regulation of cytokinesis,0.6231533223518991,0.7418316968328327,1/253
DLPFC_OUD_vs_Control,GO_BP,L-glutamate import,0.6231533223518991,0.7418316968328327,1/253
OUD_Male_vs_Female,GO_BP,negative regulation of programmed cell death,0.5772485439951373,0.7420675279733873,2/33
Female_OUD_vs_Control,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.5556880417377592,0.7420678818237157,1/198
NAC_OUD_vs_Control,GO_BP,neurotransmitter uptake,0.2570806224919269,0.7422217235871216,3/513
NAC_OUD_vs_Control,GO_BP,negative regulation of production of molecular mediator of immune response,0.2570806224919269,0.7422217235871216,3/513
NAC_OUD_vs_Control,GO_BP,dopamine secretion,0.2570806224919269,0.7422217235871216,3/513
NAC_OUD_vs_Control,GO_BP,glutamate secretion,0.2570806224919269,0.7422217235871216,3/513
Female_OUD_vs_Control,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.4121492113073669,0.7435767526234652,3/319
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.2512243720746566,0.7444538732120558,9/580
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.3299212329771696,0.7446189985869693,3/278
DLPFC_OUD_vs_Control,Reactome,Regulation of lipid metabolism by PPARalpha,0.20087070027667128,0.7452497055915802,3/172
DLPFC_OUD_vs_Control,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.20087070027667128,0.7452497055915802,3/172
DLPFC_OUD_vs_Control,Reactome,FOXO-mediated transcription of cell death genes,0.20838072980983646,0.7452497055915802,1/172
DLPFC_OUD_vs_Control,Reactome,Metabolism of Angiotensinogen to Angiotensins,0.2445546178206519,0.7452497055915802,1/172
DLPFC_OUD_vs_Control,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.2445546178206519,0.7452497055915802,1/172
DLPFC_OUD_vs_Control,Reactome,RUNX3 Regulates Immune Response and Cell Migration,0.2445546178206519,0.7452497055915802,1/172
DLPFC_OUD_vs_Control,Reactome,Cellular response to heat stress,0.2656262574982845,0.7452497055915802,2/172
DLPFC_OUD_vs_Control,Reactome,Chemokine receptors bind chemokines,0.2656262574982845,0.7452497055915802,2/172
DLPFC_OUD_vs_Control,Reactome,Metabolism of porphyrins,0.2790846751511987,0.7452497055915802,1/172
DLPFC_OUD_vs_Control,Reactome,Metabolism of nitric oxide: NOS3 activation and regulation,0.2790846751511987,0.7452497055915802,1/172
DLPFC_OUD_vs_Control,Reactome,Cellular responses to stress,0.29070325412418424,0.7452497055915802,12/172
DLPFC_OUD_vs_Control,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,0.3171828922821621,0.7452497055915802,2/172
DLPFC_OUD_vs_Control,Reactome,Metabolism of folate and pterines,0.34350709037168947,0.7452497055915802,1/172
DLPFC_OUD_vs_Control,Reactome,Hyaluronan metabolism,0.34350709037168947,0.7452497055915802,1/172
DLPFC_OUD_vs_Control,Reactome,Regulation of pyruvate metabolism,0.34350709037168947,0.7452497055915802,1/172
DLPFC_OUD_vs_Control,Reactome,Metabolism of cofactors,0.3735381490036229,0.7452497055915802,1/172
NAC_OUD_vs_Control,GO_BP,B cell activation involved in immune response,0.2594752874780069,0.7455149633868607,5/513
NAC_OUD_vs_Control,GO_BP,protein localization to synapse,0.2594752874780069,0.7455149633868607,5/513
NAC_OUD_vs_Control,GO_BP,regulation of response to cytokine stimulus,0.26111851176338924,0.7455149633868607,9/513
DLPFC_OUD_vs_Control,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.4313085103741975,0.745987678657413,15/286
Pooled_OUD_vs_Control,Reactome,Initial triggering of complement,0.18045063799029604,0.7462385758557034,2/267
NAC_OUD_vs_Control,GO_BP,positive regulation of humoral immune response,0.2674436805193745,0.7464946385078152,2/513
NAC_OUD_vs_Control,GO_BP,response to arsenic-containing substance,0.2674436805193745,0.7464946385078152,2/513
Pooled_OUD_vs_Control,GO_BP,cellular response to stress,0.48693130602047074,0.7468733500076925,38/380
Pooled_OUD_vs_Control,GO_BP,immune system development,0.49219060422826777,0.7468733500076925,4/380
Pooled_OUD_vs_Control,GO_BP,macrophage activation involved in immune response,0.5073712074351115,0.7468733500076925,1/380
Pooled_OUD_vs_Control,GO_BP,mucosal immune response,0.5073712074351115,0.7468733500076925,1/380
Pooled_OUD_vs_Control,GO_BP,cellular component disassembly involved in execution phase of apoptosis,0.5073712074351115,0.7468733500076925,1/380
Pooled_OUD_vs_Control,GO_BP,response to salt stress,0.5073712074351115,0.7468733500076925,1/380
Pooled_OUD_vs_Control,GO_BP,axon extension involved in axon guidance,0.5073712074351115,0.7468733500076925,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of neurotransmitter uptake,0.5073712074351115,0.7468733500076925,1/380
Pooled_OUD_vs_Control,GO_BP,neuron projection extension involved in neuron projection guidance,0.5073712074351115,0.7468733500076925,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of receptor localization to synapse,0.5073712074351115,0.7468733500076925,1/380
Pooled_OUD_vs_Control,GO_BP,dopamine transport,0.5083529720212725,0.7468733500076925,2/380
NAC_OUD_vs_Control,GO_MF,C-C chemokine receptor activity,0.07471172025851108,0.7471172025851108,3/528
Male_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.6434280979905027,0.7475749963348635,1/118
NAC_OUD_vs_Control,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.18367371915279396,0.7478073112171268,3/307
Female_OUD_vs_Control,Reactome,Vitamin B5 (pantothenate) metabolism,0.2451133428758211,0.7493732352806591,1/206
Female_OUD_vs_Control,Reactome,FOXO-mediated transcription of cell death genes,0.2451133428758211,0.7493732352806591,1/206
Female_OUD_vs_Control,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.5498010336657864,0.7497286822715268,4/126
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.17563757910173455,0.7503678772095047,20/6081
Female_OUD_vs_Control,GO_MF,CXCR chemokine receptor binding,0.2502029731318315,0.750548522452274,1/292
Female_OUD_vs_Control,GO_MF,CCR chemokine receptor binding,0.28535723322263207,0.750548522452274,1/292
DLPFC_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.6871331595946263,0.7509410620119652,1/161
DLPFC_OUD_vs_Control,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.6388397668147109,0.7526397782260971,1/253
DLPFC_OUD_vs_Control,GO_BP,cellular response to osmotic stress,0.6388397668147109,0.7526397782260971,1/253
Male_OUD_vs_Control,Reactome,Apoptosis,0.6782465237613522,0.7541408232788577,1/75
Female_OUD_vs_Control,WikiPathways,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.582624284155372,0.7550453411908253,1/198
Female_OUD_vs_Control,WikiPathways,WP_ONECARBON_METABOLISM,0.582624284155372,0.7550453411908253,1/198
Female_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.4198851243523195,0.7551856215978694,5/319
Pooled_OUD_vs_Control,GO_BP,cellular response to oxidative stress,0.5148799771756973,0.7559539523618967,6/380
Female_OUD_vs_Control,GO_BP,immunoglobulin production involved in immunoglobulin-mediated immune response,0.6002357800877125,0.7563825918788796,1/287
Female_OUD_vs_Control,GO_BP,regulation of postsynapse assembly,0.6002357800877125,0.7563825918788796,1/287
Male_OUD_vs_Control,KEGG,Choline metabolism in cancer,0.6178567155506633,0.757058048839974,1/64
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.18093257897481085,0.7571332535561316,8/6081
Control_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.5660179941608743,0.7574652568917581,1/55
DLPFC_OUD_vs_Control,Reactome,Diseases of metabolism,0.40191517793869524,0.7579623676561391,5/172
DLPFC_OUD_vs_Control,Reactome,Activation of ATR in response to replication stress,0.40220307009204437,0.7579623676561391,1/172
DLPFC_OUD_vs_Control,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.40220307009204437,0.7579623676561391,1/172
Pooled_OUD_vs_Control,GO_BP,regulation of axonogenesis,0.5167444847287257,0.7584363402289468,5/380
Control_DLPFC_vs_NAC,GO_CC,dendrite membrane,0.07077372878092783,0.7594133437445589,26/5212
Control_DLPFC_vs_NAC,GO_CC,neurotransmitter receptor complex,0.07077372878092783,0.7594133437445589,26/5212
NAC_OUD_vs_Control,DO,withdrawal disorder,0.6565360483015594,0.7600341291384195,2/257
Female_OUD_vs_Control,DO,substance dependence,0.7167981491102431,0.7600616862307517,3/160
Female_OUD_vs_Control,GO_BP,regulation of neuron differentiation,0.6042748932527651,0.7610010958358097,5/287
Pooled_OUD_vs_Control,GO_BP,regulation of neuron apoptotic process,0.52333922404305655,0.7611308914454402,7/380
Pooled_OUD_vs_Control,GO_BP,response to oxidative stress,0.5286050966148863,0.7611308914454402,9/380
Pooled_OUD_vs_Control,GO_BP,neutrophil activation involved in immune response,0.5381099498283227,0.7611308914454402,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of sensory perception of pain,0.5381099498283227,0.7611308914454402,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of programmed necrotic cell death,0.5381099498283227,0.7611308914454402,1/380
Pooled_OUD_vs_Control,GO_BP,synapse pruning,0.5381099498283227,0.7611308914454402,1/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of synapse organization,0.5381099498283227,0.7611308914454402,1/380
Pooled_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.49232349615399806,0.7613081877613149,2/254
DLPFC_OUD_vs_Control,GO_BP,axon regeneration,0.6538757284727457,0.7613466527026952,1/253
Female_OUD_vs_Control,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.6079352770304828,0.7621346038574565,1/198
Female_OUD_vs_Control,Reactome,Regulation of lipid metabolism by PPARalpha,0.28362882233783543,0.7622208052821526,3/206
Female_OUD_vs_Control,Reactome,RUNX3 Regulates Immune Response and Cell Migration,0.2864275435579625,0.7622208052821526,1/206
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.0980783041212153,0.7628972085299114,66/6250
DLPFC_OUD_vs_Control,GO_MF,chemokine receptor activity,0.4632214503194725,0.763352707861429,1/253
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.2741250684707306,0.7638069124736839,7/580
Pooled_OUD_vs_Control,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.4747372657931448,0.7638831755385211,1/61
Pooled_OUD_vs_Control,BioCarta,BIOCARTA_STRESS_PATHWAY,0.6593517936227236,0.7638831755385211,1/61
Male_OUD_vs_Control,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.5551625028082016,0.76429335480708,1/110
Male_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.5755504727122562,0.76429335480708,1/110
Male_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.5821385139146905,0.76429335480708,1/110
Male_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.595012120566052,0.76429335480708,1/110
Male_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.6747619225181691,0.76429335480708,1/110
Male_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.7219928817238501,0.76429335480708,1/110
Male_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.7347879178818342,0.7647097515855749,1/110
Male_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.7389218741001987,0.7647097515855749,1/110
Pooled_OUD_vs_Control,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.5164353160259361,0.7648464218515533,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.5164353160259361,0.7648464218515533,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.5164353160259361,0.7648464218515533,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.5164353160259361,0.7648464218515533,1/254
Female_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.43276364558836655,0.7652350049097174,4/319
NAC_OUD_vs_Control,GO_BP,stress-activated protein kinase signaling cascade,0.28064384851485763,0.7660730574889327,3/513
NAC_OUD_vs_Control,GO_BP,stress-activated MAPK cascade,0.28064384851485763,0.7660730574889327,3/513
Female_OUD_vs_Control,DO,nicotine dependence,0.7254115540444561,0.7670904668623318,1/160
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.4826672542475141,0.7681887285911141,1/286
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.4826672542475141,0.7681887285911141,1/286
Female_OUD_vs_Control,GO_BP,somatic diversification of immune receptors via germline recombination within a single locus,0.6191000239408575,0.7685553838027268,1/287
OUD_Male_vs_Female,Reactome,Adaptive Immune System,0.7357386761557496,0.7694366307888374,1/18
OUD_Male_vs_Female,GO_BP,programmed cell death,0.6209260765499395,0.7713958926463972,4/33
Control_Male_vs_Female,GO_BP,regulation of axonogenesis,0.37198134764091373,0.7718688149526631,1/37
DLPFC_OUD_vs_Control,GO_BP,neuron maturation,0.6682880788177746,0.7718956699846035,1/253
Pooled_OUD_vs_Control,GO_BP,neuron apoptotic process,0.5489837662290467,0.7720084212595969,8/380
Female_OUD_vs_Control,Reactome,Cellular responses to stress,0.30254738857660146,0.772082773663353,14/206
Female_OUD_vs_Control,Reactome,Metabolism of porphyrins,0.32549103705439053,0.772082773663353,1/206
Female_OUD_vs_Control,Reactome,Glycogen metabolism,0.36242587128267256,0.772082773663353,1/206
Male_OUD_vs_Control,Reactome,Fatty acid metabolism,0.7034760665250134,0.7723624469265725,1/75
NAC_OUD_vs_Control,GO_BP,negative regulation of immune system process,0.28382813068962015,0.7726560875911153,23/513
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.4487107002185672,0.7727795392653102,1/435
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.36321487442602923,0.772995758393857,10/581
OUD_Male_vs_Female,GO_BP,cell death,0.6241233361468226,0.7741085960036124,4/33
OUD_Male_vs_Female,GO_BP,cellular response to cytokine stimulus,0.630071142187498,0.7741085960036124,2/33
OUD_Male_vs_Female,GO_BP,regulation of programmed cell death,0.630445382241877,0.7741085960036124,3/33
DLPFC_OUD_vs_Control,KEGG,Arachidonic acid metabolism,0.3641433840081343,0.774960094010951,2/142
DLPFC_OUD_vs_Control,KEGG,Nicotine addiction,0.3641433840081343,0.774960094010951,2/142
Control_DLPFC_vs_NAC,GO_CC,postsynapse,0.07910564662811455,0.7750060452261658,328/5212
OUD_Male_vs_Female,GO_BP,regulation of immune effector process,0.6369679675428297,0.7759880779640166,1/33
DLPFC_OUD_vs_Control,Reactome,Regulation of necroptotic cell death,0.4556789186366047,0.7762713937525457,1/172
DLPFC_OUD_vs_Control,Reactome,Pyruvate metabolism,0.4556789186366047,0.7762713937525457,1/172
Control_Male_vs_Female,GO_BP,neuron projection extension,0.39849898365308123,0.7762839112251855,1/37
Female_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.4481158878529157,0.7766793902125948,3/319
Female_OUD_vs_Control,GO_BP,cellular response to oxidative stress,0.6353127735785484,0.7770583078196807,4/287
Female_OUD_vs_Control,GO_BP,regulation of synapse assembly,0.6353127735785484,0.7770583078196807,4/287
Female_OUD_vs_Control,GO_BP,neurotransmitter uptake,0.6370770496157421,0.7770583078196807,1/287
Female_OUD_vs_Control,GO_BP,somatic diversification of immune receptors,0.6370770496157421,0.7770583078196807,1/287
Female_OUD_vs_Control,GO_BP,regulation of neurotransmitter receptor activity,0.6370770496157421,0.7770583078196807,1/287
Female_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.5380182644287572,0.7777089718780957,1/334
Female_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.5380182644287572,0.7777089718780957,1/334
DLPFC_OUD_vs_Control,KEGG,Platinum drug resistance,0.3819435636559243,0.7778615137554099,2/142
DLPFC_OUD_vs_Control,KEGG,GABAergic synapse,0.39041552701346083,0.7778615137554099,3/142
Pooled_OUD_vs_Control,GO_BP,presynapse organization,0.5658977495973734,0.7801414463005885,2/380
Pooled_OUD_vs_Control,GO_BP,behavioral response to pain,0.5669354086992764,0.7801414463005885,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of T-helper 17 type immune response,0.5669354086992764,0.7801414463005885,1/380
Control_Male_vs_Female,DO,glucose metabolism disease,0.6220254326820198,0.7804613181734703,2/19
Pooled_OUD_vs_Control,GO_MF,chemokine receptor binding,0.2737245472268326,0.7805168108288729,2/376
Pooled_OUD_vs_Control,GO_MF,CCR chemokine receptor binding,0.3531791417270055,0.7805168108288729,1/376
OUD_DLPFC_vs_NAC,KEGG,Glycerolipid metabolism,0.1390277179590486,0.7806863931515056,24/2402
OUD_DLPFC_vs_NAC,KEGG,Pyruvate metabolism,0.14434493282257702,0.7806863931515056,10/2402
OUD_DLPFC_vs_NAC,KEGG,Amphetamine addiction,0.15900504963389758,0.7806863931515056,35/2402
NAC_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.20325004058303794,0.7812423434910521,2/307
DLPFC_OUD_vs_Control,GO_BP,dopamine transport,0.6821025835188615,0.7815920068811473,1/253
DLPFC_OUD_vs_Control,GO_BP,excitatory synapse assembly,0.6821025835188615,0.7815920068811473,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of neuron differentiation,0.6826931739966442,0.7818250245599685,4/253
Pooled_OUD_vs_Control,Reactome,Inositol phosphate metabolism,0.20121417172148615,0.7824738814345849,3/267
Pooled_OUD_vs_Control,Reactome,Surfactant metabolism,0.2069515303542353,0.7824738814345849,2/267
Female_OUD_vs_Control,GO_BP,postsynapse assembly,0.6445829406543417,0.7837844386136934,2/287
Female_OUD_vs_Control,Reactome,Metabolism of folate and pterines,0.39734750662321205,0.783929440406879,1/206
Female_OUD_vs_Control,Reactome,Defective Intrinsic Pathway for Apoptosis,0.39734750662321205,0.783929440406879,1/206
Female_OUD_vs_Control,Reactome,Regulation of pyruvate metabolism,0.39734750662321205,0.783929440406879,1/206
OUD_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter secretion,0.007796887525259951,0.784467490041477,45/5050
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.28690484655411197,0.7847394012076078,6/580
OUD_Male_vs_Female,GO_BP,innate immune response,0.6484092520715807,0.7850694980238869,2/33
Male_OUD_vs_Control,GO_MF,neurotransmitter receptor activity,0.6251624079222038,0.7853602749522686,1/99
Pooled_OUD_vs_Control,WikiPathways,WP_TRYPTOPHAN_METABOLISM,0.5539966095211691,0.7854003512437705,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_ACTIVATION,0.5886508955969181,0.7854003512437705,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.5919934125006578,0.7854003512437705,3/254
NAC_OUD_vs_Control,GO_BP,behavioral response to pain,0.2997624298859999,0.7863165801140672,2/513
NAC_OUD_vs_Control,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.29986441925633434,0.7863165801140672,4/513
Female_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.4599119705557303,0.7865536562530349,3/319
Female_OUD_vs_Control,Reactome,Response of endothelial cells to shear stress,0.43506936958400944,0.7867396365370624,3/206
Male_OUD_vs_Control,GO_BP,neuron projection extension,0.7521701843484458,0.78685158347923,1/101
NAC_OUD_vs_Control,GO_MF,CCR chemokine receptor binding,0.11307384051418928,0.7869939299787574,2/528
DLPFC_OUD_vs_Control,Reactome,Apoptosis,0.47464174971196105,0.7874977264891142,3/172
Female_OUD_vs_Control,GO_BP,stress-activated protein kinase signaling cascade,0.6542084454644725,0.7892007603305481,1/287
Female_OUD_vs_Control,GO_BP,stress-activated MAPK cascade,0.6542084454644725,0.7892007603305481,1/287
DLPFC_OUD_vs_Control,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.7445988177423464,0.790335845859198,1/161
NAC_OUD_vs_Control,GO_BP,regulation of neuron migration,0.304388866822782,0.7905375316048632,3/513
DLPFC_OUD_vs_Control,GO_BP,regulation of neurotransmitter transport,0.691384840901204,0.7906576005548178,2/253
NAC_OUD_vs_Control,GO_BP,cellular response to osmotic stress,0.3282131356501382,0.7909763199320297,3/513
NAC_OUD_vs_Control,GO_BP,negative regulation of stress fiber assembly,0.33183565655909586,0.7909763199320297,2/513
NAC_OUD_vs_Control,GO_BP,GABAergic neuron differentiation,0.33183565655909586,0.7909763199320297,2/513
NAC_OUD_vs_Control,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.33183565655909586,0.7909763199320297,2/513
NAC_OUD_vs_Control,GO_BP,regulation of cytokine-mediated signaling pathway,0.33229914006207384,0.7909763199320297,8/513
NAC_OUD_vs_Control,GO_BP,central nervous system neuron differentiation,0.3513102413736188,0.7909763199320297,11/513
NAC_OUD_vs_Control,GO_BP,response to pain,0.3520220792787627,0.7909763199320297,3/513
NAC_OUD_vs_Control,GO_BP,myeloid leukocyte cytokine production,0.3520220792787627,0.7909763199320297,3/513
NAC_OUD_vs_Control,GO_BP,noradrenergic neuron differentiation,0.3555169811758483,0.7909763199320297,1/513
NAC_OUD_vs_Control,GO_BP,forebrain neuron fate commitment,0.3555169811758483,0.7909763199320297,1/513
NAC_OUD_vs_Control,GO_BP,chemokine (C-C motif) ligand 5 production,0.3555169811758483,0.7909763199320297,1/513
NAC_OUD_vs_Control,GO_BP,regulation of chemokine (C-C motif) ligand 5 production,0.3555169811758483,0.7909763199320297,1/513
NAC_OUD_vs_Control,GO_BP,stress-induced premature senescence,0.3555169811758483,0.7909763199320297,1/513
NAC_OUD_vs_Control,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.3555169811758483,0.7909763199320297,1/513
NAC_OUD_vs_Control,GO_BP,regulation of synapse pruning,0.3555169811758483,0.7909763199320297,1/513
NAC_OUD_vs_Control,GO_BP,negative regulation of T-helper 17 type immune response,0.3555169811758483,0.7909763199320297,1/513
Female_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.5585589858985114,0.791111805531634,1/334
Female_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.4728736857903537,0.7911379447353314,5/319
NAC_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.3818284124214212,0.7936116020526279,2/581
Pooled_OUD_vs_Control,WikiPathways,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.6206223376160069,0.7940565251141787,1/254
Male_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.7905171045901951,0.7944325959841506,1/110
DLPFC_OUD_vs_Control,GO_MF,chemokine receptor binding,0.5060106624087282,0.7949911106374891,1/253
Female_OUD_vs_Control,Reactome,Activation of ATR in response to replication stress,0.46158218898251957,0.7951125448924692,1/206
Female_OUD_vs_Control,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.46158218898251957,0.7951125448924692,1/206
DLPFC_OUD_vs_Control,GO_BP,immune system development,0.7005651634570469,0.795300008445194,2/253
DLPFC_OUD_vs_Control,GO_BP,multicellular organismal response to stress,0.7005651634570469,0.795300008445194,2/253
NAC_OUD_vs_Control,GO_BP,multicellular organismal response to stress,0.3611849108046261,0.7955013679361654,6/513
NAC_OUD_vs_Control,GO_BP,negative regulation of cytokine production involved in immune response,0.36347640881811605,0.7955013679361654,2/513
NAC_OUD_vs_Control,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.36347640881811605,0.7955013679361654,2/513
NAC_OUD_vs_Control,GO_BP,positive regulation of macrophage cytokine production,0.36347640881811605,0.7955013679361654,2/513
NAC_OUD_vs_Control,GO_BP,L-glutamate transmembrane transport,0.3945307948523471,0.7955013679361654,2/513
NAC_OUD_vs_Control,GO_BP,maintenance of synapse structure,0.3945307948523471,0.7955013679361654,2/513
NAC_OUD_vs_Control,GO_BP,negative regulation of type 2 immune response,0.4097525108111485,0.7955013679361654,1/513
NAC_OUD_vs_Control,GO_BP,G protein-coupled glutamate receptor signaling pathway,0.4097525108111485,0.7955013679361654,1/513
NAC_OUD_vs_Control,GO_BP,regulation of neuron maturation,0.4097525108111485,0.7955013679361654,1/513
NAC_OUD_vs_Control,GO_BP,pyramidal neuron differentiation,0.4097525108111485,0.7955013679361654,1/513
NAC_OUD_vs_Control,GO_BP,cerebral cortex GABAergic interneuron development,0.4097525108111485,0.7955013679361654,1/513
NAC_OUD_vs_Control,GO_BP,T-helper 2 cell cytokine production,0.4097525108111485,0.7955013679361654,1/513
NAC_OUD_vs_Control,GO_BP,axonogenesis involved in innervation,0.4097525108111485,0.7955013679361654,1/513
NAC_OUD_vs_Control,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.4097525108111485,0.7955013679361654,1/513
NAC_OUD_vs_Control,GO_BP,regulation of T-helper 2 cell cytokine production,0.4097525108111485,0.7955013679361654,1/513
NAC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_1,0.390873647549803,0.7955929556395174,4/581
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.3930857649282084,0.7957589875375927,20/581
Pooled_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.48060468151992697,0.7958055230264138,1/435
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.48060468151992697,0.7958055230264138,1/435
Female_OUD_vs_Control,GO_BP,regulation of neuron projection development,0.6623788818080898,0.7962244224747762,9/287
Pooled_OUD_vs_Control,GO_BP,neuron projection organization,0.5825102823714894,0.7970712797967245,3/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of neuron apoptotic process,0.5839729441917557,0.797073765289873,2/380
Female_OUD_vs_Control,GO_BP,cellular response to chemical stress,0.6657485742161607,0.7975452393304914,5/287
Female_OUD_vs_Control,GO_BP,response to endoplasmic reticulum stress,0.66579789223261,0.7975452393304914,3/287
Female_OUD_vs_Control,GO_BP,neuron projection organization,0.6676401886102648,0.7975452393304914,2/287
Female_OUD_vs_Control,GO_BP,regulation of neuron migration,0.6705338569057782,0.7975452393304914,1/287
DLPFC_OUD_vs_Control,GO_BP,dendrite development,0.7028269932257896,0.7976434509965538,4/253
Pooled_OUD_vs_Control,GO_BP,regulation of glutamate secretion,0.5939663785899263,0.7984795942547053,1/380
OUD_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,0.709658598341196,0.7987499375268874,2/43
Control_DLPFC_vs_NAC,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.25004251662572663,0.8001360532023253,11/128
DLPFC_OUD_vs_Control,KEGG,Cholesterol metabolism,0.41688699883645963,0.8011287671058187,2/142
DLPFC_OUD_vs_Control,KEGG,Linoleic acid metabolism,0.42334040889844105,0.8011287671058187,1/142
Pooled_OUD_vs_Control,KEGG,Chemokine signaling pathway,0.2971475263575183,0.8022983211652994,8/225
DLPFC_OUD_vs_Control,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.5043964153342038,0.8023147659117159,1/172
DLPFC_OUD_vs_Control,Reactome,Metabolism of nucleotides,0.5092123777549558,0.8024566507850969,2/172
DLPFC_OUD_vs_Control,Reactome,Peptide hormone metabolism,0.5236317957690118,0.8024566507850969,2/172
Pooled_OUD_vs_Control,DO,motor neuron disease,0.7641054113389116,0.802706591445411,3/199
Pooled_OUD_vs_Control,KEGG,Intestinal immune network for IgA production,0.30337265557542814,0.8030452647584863,3/225
DLPFC_OUD_vs_Control,GO_CC,glycinergic synapse,0.1862820733284194,0.8035966729762974,1/261
OUD_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.7265197444065576,0.8039394629740835,1/43
OUD_Male_vs_Female,C8_CellType,HU_FETAL_RETINA_MICROGLIA,0.7297296663918604,0.8039394629740835,1/43
DLPFC_OUD_vs_Control,GO_BP,vesicle-mediated transport in synapse,0.7141795073536674,0.8048721324850989,5/253
Pooled_OUD_vs_Control,GO_MF,axon guidance receptor activity,0.4289396614809199,0.8049659960311625,1/376
NAC_OUD_vs_Control,GO_BP,central nervous system projection neuron axonogenesis,0.42487376241276165,0.8055825648325771,2/513
Female_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.6540660603706765,0.8058693580498306,1/198
DLPFC_OUD_vs_Control,GO_BP,cytokine production involved in inflammatory response,0.7202010322086254,0.8060343037855957,1/253
DLPFC_OUD_vs_Control,GO_BP,axonemal dynein complex assembly,0.7202010322086254,0.8060343037855957,1/253
DLPFC_OUD_vs_Control,GO_BP,regulation of cytokine production involved in inflammatory response,0.7202010322086254,0.8060343037855957,1/253
OUD_Male_vs_Female,Reactome,Metabolism of proteins,0.782596824580958,0.8061335711848966,2/18
Female_OUD_vs_Control,GO_BP,regulation of postsynapse organization,0.6839503232768083,0.8070842994703814,3/287
Female_OUD_vs_Control,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.6860910768906486,0.8070842994703814,1/287
Female_OUD_vs_Control,GO_BP,positive regulation of stress fiber assembly,0.6860910768906486,0.8070842994703814,1/287
Female_OUD_vs_Control,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.6860910768906486,0.8070842994703814,1/287
Female_OUD_vs_Control,GO_BP,cellular response to osmotic stress,0.6860910768906486,0.8070842994703814,1/287
NAC_OUD_vs_Control,GO_BP,execution phase of apoptosis,0.4454917005960738,0.8073515156908139,3/513
NAC_OUD_vs_Control,GO_BP,central nervous system neuron development,0.44686176885156603,0.8073515156908139,5/513
NAC_OUD_vs_Control,GO_BP,sperm axoneme assembly,0.45440535233757706,0.8073515156908139,2/513
NAC_OUD_vs_Control,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.45440535233757706,0.8073515156908139,2/513
NAC_OUD_vs_Control,GO_BP,neuron projection guidance,0.4572239450221447,0.8073515156908139,13/513
NAC_OUD_vs_Control,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.4594320779898001,0.8073515156908139,1/513
NAC_OUD_vs_Control,GO_BP,G protein-coupled opioid receptor signaling pathway,0.4594320779898001,0.8073515156908139,1/513
NAC_OUD_vs_Control,GO_BP,neurotransmitter loading into synaptic vesicle,0.4594320779898001,0.8073515156908139,1/513
NAC_OUD_vs_Control,GO_BP,L-glutamate import across plasma membrane,0.4594320779898001,0.8073515156908139,1/513
NAC_OUD_vs_Control,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.4594320779898001,0.8073515156908139,1/513
NAC_OUD_vs_Control,GO_BP,regulation of microglial cell activation,0.4594320779898001,0.8073515156908139,1/513
NAC_OUD_vs_Control,GO_BP,protein localization to presynapse,0.4594320779898001,0.8073515156908139,1/513
DLPFC_OUD_vs_Control,GO_CC,dendrite terminus,0.250720886366679,0.8075749844151583,1/261
DLPFC_OUD_vs_Control,GO_CC,dopaminergic synapse,0.250720886366679,0.8075749844151583,1/261
DLPFC_OUD_vs_Control,GO_BP,neurotransmitter transport,0.7220283826245908,0.8076317476559827,4/253
Pooled_OUD_vs_Control,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.2176828721574064,0.8076644882849564,4/267
OUD_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.7526588139369398,0.8119970606788561,1/43
Pooled_OUD_vs_Control,GO_BP,negative regulation of cytokine production involved in immune response,0.6193142964699703,0.8127379191540012,1/380
Pooled_OUD_vs_Control,GO_BP,axonal fasciculation,0.6193142964699703,0.8127379191540012,1/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of macrophage cytokine production,0.6193142964699703,0.8127379191540012,1/380
Pooled_OUD_vs_Control,GO_BP,neuron projection fasciculation,0.6193142964699703,0.8127379191540012,1/380
Female_OUD_vs_Control,GO_CC,ribbon synapse,0.28715997617263667,0.8132545890080015,1/305
Pooled_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_PHOSPHORYLATION,0.6501178767177929,0.8139545534241535,1/254
Male_OUD_vs_Control,DO,substance abuse,0.7934369786270922,0.8141128608062997,2/61
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.4098740056661174,0.814297559129228,2/581
DLPFC_OUD_vs_Control,GO_BP,axon development,0.7331718018928672,0.8146801695221237,10/253
Pooled_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.5106574832675768,0.8163649900667763,1/435
Female_OUD_vs_Control,GO_BP,regulation of cellular response to stress,0.7036314731157751,0.8163890687505243,6/287
NAC_OUD_vs_Control,GO_BP,cytokine production involved in inflammatory response,0.4680818308823238,0.8167568024220303,3/513
NAC_OUD_vs_Control,GO_BP,regulation of cytokine production involved in inflammatory response,0.4680818308823238,0.8167568024220303,3/513
Control_Male_vs_Female,GO_CC,presynapse,0.5260262596127587,0.8173638803213635,2/33
OUD_DLPFC_vs_NAC,KEGG,Sphingolipid metabolism,0.17232220904242465,0.8177334472620432,16/2402
DLPFC_OUD_vs_Control,Reactome,Metabolism of proteins,0.543186768226313,0.8187546361593728,26/172
DLPFC_OUD_vs_Control,Reactome,Glycosphingolipid metabolism,0.5487767089672471,0.8187546361593728,1/172
DLPFC_OUD_vs_Control,Reactome,Drug ADME,0.5516113384457151,0.8187546361593728,2/172
DLPFC_OUD_vs_Control,Reactome,Bile acid and bile salt metabolism,0.5694617852086206,0.8187546361593728,1/172
DLPFC_OUD_vs_Control,Reactome,Glycosaminoglycan metabolism,0.5867108434105226,0.8187546361593728,3/172
DLPFC_OUD_vs_Control,Reactome,Regulation of Complement cascade,0.5892038734368575,0.8187546361593728,1/172
DLPFC_OUD_vs_Control,Reactome,Diseases associated with glycosaminoglycan metabolism,0.6080457224418871,0.8187546361593728,1/172
Control_DLPFC_vs_NAC,C8_CellType,HU_FETAL_RETINA_MICROGLIA,0.207762903221529,0.8190073866124041,187/6081
Female_OUD_vs_Control,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.6928047676811366,0.8207722120545776,2/198
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,0.5718425450838558,0.8227043673156674,2/286
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.5739515718883639,0.8227043673156674,1/286
NAC_OUD_vs_Control,GO_BP,positive regulation of synapse assembly,0.47550232965046546,0.822864514535695,4/513
NAC_OUD_vs_Control,GO_BP,myeloid cell activation involved in immune response,0.48044778842897684,0.822864514535695,5/513
NAC_OUD_vs_Control,GO_BP,cerebral cortex neuron differentiation,0.483047376330182,0.822864514535695,2/513
NAC_OUD_vs_Control,GO_BP,programmed necrotic cell death,0.483047376330182,0.822864514535695,2/513
NAC_OUD_vs_Control,GO_BP,regulation of postsynapse assembly,0.483047376330182,0.822864514535695,2/513
NAC_OUD_vs_Control,GO_BP,cellular response to dopamine,0.4902522866536434,0.822864514535695,3/513
NAC_OUD_vs_Control,GO_BP,dendritic cell cytokine production,0.5049377136956146,0.822864514535695,1/513
NAC_OUD_vs_Control,GO_BP,regulation of dendritic cell cytokine production,0.5049377136956146,0.822864514535695,1/513
NAC_OUD_vs_Control,GO_BP,positive regulation of glutamate secretion,0.5049377136956146,0.822864514535695,1/513
NAC_OUD_vs_Control,GO_BP,neuron remodeling,0.5049377136956146,0.822864514535695,1/513
NAC_OUD_vs_Control,GO_BP,peripheral nervous system neuron development,0.5049377136956146,0.822864514535695,1/513
NAC_OUD_vs_Control,GO_BP,negative regulation of synapse assembly,0.5049377136956146,0.822864514535695,1/513
NAC_OUD_vs_Control,GO_BP,positive regulation of neuron migration,0.5049377136956146,0.822864514535695,1/513
NAC_OUD_vs_Control,GO_BP,somatic diversification of immune receptors via germline recombination within a single locus,0.5107404743388164,0.822864514535695,2/513
NAC_OUD_vs_Control,GO_BP,forebrain neuron development,0.5107404743388164,0.822864514535695,2/513
NAC_OUD_vs_Control,GO_BP,detection of stimulus involved in sensory perception of pain,0.5107404743388164,0.822864514535695,2/513
NAC_OUD_vs_Control,GO_BP,regulation of response to endoplasmic reticulum stress,0.5107404743388164,0.822864514535695,2/513
NAC_OUD_vs_Control,GO_BP,response to dopamine,0.5119605168231864,0.822864514535695,3/513
Female_OUD_vs_Control,Reactome,Surfactant metabolism,0.4910963106082781,0.8229459096176375,1/206
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.4232616588012563,0.8231239242979635,4/278
Pooled_OUD_vs_Control,WikiPathways,WP_ONECARBON_METABOLISM,0.6773285501145107,0.8233724997162656,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_CHEMOKINE_SIGNALING,0.6787974569395336,0.8233724997162656,5/254
NAC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.4166534521662282,0.8233865840427843,8/581
NAC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.42267597607548524,0.8265417647339987,7/581
NAC_OUD_vs_Control,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,0.423954162422889,0.8268766562138332,24/581
Pooled_OUD_vs_Control,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.6348352109498172,0.8270655080530874,2/380
Pooled_OUD_vs_Control,GO_BP,L-glutamate transmembrane transport,0.6430836962960318,0.8270655080530874,1/380
Pooled_OUD_vs_Control,GO_BP,neurotransmitter reuptake,0.6430836962960318,0.8270655080530874,1/380
Pooled_OUD_vs_Control,GO_BP,maintenance of synapse structure,0.6430836962960318,0.8270655080530874,1/380
Control_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.6731769024096468,0.827096024529607,1/55
OUD_Male_vs_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.776352148543349,0.8272604861527489,1/43
DLPFC_OUD_vs_Control,Reactome,Inositol phosphate metabolism,0.6431901490236227,0.8278283306045364,1/172
DLPFC_OUD_vs_Control,Reactome,Complement cascade,0.6431901490236227,0.8278283306045364,1/172
NAC_OUD_vs_Control,GO_BP,forebrain neuron differentiation,0.5308356985837737,0.8282006551402242,4/513
NAC_OUD_vs_Control,GO_BP,neuron fate commitment,0.5331701265798716,0.8282006551402242,3/513
NAC_OUD_vs_Control,GO_BP,somatic diversification of immune receptors,0.5374415113753311,0.8282006551402242,2/513
NAC_OUD_vs_Control,GO_BP,G protein-coupled dopamine receptor signaling pathway,0.5374415113753311,0.8282006551402242,2/513
NAC_OUD_vs_Control,GO_BP,macrophage cytokine production,0.5374415113753311,0.8282006551402242,2/513
NAC_OUD_vs_Control,GO_BP,regulation of macrophage cytokine production,0.5374415113753311,0.8282006551402242,2/513
NAC_OUD_vs_Control,GO_BP,central nervous system neuron axonogenesis,0.5374415113753311,0.8282006551402242,2/513
NAC_OUD_vs_Control,GO_BP,regulation of neurotransmitter receptor activity,0.5374415113753311,0.8282006551402242,2/513
NAC_OUD_vs_Control,GO_BP,neuron migration,0.5413543587249073,0.8282006551402242,7/513
NAC_OUD_vs_Control,GO_BP,adenylate cyclase-activating dopamine receptor signaling pathway,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,regulation of dopamine metabolic process,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,negative regulation of axon regeneration,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,peripheral nervous system neuron differentiation,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,negative regulation of programmed necrotic cell death,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,negative regulation of neuron projection regeneration,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,dopamine uptake,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,neurotransmitter receptor diffusion trapping,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.5466194719221285,0.8282006551402242,1/513
NAC_OUD_vs_Control,GO_BP,regulation of protein localization to synapse,0.5466194719221285,0.8282006551402242,1/513
OUD_Male_vs_Female,DO,disease of metabolism,0.7620753319046573,0.8283427520702796,3/17
DLPFC_OUD_vs_Control,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.6595689305469579,0.8305682829109841,1/172
DLPFC_OUD_vs_Control,Reactome,Retinoid metabolism and transport,0.6595689305469579,0.8305682829109841,1/172
NAC_OUD_vs_Control,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.4805627304978417,0.8306148239358847,1/62
Female_OUD_vs_Control,GO_BP,excitatory synapse assembly,0.7285055143787871,0.8310932749139182,1/287
Male_OUD_vs_Control,Reactome,Metabolism of RNA,0.7773449463759249,0.8312648270493994,1/75
Control_DLPFC_vs_NAC,GO_CC,apical dendrite,0.09346411886734278,0.8314459326381756,11/5212
Control_DLPFC_vs_NAC,GO_CC,ionotropic glutamate receptor complex,0.09593606915055873,0.8314459326381756,24/5212
DLPFC_OUD_vs_Control,GO_BP,neuron development,0.7622301925712769,0.8320116533718139,21/253
Pooled_OUD_vs_Control,GO_BP,regulation of neuronal synaptic plasticity,0.650673815853825,0.8333894384395382,2/380
DLPFC_OUD_vs_Control,GO_BP,"synaptic transmission, glutamatergic",0.7661020976553811,0.8336082647082804,2/253
NAC_OUD_vs_Control,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.5538504770376547,0.8343214932583877,3/513
NAC_OUD_vs_Control,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.23415749103274605,0.8345688584047588,3/307
Control_DLPFC_vs_NAC,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.22131147175768737,0.8348748126106773,95/6081
NAC_OUD_vs_Control,GO_MF,chemokine receptor activity,0.12824269923303827,0.8350895644975166,3/528
Female_OUD_vs_Control,KEGG,alpha-Linolenic acid metabolism,0.3910904551917186,0.8355114270004896,1/175
Pooled_OUD_vs_Control,GO_BP,negative regulation of neuron apoptotic process,0.6537587326382438,0.8356242658758226,4/380
NAC_OUD_vs_Control,GO_BP,cellular response to stress,0.5569650657991092,0.8378718844056786,50/513
Female_OUD_vs_Control,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.7307468886492581,0.8379230989844826,1/198
Female_OUD_vs_Control,WikiPathways,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.7307468886492581,0.8379230989844826,1/198
DLPFC_OUD_vs_Control,Reactome,Intrinsic Pathway for Apoptosis,0.6752000421182136,0.8386046185212516,1/172
Pooled_OUD_vs_Control,GO_BP,central nervous system projection neuron axonogenesis,0.6653726355577423,0.8389394678841424,1/380
Pooled_OUD_vs_Control,GO_BP,axon ensheathment in central nervous system,0.6653726355577423,0.8389394678841424,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of presynapse organization,0.6653726355577423,0.8389394678841424,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of presynapse assembly,0.6653726355577423,0.8389394678841424,1/380
Female_OUD_vs_Control,GO_BP,axonogenesis,0.7385514665791839,0.8411843759760939,10/287
OUD_Male_vs_Female,DO,immune system disease,0.785833594916491,0.8419645659819546,1/17
Female_OUD_vs_Control,Reactome,Pyruvate metabolism,0.5189999997258441,0.8422957461945783,1/206
NAC_OUD_vs_Control,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.5660800392737491,0.8430387488857385,4/513
NAC_OUD_vs_Control,GO_BP,axon guidance,0.5677045248634793,0.8430387488857385,12/513
NAC_OUD_vs_Control,GO_BP,regulation of neuronal synaptic plasticity,0.57397628084716,0.8430387488857385,3/513
NAC_OUD_vs_Control,GO_BP,forebrain generation of neurons,0.5831455284067955,0.8430387488857385,4/513
NAC_OUD_vs_Control,GO_BP,neuron projection organization,0.5831455284067955,0.8430387488857385,4/513
NAC_OUD_vs_Control,GO_BP,antifungal innate immune response,0.5847981014204784,0.8430387488857385,1/513
NAC_OUD_vs_Control,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.5847981014204784,0.8430387488857385,1/513
NAC_OUD_vs_Control,GO_BP,positive regulation of response to endoplasmic reticulum stress,0.5847981014204784,0.8430387488857385,1/513
NAC_OUD_vs_Control,GO_BP,L-glutamate import,0.5877624596460068,0.8430387488857385,2/513
Pooled_OUD_vs_Control,KEGG,Arachidonic acid metabolism,0.3252160415340183,0.8432885247112819,3/225
Female_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.6320089403801905,0.843517908475553,1/334
DLPFC_OUD_vs_Control,Reactome,Metabolism of vitamins and cofactors,0.6824426693472064,0.8436146358717224,3/172
DLPFC_OUD_vs_Control,Reactome,Glucose metabolism,0.6901174233613823,0.8436146358717224,1/172
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.5051959375460933,0.8445912448175921,4/410
DLPFC_OUD_vs_Control,KEGG,Nucleotide metabolism,0.49957412452191985,0.845138527242795,2/142
DLPFC_OUD_vs_Control,KEGG,Fructose and mannose metabolism,0.5039167813187362,0.845138527242795,1/142
DLPFC_OUD_vs_Control,KEGG,Starch and sucrose metabolism,0.5282077527162324,0.845138527242795,1/142
DLPFC_OUD_vs_Control,KEGG,Amino sugar and nucleotide sugar metabolism,0.5282077527162324,0.845138527242795,1/142
DLPFC_OUD_vs_Control,KEGG,Fatty acid metabolism,0.5513172729350304,0.845138527242795,1/142
DLPFC_OUD_vs_Control,GO_MF,glutamate receptor binding,0.6873353061095738,0.845241621950868,1/253
Control_Male_vs_Female,GO_BP,innate immune response-activating signaling pathway,0.5418969112946896,0.8461763277557951,1/37
DLPFC_OUD_vs_Control,GO_BP,neuron projection morphogenesis,0.7813605816258521,0.8463342351408775,12/253
DLPFC_OUD_vs_Control,GO_BP,neuron cellular homeostasis,0.783289316673499,0.8463800537135641,1/253
DLPFC_OUD_vs_Control,GO_BP,receptor localization to synapse,0.783289316673499,0.8463800537135641,1/253
Pooled_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.7469481189886921,0.8466620669119398,1/254
Female_OUD_vs_Control,Reactome,Nicotinate metabolism,0.545380723915534,0.8475279194479637,1/206
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.4668595119825404,0.8478084274876615,4/278
Pooled_OUD_vs_Control,GO_MF,chemokine activity,0.5263087780090568,0.847882369460619,1/376
Control_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.722847469070294,0.8486750334065514,1/55
Control_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.7330576134611542,0.8486750334065514,1/55
Control_Male_vs_Female,C8_CellType,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.739870541944173,0.8486750334065514,3/55
Female_OUD_vs_Control,GO_BP,neuron migration,0.74921027198546,0.8494111442487704,3/287
Pooled_OUD_vs_Control,DO,substance-related disorder,0.8132801829068392,0.8510583591450923,10/199
Pooled_OUD_vs_Control,GO_BP,positive regulation of axonogenesis,0.6807074392135637,0.8512594663258121,2/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of response to cytokine stimulus,0.6807074392135637,0.8512594663258121,2/380
Pooled_OUD_vs_Control,GO_BP,motor neuron axon guidance,0.6862730955327682,0.8512594663258121,1/380
Pooled_OUD_vs_Control,GO_BP,response to fluid shear stress,0.6862730955327682,0.8512594663258121,1/380
Pooled_OUD_vs_Control,GO_BP,dendrite extension,0.6862730955327682,0.8512594663258121,1/380
DLPFC_OUD_vs_Control,GO_CC,cholinergic synapse,0.28100768343316485,0.8512873055950594,1/261
DLPFC_OUD_vs_Control,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.28100768343316485,0.8512873055950594,1/261
Female_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.640761804162427,0.851795340469826,7/334
Control_Male_vs_Female,GO_BP,activation of innate immune response,0.5531437638222373,0.851906344673387,1/37
DLPFC_OUD_vs_Control,C8_CellType,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.5989492004132259,0.8522927222409412,19/286
NAC_OUD_vs_Control,GO_BP,dopamine metabolic process,0.6113578527365402,0.8523161395898068,2/513
NAC_OUD_vs_Control,GO_BP,negative regulation of response to cytokine stimulus,0.6124874475095051,0.8523161395898068,3/513
NAC_OUD_vs_Control,GO_BP,axonogenesis,0.6136125675437077,0.8523161395898068,20/513
NAC_OUD_vs_Control,GO_BP,cellular component disassembly involved in execution phase of apoptosis,0.6197674946188523,0.8523161395898068,1/513
NAC_OUD_vs_Control,GO_BP,response to salt stress,0.6197674946188523,0.8523161395898068,1/513
NAC_OUD_vs_Control,GO_BP,regulation of short-term neuronal synaptic plasticity,0.6197674946188523,0.8523161395898068,1/513
NAC_OUD_vs_Control,GO_BP,regulation of neurotransmitter uptake,0.6197674946188523,0.8523161395898068,1/513
NAC_OUD_vs_Control,GO_BP,regulation of synapse maturation,0.6197674946188523,0.8523161395898068,1/513
NAC_OUD_vs_Control,GO_BP,neuronal stem cell population maintenance,0.6197674946188523,0.8523161395898068,1/513
NAC_OUD_vs_Control,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.6197674946188523,0.8523161395898068,1/513
Female_OUD_vs_Control,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.5623695554545047,0.8525335253621964,2/206
Female_OUD_vs_Control,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.570321222150794,0.8525335253621964,1/206
Female_OUD_vs_Control,Reactome,Metabolism of RNA,0.5828249008300281,0.8525335253621964,4/206
DLPFC_OUD_vs_Control,Reactome,Metabolism of fat-soluble vitamins,0.7043534819035411,0.852748699131762,1/172
DLPFC_OUD_vs_Control,Reactome,Arachidonate metabolism,0.7179391621366672,0.852748699131762,1/172
Female_OUD_vs_Control,GO_BP,regulation of neurotransmitter transport,0.7567634867797812,0.852983553381421,2/287
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.12237249420195462,0.8534697031520938,26/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.12237249420195462,0.8534697031520938,26/6250
Pooled_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.5163127475436196,0.8544435789877317,6/410
Control_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.23382200704198838,0.8552867929663863,33/6081
OUD_Male_vs_Female,GO_CC,presynapse,0.5093833829041794,0.8554671318229303,2/32
OUD_Male_vs_Female,GO_CC,distal axon,0.5338824912239611,0.8554671318229303,1/32
DLPFC_OUD_vs_Control,GO_BP,neuron projection development,0.7965047093560167,0.8558504567268748,18/253
DLPFC_OUD_vs_Control,KEGG,Folate transport and metabolism,0.5733024169112988,0.8564578789223671,1/142
NAC_OUD_vs_Control,GO_BP,regulation of axonogenesis,0.6252500897926705,0.856851171393217,6/513
OUD_DLPFC_vs_NAC,GO_CC,parallel fiber to Purkinje cell synapse,0.13882081945585906,0.8576945183033781,18/5358
OUD_DLPFC_vs_NAC,GO_CC,axon initial segment,0.1528934387964617,0.8576945183033781,10/5358
OUD_DLPFC_vs_NAC,GO_CC,dynein axonemal particle,0.1528934387964617,0.8576945183033781,10/5358
OUD_DLPFC_vs_NAC,GO_CC,axonemal B tubule inner sheath,0.1528934387964617,0.8576945183033781,10/5358
OUD_DLPFC_vs_NAC,GO_CC,axon cytoplasm,0.1732451423332492,0.8576945183033781,23/5358
OUD_DLPFC_vs_NAC,GO_CC,axon terminus,0.17585636213349257,0.8576945183033781,64/5358
Female_OUD_vs_Control,GO_BP,axonemal dynein complex assembly,0.7652062910094892,0.858536388249242,1/287
Female_OUD_vs_Control,GO_BP,multicellular organismal response to stress,0.7652768444777589,0.858536388249242,2/287
Female_OUD_vs_Control,DO,motor neuron disease,0.8340144581453167,0.8587961122148187,2/160
Female_OUD_vs_Control,DO,alcohol dependence,0.834881549059305,0.8587961122148187,1/160
DLPFC_OUD_vs_Control,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,0.7419393442153484,0.8590841530878353,4/172
DLPFC_OUD_vs_Control,Reactome,Metabolism of steroids,0.7423543063850528,0.8590841530878353,2/172
Pooled_OUD_vs_Control,GO_BP,regulation of axon extension,0.6949175348221268,0.8592960451837346,2/380
DLPFC_OUD_vs_Control,GO_CC,paranode region of axon,0.3100747519932552,0.86000155729401,1/261
DLPFC_OUD_vs_Control,GO_CC,dendrite membrane,0.31316583318829494,0.86000155729401,2/261
Pooled_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.5261864942345298,0.8612623427772873,6/410
Control_Male_vs_Female,GO_BP,negative regulation of cytokine production,0.5748372108117168,0.8619787314781753,1/37
Control_Male_vs_Female,GO_BP,vesicle-mediated transport in synapse,0.58529616741491175,0.8619787314781753,1/37
Control_Male_vs_Female,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.592975671260022,0.8619787314781753,1/37
Control_Male_vs_Female,GO_BP,synapse assembly,0.5955046217492543,0.8619787314781753,1/37
Pooled_OUD_vs_Control,GO_BP,regulation of dopamine secretion,0.7058713568672328,0.8635954851207859,1/380
NAC_OUD_vs_Control,GO_BP,axon extension,0.6319329065194238,0.8637456456812107,4/513
NAC_OUD_vs_Control,GO_BP,negative regulation of neuron projection development,0.6484533184476331,0.8638007218348646,5/513
NAC_OUD_vs_Control,GO_BP,positive regulation of neurotransmitter secretion,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,organ or tissue specific immune response,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,neutrophil activation involved in immune response,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,regulation of axon regeneration,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,regulation of sensory perception of pain,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,regulation of programmed necrotic cell death,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,regulation of neuron projection regeneration,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,dendrite self-avoidance,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,synapse pruning,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,positive regulation of dendrite extension,0.6517969322642592,0.8638007218348646,1/513
NAC_OUD_vs_Control,GO_BP,negative regulation of synapse organization,0.6517969322642592,0.8638007218348646,1/513
Female_OUD_vs_Control,Reactome,Metabolism of vitamins and cofactors,0.6042593900105573,0.8643067346401007,4/206
NAC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.37324864616427816,0.8648075554006034,8/580
NAC_OUD_vs_Control,Reactome,Chemokine receptors bind chemokines,0.04663548257315467,0.8649562145171893,5/349
Control_Male_vs_Female,GO_CC,asymmetric synapse,0.6273110407653333,0.8652352104788993,1/33
Control_Male_vs_Female,GO_CC,neuron to neuron synapse,0.6682014496767736,0.8652352104788993,1/33
NAC_OUD_vs_Control,GO_BP,oxidative phosphorylation,0.6554237602456642,0.8654388932985677,2/513
NAC_OUD_vs_Control,GO_BP,neuron maturation,0.6554237602456642,0.8654388932985677,2/513
DLPFC_OUD_vs_Control,GO_BP,negative regulation of neuron differentiation,0.8092979467914568,0.8656808236142788,1/253
Female_OUD_vs_Control,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.7735310083218105,0.8661334666510394,2/287
Female_OUD_vs_Control,GO_BP,axon development,0.7751822755053073,0.8661334666510394,11/287
Female_OUD_vs_Control,GO_BP,cellular response to dopamine,0.7763059112500222,0.8661334666510394,1/287
DLPFC_OUD_vs_Control,WikiPathways,WP_AXON_GUIDANCE,0.8383751066460668,0.8664546556724902,1/161
OUD_Male_vs_Female,GO_CC,asymmetric synapse,0.6159667757453737,0.8673770202757632,1/32
Pooled_OUD_vs_Control,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.6004539972042641,0.8684013383949148,2/376
DLPFC_OUD_vs_Control,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,0.7610596694473347,0.8685292886359889,4/172
DLPFC_OUD_vs_Control,Reactome,Heparan sulfate/heparin (HS-GAG) metabolism,0.7663493723258725,0.8685292886359889,1/172
DLPFC_OUD_vs_Control,Reactome,Fatty acid metabolism,0.767757452500225,0.8689182818865236,2/172
Pooled_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.5437206206100925,0.8696611603719964,5/410
OUD_DLPFC_vs_NAC,KEGG,"Glycine, serine and threonine metabolism",0.199572311024003,0.8702554316728008,15/2402
OUD_DLPFC_vs_NAC,KEGG,Tyrosine metabolism,0.199572311024003,0.8702554316728008,15/2402
OUD_DLPFC_vs_NAC,KEGG,Choline metabolism in cancer,0.20720367420780972,0.8702554316728008,38/2402
DLPFC_OUD_vs_Control,KEGG,Nicotinate and nicotinamide metabolism,0.5942175210875483,0.8717562435116727,1/142
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.637037615745468,0.8725484918695501,6/286
Pooled_OUD_vs_Control,WikiPathways,WP_AXON_GUIDANCE,0.7808729691852938,0.8726538153970835,2/254
Female_OUD_vs_Control,GO_BP,response to dopamine,0.7868825510311167,0.8726696920538605,1/287
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.5542917929849156,0.8730965539980434,5/410
Female_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.5850065166178291,0.8732571991106216,4/319
NAC_OUD_vs_Control,GO_BP,regulation of stress fiber assembly,0.6657265865839244,0.8734065560256337,3/513
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.5092311222700636,0.8740223388553472,4/278
Control_Male_vs_Female,Reactome,Innate Immune System,0.8744417924618648,0.8744417924618648,1/19
Control_Male_vs_Female,DO,disease of metabolism,0.8269846598122208,0.8745808992258739,3/19
Female_OUD_vs_Control,GO_BP,neurotransmitter secretion,0.7907427388858707,0.8752807955730706,3/287
Female_OUD_vs_Control,GO_BP,signal release from synapse,0.7907427388858707,0.8752807955730706,3/287
Pooled_OUD_vs_Control,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.7208480502514626,0.8754760610564797,3/380
Pooled_OUD_vs_Control,GO_BP,synapse maturation,0.7242483519988426,0.8754760610564797,1/380
DLPFC_OUD_vs_Control,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.7771005515553935,0.8758481354546976,1/172
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.6549751626454619,0.8758839453128661,4/286
NAC_OUD_vs_Control,GO_BP,dendrite morphogenesis,0.6750561375700384,0.8762666079804445,5/513
NAC_OUD_vs_Control,GO_BP,response to osmotic stress,0.6822441248704523,0.8762666079804445,3/513
Control_DLPFC_vs_NAC,GO_CC,distal axon,0.10631952637023556,0.876487802759503,129/5212
DLPFC_OUD_vs_Control,GO_BP,B cell activation involved in immune response,0.8248850852435632,0.8770105250693807,1/253
DLPFC_OUD_vs_Control,GO_BP,response to osmotic stress,0.8248850852435632,0.8770105250693807,1/253
OUD_Male_vs_Female,GO_BP,synapse organization,0.8026598734840565,0.8774014811364181,1/33
Pooled_OUD_vs_Control,DO,substance abuse,0.8439256053706238,0.8774662384045845,7/199
Pooled_OUD_vs_Control,Reactome,Fatty acid metabolism,0.24931331516048655,0.8777249821355607,6/267
Pooled_OUD_vs_Control,Reactome,Cellular response to chemical stress,0.2925387565983111,0.8777249821355607,5/267
Pooled_OUD_vs_Control,Reactome,p75NTR regulates axonogenesis,0.30759196894585283,0.8777249821355607,1/267
Pooled_OUD_vs_Control,Reactome,Vitamin B5 (pantothenate) metabolism,0.30759196894585283,0.8777249821355607,1/267
Pooled_OUD_vs_Control,Reactome,Diseases of carbohydrate metabolism,0.30759196894585283,0.8777249821355607,1/267
Pooled_OUD_vs_Control,Reactome,Metabolism of Angiotensinogen to Angiotensins,0.35670805403922623,0.8777249821355607,1/267
Pooled_OUD_vs_Control,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.35670805403922623,0.8777249821355607,1/267
Pooled_OUD_vs_Control,Reactome,RUNX3 Regulates Immune Response and Cell Migration,0.35670805403922623,0.8777249821355607,1/267
Pooled_OUD_vs_Control,Reactome,Apoptosis,0.3642455106807907,0.8777249821355607,5/267
Pooled_OUD_vs_Control,Reactome,Metabolism of nitric oxide: NOS3 activation and regulation,0.4023522075262117,0.8777249821355607,1/267
Pooled_OUD_vs_Control,Reactome,Diseases associated with glycosaminoglycan metabolism,0.41951941944065196,0.8777249821355607,2/267
Pooled_OUD_vs_Control,Reactome,Regulation of lipid metabolism by PPARalpha,0.4368336770208687,0.8777249821355607,3/267
Pooled_OUD_vs_Control,Reactome,Adaptive Immune System,0.4376318986482218,0.8777249821355607,20/267
Pooled_OUD_vs_Control,Reactome,Glycogen metabolism,0.4447689966252285,0.8777249821355607,1/267
Pooled_OUD_vs_Control,Reactome,Metabolism of folate and pterines,0.48418582137956623,0.8777249821355607,1/267
Pooled_OUD_vs_Control,Reactome,Regulation of pyruvate metabolism,0.48418582137956623,0.8777249821355607,1/267
Control_Male_vs_Female,GO_BP,positive regulation of innate immune response,0.6270217188475931,0.8780535457883555,1/37
Female_OUD_vs_Control,WikiPathways,WP_AMINO_ACID_METABOLISM,0.8152207165272298,0.8785586669341073,1/198
Female_OUD_vs_Control,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.8152207165272298,0.8785586669341073,1/198
Pooled_OUD_vs_Control,DO,mitochondrial metabolism disease,0.8506910809311536,0.8799878400958745,1/199
Female_OUD_vs_Control,GO_BP,cell morphogenesis involved in neuron differentiation,0.7992496721878659,0.880148015191455,12/287
Female_OUD_vs_Control,Reactome,Diseases of programmed cell death,0.6517649890368562,0.8802750326701585,2/206
Female_OUD_vs_Control,Reactome,Regulation of Complement cascade,0.6571841067874591,0.8802750326701585,1/206
Female_OUD_vs_Control,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.3096984772256064,0.8807568144296251,2/15
Male_OUD_vs_Control,GO_BP,neurotransmitter transport,0.8608321180353676,0.8810248598875146,1/101
Female_OUD_vs_Control,Reactome,Diseases associated with glycosaminoglycan metabolism,0.6760161265212681,0.8819037741751395,1/206
DLPFC_OUD_vs_Control,GO_BP,neuron differentiation,0.8329151512087067,0.8825272580899391,25/253
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.6625494385105666,0.8825314721221299,1/286
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.6625494385105666,0.8825314721221299,1/286
Pooled_OUD_vs_Control,GO_BP,response to osmotic stress,0.7344344133560436,0.8826558960074699,2/380
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.398622281373354,0.8826579154046441,8/580
Pooled_OUD_vs_Control,GO_BP,neurotransmitter uptake,0.7414799958469664,0.8830996403470692,1/380
Pooled_OUD_vs_Control,GO_BP,macrophage cytokine production,0.7414799958469664,0.8830996403470692,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of macrophage cytokine production,0.7414799958469664,0.8830996403470692,1/380
Pooled_OUD_vs_Control,GO_BP,glutamate secretion,0.7414799958469664,0.8830996403470692,1/380
Pooled_OUD_vs_Control,GO_BP,central nervous system neuron axonogenesis,0.7414799958469664,0.8830996403470692,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of neurotransmitter receptor activity,0.7414799958469664,0.8830996403470692,1/380
OUD_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.12880123392696946,0.8832084612135048,11/6250
DLPFC_OUD_vs_Control,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.8612783293956646,0.8837820387147913,1/161
DLPFC_OUD_vs_Control,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.8612783293956646,0.8837820387147913,1/161
NAC_OUD_vs_Control,GO_BP,cell morphogenesis involved in neuron differentiation,0.6985094281143553,0.8842993485724152,24/513
NAC_OUD_vs_Control,GO_BP,regulation of neuron projection development,0.6993276108909929,0.8842993485724152,16/513
NAC_OUD_vs_Control,GO_BP,neuron projection development,0.7042711420257962,0.8842993485724152,40/513
NAC_OUD_vs_Control,GO_BP,negative regulation of chemokine production,0.7080021780447566,0.8842993485724152,1/513
NAC_OUD_vs_Control,GO_BP,neurotransmitter receptor localization to postsynaptic specialization membrane,0.7080021780447566,0.8842993485724152,1/513
NAC_OUD_vs_Control,GO_BP,neuron projection arborization,0.7080021780447566,0.8842993485724152,1/513
NAC_OUD_vs_Control,GO_BP,regulation of dendrite extension,0.7080021780447566,0.8842993485724152,1/513
NAC_OUD_vs_Control,Reactome,Vitamin B5 (pantothenate) metabolism,0.07082363333011334,0.8844328679403665,2/349
NAC_OUD_vs_Control,Reactome,FOXO-mediated transcription of cell death genes,0.07082363333011334,0.8844328679403665,2/349
NAC_OUD_vs_Control,Reactome,Regulation of Complement cascade,0.09205383581737861,0.8844328679403665,4/349
NAC_OUD_vs_Control,Reactome,Surfactant metabolism,0.09235323683261853,0.8844328679403665,3/349
NAC_OUD_vs_Control,Reactome,Metabolism of Angiotensinogen to Angiotensins,0.09986983554565684,0.8844328679403665,2/349
NAC_OUD_vs_Control,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.09986983554565684,0.8844328679403665,2/349
NAC_OUD_vs_Control,Reactome,IL-6-type cytokine receptor ligand interactions,0.09986983554565684,0.8844328679403665,2/349
Female_OUD_vs_Control,GO_BP,neurotransmitter transport,0.8082288481294645,0.8847681417914424,4/287
Pooled_OUD_vs_Control,Reactome,Metabolism of cofactors,0.5208141154464963,0.8854955196242356,1/267
Pooled_OUD_vs_Control,Reactome,MECP2 regulates neuronal receptors and channels,0.5208141154464963,0.8854955196242356,1/267
NAC_OUD_vs_Control,GO_BP,neuron projection extension,0.7095148850924037,0.8856703048394833,6/513
NAC_OUD_vs_Control,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.48782463200537574,0.8861179895976437,29/581
OUD_DLPFC_vs_NAC,GO_CC,A axonemal microtubule,0.19794314760714432,0.8861560780293348,28/5358
Female_OUD_vs_Control,WikiPathways,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.8264711157054612,0.8862408472652078,1/198
Male_OUD_vs_Control,GO_BP,postsynapse organization,0.8677617573315008,0.8868368806458149,1/101
OUD_Male_vs_Female,GO_CC,neuron to neuron synapse,0.6568925601802265,0.8871435606557698,1/32
NAC_OUD_vs_Control,GO_BP,neuron projection regeneration,0.7139208025493223,0.8876383875289593,2/513
NAC_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.27545928350249227,0.8877715262498781,2/307
NAC_OUD_vs_Control,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.30494310882680364,0.8877715262498781,9/307
NAC_OUD_vs_Control,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.31160130864735736,0.8877715262498781,2/307
NAC_OUD_vs_Control,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.31160130864735736,0.8877715262498781,2/307
NAC_OUD_vs_Control,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.3473480916773559,0.8877715262498781,2/307
NAC_OUD_vs_Control,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.3473480916773559,0.8877715262498781,2/307
NAC_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.3667028946549473,0.8877715262498781,3/307
NAC_OUD_vs_Control,WikiPathways,WP_CHEMOKINE_SIGNALING,0.3748492059018657,0.8877715262498781,8/307
NAC_OUD_vs_Control,WikiPathways,WP_ONECARBON_METABOLISM,0.3824573210908524,0.8877715262498781,2/307
NAC_OUD_vs_Control,WikiPathways,WP_ALANINE_AND_ASPARTATE_METABOLISM,0.38849502352341025,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.38849502352341025,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_BENZOAPYRENE_METABOLISM,0.38849502352341025,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.38849502352341025,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.38849502352341025,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_GLYOXYLATE_METABOLISM,0.38849502352341025,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_NAD_METABOLISM,0.38849502352341025,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.38849502352341025,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_PURINE_METABOLISM,0.38849502352341025,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_AXON_GUIDANCE,0.4394745861770357,0.8877715262498781,4/307
NAC_OUD_vs_Control,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.44583528857481936,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.44583528857481936,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_ESTROGEN_METABOLISM_WP5276,0.44583528857481936,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.44583528857481936,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_TAMOXIFEN_METABOLISM,0.44583528857481936,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.45002974833088816,0.8877715262498781,2/307
NAC_OUD_vs_Control,WikiPathways,WP_ESTROGEN_METABOLISM_WP697,0.4978146855829252,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_GLUTATHIONE_METABOLISM,0.4978146855829252,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.4978146855829252,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.4978146855829252,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,0.4978146855829252,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.5449329287143561,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.5449329287143561,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.5449329287143561,0.8877715262498781,1/307
NAC_OUD_vs_Control,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.5876432897307708,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.5876432897307708,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_RETINOL_METABOLISM,0.5876432897307708,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.5876432897307708,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.5986394430593149,0.890379441940907,2/307
NAC_OUD_vs_Control,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.626356901367668,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_COMPLEMENT_ACTIVATION,0.6614466631541855,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.6614466631541855,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,0.6614466631541855,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.6932507862911697,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.6932507862911697,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.6932507862911697,0.890379441940907,1/307
NAC_OUD_vs_Control,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.7024676347327841,0.890379441940907,4/307
NAC_OUD_vs_Control,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.7219202767791258,0.890379441940907,3/307
NAC_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_PHOSPHORYLATION,0.722076010842321,0.890379441940907,1/307
Pooled_OUD_vs_Control,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.5808306473777725,0.8904824844685593,3/410
Control_DLPFC_vs_NAC,GO_CC,axonemal B tubule inner sheath,0.11595875108993287,0.8907740424635752,10/5212
Pooled_OUD_vs_Control,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.8170562544600988,0.8915076421328648,1/254
Female_OUD_vs_Control,GO_BP,postsynapse organization,0.8236463839312353,0.8918010907477122,4/287
Female_OUD_vs_Control,GO_BP,receptor localization to synapse,0.8244335660154171,0.8918010907477122,1/287
Female_OUD_vs_Control,Reactome,Inositol phosphate metabolism,0.7106469396926415,0.8922072079840218,1/206
Female_OUD_vs_Control,Reactome,Complement cascade,0.7106469396926415,0.8922072079840218,1/206
Female_OUD_vs_Control,Reactome,Cellular response to heat stress,0.7106469396926415,0.8922072079840218,1/206
Pooled_OUD_vs_Control,KEGG,Tryptophan metabolism,0.3536002685298364,0.8922623598416433,2/225
OUD_Male_vs_Female,GO_BP,cell morphogenesis involved in neuron differentiation,0.8219202802329796,0.8924335482422433,1/33
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.5453096964993529,0.8924831154688098,3/278
NAC_OUD_vs_Control,GO_BP,neuron development,0.7201247481806787,0.8939348628167434,45/513
DLPFC_OUD_vs_Control,Reactome,Sphingolipid metabolism,0.8239098516055815,0.8940298389762692,1/172
Female_OUD_vs_Control,KEGG,Linoleic acid metabolism,0.49463832200223457,0.8941538897732701,1/175
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.5150485817559776,0.8947471873760819,2/581
Female_OUD_vs_Control,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.7265547940890429,0.895339061638959,1/206
DLPFC_OUD_vs_Control,KEGG,Pyrimidine metabolism,0.6141143139071505,0.8955833744479278,1/142
DLPFC_OUD_vs_Control,GO_BP,generation of neurons,0.8521787097078619,0.8956039850109448,26/253
DLPFC_OUD_vs_Control,GO_BP,forebrain neuron differentiation,0.8523541640408769,0.8956039850109448,1/253
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.1383322856615019,0.8958662309506791,56/6250
NAC_OUD_vs_Control,GO_BP,axonal fasciculation,0.732611161560945,0.8961965495985982,1/513
NAC_OUD_vs_Control,GO_BP,positive regulation of neurotransmitter transport,0.732611161560945,0.8961965495985982,1/513
NAC_OUD_vs_Control,GO_BP,neuron projection fasciculation,0.732611161560945,0.8961965495985982,1/513
Female_OUD_vs_Control,GO_BP,synapse assembly,0.829033817999627,0.8962111066526255,5/287
Female_OUD_vs_Control,GO_BP,dendrite morphogenesis,0.8308959171508215,0.8970324985106639,2/287
NAC_OUD_vs_Control,WikiPathways,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.7346554056716623,0.8977855686174324,2/307
NAC_OUD_vs_Control,WikiPathways,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.7482005254385878,0.8977855686174324,1/307
NAC_OUD_vs_Control,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.7718766169210852,0.8977855686174324,1/307
Male_OUD_vs_Control,KEGG,Axon guidance,0.888178387901212,0.8988793323337566,1/64
DLPFC_OUD_vs_Control,GO_BP,regulation of dendrite development,0.8585223272670424,0.8990438686473852,1/253
DLPFC_OUD_vs_Control,GO_BP,postsynapse assembly,0.8585223272670424,0.8990438686473852,1/253
Pooled_OUD_vs_Control,GO_BP,neuron projection extension,0.7690035330458864,0.8995248180822739,4/380
Pooled_OUD_vs_Control,GO_BP,L-glutamate import,0.772787644400579,0.8995248180822739,1/380
DLPFC_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.5579804015366672,0.9003921652830338,4/278
Control_Male_vs_Female,GO_BP,regulation of cytokine production,0.6601481685870454,0.9004100670329371,2/37
Female_OUD_vs_Control,GO_BP,positive regulation of neuron projection development,0.8370665718727848,0.9008564603968497,2/287
DLPFC_OUD_vs_Control,GO_BP,neuron migration,0.8607140539862168,0.9008717858984819,2/253
DLPFC_OUD_vs_Control,KEGG,Arginine and proline metabolism,0.6330420401334664,0.9017168594924377,1/142
DLPFC_OUD_vs_Control,KEGG,Retinol metabolism,0.6330420401334664,0.9017168594924377,1/142
Control_Male_vs_Female,GO_BP,cytokine production,0.664637291606734,0.9034016381597576,2/37
Pooled_OUD_vs_Control,WikiPathways,WP_OPIOID_RECEPTOR_PATHWAYS,0.8444736468969611,0.9045164979378002,1/254
OUD_DLPFC_vs_NAC,KEGG,Oxidative phosphorylation,0.22347597163194896,0.9046738128715042,26/2402
NAC_OUD_vs_Control,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.5332261131474896,0.9047195067967504,3/581
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,0.5459225076307741,0.9047195067967504,4/581
NAC_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.5521466401349444,0.9047195067967504,3/581
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.5522785744301448,0.9047195067967504,1/581
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.5522785744301448,0.9047195067967504,1/581
Female_OUD_vs_Control,Reactome,Diseases of metabolism,0.7425028870167281,0.905243245814915,4/206
Pooled_OUD_vs_Control,GO_BP,negative regulation of neuron projection development,0.7798233443644296,0.9055924583082503,3/380
NAC_OUD_vs_Control,GO_BP,axon development,0.7439282744933186,0.9056407135980549,21/513
NAC_OUD_vs_Control,GO_BP,dendrite development,0.7540837741859978,0.9056407135980549,8/513
NAC_OUD_vs_Control,GO_BP,negative regulation of axon extension,0.7551498526748517,0.9056407135980549,1/513
NAC_OUD_vs_Control,GO_BP,retinal ganglion cell axon guidance,0.7551498526748517,0.9056407135980549,1/513
NAC_OUD_vs_Control,GO_BP,dopaminergic neuron differentiation,0.7551498526748517,0.9056407135980549,1/513
Female_OUD_vs_Control,DO,substance abuse,0.8856239370183359,0.9056552258638493,5/160
Female_OUD_vs_Control,DO,substance-related disorder,0.8857378405602458,0.9056552258638493,7/160
Pooled_OUD_vs_Control,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.7869930894693155,0.9063917771856363,1/380
Pooled_OUD_vs_Control,GO_BP,presynapse assembly,0.7869930894693155,0.9063917771856363,1/380
Pooled_OUD_vs_Control,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,0.53776010189299694,0.9065425072251372,2/267
DLPFC_OUD_vs_Control,GO_BP,forebrain generation of neurons,0.8700991679018316,0.9068905852675956,1/253
DLPFC_OUD_vs_Control,Reactome,Diseases of programmed cell death,0.8471578024707658,0.907192607370269,1/172
Pooled_OUD_vs_Control,GO_BP,dendrite morphogenesis,0.7970598532908938,0.9085234567919735,3/380
Pooled_OUD_vs_Control,GO_BP,negative regulation of axonogenesis,0.8003125935011832,0.9085234567919735,1/380
NAC_OUD_vs_Control,GO_BP,neuron differentiation,0.7597521263132938,0.9086133434384652,55/513
Male_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.8662459910301521,0.9091564847010594,2/118
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.27747259423548754,0.909307778699429,6/6081
Female_OUD_vs_Control,GO_BP,negative regulation of neuron differentiation,0.8482002656275361,0.909846034267736,1/287
Female_OUD_vs_Control,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,0.7558062505576165,0.9103771529272945,1/206
DLPFC_OUD_vs_Control,Reactome,Metabolism of water-soluble vitamins and cofactors,0.8542076437083705,0.9111548199555952,1/172
Male_OUD_vs_Control,DO,substance-related disorder,0.9040662490334594,0.9112987790257271,2/61
Control_Male_vs_Female,GO_CC,glutamatergic synapse,0.7856271636945992,0.9120499256684428,1/33
OUD_DLPFC_vs_NAC,GO_BP,dopamine metabolic process,0.01059907515647642,0.9121420009723031,24/5050
Pooled_OUD_vs_Control,GO_BP,positive regulation of neuron projection development,0.8052477937050649,0.9127256867106228,3/380
NAC_OUD_vs_Control,WikiPathways,WP_DOPAMINERGIC_NEUROGENESIS,0.8127773733340184,0.912982802923144,1/307
NAC_OUD_vs_Control,WikiPathways,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.8127773733340184,0.912982802923144,1/307
NAC_OUD_vs_Control,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.8127773733340184,0.912982802923144,1/307
NAC_OUD_vs_Control,GO_BP,stress fiber assembly,0.7686574338060341,0.9129970961372124,3/513
NAC_OUD_vs_Control,GO_BP,vesicle-mediated transport in synapse,0.7743232707663952,0.9129970961372124,10/513
NAC_OUD_vs_Control,GO_BP,"synaptic transmission, dopaminergic",0.7757921083162322,0.9129970961372124,1/513
NAC_OUD_vs_Control,GO_BP,somatic recombination of immunoglobulin genes involved in immune response,0.7757921083162322,0.9129970961372124,1/513
NAC_OUD_vs_Control,GO_BP,somatic diversification of immunoglobulins involved in immune response,0.7757921083162322,0.9129970961372124,1/513
NAC_OUD_vs_Control,GO_BP,positive regulation of immunoglobulin mediated immune response,0.7757921083162322,0.9129970961372124,1/513
NAC_OUD_vs_Control,GO_BP,axon ensheathment in central nervous system,0.7757921083162322,0.9129970961372124,1/513
NAC_OUD_vs_Control,GO_BP,inhibitory synapse assembly,0.7757921083162322,0.9129970961372124,1/513
NAC_OUD_vs_Control,GO_BP,neuron recognition,0.7787442294719019,0.9129970961372124,2/513
NAC_OUD_vs_Control,GO_BP,neurotransmitter transport,0.7791384471061862,0.9132317639057814,8/513
DLPFC_OUD_vs_Control,Reactome,Metabolism of RNA,0.8595099091266833,0.9132376834295717,2/172
Female_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.7199707931273963,0.9135993018851432,1/334
Pooled_OUD_vs_Control,GO_BP,oxidative phosphorylation,0.8128012726436371,0.9136949665437744,1/380
DLPFC_OUD_vs_Control,Reactome,Oxidative Stress Induced Senescence,0.873475278828371,0.9137895224666035,1/172
DLPFC_OUD_vs_Control,Reactome,Adaptive Immune System,0.8746240758532895,0.9138197770759081,9/172
Pooled_OUD_vs_Control,Reactome,Activation of ATR in response to replication stress,0.5548504631921158,0.9140067796152281,1/267
Pooled_OUD_vs_Control,KEGG,Porphyrin metabolism,0.38280809038928787,0.9146741982752896,1/225
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.6246811249609712,0.9170195824550217,5/410
DLPFC_OUD_vs_Control,Reactome,Metabolism of lipids,0.882556820745166,0.9174093830930642,9/172
DLPFC_OUD_vs_Control,GO_BP,neurotransmitter secretion,0.8861061239461383,0.9179313823741679,2/253
DLPFC_OUD_vs_Control,GO_BP,signal release from synapse,0.8861061239461383,0.9179313823741679,2/253
Pooled_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.6207313860684707,0.9182188345784639,5/435
NAC_OUD_vs_Control,GO_BP,motor neuron axon guidance,0.7946972116090943,0.9183701298754398,1/513
NAC_OUD_vs_Control,GO_BP,response to fluid shear stress,0.7946972116090943,0.9183701298754398,1/513
NAC_OUD_vs_Control,GO_BP,positive regulation of axon extension,0.7946972116090943,0.9183701298754398,1/513
NAC_OUD_vs_Control,GO_BP,dendrite extension,0.7946972116090943,0.9183701298754398,1/513
NAC_OUD_vs_Control,GO_BP,mitochondrial outer membrane permeabilization involved in programmed cell death,0.7946972116090943,0.9183701298754398,1/513
NAC_OUD_vs_Control,GO_BP,cellular response to chemical stress,0.7947773763626773,0.9183701298754398,8/513
Pooled_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.6319944573183041,0.9184241305984986,4/410
NAC_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.5702055031171211,0.918625229816148,5/581
Pooled_OUD_vs_Control,GO_CC,glycinergic synapse,0.2716850066699741,0.9190040660401732,1/397
Pooled_OUD_vs_Control,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.6242055565974827,0.9190202171927578,2/435
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.626428927848079,0.9190202171927578,4/435
Female_OUD_vs_Control,GO_BP,protein localization to synapse,0.8622347883755433,0.9196417703538887,1/287
Female_OUD_vs_Control,GO_BP,cytoskeleton-dependent cytokinesis,0.8622347883755433,0.9196417703538887,1/287
Female_OUD_vs_Control,Reactome,Arachidonate metabolism,0.7819421305589851,0.9197292901288503,1/206
Pooled_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.6341786328299426,0.9201958981537328,5/410
Pooled_OUD_vs_Control,Reactome,Metabolism of water-soluble vitamins and cofactors,0.563861285634023,0.9202830934590763,3/267
Pooled_OUD_vs_Control,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.5802157208921871,0.9202830934590763,2/267
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.6368096420847353,0.9213127675486463,1/435
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.6368096420847353,0.9213127675486463,1/435
Control_Male_vs_Female,GO_BP,regulation of innate immune response,0.6966772049656721,0.9213534177927573,1/37
Female_OUD_vs_Control,Reactome,"Cell death signalling via NRAGE, NRIF and NADE",0.8261538557731691,0.9229417551942937,1/206
Female_OUD_vs_Control,GO_BP,positive regulation of synapse assembly,0.8687593124244244,0.9236952292278503,1/287
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.7622163447652982,0.9240100918721845,1/286
Control_Male_vs_Female,GO_CC,synapse,0.8142659123339647,0.9240545746711286,3/33
Pooled_OUD_vs_Control,WikiPathways,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.8876323259576693,0.9245306161781288,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.8876323259576693,0.9245306161781288,1/254
Pooled_OUD_vs_Control,WikiPathways,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.896408890904395,0.9245306161781288,1/254
Pooled_OUD_vs_Control,KEGG,Adipocytokine signaling pathway,0.39048794551228505,0.9248398709501487,3/225
DLPFC_OUD_vs_Control,KEGG,Ether lipid metabolism,0.6681755584547935,0.9248757730023978,1/142
DLPFC_OUD_vs_Control,KEGG,Drug metabolism - other enzymes,0.6681755584547935,0.9248757730023978,1/142
Control_Male_vs_Female,GO_BP,innate immune response,0.7097084047146391,0.9251241019766555,2/37
DLPFC_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.7781785835903778,0.925244749120768,2/286
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.7781785835903778,0.925244749120768,2/286
NAC_OUD_vs_Control,KEGG,Nicotine addiction,0.23174356309241206,0.9262480672887687,4/278
NAC_OUD_vs_Control,GO_BP,regulation of cellular response to stress,0.809236174610048,0.927055845676394,10/513
NAC_OUD_vs_Control,GO_BP,immunoglobulin production involved in immunoglobulin-mediated immune response,0.8120110913468117,0.927055845676394,1/513
NAC_OUD_vs_Control,GO_BP,antiviral innate immune response,0.8120110913468117,0.927055845676394,1/513
Female_OUD_vs_Control,GO_BP,regulation of synapse organization,0.8724107070309912,0.9273352055666415,5/287
Female_OUD_vs_Control,KEGG,Histidine metabolism,0.525102770383085,0.9278131657144735,1/175
Male_OUD_vs_Control,GO_BP,axon guidance,0.9136882442495118,0.9287526382407223,1/101
Male_OUD_vs_Control,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.8301843646658134,0.9288517972020579,1/57
Male_OUD_vs_Control,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.8359666174818521,0.9288517972020579,1/57
Male_OUD_vs_Control,GO_BP,neuron projection guidance,0.9151518922231181,0.9299071180024232,1/101
NAC_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.5868744180604262,0.9307753509365996,1/581
DLPFC_OUD_vs_Control,GO_BP,cytokinesis,0.9036731412066537,0.9311130758337504,1/253
Pooled_OUD_vs_Control,KEGG,Nicotinate and nicotinamide metabolism,0.4103848331743203,0.9311252517400544,2/225
Female_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.7240182389983982,0.9312467709121555,3/319
Female_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.7390640816168395,0.9313232810769297,2/319
DLPFC_OUD_vs_Control,KEGG,Axon guidance,0.7057508039943803,0.9314024808248583,4/142
DLPFC_OUD_vs_Control,KEGG,Intestinal immune network for IgA production,0.7147088424288709,0.9314024808248583,1/142
Female_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.7524998211020626,0.9319313865774157,2/334
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.6329833395720217,0.9319447596454329,3/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.6375672953009468,0.9319447596454329,2/278
Female_OUD_vs_Control,GO_BP,"regulation of synaptic transmission, glutamatergic",0.8808989275162621,0.9322381428222896,1/287
Control_Male_vs_Female,GO_BP,regulation of neuron projection development,0.727441945734056,0.9324052301184071,1/37
NAC_OUD_vs_Control,GO_BP,synapse maturation,0.8278674396103904,0.9324902275745566,1/513
DLPFC_OUD_vs_Control,KEGG,Morphine addiction,0.7397274180704434,0.9327504319685754,2/142
Female_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.7460860912733018,0.9329216238561168,3/319
Female_OUD_vs_Control,GO_BP,regulation of synapse structure or activity,0.8824948181334932,0.9333266749946534,5/287
NAC_OUD_vs_Control,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.5900894332401769,0.9338915394712122,6/581
NAC_OUD_vs_Control,GO_BP,positive regulation of axonogenesis,0.8303400072164189,0.9341573210519883,2/513
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.4869123106041304,0.9342931266839651,8/580
NAC_OUD_vs_Control,C8_CellType,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.5916146359690312,0.9343258627248758,39/581
Control_Male_vs_Female,GO_BP,adaptive immune response,0.7342269105521664,0.9350106449911892,1/37
Female_OUD_vs_Control,GO_BP,forebrain neuron differentiation,0.8865423166202464,0.9350286900797777,1/287
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.15520135863732104,0.9351023310097727,10/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.16378072967322335,0.9351023310097727,17/6250
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_1,0.30141338426279557,0.9351837321613733,35/6081
Female_OUD_vs_Control,Reactome,Fatty acid metabolism,0.8488846586291243,0.9363445164040609,2/206
Pooled_OUD_vs_Control,Reactome,Pyruvate metabolism,0.6158655735366597,0.9367763704753023,1/267
DLPFC_OUD_vs_Control,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.8138566036362431,0.9368332381415498,2/286
Female_OUD_vs_Control,Reactome,Sphingolipid metabolism,0.8763051258660993,0.9371433989569367,1/206
NAC_OUD_vs_Control,GO_BP,regulation of neuron differentiation,0.8361184547216645,0.9384148456761634,7/513
Control_DLPFC_vs_NAC,GO_CC,neuronal cell body,0.1258432016628216,0.9384703581763751,223/5212
DLPFC_OUD_vs_Control,Reactome,Transmission across Chemical Synapses,0.9113075615378017,0.9389229421904624,4/172
NAC_OUD_vs_Control,GO_BP,generation of neurons,0.8373733566910393,0.9389581695216026,56/513
NAC_OUD_vs_Control,GO_BP,regulation of axon extension,0.841423040638184,0.9389581695216026,2/513
Female_OUD_vs_Control,Reactome,Peptide hormone metabolism,0.88313287079417635,0.9394281932352393,1/206
Control_Male_vs_Female,GO_BP,response to cytokine,0.7474361079890368,0.9396680782545878,2/37
NAC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.6188012553984006,0.940262681759721,1/581
Pooled_OUD_vs_Control,GO_BP,positive regulation of neuron differentiation,0.8515879024232771,0.9403103728547519,2/380
Male_OUD_vs_Control,Reactome,Metabolism of lipids,0.9150577712152062,0.9404760426378507,3/75
Pooled_OUD_vs_Control,GO_BP,axonogenesis,0.8567176978029102,0.9414835727365818,12/380
Control_Male_vs_Female,GO_BP,immune response-activating signaling pathway,0.7567044846800228,0.9420175272368829,1/37
Female_OUD_vs_Control,GO_BP,regulation of neurotransmitter secretion,0.8970420970089824,0.9424384954117091,1/287
Female_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.7693180081941964,0.9431210911336707,4/334
DLPFC_OUD_vs_Control,GO_BP,axoneme assembly,0.9222155224152321,0.9439559643885188,1/253
OUD_DLPFC_vs_NAC,GO_CC,juxtaparanode region of axon,0.26866931776688974,0.9440607384372547,7/5358
OUD_DLPFC_vs_NAC,GO_CC,dendrite membrane,0.269532133902944,0.9440607384372547,25/5358
NAC_OUD_vs_Control,GO_BP,negative regulation of neuron differentiation,0.8518462726444169,0.94438646793945,2/513
Male_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.9101488360456691,0.9443920595800607,1/118
Control_Male_vs_Female,GO_CC,postsynapse,0.8744725165761741,0.9447339476989652,1/33
Pooled_OUD_vs_Control,GO_BP,cellular response to dopamine,0.8644834311370431,0.9447847213102637,1/380
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.5032569743074529,0.9450697831471353,7/580
Female_OUD_vs_Control,GO_BP,forebrain generation of neurons,0.9019229886770402,0.9451260986162443,1/287
DLPFC_OUD_vs_Control,GO_CC,neuron projection membrane,0.4712640301799237,0.9451756110911953,2/261
Female_OUD_vs_Control,GO_CC,dendrite cytoplasm,0.46684280918140686,0.9464408863732345,1/305
DLPFC_OUD_vs_Control,KEGG,Cocaine addiction,0.766822781231018,0.9465605994000822,1/142
DLPFC_OUD_vs_Control,KEGG,Chemokine signaling pathway,0.772702530122516,0.9465605994000822,3/142
DLPFC_OUD_vs_Control,Reactome,Integration of energy metabolism,0.9248337989007571,0.9468812796775632,1/172
Female_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.7869772767342609,0.9469792810231628,2/319
NAC_OUD_vs_Control,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.873942295553899,0.9470916506883663,1/307
NAC_OUD_vs_Control,WikiPathways,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.873942295553899,0.9470916506883663,1/307
Control_Male_vs_Female,GO_BP,negative regulation of immune system process,0.774489634352096,0.9471436022309625,1/37
Control_Male_vs_Female,GO_BP,activation of immune response,0.782901254973164,0.9471436022309625,1/37
Control_Male_vs_Female,GO_BP,immune response-regulating signaling pathway,0.782901254973164,0.9471436022309625,1/37
Control_Male_vs_Female,GO_BP,axonogenesis,0.7856366792590909,0.9471436022309625,1/37
DLPFC_OUD_vs_Control,KEGG,Inositol phosphate metabolism,0.8094717923546518,0.9475139681271919,1/142
DLPFC_OUD_vs_Control,KEGG,Cortisol synthesis and secretion,0.8188626307738256,0.9475139681271919,1/142
DLPFC_OUD_vs_Control,KEGG,Carbon metabolism,0.8520466112680456,0.9475139681271919,1/142
DLPFC_OUD_vs_Control,KEGG,Amphetamine addiction,0.8593516812262991,0.9475139681271919,1/142
DLPFC_OUD_vs_Control,KEGG,Glycerophospholipid metabolism,0.8662984851448612,0.9475139681271919,1/142
NAC_OUD_vs_Control,GO_BP,negative regulation of neuron apoptotic process,0.8592380029333841,0.9476386317798232,4/513
Female_OUD_vs_Control,Reactome,Drug ADME,0.8956834258216493,0.9477442854466858,1/206
Female_OUD_vs_Control,GO_BP,central nervous system neuron differentiation,0.9070792525054803,0.9483313151194243,3/287
Pooled_OUD_vs_Control,GO_BP,response to dopamine,0.8729671702091888,0.9484081857748212,1/380
Female_OUD_vs_Control,GO_BP,response to oxidative stress,0.9080049333871043,0.9488992224485996,4/287
DLPFC_OUD_vs_Control,KEGG,Choline metabolism in cancer,0.8851596401364443,0.9489378964963388,1/142
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.6932470387566692,0.9491180527295863,2/278
Pooled_OUD_vs_Control,Reactome,Metabolism of vitamins and cofactors,0.634534423671123,0.9492170440252762,5/267
Pooled_OUD_vs_Control,Reactome,Nicotinate metabolism,0.6431722540120889,0.9492170440252762,1/267
OUD_Male_vs_Female,GO_CC,glutamatergic synapse,0.7753590610758655,0.9492713738405456,1/32
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.6964215182968929,0.9499745148602681,5/410
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.7009249881036961,0.9499745148602681,4/410
Pooled_OUD_vs_Control,GO_BP,ensheathment of neurons,0.8782769833649469,0.9506107925202212,3/380
Pooled_OUD_vs_Control,GO_BP,axon ensheathment,0.8782769833649469,0.9506107925202212,3/380
Pooled_OUD_vs_Control,GO_BP,neuron recognition,0.8809211124271008,0.9506107925202212,1/380
Pooled_OUD_vs_Control,GO_BP,neuron fate commitment,0.8809211124271008,0.9506107925202212,1/380
Female_OUD_vs_Control,GO_BP,vesicle-mediated transport in synapse,0.9108091862314118,0.9507243819495312,4/287
Pooled_OUD_vs_Control,GO_MF,postsynaptic neurotransmitter receptor activity,0.7300173793042585,0.9513076557325674,2/376
Control_Male_vs_Female,GO_BP,axon development,0.8251025589006125,0.9514255854925999,1/37
Control_Male_vs_Female,GO_BP,synapse organization,0.8379980902498098,0.9514255854925999,1/37
Control_Male_vs_Female,GO_BP,immune effector process,0.8440940763056541,0.9514255854925999,1/37
Female_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.79090913344253,0.9518446775637429,2/334
NAC_OUD_vs_Control,GO_BP,regulation of cytokinesis,0.8678655830918327,0.9524662859212139,1/513
NAC_OUD_vs_Control,WikiPathways,WP_OPIOID_RECEPTOR_PATHWAYS,0.8965830366996947,0.9527405055210579,1/307
NAC_OUD_vs_Control,GO_BP,neuron projection morphogenesis,0.86932389126256715,0.9528372852826942,24/513
NAC_OUD_vs_Control,GO_BP,regulation of neurotransmitter transport,0.8694184664266658,0.9528372852826942,3/513
OUD_DLPFC_vs_NAC,KEGG,Cysteine and methionine metabolism,0.2586393669246656,0.9530951493435069,19/2402
OUD_DLPFC_vs_NAC,KEGG,Nucleotide metabolism,0.2613110708388518,0.9530951493435069,30/2402
OUD_DLPFC_vs_NAC,KEGG,beta-Alanine metabolism,0.2656886464834142,0.9530951493435069,13/2402
NAC_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.6436872029581983,0.9532553283581233,16/581
NAC_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.6478598060955809,0.9532553283581233,2/581
OUD_Male_vs_Female,GO_CC,dendrite,0.8108652950023812,0.9532690628158026,1/32
OUD_Male_vs_Female,GO_CC,axon,0.8269693839776684,0.9532690628158026,1/32
Pooled_OUD_vs_Control,GO_BP,multicellular organismal response to stress,0.8847433626041281,0.953321347264137,2/380
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,0.34359838693676814,0.9547054152919693,5/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.34359838693676814,0.9547054152919693,5/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.34359838693676814,0.9547054152919693,5/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,0.34514472734207224,0.9547054152919693,10/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.34514472734207224,0.9547054152919693,10/6081
NAC_OUD_vs_Control,GO_BP,neurotransmitter secretion,0.8734484560701903,0.9550483800223326,5/513
NAC_OUD_vs_Control,GO_BP,signal release from synapse,0.8734484560701903,0.9550483800223326,5/513
NAC_OUD_vs_Control,GO_BP,positive regulation of stress fiber assembly,0.8790180931072802,0.9556262304166508,1/513
NAC_OUD_vs_Control,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.8790180931072802,0.9556262304166508,1/513
NAC_OUD_vs_Control,GO_BP,response to axon injury,0.8794766689193615,0.9556262304166508,2/513
Female_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.7980826685066296,0.9557161367537553,3/319
Control_DLPFC_vs_NAC,GO_CC,main axon,0.1498006876570641,0.955977965636558,37/5212
OUD_DLPFC_vs_NAC,GO_CC,axonemal doublet microtubule,0.28529432028994506,0.9561779105980243,30/5358
OUD_DLPFC_vs_NAC,GO_CC,excitatory synapse,0.3062737115768805,0.9561779105980243,40/5358
OUD_DLPFC_vs_NAC,GO_CC,neuron spine,0.3206355142214476,0.9561779105980243,76/5358
OUD_DLPFC_vs_NAC,GO_CC,dendrite cytoplasm,0.3209227021964228,0.9561779105980243,12/5358
OUD_DLPFC_vs_NAC,GO_CC,neuron projection membrane,0.32163737228488076,0.9561779105980243,34/5358
OUD_DLPFC_vs_NAC,GO_CC,axonemal microtubule doublet inner sheath,0.33894013361028213,0.9561779105980243,28/5358
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,0.696328177416017,0.9568363844695584,1/435
NAC_OUD_vs_Control,WikiPathways,WP_PYRIMIDINE_METABOLISM,0.9063339604506756,0.95690194966037,1/307
Control_Male_vs_Female,GO_BP,cell morphogenesis involved in neuron differentiation,0.8556237728667121,0.9573168850142414,1/37
Control_Male_vs_Female,GO_BP,immune response,0.8563546214104523,0.9573168850142414,3/37
Female_OUD_vs_Control,Reactome,Oxidative Stress Induced Senescence,0.9169014455327702,0.9575463596763348,1/206
NAC_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.5288563579692664,0.9581753342562571,5/580
NAC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.5294096264728935,0.9581753342562571,7/580
NAC_OUD_vs_Control,GO_BP,axon regeneration,0.8892309807551271,0.9582599027784814,1/513
NAC_OUD_vs_Control,GO_BP,negative regulation of axonogenesis,0.8892309807551271,0.9582599027784814,1/513
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.17852798714453635,0.9584134046706688,70/6250
OUD_Male_vs_Female,GO_CC,neuron projection,0.8659448401895427,0.9585107065291688,2/32
OUD_Male_vs_Female,GO_CC,postsynapse,0.8663035645997602,0.9585107065291688,1/32
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.7183440558022469,0.9585533253291832,2/278
Male_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.9370120311590118,0.9589732506393011,1/118
NAC_OUD_vs_Control,GO_MF,chemokine activity,0.2702709796177337,0.9594973919683156,2/528
NAC_OUD_vs_Control,GO_MF,postsynaptic neurotransmitter receptor activity,0.28110720856505117,0.9594973919683156,5/528
NAC_OUD_vs_Control,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.3045510795888257,0.9594973919683156,4/528
NAC_OUD_vs_Control,GO_MF,dopamine binding,0.35766682916647574,0.9594973919683156,1/528
NAC_OUD_vs_Control,GO_MF,neurotransmitter receptor activity,0.41450928380456253,0.9594973919683156,6/528
NAC_OUD_vs_Control,GO_MF,chemokine receptor binding,0.4286193134784996,0.9594973919683156,2/528
NAC_OUD_vs_Control,GO_MF,L-glutamate transmembrane transporter activity,0.5075761229150446,0.9594973919683156,1/528
NAC_OUD_vs_Control,GO_MF,axon guidance receptor activity,0.5493364517137685,0.9594973919683156,1/528
Pooled_OUD_vs_Control,GO_BP,axon development,0.8987479380439781,0.9603512238829779,13/380
Pooled_OUD_vs_Control,GO_BP,neuron cellular homeostasis,0.9019240627414669,0.9611568686197517,1/380
Pooled_OUD_vs_Control,GO_BP,receptor localization to synapse,0.9019240627414669,0.9611568686197517,1/380
NAC_OUD_vs_Control,GO_BP,"regulation of synaptic transmission, glutamatergic",0.8951687365779639,0.9615759128819672,2/513
Female_OUD_vs_Control,GO_BP,cytokinesis,0.930205705640137,0.9616379614455582,1/287
NAC_OUD_vs_Control,GO_BP,cellular response to oxidative stress,0.8964230504061006,0.9617297566884357,5/513
NAC_OUD_vs_Control,WikiPathways,WP_AMINO_ACID_METABOLISM,0.9304223253323292,0.9637216506600126,1/307
NAC_OUD_vs_Control,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.9304223253323292,0.9637216506600126,1/307
Male_OUD_vs_Control,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.9183254095528819,0.9650286230410916,1/57
Control_Male_vs_Female,GO_BP,positive regulation of immune response,0.8671780586810683,0.9653028743734098,1/37
OUD_DLPFC_vs_NAC,Hallmark,HALLMARK_HEME_METABOLISM,0.12875364727030844,0.9653716578925284,53/1389
OUD_DLPFC_vs_NAC,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.1576630048959235,0.9653716578925284,46/1389
OUD_DLPFC_vs_NAC,Hallmark,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.15849592744030516,0.9653716578925284,36/1389
OUD_DLPFC_vs_NAC,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.17376689842065512,0.9653716578925284,45/1389
Control_Male_vs_Female,GO_BP,neuron projection morphogenesis,0.8854547298667016,0.9655300246627686,1/37
Control_Male_vs_Female,GO_BP,negative regulation of programmed cell death,0.8905139822307936,0.9655300246627686,1/37
Male_OUD_vs_Control,Reactome,Axon guidance,0.9527902064450657,0.9658421270812996,2/75
NAC_OUD_vs_Control,GO_BP,regulation of dendrite development,0.9089441984253023,0.9659193847703633,2/513
OUD_DLPFC_vs_NAC,KEGG,Nicotine addiction,0.3047484991944457,0.9669915208492214,23/2402
OUD_DLPFC_vs_NAC,KEGG,Porphyrin metabolism,0.31334556140759384,0.9669915208492214,6/2402
Pooled_OUD_vs_Control,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.6685445597853972,0.967504434095422,1/267
OUD_Male_vs_Female,GO_CC,synapse,0.9298411918526048,0.9676004229332208,2/32
Male_OUD_vs_Control,GO_BP,synapse organization,0.9582694122201327,0.9678248052194787,2/101
OUD_Male_vs_Female,GO_BP,neuron projection development,0.9440179660102467,0.9679171550231642,1/33
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.18873507731155748,0.9686026609196912,16/6250
NAC_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.5498924492625794,0.9686789362220508,6/580
NAC_OUD_vs_Control,GO_BP,regulation of neurotransmitter secretion,0.9151791657417142,0.9686984152002941,2/513
NAC_OUD_vs_Control,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.886482090136206,0.9687794662328567,3/164
NAC_OUD_vs_Control,Hallmark,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.9140883715546058,0.9687794662328567,2/164
NAC_OUD_vs_Control,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.9293263332825681,0.9687794662328567,4/164
NAC_OUD_vs_Control,Hallmark,HALLMARK_HEME_METABOLISM,0.9407346633570816,0.9687794662328567,3/164
NAC_OUD_vs_Control,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.9687794662328567,0.9687794662328567,2/164
OUD_DLPFC_vs_NAC,GO_BP,synapse organization,0.011856612318429296,0.9688308157762473,256/5050
Pooled_OUD_vs_Control,GO_BP,regulation of neuron projection development,0.914716463337474,0.9688758462674288,9/380
Control_DLPFC_vs_NAC,GO_CC,GABA-ergic synapse,0.1987423248823516,0.9700611269238966,49/5212
Control_DLPFC_vs_NAC,GO_CC,dopaminergic synapse,0.22140235513868575,0.9700611269238966,7/5212
Control_DLPFC_vs_NAC,GO_CC,parallel fiber to Purkinje cell synapse,0.2578023119477095,0.9700611269238966,17/5212
Control_DLPFC_vs_NAC,GO_CC,axon terminus,0.3210964671496199,0.9700611269238966,61/5212
Control_DLPFC_vs_NAC,GO_CC,neuron to neuron synapse,0.3303164445841716,0.9700611269238966,174/5212
Control_DLPFC_vs_NAC,GO_CC,asymmetric synapse,0.33951572322797413,0.9700611269238966,156/5212
Female_OUD_vs_Control,GO_BP,axoneme assembly,0.9452758803675845,0.9703147218001265,1/287
Pooled_OUD_vs_Control,KEGG,Retinol metabolism,0.46463187519058424,0.9710582395168496,2/225
Pooled_OUD_vs_Control,KEGG,alpha-Linolenic acid metabolism,0.4746360884900722,0.9710582395168496,1/225
Pooled_OUD_vs_Control,KEGG,2-Oxocarboxylic acid metabolism,0.4746360884900722,0.9710582395168496,1/225
DLPFC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.7535417598021961,0.9710742531598344,3/278
NAC_OUD_vs_Control,GO_BP,response to oxidative stress,0.9197492840237238,0.9714810273642539,8/513
NAC_OUD_vs_Control,GO_BP,glutamate receptor signaling pathway,0.9221705564502731,0.9714810273642539,1/513
NAC_OUD_vs_Control,GO_BP,regulation of dendrite morphogenesis,0.9221705564502731,0.9714810273642539,1/513
NAC_OUD_vs_Control,GO_BP,neuron apoptotic process,0.9225560372483745,0.9714810273642539,7/513
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.7304949910358027,0.9717218817323272,1/435
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.7304949910358027,0.9717218817323272,1/435
Female_OUD_vs_Control,GO_MF,neurotransmitter receptor activity,0.7872236395736749,0.9717885100875644,2/292
Female_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_1,0.8451790463541092,0.9729724416791291,1/334
DLPFC_OUD_vs_Control,GO_CC,excitatory synapse,0.5600009563404313,0.9731333607193439,2/261
DLPFC_OUD_vs_Control,GO_CC,axonal growth cone,0.5620037042760462,0.9731333607193439,1/261
NAC_OUD_vs_Control,GO_BP,"synaptic transmission, glutamatergic",0.9247478458846938,0.973135814564707,3/513
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.8725178579426159,0.973170561484647,1/286
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.7769430632687672,0.9739018238029677,2/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.7960178130430388,0.9739018238029677,2/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.8350213321227447,0.9739018238029677,2/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.8495803633611024,0.9739018238029677,2/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.8541682374276478,0.9739018238029677,2/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.875251916391899,0.9739018238029677,2/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.8865200300784593,0.9739018238029677,2/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.8926991605324468,0.9739018238029677,1/278
DLPFC_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.900953891977554,0.9739018238029677,1/278
Female_OUD_vs_Control,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,0.9435968347200541,0.9746364903746737,3/206
Female_OUD_vs_Control,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.795516168276378,0.9752858361964849,1/292
Pooled_OUD_vs_Control,GO_BP,synapse organization,0.926697829728546,0.9756478598082738,13/380
DLPFC_OUD_vs_Control,Reactome,Axon guidance,0.9625259919822594,0.9756785210652469,6/172
Pooled_OUD_vs_Control,GO_BP,cytoskeleton-dependent cytokinesis,0.9290401158118471,0.9757603718764949,1/380
Control_Male_vs_Female,GO_BP,cellular response to cytokine stimulus,0.912721905791333,0.9758467355893062,1/37
NAC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.5714078483296638,0.9762348024161871,8/580
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.36502152312940384,0.9765821733560444,19/6081
Female_OUD_vs_Control,GO_BP,neuron projection development,0.953783385614132,0.9765839446562413,17/287
Pooled_OUD_vs_Control,Reactome,Bile acid and bile salt metabolism,0.7343733765492064,0.9766767405416323,1/267
Female_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.8873725086751423,0.9767094752907707,2/319
NAC_OUD_vs_Control,GO_BP,positive regulation of neuron apoptotic process,0.9347670308828154,0.9769073167520608,1/513
NAC_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.5770031648568645,0.9771339859250293,6/580
DLPFC_OUD_vs_Control,GO_CC,cytoplasmic stress granule,0.5967679704764501,0.9772759883490492,1/261
Pooled_OUD_vs_Control,GO_BP,dendrite development,0.9314516515161991,0.9773783188964887,4/380
DLPFC_OUD_vs_Control,WikiPathways,WP_CHEMOKINE_SIGNALING,0.975701285026025,0.9779650931119322,1/161
Female_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.9391509138080534,0.9779773909624588,1/319
Pooled_OUD_vs_Control,GO_BP,regulation of synapse assembly,0.9325071765556199,0.9779898668104952,3/380
Pooled_OUD_vs_Control,GO_BP,positive regulation of synapse assembly,0.9334897455134146,0.9780803502558941,1/380
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.7677344324547319,0.9781506694638453,4/410
Pooled_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.7752048841784936,0.9781506694638453,4/410
NAC_OUD_vs_Control,DO,motor neuron disease,0.968668652020163,0.9782121855376029,2/257
Female_OUD_vs_Control,GO_BP,"synaptic transmission, glutamatergic",0.9591406838293313,0.9791127552688281,1/287
Female_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.9633662771048985,0.9793325283612647,1/319
Pooled_OUD_vs_Control,GO_BP,regulation of synapse organization,0.9353237429816196,0.9793361183081991,6/380
NAC_OUD_vs_Control,GO_BP,positive regulation of neuron differentiation,0.9449244666259775,0.9798473282759973,2/513
Female_OUD_vs_Control,Reactome,Integration of energy metabolism,0.9555941435288016,0.9800651843361972,1/206
OUD_Male_vs_Female,GO_BP,neuron development,0.9619810171546083,0.9801316023839405,1/33
NAC_OUD_vs_Control,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.6916321836309376,0.980147584803389,7/581
DLPFC_OUD_vs_Control,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.9812228139894426,0.9812228139894426,1/161
OUD_Male_vs_Female,Reactome,Metabolism,0.9814280842579781,0.9814280842579781,1/18
DLPFC_OUD_vs_Control,KEGG,Purine metabolism,0.9491053654958008,0.9814865930233194,1/142
DLPFC_OUD_vs_Control,KEGG,Serotonergic synapse,0.9605714595529427,0.9814865930233194,1/142
Female_OUD_vs_Control,Hallmark,HALLMARK_HEME_METABOLISM,0.9460295024787457,0.9817489833176234,2/126
Female_OUD_vs_Control,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.9817489833176234,0.9817489833176234,1/126
Pooled_OUD_vs_Control,GO_BP,"regulation of synaptic transmission, glutamatergic",0.9415713778571441,0.981834463532354,1/380
Pooled_OUD_vs_Control,GO_BP,regulation of synapse structure or activity,0.942186463101768,0.9822412016812079,6/380
OUD_DLPFC_vs_NAC,WikiPathways,WP_ENERGY_METABOLISM,0.02065045460687261,0.9823716262983684,19/2675
DLPFC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.9823825612068038,0.9825953823855746,1/278
Female_OUD_vs_Control,GO_BP,neuron development,0.966010291611056,0.9831655519173054,19/287
NAC_OUD_vs_Control,GO_MF,structural constituent of postsynapse,0.6838879322476656,0.9834421505049077,1/528
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.5829774576751771,0.9834699799569055,8/580
NAC_OUD_vs_Control,GO_BP,cytokinesis,0.9524115103982307,0.9835524616927965,2/513
Control_Male_vs_Female,GO_BP,regulation of immune response,0.9243672179602687,0.9836552685793514,1/37
Control_Male_vs_Female,GO_BP,regulation of immune system process,0.9327949014304794,0.9836552685793514,2/37
Pooled_OUD_vs_Control,GO_BP,postsynapse organization,0.9470007049213289,0.9837710153866253,4/380
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.19292459433604975,0.9839154311138536,80/6250
OUD_DLPFC_vs_NAC,GO_BP,cell morphogenesis involved in neuron differentiation,0.013565935274682445,0.9840035377147569,271/5050
Pooled_OUD_vs_Control,GO_BP,regulation of dendrite development,0.9486732830779125,0.9840681750558671,1/380
Pooled_OUD_vs_Control,GO_BP,vesicle-mediated transport in synapse,0.9491765183748182,0.9841224471985942,5/380
Pooled_OUD_vs_Control,GO_BP,regulation of postsynapse organization,0.9502284552501357,0.9846017214868494,2/380
Pooled_OUD_vs_Control,GO_BP,stress fiber assembly,0.9518944478063012,0.9846017214868494,1/380
NAC_OUD_vs_Control,GO_BP,neuron cellular homeostasis,0.9580569903300689,0.9846290011996733,1/513
NAC_OUD_vs_Control,GO_BP,regulation of neuron apoptotic process,0.9583200183763074,0.98468428089059,5/513
Female_OUD_vs_Control,GO_BP,neuron projection morphogenesis,0.9691199432779084,0.9848610081816869,10/287
Female_OUD_vs_Control,GO_BP,synapse organization,0.9696050672957783,0.9848610081816869,8/287
Female_OUD_vs_Control,GO_BP,dendrite development,0.9736908742634326,0.9853141425958486,2/287
DLPFC_OUD_vs_Control,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.8600752148738491,0.985939880465144,2/109
Female_OUD_vs_Control,GO_BP,generation of neurons,0.9773040125633601,0.9862723281548392,25/287
Female_OUD_vs_Control,GO_BP,ensheathment of neurons,0.9783267650828359,0.9863259680679037,1/287
Female_OUD_vs_Control,GO_BP,axon ensheathment,0.9783267650828359,0.9863259680679037,1/287
Female_OUD_vs_Control,KEGG,Fatty acid metabolism,0.6297518602114353,0.9866112476645819,1/175
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.6028866603941578,0.986772229797887,5/580
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.6042834274118329,0.986772229797887,7/580
Control_Male_vs_Female,GO_BP,positive regulation of immune system process,0.9519086395187435,0.9869265368247121,1/37
Control_Male_vs_Female,GO_BP,neuron projection development,0.9605711831136061,0.9869582473898669,1/37
Pooled_OUD_vs_Control,GO_BP,cell morphogenesis involved in neuron differentiation,0.9562802558036438,0.9877338657318753,13/380
Female_OUD_vs_Control,GO_BP,neuron differentiation,0.9827748814550794,0.9877667188745464,23/287
DLPFC_OUD_vs_Control,Reactome,Phospholipid metabolism,0.981980664876696,0.9880347996786484,1/172
Pooled_OUD_vs_Control,GO_BP,synapse assembly,0.9568342248444495,0.988072247798917,5/380
NAC_OUD_vs_Control,GO_BP,axoneme assembly,0.9671115150649318,0.9884098135792246,2/513
OUD_DLPFC_vs_NAC,GO_CC,AMPA glutamate receptor complex,0.4239132970703292,0.9886654939720365,15/5358
OUD_Male_vs_Female,GO_BP,neuron differentiation,0.9830221696772674,0.9888181493519907,1/33
NAC_OUD_vs_Control,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.9788764965244396,0.9889265632238693,1/307
Female_OUD_vs_Control,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.8763767447773685,0.9889487821572611,2/334
Pooled_OUD_vs_Control,GO_CC,symmetric synapse,0.35847122427898304,0.9889738031526553,1/397
Pooled_OUD_vs_Control,GO_CC,dendrite terminus,0.35847122427898304,0.9889738031526553,1/397
DLPFC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.9029896700743756,0.9890581523593323,1/286
OUD_Male_vs_Female,GO_BP,generation of neurons,0.9863973439620495,0.9897356519233538,1/33
DLPFC_OUD_vs_Control,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.9076799671421093,0.9899198645364787,2/286
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.9118200796264355,0.9899198645364787,4/286
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.9137138174448307,0.9899198645364787,1/286
Pooled_OUD_vs_Control,GO_BP,central nervous system neuron development,0.965215824780441,0.9900636641306492,1/380
Control_DLPFC_vs_NAC,GO_CC,cytoplasmic stress granule,0.35891337376364735,0.990307921078472,19/5212
Control_DLPFC_vs_NAC,GO_CC,neuronal cell body membrane,0.35891337376364735,0.990307921078472,19/5212
NAC_OUD_vs_Control,GO_BP,cytoskeleton-dependent cytokinesis,0.9730420630292449,0.9907260814832597,1/513
Pooled_OUD_vs_Control,Reactome,Drug ADME,0.7872906265212816,0.9909016619069522,2/267
Pooled_OUD_vs_Control,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.8164145709091095,0.9909016619069522,1/267
Pooled_OUD_vs_Control,Reactome,Retinoid metabolism and transport,0.8164145709091095,0.9909016619069522,1/267
DLPFC_OUD_vs_Control,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.9680966915961351,0.9911866505750058,1/109
DLPFC_OUD_vs_Control,Hallmark,HALLMARK_HEME_METABOLISM,0.98262147415196055,0.9911866505750058,1/109
Male_OUD_vs_Control,GO_BP,axonogenesis,0.9854010126937867,0.991657900043045,1/101
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.8327144348140622,0.9920497045767691,2/410
Pooled_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.8401628999750406,0.9920497045767691,2/410
Female_OUD_vs_Control,KEGG,Folate transport and metabolism,0.6521098396672665,0.9924796227261609,1/175
Control_DLPFC_vs_NAC,GO_CC,axon initial segment,0.39499076409126976,0.9926161952628192,9/5212
DLPFC_OUD_vs_Control,GO_BP,central nervous system neuron differentiation,0.9920240901003621,0.9927616544796188,1/253
Pooled_OUD_vs_Control,GO_BP,cytokinesis,0.9713690416164136,0.9932128991931706,1/380
Control_Male_vs_Female,GO_BP,regulation of response to stress,0.9681362404741299,0.9933809925073538,1/37
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.8541660440639722,0.9935749446443084,2/410
Female_OUD_vs_Control,Reactome,Glycosaminoglycan metabolism,0.9763159273537348,0.9936836820970034,1/206
Female_OUD_vs_Control,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.9926862876891143,0.9943354842143994,1/198
Male_OUD_vs_Control,GO_BP,neuron development,0.9887812516651562,0.9943913580575826,4/101
Female_OUD_vs_Control,Reactome,Metabolism of proteins,0.9782755487474384,0.9944146123689063,22/206
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.863413821972703,0.9948805814840121,3/410
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.924706691882075,0.9948805814840121,2/410
Pooled_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.9732722148851789,0.9948805814840121,1/410
NAC_OUD_vs_Control,GO_BP,positive regulation of neuron projection development,0.9819872443413817,0.9948830940517851,2/513
Pooled_OUD_vs_Control,GO_BP,regulation of neurotransmitter transport,0.9748552152605887,0.9949130265635888,1/380
Control_Male_vs_Female,GO_BP,neuron development,0.9744537038929867,0.9950238255231427,1/37
Control_Male_vs_Female,GO_BP,regulation of programmed cell death,0.9769051345146996,0.9950279415782093,1/37
Control_Male_vs_Female,GO_BP,cellular response to stress,0.978700018782565,0.9950279415782093,1/37
Control_Male_vs_Female,GO_BP,neuron differentiation,0.9896574775110603,0.9950279415782093,1/37
Control_Male_vs_Female,GO_BP,generation of neurons,0.991933968132005,0.9950279415782093,1/37
Control_Male_vs_Female,GO_BP,programmed cell death,0.9936317354077461,0.9950279415782093,1/37
Control_Male_vs_Female,GO_BP,cell death,0.9937636112839549,0.9950279415782093,1/37
NAC_OUD_vs_Control,Reactome,Complement cascade,0.14011699005856856,0.995170154694874,4/349
NAC_OUD_vs_Control,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.1579852685952437,0.995170154694874,4/349
NAC_OUD_vs_Control,Reactome,Sema3A PAK dependent Axon repulsion,0.16502101646982795,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.16907933671211892,0.995170154694874,5/349
NAC_OUD_vs_Control,Reactome,Programmed Cell Death,0.18426753919164082,0.995170154694874,9/349
NAC_OUD_vs_Control,Reactome,Hyaluronan metabolism,0.1997846435960016,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Sulfur amino acid metabolism,0.23528445524609057,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Peptide hormone metabolism,0.272813112761195,0.995170154694874,5/349
NAC_OUD_vs_Control,Reactome,Regulation of necroptotic cell death,0.3422291918105157,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Pyruvate metabolism,0.3422291918105157,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Acetylcholine Neurotransmitter Release Cycle,0.37703110614807,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Response of endothelial cells to shear stress,0.38622085873544865,0.995170154694874,5/349
NAC_OUD_vs_Control,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.3874959749492053,0.995170154694874,4/349
NAC_OUD_vs_Control,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,0.41208642333162915,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,Apoptosis,0.4181519943697328,0.995170154694874,6/349
NAC_OUD_vs_Control,Reactome,Arachidonate metabolism,0.46281776064591684,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.46281776064591684,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,Metabolism of nitric oxide: NOS3 activation and regulation,0.49376455502973315,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Class C/3 (Metabotropic glutamate/pheromone receptors),0.49376455502973315,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.49376455502973315,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Metabolism of water-soluble vitamins and cofactors,0.5345726529442251,0.995170154694874,4/349
NAC_OUD_vs_Control,Reactome,Glycogen metabolism,0.5407279176811479,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Diseases of the neuronal system,0.5407279176811479,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,"Cell death signalling via NRAGE, NRIF and NADE",0.5578755058798265,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,Diseases associated with glycosaminoglycan metabolism,0.5650997520926953,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Glycosaminoglycan metabolism,0.5820971216773089,0.995170154694874,6/349
NAC_OUD_vs_Control,Reactome,Metabolism of folate and pterines,0.5833458269417913,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Aspartate and asparagine metabolism,0.5833458269417913,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Defective Intrinsic Pathway for Apoptosis,0.5833458269417913,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Regulation of pyruvate metabolism,0.5833458269417913,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Protein-protein interactions at synapses,0.5921139790866967,0.995170154694874,4/349
NAC_OUD_vs_Control,Reactome,Inositol phosphate metabolism,0.6181057264537099,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,MECP2 regulates neuronal receptors and channels,0.6220193126857578,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Regulation of lipid metabolism by PPARalpha,0.6221654057433224,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,Initial triggering of complement,0.6571124916888627,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Activation of ATR in response to replication stress,0.6571124916888627,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Metabolism of amine-derived hormones,0.6571124916888627,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.6571124916888627,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.6571124916888627,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Fatty acid metabolism,0.6646385214478976,0.995170154694874,5/349
NAC_OUD_vs_Control,Reactome,Metabolism of nucleotides,0.6797927694509487,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,Adaptive Immune System,0.6868828089333042,0.995170154694874,23/349
NAC_OUD_vs_Control,Reactome,Metabolism of steroid hormones,0.6889559564042929,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Norepinephrine Neurotransmitter Release Cycle,0.7178498534537743,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,0.7230838256003989,0.995170154694874,9/349
NAC_OUD_vs_Control,Reactome,Drug ADME,0.7306552348240958,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,Nicotinate metabolism,0.7440666801695978,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,"Sensory perception of sweet, bitter, and umami (glutamate) taste",0.7440666801695978,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Metabolism of proteins,0.755451857634918,0.995170154694874,49/349
NAC_OUD_vs_Control,Reactome,Serotonin Neurotransmitter Release Cycle,0.7678538249421172,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.7678538249421172,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Neurotransmitter release cycle,0.7810612710178142,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Dopamine Neurotransmitter Release Cycle,0.7894358747810093,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Glycosphingolipid metabolism,0.8090167113654558,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Glutamate Neurotransmitter Release Cycle,0.8090167113654558,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Bile acid and bile salt metabolism,0.8267814149191487,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.8267814149191487,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Activation of kainate receptors upon glutamate binding,0.8428979934830563,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Metabolism of vitamins and cofactors,0.8461428008574928,0.995170154694874,5/349
NAC_OUD_vs_Control,Reactome,Cellular response to chemical stress,0.8645463080178873,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,Sphingolipid metabolism,0.8701651324714971,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Cellular responses to stress,0.872499824217402,0.995170154694874,16/349
NAC_OUD_vs_Control,Reactome,Cellular response to heat stress,0.8828149647211483,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Transmission across Chemical Synapses,0.8875856329394284,0.995170154694874,10/349
NAC_OUD_vs_Control,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,0.8909190023449323,0.995170154694874,7/349
NAC_OUD_vs_Control,Reactome,Neuronal System,0.8923886030517991,0.995170154694874,17/349
NAC_OUD_vs_Control,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.8937297171397016,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Retinoid metabolism and transport,0.8937297171397016,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Diseases of programmed cell death,0.8970116616017475,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Intrinsic Pathway for Apoptosis,0.9036304989651806,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Phospholipid metabolism,0.9064326714147246,0.995170154694874,5/349
NAC_OUD_vs_Control,Reactome,Metabolism of steroids,0.9095278452583349,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,Glucose metabolism,0.9126112615449273,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Metabolism of fat-soluble vitamins,0.9207572737566849,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Metabolism of lipids,0.9287090022278448,0.995170154694874,19/349
NAC_OUD_vs_Control,Reactome,Metabolism of amino acids and derivatives,0.9442619935513856,0.995170154694874,6/349
NAC_OUD_vs_Control,Reactome,Heparan sulfate/heparin (HS-GAG) metabolism,0.9514376100659778,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Axon guidance,0.9581574308159029,0.995170154694874,15/349
NAC_OUD_vs_Control,Reactome,PI Metabolism,0.9600834840623934,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Opioid Signalling,0.9637412849942693,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Integration of energy metabolism,0.9692672128262141,0.995170154694874,2/349
NAC_OUD_vs_Control,Reactome,Metabolism of RNA,0.9734127997536413,0.995170154694874,3/349
NAC_OUD_vs_Control,Reactome,Oxidative Stress Induced Senescence,0.9864486004120625,0.995170154694874,1/349
NAC_OUD_vs_Control,Reactome,Metabolism,0.992020249644443,0.995170154694874,53/349
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.7501579154049484,0.9952856815999539,2/581
Male_OUD_vs_Control,GO_BP,axon development,0.9916484814033291,0.995862285148669,1/101
Pooled_OUD_vs_Control,GO_BP,neurotransmitter secretion,0.976824350812303,0.995991191613105,2/380
Pooled_OUD_vs_Control,GO_BP,signal release from synapse,0.976824350812303,0.995991191613105,2/380
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,0.770327155199191,0.9960021687740988,9/581
Male_OUD_vs_Control,GO_BP,neuron projection development,0.992497438009067,0.9960094600827013,3/101
Female_OUD_vs_Control,Reactome,Metabolism of lipids,0.9852264633576557,0.9964222186230838,8/206
Pooled_OUD_vs_Control,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.628133345152863,0.9966164854875633,6/151
Pooled_OUD_vs_Control,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.8576846796045126,0.9966164854875633,3/151
Pooled_OUD_vs_Control,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.951153896451585,0.9966164854875633,2/151
Pooled_OUD_vs_Control,Hallmark,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.9776272789526765,0.9966164854875633,1/151
Pooled_OUD_vs_Control,Hallmark,HALLMARK_HEME_METABOLISM,0.9966164854875633,0.9966164854875633,1/151
Female_OUD_vs_Control,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,0.9871370236833954,0.9968641384328073,2/206
Female_OUD_vs_Control,Reactome,Transmission across Chemical Synapses,0.9893969913284417,0.9968641384328073,3/206
DLPFC_OUD_vs_Control,Reactome,Neuronal System,0.9956661801942879,0.9968878564890048,4/172
Female_OUD_vs_Control,Reactome,Axon guidance,0.9910267384424072,0.997017869882081,6/206
Female_OUD_vs_Control,Reactome,Phospholipid metabolism,0.9920390041148796,0.997017869882081,1/206
Pooled_OUD_vs_Control,GO_BP,neurotransmitter transport,0.9799446361413062,0.9970765353745459,3/380
DLPFC_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.927732153907533,0.9972711356356715,5/286
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.930550923600665,0.9972711356356715,2/286
Female_OUD_vs_Control,GO_MF,postsynaptic neurotransmitter receptor activity,0.867564446061114,0.9974933026888594,1/292
Male_OUD_vs_Control,GO_BP,cell morphogenesis involved in neuron differentiation,0.995066634238463,0.9975287998233584,1/101
NAC_OUD_vs_Control,GO_BP,ensheathment of neurons,0.9922694020602604,0.9975809897550009,2/513
NAC_OUD_vs_Control,GO_BP,axon ensheathment,0.9922694020602604,0.9975809897550009,2/513
Pooled_OUD_vs_Control,Reactome,Glucose metabolism,0.8416556322647338,0.9986131940488419,1/267
DLPFC_OUD_vs_Control,Reactome,Metabolism,0.9987428965702455,0.9987428965702455,20/172
Male_OUD_vs_Control,GO_BP,neuron projection morphogenesis,0.9973865485010293,0.99893312847768,1/101
Male_OUD_vs_Control,GO_BP,neuron differentiation,0.9982286622375689,0.99893312847768,4/101
Male_OUD_vs_Control,GO_BP,generation of neurons,0.9989534586506135,0.9993058231862926,4/101
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.6764340105178077,0.9993441586205056,6/580
NAC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.6987909653997659,0.9993441586205056,6/580
NAC_OUD_vs_Control,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.8059803602297424,0.9993441586205056,3/580
NAC_OUD_vs_Control,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.839848943049566,0.9993441586205056,6/580
NAC_OUD_vs_Control,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.8444180049529086,0.9993441586205056,3/580
NAC_OUD_vs_Control,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.8721496728220357,0.9993441586205056,5/580
NAC_OUD_vs_Control,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.8892853824131857,0.9993441586205056,5/580
NAC_OUD_vs_Control,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.8991849292719041,0.9993441586205056,4/580
NAC_OUD_vs_Control,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.9640842033217685,0.9993441586205056,2/580
Male_OUD_vs_Control,Reactome,Metabolism,0.9996681960304288,0.9996681960304288,5/75
Pooled_OUD_vs_Control,KEGG,Ether lipid metabolism,0.5158419049203928,0.9996715223698593,2/225
Pooled_OUD_vs_Control,KEGG,Metabolism of xenobiotics by cytochrome P450,0.5158419049203928,0.9996715223698593,2/225
Pooled_OUD_vs_Control,KEGG,Phenylalanine metabolism,0.587497865969249,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Linoleic acid metabolism,0.587497865969249,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Amphetamine addiction,0.5898948273622519,0.9996715223698593,3/225
Pooled_OUD_vs_Control,KEGG,Autoimmune thyroid disease,0.6194692680212363,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Cocaine addiction,0.6681664880652132,0.9996715223698593,2/225
Pooled_OUD_vs_Control,KEGG,Fructose and mannose metabolism,0.6761983332821218,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Amino sugar and nucleotide sugar metabolism,0.7013208763895433,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Tyrosine metabolism,0.7245022502468572,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Fatty acid metabolism,0.7245022502468572,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,"Alanine, aspartate and glutamate metabolism",0.7458918270910453,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Drug metabolism - cytochrome P450,0.7458918270910453,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Cortisol synthesis and secretion,0.7515423522393676,0.9996715223698593,2/225
Pooled_OUD_vs_Control,KEGG,Arginine and proline metabolism,0.8006369744433557,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Cysteine and methionine metabolism,0.8161368641289968,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Glycerophospholipid metabolism,0.8272927242545359,0.9996715223698593,2/225
Pooled_OUD_vs_Control,KEGG,Glutathione metabolism,0.8304366240913111,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Nicotine addiction,0.8773818147524457,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Axon guidance,0.8814380354961628,0.9996715223698593,5/225
Pooled_OUD_vs_Control,KEGG,GABAergic synapse,0.8816712222756773,0.9996715223698593,2/225
Pooled_OUD_vs_Control,KEGG,Platinum drug resistance,0.8869348243371755,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Oxidative phosphorylation,0.9038744856021699,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Cholesterol metabolism,0.9038744856021699,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Inositol phosphate metabolism,0.9305446843393769,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Nucleotide metabolism,0.9359689974333165,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Purine metabolism,0.9497917894393197,0.9996715223698593,2/225
Pooled_OUD_vs_Control,KEGG,Carbon metabolism,0.9537617156534544,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Choline metabolism in cancer,0.9692406157545057,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Morphine addiction,0.986417993336337,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Serotonergic synapse,0.994492525288149,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Cholinergic synapse,0.9956970465629094,0.9996715223698593,1/225
Pooled_OUD_vs_Control,KEGG,Dopaminergic synapse,0.9963504107227458,0.9996715223698593,1/225
NAC_OUD_vs_Control,GO_MF,glutamate receptor activity,0.7107175692470604,0.999682153213223,1/528
NAC_OUD_vs_Control,GO_MF,structural constituent of synapse,0.797147105666152,0.999682153213223,1/528
NAC_OUD_vs_Control,GO_MF,glutamate receptor binding,0.916559890354683,0.999682153213223,1/528
OUD_DLPFC_vs_NAC,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.5379297079355142,0.9997196857717847,10/128
OUD_DLPFC_vs_NAC,BioCarta,BIOCARTA_MCALPAIN_PATHWAY,0.3415602466317723,0.9997288161499529,5/486
OUD_DLPFC_vs_NAC,BioCarta,BIOCARTA_STRESS_PATHWAY,0.39635745095370467,0.9997288161499529,9/486
OUD_DLPFC_vs_NAC,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.9856566782122478,0.9997288161499529,3/486
Pooled_OUD_vs_Control,Reactome,Metabolism of fat-soluble vitamins,0.8529478187458546,0.9997746867402915,1/267
Pooled_OUD_vs_Control,Reactome,Cellular responses to stress,0.8599725378815803,0.9997746867402915,12/267
Pooled_OUD_vs_Control,Reactome,Metabolism of proteins,0.8949719888994845,0.9997746867402915,34/267
Pooled_OUD_vs_Control,Reactome,"Cell death signalling via NRAGE, NRIF and NADE",0.8984495211379135,0.9997746867402915,1/267
Pooled_OUD_vs_Control,Reactome,Metabolism of steroids,0.9204437054923448,0.9997746867402915,2/267
Pooled_OUD_vs_Control,Reactome,Metabolism of nucleotides,0.9349211783671763,0.9997746867402915,1/267
Pooled_OUD_vs_Control,Reactome,Peptide hormone metabolism,0.9395771390788493,0.9997746867402915,1/267
Pooled_OUD_vs_Control,Reactome,Glycosaminoglycan metabolism,0.9540670424685844,0.9997746867402915,2/267
Pooled_OUD_vs_Control,Reactome,Metabolism of lipids,0.9563672713981264,0.9997746867402915,13/267
Pooled_OUD_vs_Control,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,0.962906503634721,0.9997746867402915,4/267
Pooled_OUD_vs_Control,Reactome,Metabolism of RNA,0.9721590993572162,0.9997746867402915,2/267
Pooled_OUD_vs_Control,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.9982829083766673,0.9998232947872452,1/254
Pooled_OUD_vs_Control,GO_MF,neurotransmitter receptor activity,0.8906505362247186,0.9999004513000109,2/376
NAC_OUD_vs_Control,KEGG,Adipocytokine signaling pathway,0.2974016481498311,0.9999072451192372,4/278
NAC_OUD_vs_Control,KEGG,Starch and sucrose metabolism,0.42648246226107056,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Amino sugar and nucleotide sugar metabolism,0.42648246226107056,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Intestinal immune network for IgA production,0.4317087737816052,0.9999072451192372,3/278
NAC_OUD_vs_Control,KEGG,Propanoate metabolism,0.45235507195059466,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Porphyrin metabolism,0.45235507195059466,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Nicotinate and nicotinamide metabolism,0.5238093614920246,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Galactose metabolism,0.5520743108977852,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Taurine and hypotaurine metabolism,0.5520743108977852,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Retinol metabolism,0.5822591497600309,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Axon guidance,0.588035108014727,0.9999072451192372,9/278
NAC_OUD_vs_Control,KEGG,Central carbon metabolism in cancer,0.6228028797194147,0.9999072451192372,3/278
NAC_OUD_vs_Control,KEGG,Glutathione metabolism,0.6352700402940143,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Ether lipid metabolism,0.6352700402940143,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Cortisol synthesis and secretion,0.6433975266800669,0.9999072451192372,3/278
NAC_OUD_vs_Control,KEGG,Histidine metabolism,0.7004770950550596,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Apoptosis - multiple species,0.7004770950550596,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Autoimmune thyroid disease,0.7004770950550596,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Platinum drug resistance,0.7446569462807555,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Glycerophospholipid metabolism,0.7501588936140997,0.9999072451192372,3/278
NAC_OUD_vs_Control,KEGG,Fructose and mannose metabolism,0.755123548374132,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,beta-Alanine metabolism,0.755123548374132,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Cocaine addiction,0.7798842481615385,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Cholinergic synapse,0.7810636297066867,0.9999072451192372,5/278
NAC_OUD_vs_Control,KEGG,Tryptophan metabolism,0.7998292950954204,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Fatty acid metabolism,0.7998292950954204,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,"Alanine, aspartate and glutamate metabolism",0.8190313157867499,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Sphingolipid metabolism,0.8190313157867499,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Nucleotide metabolism,0.8499269516466622,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Pyrimidine metabolism,0.8521022671585288,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Carbon metabolism,0.8906746875625658,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Metabolism of xenobiotics by cytochrome P450,0.8907606408623121,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Drug metabolism - other enzymes,0.8907606408623121,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Amphetamine addiction,0.8991252404822474,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Arachidonic acid metabolism,0.9271025366606189,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Choline metabolism in cancer,0.9272060965444386,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,GABAergic synapse,0.9432479359674457,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Oxidative phosphorylation,0.9461985116406084,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Cholesterol metabolism,0.9461985116406084,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Inositol phosphate metabolism,0.9641343465528025,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Purine metabolism,0.9813520705729238,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Glutamatergic synapse,0.9879928704082073,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Dopaminergic synapse,0.992311804072969,0.9999072451192372,2/278
NAC_OUD_vs_Control,KEGG,Morphine addiction,0.9953202416665999,0.9999072451192372,1/278
NAC_OUD_vs_Control,KEGG,Serotonergic synapse,0.9984829686010468,0.9999072451192372,1/278
Control_DLPFC_vs_NAC,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.6365097764215076,0.999927249043856,5/477
Control_DLPFC_vs_NAC,BioCarta,BIOCARTA_MCALPAIN_PATHWAY,0.9368352281918473,0.999927249043856,3/477
Control_DLPFC_vs_NAC,BioCarta,BIOCARTA_STRESS_PATHWAY,0.9927623269074117,0.999927249043856,5/477
Control_DLPFC_vs_NAC,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.3802697136213673,0.9999319101417963,43/1379
Control_DLPFC_vs_NAC,Hallmark,HALLMARK_HEME_METABOLISM,0.41324703577333427,0.9999319101417963,50/1379
Control_DLPFC_vs_NAC,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.49001273569656467,0.9999319101417963,59/1379
Control_DLPFC_vs_NAC,Hallmark,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.5551874662398915,0.9999319101417963,33/1379
Control_DLPFC_vs_NAC,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.839510181562467,0.9999319101417963,40/1379
Control_DLPFC_vs_NAC,Hallmark,HALLMARK_COMPLEMENT,0.9216451709268954,0.9999319101417963,64/1379
Control_DLPFC_vs_NAC,Hallmark,HALLMARK_APOPTOSIS,0.9330792514918298,0.9999319101417963,56/1379
Control_DLPFC_vs_NAC,GO_BP,forebrain generation of neurons,0.03029743939412091,0.9999468545471409,44/4916
Control_DLPFC_vs_NAC,GO_BP,cytokinesis,0.030356009780255013,0.9999468545471409,50/4916
Control_DLPFC_vs_NAC,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.037810292469537196,0.9999468545471409,23/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of neurotransmitter transport,0.039026342114805226,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of neuron differentiation,0.0394416348552332,0.9999468545471409,48/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of neuron differentiation,0.03945143348685756,0.9999468545471409,36/4916
Control_DLPFC_vs_NAC,GO_BP,forebrain neuron differentiation,0.045838045955650324,0.9999468545471409,41/4916
Control_DLPFC_vs_NAC,GO_BP,neuron projection arborization,0.04846049458441842,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,axonemal dynein complex assembly,0.051057614882709455,0.9999468545471409,28/4916
Control_DLPFC_vs_NAC,GO_BP,"regulation of synaptic transmission, glutamatergic",0.052454806777826456,0.9999468545471409,40/4916
Control_DLPFC_vs_NAC,GO_BP,neuronal action potential,0.05417300125413474,0.9999468545471409,21/4916
Control_DLPFC_vs_NAC,GO_BP,G protein-coupled dopamine receptor signaling pathway,0.06470133759840241,0.9999468545471409,20/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of neurotransmitter secretion,0.07471298795662368,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,neutrophil activation involved in immune response,0.07471298795662368,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,cytoskeleton-dependent cytokinesis,0.07779484606597982,0.9999468545471409,37/4916
Control_DLPFC_vs_NAC,GO_BP,stress fiber assembly,0.08330199314737555,0.9999468545471409,42/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of chemokine production,0.08839022037420965,0.9999468545471409,36/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of stress fiber assembly,0.08839022037420965,0.9999468545471409,36/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of neuron projection development,0.09207728793918184,0.9999468545471409,57/4916
Control_DLPFC_vs_NAC,GO_BP,macrophage activation involved in immune response,0.09276291471067045,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of short-term neuronal synaptic plasticity,0.09276291471067045,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,calcium ion-regulated exocytosis of neurotransmitter,0.09276291471067045,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,detection of mechanical stimulus involved in sensory perception of pain,0.09276291471067045,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter uptake,0.09276291471067045,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,neuronal stem cell population maintenance,0.09276291471067045,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neuron projection development,0.09564336920365227,0.9999468545471409,177/4916
Control_DLPFC_vs_NAC,GO_BP,multicellular organismal response to stress,0.10012428423507261,0.9999468545471409,51/4916
Control_DLPFC_vs_NAC,GO_BP,neuron migration,0.10324926279403747,0.9999468545471409,71/4916
Control_DLPFC_vs_NAC,GO_BP,muscle hypertrophy in response to stress,0.11516895913222458,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,cardiac muscle hypertrophy in response to stress,0.11516895913222458,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of stress fiber assembly,0.12756367074314098,0.9999468545471409,22/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to osmotic stress,0.12756367074314098,0.9999468545471409,22/4916
Control_DLPFC_vs_NAC,GO_BP,vesicle-mediated transport in synapse,0.12812582294987743,0.9999468545471409,121/4916
Control_DLPFC_vs_NAC,GO_BP,central nervous system projection neuron axonogenesis,0.12935137669946908,0.9999468545471409,16/4916
Control_DLPFC_vs_NAC,GO_BP,axon ensheathment in central nervous system,0.12935137669946908,0.9999468545471409,16/4916
Control_DLPFC_vs_NAC,GO_BP,mitotic cytokinesis,0.13815829296395643,0.9999468545471409,27/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of dopamine metabolic process,0.1429813122138805,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,peripheral nervous system neuron differentiation,0.1429813122138805,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,glutamate receptor signaling pathway,0.15710669814653921,0.9999468545471409,26/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of neuron apoptotic process,0.1602128716467018,0.9999468545471409,61/4916
Control_DLPFC_vs_NAC,GO_BP,tumor necrosis factor superfamily cytokine production,0.16169648783602783,0.9999468545471409,80/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,0.16169648783602783,0.9999468545471409,80/4916
Control_DLPFC_vs_NAC,GO_BP,response to osmotic stress,0.16467691539346396,0.9999468545471409,36/4916
Control_DLPFC_vs_NAC,GO_BP,chemokine production,0.1650491718476409,0.9999468545471409,46/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of chemokine production,0.1650491718476409,0.9999468545471409,46/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of synapse structure or activity,0.16795831013087142,0.9999468545471409,135/4916
Control_DLPFC_vs_NAC,GO_BP,neuron remodeling,0.17750308380586283,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,stress granule assembly,0.17750308380586283,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,peripheral nervous system neuron development,0.17750308380586283,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,response to immobilization stress,0.180538629159004,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of macrophage cytokine production,0.180538629159004,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neuron apoptotic process,0.18607807905142956,0.9999468545471409,92/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,0.19248106231708942,0.9999468545471409,54/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter uptake,0.19541868489909228,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,macrophage cytokine production,0.19541868489909228,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of macrophage cytokine production,0.19541868489909228,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,glutamate secretion,0.19541868489909228,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,central nervous system neuron axonogenesis,0.19541868489909228,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter receptor activity,0.19541868489909228,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of synapse organization,0.19818606081405832,0.9999468545471409,132/4916
Control_DLPFC_vs_NAC,GO_BP,neuron recognition,0.20351361079575517,0.9999468545471409,29/4916
Control_DLPFC_vs_NAC,GO_BP,neuron fate commitment,0.20351361079575517,0.9999468545471409,29/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of glutamate secretion,0.21243349176073967,0.9999468545471409,13/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of dendrite extension,0.21243349176073967,0.9999468545471409,13/4916
Control_DLPFC_vs_NAC,GO_BP,synapse organization,0.21612244739730718,0.9999468545471409,241/4916
Control_DLPFC_vs_NAC,GO_BP,cortisol metabolic process,0.22035114946280843,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,dopamine biosynthetic process,0.22035114946280843,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,"glutamate secretion, neurotransmission",0.22035114946280843,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter loading into synaptic vesicle,0.22035114946280843,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,neuronal dense core vesicle exocytosis,0.22035114946280843,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,dendrite arborization,0.22035114946280843,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,microglial cell activation,0.22398363672858157,0.9999468545471409,18/4916
Control_DLPFC_vs_NAC,GO_BP,neuron apoptotic process,0.2267742932224414,0.9999468545471409,107/4916
Control_DLPFC_vs_NAC,GO_BP,response to dopamine,0.2270552411101285,0.9999468545471409,28/4916
Control_DLPFC_vs_NAC,GO_BP,neuron projection extension,0.23608233758223,0.9999468545471409,70/4916
Control_DLPFC_vs_NAC,GO_BP,myeloid cell activation involved in immune response,0.2521437506015169,0.9999468545471409,46/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to dopamine,0.2526258864528756,0.9999468545471409,27/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of axonogenesis,0.2556927598193747,0.9999468545471409,22/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of dopamine secretion,0.25589486858561594,0.9999468545471409,17/4916
Control_DLPFC_vs_NAC,GO_BP,cerebral cortex neuron differentiation,0.25589486858561594,0.9999468545471409,17/4916
Control_DLPFC_vs_NAC,GO_BP,sensory perception of pain,0.2590953428855166,0.9999468545471409,41/4916
Control_DLPFC_vs_NAC,GO_BP,immunoglobulin mediated immune response,0.26506218688277394,0.9999468545471409,50/4916
Control_DLPFC_vs_NAC,GO_BP,neuron cellular homeostasis,0.27330857256561514,0.9999468545471409,31/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neuron maturation,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,cortisol biosynthetic process,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of dendrite morphogenesis,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,dopamine uptake involved in synaptic transmission,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of dopamine uptake involved in synaptic transmission,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of synapse structural plasticity,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of dopamine receptor signaling pathway,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,motor neuron apoptotic process,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,"neurotransmitter receptor transport, postsynaptic endosome to lysosome",0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of mitotic cytokinesis,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,midbrain dopaminergic neuron differentiation,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of chemokine (C-X-C motif) ligand 2 production,0.2735316203616739,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to chemical stress,0.27533290712302533,0.9999468545471409,99/4916
Control_DLPFC_vs_NAC,GO_BP,response to toxic substance,0.29034500698485743,0.9999468545471409,98/4916
Control_DLPFC_vs_NAC,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.2913121090051841,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,synapse pruning,0.2913121090051841,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of dendrite extension,0.2913121090051841,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.2913345023839637,0.9999468545471409,16/4916
Control_DLPFC_vs_NAC,GO_BP,dendrite extension,0.2913345023839637,0.9999468545471409,16/4916
Control_DLPFC_vs_NAC,GO_BP,central nervous system neuron development,0.2953702603558174,0.9999468545471409,44/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of neuron projection development,0.3074276487662198,0.9999468545471409,57/4916
Control_DLPFC_vs_NAC,GO_BP,neuron projection regeneration,0.31001114626475296,0.9999468545471409,25/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of cytokinesis,0.32023445796157773,0.9999468545471409,20/4916
Control_DLPFC_vs_NAC,GO_BP,"synaptic transmission, dopaminergic",0.3304338775491872,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of immunoglobulin mediated immune response,0.3304338775491872,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,inhibitory synapse assembly,0.3304338775491872,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,programmed cell death involved in cell development,0.33922940334776547,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to fluid shear stress,0.33922940334776547,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of dendritic cell cytokine production,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of natural killer cell mediated immune response to tumor cell,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,branchiomotor neuron axon guidance,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,forebrain neuron fate commitment,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,astrocyte cell migration,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,autophagic cell death,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,spontaneous neurotransmitter secretion,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,sympathetic neuron projection extension,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,mitotic cytokinetic process,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,"regulation of glutamate secretion, neurotransmission",0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,axonemal central apparatus assembly,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of cortisol biosynthetic process,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of motor neuron apoptotic process,0.3395334468997686,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.35361908789533475,0.9999468545471409,120/4916
Control_DLPFC_vs_NAC,GO_BP,dendrite development,0.35491155563857185,0.9999468545471409,94/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of cytokine production,0.367596736175641,0.9999468545471409,196/4916
Control_DLPFC_vs_NAC,GO_BP,cell activation involved in immune response,0.3688297268701944,0.9999468545471409,119/4916
Control_DLPFC_vs_NAC,GO_BP,central nervous system neuron differentiation,0.37209335114008973,0.9999468545471409,93/4916
Control_DLPFC_vs_NAC,GO_BP,ionotropic glutamate receptor signaling pathway,0.373252042734804,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter reuptake,0.373252042734804,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,maintenance of synapse structure,0.373252042734804,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,dopamine transport,0.37568676330677475,0.9999468545471409,23/4916
Control_DLPFC_vs_NAC,GO_BP,leukocyte activation involved in immune response,0.3843257716623886,0.9999468545471409,118/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.3872636953890915,0.9999468545471409,49/4916
Control_DLPFC_vs_NAC,GO_BP,immunological synapse formation,0.39329248994878374,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,tolerance induction,0.39329248994878374,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,antifungal innate immune response,0.39329248994878374,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of cellular response to oxidative stress,0.39329248994878374,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.39329248994878374,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,neuron projection organization,0.39487798893011594,0.9999468545471409,40/4916
Control_DLPFC_vs_NAC,GO_BP,dopamine secretion,0.395373347705517,0.9999468545471409,18/4916
Control_DLPFC_vs_NAC,GO_BP,neuron maturation,0.4114784157691233,0.9999468545471409,22/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor internalization,0.4114784157691233,0.9999468545471409,22/4916
Control_DLPFC_vs_NAC,GO_BP,immune system development,0.41176041506741656,0.9999468545471409,48/4916
Control_DLPFC_vs_NAC,GO_BP,response to axon injury,0.41329433955299394,0.9999468545471409,35/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of synapse assembly,0.41329433955299394,0.9999468545471409,35/4916
Control_DLPFC_vs_NAC,GO_BP,ensheathment of neurons,0.4151974008326257,0.9999468545471409,65/4916
Control_DLPFC_vs_NAC,GO_BP,axon ensheathment,0.4151974008326257,0.9999468545471409,65/4916
Control_DLPFC_vs_NAC,GO_BP,neuron fate specification,0.4197500986720203,0.9999468545471409,13/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor transport,0.4197500986720203,0.9999468545471409,13/4916
Control_DLPFC_vs_NAC,GO_BP,forebrain neuron development,0.43672518244214376,0.9999468545471409,17/4916
Control_DLPFC_vs_NAC,GO_BP,detection of stimulus involved in sensory perception of pain,0.43672518244214376,0.9999468545471409,17/4916
Control_DLPFC_vs_NAC,GO_BP,B cell activation involved in immune response,0.44287537057632353,0.9999468545471409,34/4916
Control_DLPFC_vs_NAC,GO_BP,axon regeneration,0.44906429108611134,0.9999468545471409,21/4916
Control_DLPFC_vs_NAC,GO_BP,myeloid leukocyte cytokine production,0.44906429108611134,0.9999468545471409,21/4916
Control_DLPFC_vs_NAC,GO_BP,adenylate cyclase-activating dopamine receptor signaling pathway,0.45367725654171964,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,microglia differentiation,0.45367725654171964,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of long-term neuronal synaptic plasticity,0.45367725654171964,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of axon regeneration,0.45367725654171964,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of neuron projection regeneration,0.45367725654171964,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,dopamine uptake,0.45367725654171964,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.45367725654171964,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor diffusion trapping,0.45367725654171964,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,lymphocyte activation involved in immune response,0.4552935483525594,0.9999468545471409,80/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neuronal synaptic plasticity,0.4666174365601867,0.9999468545471409,29/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of stress fiber assembly,0.46976142533924004,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,GABAergic neuron differentiation,0.46976142533924004,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.46976142533924004,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor localization to postsynaptic specialization membrane,0.46976142533924004,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of response to oxidative stress,0.46976142533924004,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to oxidative stress,0.47143136265412966,0.9999468545471409,75/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of synapse assembly,0.47143136265412966,0.9999468545471409,75/4916
Control_DLPFC_vs_NAC,GO_BP,immunoglobulin production involved in immunoglobulin-mediated immune response,0.480345882641821,0.9999468545471409,16/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of humoral immune response,0.480345882641821,0.9999468545471409,16/4916
Control_DLPFC_vs_NAC,GO_BP,immune effector process,0.4827193230799962,0.9999468545471409,241/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of adaptive immune response,0.48429114287266606,0.9999468545471409,41/4916
Control_DLPFC_vs_NAC,GO_BP,type 2 immune response,0.4882457236592016,0.9999468545471409,20/4916
Control_DLPFC_vs_NAC,GO_BP,immune response-regulating cell surface receptor signaling pathway,0.49732318085467253,0.9999468545471409,136/4916
Control_DLPFC_vs_NAC,GO_BP,synapse assembly,0.5038446883074931,0.9999468545471409,119/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.5122237857944759,0.9999468545471409,40/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of oxidative phosphorylation,0.520287609061429,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,innate immune response in mucosa,0.520287609061429,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,dendritic cell cytokine production,0.520287609061429,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of dendritic cell cytokine production,0.520287609061429,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,neuron cell-cell adhesion,0.520287609061429,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of glutamate secretion,0.520287609061429,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,response to laminar fluid shear stress,0.520287609061429,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,ectopic germ cell programmed cell death,0.520287609061429,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter-gated ion channel clustering,0.520287609061429,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of type 2 immune response,0.5259307533753015,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,sperm axoneme assembly,0.5259307533753015,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,motor neuron axon guidance,0.5259307533753015,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,response to fluid shear stress,0.5259307533753015,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of postsynapse organization,0.5267502055207184,0.9999468545471409,60/4916
Control_DLPFC_vs_NAC,GO_BP,L-glutamate import,0.5287646750149089,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,protein localization to postsynapse,0.5287646750149089,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neuron migration,0.5287646750149089,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.5338928732526165,0.9999468545471409,27/4916
Control_DLPFC_vs_NAC,GO_BP,production of molecular mediator of immune response,0.5377150974468563,0.9999468545471409,80/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of response to cytokine stimulus,0.5684155126795617,0.9999468545471409,26/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of immunoglobulin mediated immune response,0.5689616866034606,0.9999468545471409,22/4916
Control_DLPFC_vs_NAC,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.5690477929002329,0.9999468545471409,38/4916
Control_DLPFC_vs_NAC,GO_BP,adaptive immune response,0.5716549095069039,0.9999468545471409,172/4916
Control_DLPFC_vs_NAC,GO_BP,dendrite morphogenesis,0.5719489653950223,0.9999468545471409,54/4916
Control_DLPFC_vs_NAC,GO_BP,somatic recombination of immunoglobulin genes involved in immune response,0.573070146934352,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,somatic diversification of immunoglobulins involved in immune response,0.573070146934352,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of presynapse organization,0.573070146934352,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of presynapse assembly,0.573070146934352,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of production of molecular mediator of immune response,0.5765069111231267,0.9999468545471409,74/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of humoral immune response,0.5788158750606721,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,spinal cord motor neuron differentiation,0.5788158750606721,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of cytokinesis,0.5788158750606721,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,cytokinetic process,0.5788158750606721,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,response to arsenic-containing substance,0.5788158750606721,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of axon regeneration,0.5788158750606721,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neuron projection regeneration,0.5788158750606721,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,dendrite self-avoidance,0.5788158750606721,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of cytokine production,0.5808646081526871,0.9999468545471409,294/4916
Control_DLPFC_vs_NAC,GO_BP,peripheral nervous system axon regeneration,0.5926144457548649,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.5926144457548649,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,G protein-coupled opioid receptor signaling pathway,0.5926144457548649,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of astrocyte differentiation,0.5926144457548649,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.5926144457548649,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of microglial cell activation,0.5926144457548649,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,axon extension,0.5968341662462799,0.9999468545471409,41/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.5968727331851917,0.9999468545471409,73/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of dendrite development,0.5976679286539279,0.9999468545471409,37/4916
Control_DLPFC_vs_NAC,GO_BP,humoral immune response,0.5977404752965527,0.9999468545471409,81/4916
Control_DLPFC_vs_NAC,GO_BP,receptor localization to synapse,0.600672486451644,0.9999468545471409,29/4916
Control_DLPFC_vs_NAC,GO_BP,cytokine production,0.6024339927189508,0.9999468545471409,296/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of neuron apoptotic process,0.6032209292976829,0.9999468545471409,25/4916
Control_DLPFC_vs_NAC,GO_BP,immune response-activating cell surface receptor signaling pathway,0.6036568495827621,0.9999468545471409,121/4916
Control_DLPFC_vs_NAC,GO_BP,axonal transport,0.6069249674174584,0.9999468545471409,21/4916
Control_DLPFC_vs_NAC,GO_BP,somatic diversification of immune receptors,0.6124704800728107,0.9999468545471409,17/4916
Control_DLPFC_vs_NAC,GO_BP,anterograde axonal transport,0.6124704800728107,0.9999468545471409,17/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of production of molecular mediator of immune response,0.6196841002378013,0.9999468545471409,52/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of axon extension,0.6212416743999576,0.9999468545471409,13/4916
Control_DLPFC_vs_NAC,GO_BP,dopaminergic neuron differentiation,0.6212416743999576,0.9999468545471409,13/4916
Control_DLPFC_vs_NAC,GO_BP,natural killer cell activation involved in immune response,0.63657637965337,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,mucosal immune response,0.63657637965337,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of type 2 immune response,0.63657637965337,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,retrograde axonal transport,0.63657637965337,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,response to salt stress,0.63657637965337,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,response to morphine,0.63657637965337,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,chemokine (C-X-C motif) ligand 2 production,0.63657637965337,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of synapse maturation,0.63657637965337,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of chemokine (C-X-C motif) ligand 2 production,0.63657637965337,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.6380488377446523,0.9999468545471409,24/4916
Control_DLPFC_vs_NAC,GO_BP,somatic diversification of immune receptors via germline recombination within a single locus,0.6548286834405284,0.9999468545471409,16/4916
Control_DLPFC_vs_NAC,GO_BP,postsynaptic neurotransmitter receptor internalization,0.6548286834405284,0.9999468545471409,16/4916
Control_DLPFC_vs_NAC,GO_BP,cytokine production involved in immune response,0.6667090505623741,0.9999468545471409,50/4916
Control_DLPFC_vs_NAC,GO_BP,assembly of actomyosin apparatus involved in cytokinesis,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,natural killer cell mediated immune response to tumor cell,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of type 2 immune response,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of immune response to tumor cell,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,hydrogen peroxide-mediated programmed cell death,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of macrophage cytokine production,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,spinal cord association neuron differentiation,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,T-helper 2 cell cytokine production,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of astrocyte differentiation,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,axonogenesis involved in innervation,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to salt stress,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,commissural neuron axon guidance,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,programmed cell death in response to reactive oxygen species,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,protein localization to axon,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,anterograde axonal protein transport,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of T-helper 2 cell cytokine production,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of response to drug,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of neuron migration,0.669542579590242,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,glutamate metabolic process,0.6698067320081189,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,axonal fasciculation,0.6698067320081189,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of stress-activated MAPK cascade,0.6698067320081189,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.6698067320081189,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,neuron projection fasciculation,0.6698067320081189,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of dendrite morphogenesis,0.6726190780359349,0.9999468545471409,23/4916
Control_DLPFC_vs_NAC,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.6827366901665932,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of axon extension,0.6888252251283643,0.9999468545471409,30/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of cytokine production involved in immune response,0.6897272909293493,0.9999468545471409,49/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of adaptive immune response,0.6919960408984824,0.9999468545471409,76/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of immune response to tumor cell,0.6952163229134609,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.6952163229134609,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,peripheral nervous system axon ensheathment,0.6952163229134609,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of stress-activated MAPK cascade,0.6952163229134609,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of stress-activated protein kinase signaling cascade,0.6952163229134609,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of postsynapse assembly,0.6968740186258524,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,postsynapse organization,0.7011022870013011,0.9999468545471409,95/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of axonogenesis,0.7014135605549008,0.9999468545471409,60/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to cytokine stimulus,0.7112348670472712,0.9999468545471409,309/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of immune effector process,0.7170344343282202,0.9999468545471409,94/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of immune effector process,0.7343244229040654,0.9999468545471409,47/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of cytokine production involved in immune response,0.7367652111798889,0.9999468545471409,32/4916
Control_DLPFC_vs_NAC,GO_BP,protein localization to synapse,0.7367652111798889,0.9999468545471409,32/4916
Control_DLPFC_vs_NAC,GO_BP,mature B cell differentiation involved in immune response,0.7380580243910301,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of axon extension,0.7380580243910301,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,mitochondrial outer membrane permeabilization involved in programmed cell death,0.7380580243910301,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of tolerance induction,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,noradrenergic neuron differentiation,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,ventral spinal cord interneuron specification,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,"regulation of synaptic transmission, dopaminergic",0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of translation in response to stress,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,"negative regulation of synaptic transmission, glutamatergic",0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,phospholipase C-activating dopamine receptor signaling pathway,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,chemokine (C-C motif) ligand 5 production,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of chemokine (C-C motif) ligand 5 production,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,stress-induced premature senescence,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,AMPA glutamate receptor clustering,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,glutamate receptor clustering,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,antibacterial innate immune response,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of hydrogen peroxide-mediated programmed cell death,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of synapse pruning,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,neuron projection maintenance,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of T-helper 17 type immune response,0.7490887548967405,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,T cell activation involved in immune response,0.7502025900452015,0.9999468545471409,50/4916
Control_DLPFC_vs_NAC,GO_BP,ventral spinal cord interneuron differentiation,0.7534238428804134,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,cerebral cortex GABAergic interneuron differentiation,0.7534238428804134,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of response to osmotic stress,0.7534238428804134,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,astrocyte activation,0.7534238428804134,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.7534238428804134,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of protein localization to synapse,0.7534238428804134,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,glutamatergic neuron differentiation,0.7534238428804134,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of programmed cell death,0.7551733191442817,0.9999468545471409,280/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of immune effector process,0.7644489143623528,0.9999468545471409,145/4916
Control_DLPFC_vs_NAC,GO_BP,behavioral response to pain,0.7650078908506995,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of T-helper 17 type immune response,0.7650078908506995,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,response to cytokine,0.7691316246854344,0.9999468545471409,342/4916
Control_DLPFC_vs_NAC,GO_BP,astrocyte differentiation,0.7776961385135381,0.9999468545471409,34/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of astrocyte differentiation,0.7777991386631768,0.9999468545471409,13/4916
Control_DLPFC_vs_NAC,GO_BP,mast cell activation involved in immune response,0.7862070104215764,0.9999468545471409,23/4916
Control_DLPFC_vs_NAC,GO_BP,presynapse organization,0.7862070104215764,0.9999468545471409,23/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of cellular response to stress,0.7873864257595122,0.9999468545471409,116/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of production of molecular mediator of immune response,0.7903749342172253,0.9999468545471409,16/4916
Control_DLPFC_vs_NAC,GO_BP,programmed cell death,0.7982685040348809,0.9999468545471409,618/4916
Control_DLPFC_vs_NAC,GO_BP,response to oxidative stress,0.8016466739100191,0.9999468545471409,111/4916
Control_DLPFC_vs_NAC,GO_BP,response to pain,0.8023266048475131,0.9999468545471409,19/4916
Control_DLPFC_vs_NAC,GO_BP,cell death,0.8089528492300347,0.9999468545471409,620/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of T-helper 1 type immune response,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,olfactory bulb interneuron differentiation,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of axon extension involved in axon guidance,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of synapse assembly,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,ventral spinal cord interneuron fate commitment,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,stress response to metal ion,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor transport to plasma membrane,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor transport to postsynaptic membrane,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of dendrite development,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of axon guidance,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of neuron migration,0.8095949558351707,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,organ or tissue specific immune response,0.8098578934314642,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of sensory perception of pain,0.8098578934314642,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of synapse organization,0.8098578934314642,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to toxic substance,0.8154261934430989,0.9999468545471409,43/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of T-helper 1 type immune response,0.8155019048326022,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.8155019048326022,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,L-glutamate transmembrane transport,0.8155019048326022,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,retinal ganglion cell axon guidance,0.8155019048326022,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.8155019048326022,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,complement activation,0.8230100241818247,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,synapse maturation,0.8230100241818247,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,T-helper 1 type immune response,0.831113152297249,0.9999468545471409,18/4916
Control_DLPFC_vs_NAC,GO_BP,presynapse assembly,0.831113152297249,0.9999468545471409,18/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of axonogenesis,0.8338292264188564,0.9999468545471409,28/4916
Control_DLPFC_vs_NAC,GO_BP,innate immune response,0.8400409495459642,0.9999468545471409,316/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of cytokine production involved in immune response,0.8505816192272434,0.9999468545471409,11/4916
Control_DLPFC_vs_NAC,GO_BP,immune response to tumor cell,0.8515895049403694,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,axon extension involved in axon guidance,0.8515895049403694,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,neuron projection extension involved in neuron projection guidance,0.8515895049403694,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of receptor localization to synapse,0.8515895049403694,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,interneuron migration,0.8515895049403694,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,programmed necrotic cell death,0.8533732405335273,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to stress,0.8553776413381247,0.9999468545471409,475/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of humoral immune response,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of complement activation,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,neuronal ion channel clustering,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,L-glutamate import across plasma membrane,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of cellular response to osmotic stress,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of execution phase of apoptosis,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,response to L-glutamate,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of dopaminergic neuron differentiation,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,protein localization to presynapse,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,stress response to copper ion,0.8618629141786855,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,excitatory synapse assembly,0.8632120056332784,0.9999468545471409,20/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of programmed cell death,0.865365147888502,0.9999468545471409,465/4916
Control_DLPFC_vs_NAC,GO_BP,T cell differentiation involved in immune response,0.880246660340606,0.9999468545471409,29/4916
Control_DLPFC_vs_NAC,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,0.880246660340606,0.9999468545471409,29/4916
Control_DLPFC_vs_NAC,GO_BP,"complement activation, classical pathway",0.8824941964777346,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.8824941964777346,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,cytokine production involved in inflammatory response,0.8887355538039974,0.9999468545471409,22/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of cytokine production involved in inflammatory response,0.8887355538039974,0.9999468545471409,22/4916
Control_DLPFC_vs_NAC,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",0.8892413894699693,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of response to endoplasmic reticulum stress,0.8892413894699693,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of immune system process,0.9036426561403239,0.9999468545471409,186/4916
Control_DLPFC_vs_NAC,GO_BP,astrocyte development,0.9045977490933235,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,postsynapse assembly,0.9051798958901917,0.9999468545471409,34/4916
Control_DLPFC_vs_NAC,GO_BP,T cell cytokine production,0.905988543639223,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of T cell cytokine production,0.905988543639223,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.9081811055097379,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,"complement activation, alternative pathway",0.9081811055097379,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,G protein-coupled glutamate receptor signaling pathway,0.9081811055097379,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,interneuron migration from the subpallium to the cortex,0.9081811055097379,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,substrate-independent telencephalic tangential interneuron migration,0.9081811055097379,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,pyramidal neuron differentiation,0.9081811055097379,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,cerebral cortex GABAergic interneuron development,0.9081811055097379,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of execution phase of apoptosis,0.9081811055097379,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of response to oxidative stress,0.9081811055097379,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of dendrite morphogenesis,0.9107703992381846,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of cytokine production involved in inflammatory response,0.9107703992381846,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,alpha-beta T cell activation involved in immune response,0.9119488197312617,0.9999468545471409,27/4916
Control_DLPFC_vs_NAC,GO_BP,alpha-beta T cell differentiation involved in immune response,0.9119488197312617,0.9999468545471409,27/4916
Control_DLPFC_vs_NAC,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.9119488197312617,0.9999468545471409,27/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of immune system process,0.9178930040259105,0.9999468545471409,542/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of cytokine production,0.9180873650203948,0.9999468545471409,106/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of programmed necrotic cell death,0.9219371817446852,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,immune response-regulating signaling pathway,0.9221860177513128,0.9999468545471409,190/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.9240601721593015,0.9999468545471409,23/4916
Control_DLPFC_vs_NAC,GO_BP,T-helper 17 type immune response,0.9242207453541672,0.9999468545471409,14/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of programmed necrotic cell death,0.9350527279581798,0.9999468545471409,8/4916
Control_DLPFC_vs_NAC,GO_BP,activation of immune response,0.9426718002118426,0.9999468545471409,189/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of immune system process,0.9456910940011688,0.9999468545471409,373/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of T-helper 1 type immune response,0.9464889114888089,0.9999468545471409,3/4916
Control_DLPFC_vs_NAC,GO_BP,cerebral cortex GABAergic interneuron migration,0.9464889114888089,0.9999468545471409,3/4916
Control_DLPFC_vs_NAC,GO_BP,olfactory bulb interneuron development,0.9464889114888089,0.9999468545471409,3/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of stress-activated protein kinase signaling cascade,0.9464889114888089,0.9999468545471409,3/4916
Control_DLPFC_vs_NAC,GO_BP,motor neuron migration,0.9464889114888089,0.9999468545471409,3/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of T-helper 17 type immune response,0.9464889114888089,0.9999468545471409,3/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of adaptive immune response,0.9487794265210556,0.9999468545471409,24/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of immunoglobulin mediated immune response,0.9489761780845439,0.9999468545471409,5/4916
Control_DLPFC_vs_NAC,GO_BP,stress-activated protein kinase signaling cascade,0.9520608712992397,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,stress-activated MAPK cascade,0.9520608712992397,0.9999468545471409,15/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of immune response,0.95329596788715,0.9999468545471409,249/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of excitatory synapse assembly,0.9557135593761508,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,immune response-activating signaling pathway,0.9567387000527543,0.9999468545471409,174/4916
Control_DLPFC_vs_NAC,GO_BP,response to chemokine,0.9582892846194297,0.9999468545471409,23/4916
Control_DLPFC_vs_NAC,GO_BP,cellular response to chemokine,0.9582892846194297,0.9999468545471409,23/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of chemokine production,0.9616675642069946,0.9999468545471409,9/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of programmed cell death,0.9661917117373506,0.9999468545471409,178/4916
Control_DLPFC_vs_NAC,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.9728960218225304,0.9999468545471409,13/4916
Control_DLPFC_vs_NAC,GO_BP,integrated stress response signaling,0.9728960218225304,0.9999468545471409,13/4916
Control_DLPFC_vs_NAC,GO_BP,innate immune response-activating signaling pathway,0.9741916531912211,0.9999468545471409,94/4916
Control_DLPFC_vs_NAC,GO_BP,chemokine-mediated signaling pathway,0.979395497814437,0.9999468545471409,20/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of innate immune response,0.979983191121014,0.9999468545471409,119/4916
Control_DLPFC_vs_NAC,GO_BP,antiviral innate immune response,0.9804960746756759,0.9999468545471409,12/4916
Control_DLPFC_vs_NAC,GO_BP,oxidative phosphorylation,0.9811108494296371,0.9999468545471409,17/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of immune response,0.9830702784784291,0.9999468545471409,61/4916
Control_DLPFC_vs_NAC,GO_BP,complement receptor mediated signaling pathway,0.9832434306107939,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,positive regulation of T cell cytokine production,0.9832434306107939,0.9999468545471409,7/4916
Control_DLPFC_vs_NAC,GO_BP,axonal transport of mitochondrion,0.9847967174678798,0.9999468545471409,3/4916
Control_DLPFC_vs_NAC,GO_BP,activation of innate immune response,0.9850754024314434,0.9999468545471409,96/4916
Control_DLPFC_vs_NAC,GO_BP,immune response,0.9872730351632322,0.9999468545471409,589/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of immune response,0.9882433087805245,0.9999468545471409,313/4916
Control_DLPFC_vs_NAC,GO_BP,cellular component disassembly involved in execution phase of apoptosis,0.9899992894687468,0.9999468545471409,6/4916
Control_DLPFC_vs_NAC,GO_BP,cytokine-mediated signaling pathway,0.992701801748173,0.9999468545471409,185/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of response to cytokine stimulus,0.9936913289107345,0.9999468545471409,58/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of innate immune response,0.9938991163967428,0.9999468545471409,142/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of innate immune response,0.9941664358894726,0.9999468545471409,26/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of response to stress,0.9955252142501549,0.9999468545471409,413/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of cytokine-mediated signaling pathway,0.9975420541691263,0.9999468545471409,53/4916
Control_DLPFC_vs_NAC,GO_BP,execution phase of apoptosis,0.9984122839581118,0.9999468545471409,17/4916
Control_DLPFC_vs_NAC,GO_BP,regulation of response to endoplasmic reticulum stress,0.9995780590010596,0.9999468545471409,10/4916
Control_DLPFC_vs_NAC,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.9997254451859079,0.9999468545471409,1/4916
Control_DLPFC_vs_NAC,GO_BP,response to endoplasmic reticulum stress,0.9997474415465102,0.9999468545471409,46/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of response to cytokine stimulus,0.9997830107217625,0.9999468545471409,21/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.9998133833478302,0.9999468545471409,4/4916
Control_DLPFC_vs_NAC,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.9999424491659832,0.9999468545471409,18/4916
Female_OUD_vs_Control,KEGG,Pyrimidine metabolism,0.6928774144220529,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Axon guidance,0.7032294805360145,0.9999813333778547,5/175
Female_OUD_vs_Control,KEGG,Glycerophospholipid metabolism,0.7035100422578541,0.9999813333778547,2/175
Female_OUD_vs_Control,KEGG,Ether lipid metabolism,0.7452912932072933,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,GABAergic synapse,0.7743060130039751,0.9999813333778547,2/175
Female_OUD_vs_Control,KEGG,Glycerolipid metabolism,0.8015956877186968,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Arachidonic acid metabolism,0.8015956877186968,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Nicotine addiction,0.8015956877186968,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Platinum drug resistance,0.8136181096886512,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Inositol phosphate metabolism,0.8719689451930864,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Purine metabolism,0.8791150185373209,0.9999813333778547,2/175
Female_OUD_vs_Control,KEGG,Nucleotide metabolism,0.8797459096468212,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Cortisol synthesis and secretion,0.8797459096468212,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Carbon metabolism,0.906429187525394,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Choline metabolism in cancer,0.9316527619677515,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Morphine addiction,0.9635963393952749,0.9999813333778547,1/175
Female_OUD_vs_Control,KEGG,Serotonergic synapse,0.9818419427252747,0.9999813333778547,1/175
Control_DLPFC_vs_NAC,DO,substance abuse,0.04660490474189131,0.9999841676159802,122/2417
Control_DLPFC_vs_NAC,DO,metal metabolism disorder,0.10227576284852767,0.9999841676159802,26/2417
Control_DLPFC_vs_NAC,DO,substance-related disorder,0.10700325341931596,0.9999841676159802,158/2417
Control_DLPFC_vs_NAC,DO,autoimmune disease,0.19146129198335032,0.9999841676159802,117/2417
Control_DLPFC_vs_NAC,DO,nicotine dependence,0.19679195223700544,0.9999841676159802,21/2417
Control_DLPFC_vs_NAC,DO,post-traumatic stress disorder,0.2540201473400865,0.9999841676159802,7/2417
Control_DLPFC_vs_NAC,DO,autoimmune disease of blood,0.25974013589682193,0.9999841676159802,13/2417
Control_DLPFC_vs_NAC,DO,autoimmune thrombocytopenic purpura,0.25974013589682193,0.9999841676159802,13/2417
Control_DLPFC_vs_NAC,DO,motor neuron disease,0.2735585681912726,0.9999841676159802,50/2417
Control_DLPFC_vs_NAC,DO,autoimmune disease of peripheral nervous system,0.3090174583776329,0.9999841676159802,6/2417
Control_DLPFC_vs_NAC,DO,autosomal dominant distal hereditary motor neuronopathy,0.3090174583776329,0.9999841676159802,6/2417
Control_DLPFC_vs_NAC,DO,substance-induced psychosis,0.3090174583776329,0.9999841676159802,6/2417
Control_DLPFC_vs_NAC,DO,withdrawal disorder,0.3271084954743792,0.9999841676159802,22/2417
Control_DLPFC_vs_NAC,DO,immune system disease,0.33125621870574823,0.9999841676159802,212/2417
Control_DLPFC_vs_NAC,DO,opioid abuse,0.3923882826049212,0.9999841676159802,10/2417
Control_DLPFC_vs_NAC,DO,cocaine dependence,0.43959115097906065,0.9999841676159802,14/2417
Control_DLPFC_vs_NAC,DO,heroin dependence,0.5729453526229369,0.9999841676159802,20/2417
Control_DLPFC_vs_NAC,DO,glycogen metabolism disorder,0.6390013246029131,0.9999841676159802,6/2417
Control_DLPFC_vs_NAC,DO,alcohol dependence,0.663172057284799,0.9999841676159802,26/2417
Control_DLPFC_vs_NAC,DO,autoimmune disease of the nervous system,0.6872345452403177,0.9999841676159802,13/2417
Control_DLPFC_vs_NAC,DO,substance dependence,0.7058706350126851,0.9999841676159802,54/2417
Control_DLPFC_vs_NAC,DO,combined oxidative phosphorylation deficiency,0.7102789341814251,0.9999841676159802,5/2417
Control_DLPFC_vs_NAC,DO,disease of metabolism,0.7160912525599843,0.9999841676159802,531/2417
Control_DLPFC_vs_NAC,DO,autoimmune disease of central nervous system,0.7824771759599083,0.9999841676159802,4/2417
Control_DLPFC_vs_NAC,DO,glucose intolerance,0.7824771759599083,0.9999841676159802,4/2417
Control_DLPFC_vs_NAC,DO,plasma protein metabolism disease,0.7824771759599083,0.9999841676159802,4/2417
Control_DLPFC_vs_NAC,DO,autoimmune thyroiditis,0.7824771759599083,0.9999841676159802,4/2417
Control_DLPFC_vs_NAC,DO,adult respiratory distress syndrome,0.7879291475916879,0.9999841676159802,18/2417
Control_DLPFC_vs_NAC,DO,"autoimmune disease of eyes, ear, nose and throat",0.7956815119990814,0.9999841676159802,7/2417
Control_DLPFC_vs_NAC,DO,glucose metabolism disease,0.8398060328144734,0.9999841676159802,254/2417
Control_DLPFC_vs_NAC,DO,autoimmune disease of skin and connective tissue,0.8442283300810163,0.9999841676159802,6/2417
Control_DLPFC_vs_NAC,DO,complement deficiency,0.8442283300810163,0.9999841676159802,6/2417
Control_DLPFC_vs_NAC,DO,autoimmune disease of endocrine system,0.8456920662214509,0.9999841676159802,16/2417
Control_DLPFC_vs_NAC,DO,lipid metabolism disorder,0.8672414258359521,0.9999841676159802,41/2417
Control_DLPFC_vs_NAC,DO,morphine dependence,0.8851879935630536,0.9999841676159802,8/2417
Control_DLPFC_vs_NAC,DO,drug dependence,0.8888439034396153,0.9999841676159802,32/2417
Control_DLPFC_vs_NAC,DO,opiate dependence,0.8940146616579197,0.9999841676159802,28/2417
Control_DLPFC_vs_NAC,DO,newborn respiratory distress syndrome,0.9268736595168744,0.9999841676159802,4/2417
Control_DLPFC_vs_NAC,DO,mitochondrial metabolism disease,0.962452019681048,0.9999841676159802,19/2417
Control_DLPFC_vs_NAC,DO,mineral metabolism disease,0.9639164701019767,0.9999841676159802,10/2417
Control_DLPFC_vs_NAC,DO,calcium metabolism disease,0.9686126169628968,0.9999841676159802,7/2417
Control_DLPFC_vs_NAC,DO,neuronal ceroid lipofuscinosis,0.9780745947024335,0.9999841676159802,4/2417
Control_DLPFC_vs_NAC,DO,autoimmune disease of gastrointestinal tract,0.993705747153509,0.9999841676159802,6/2417
Control_DLPFC_vs_NAC,DO,bone inflammation disease,0.9988262882304497,0.9999841676159802,86/2417
Control_DLPFC_vs_NAC,DO,autoimmune hepatitis,0.9991094257897388,0.9999841676159802,2/2417
Pooled_OUD_vs_Control,GO_BP,"synaptic transmission, glutamatergic",0.9859891880023082,0.9999844633139112,1/380
Pooled_OUD_vs_Control,GO_BP,neuron projection morphogenesis,0.9860078156073313,0.9999844633139112,13/380
Pooled_OUD_vs_Control,GO_BP,neuron projection development,0.9931798372860684,0.9999844633139112,20/380
Pooled_OUD_vs_Control,GO_BP,regulation of neuron differentiation,0.9936766469587156,0.9999844633139112,2/380
Pooled_OUD_vs_Control,GO_BP,neuron development,0.9943085823653792,0.9999844633139112,23/380
Pooled_OUD_vs_Control,GO_BP,central nervous system neuron differentiation,0.994363576783712,0.9999844633139112,2/380
Pooled_OUD_vs_Control,GO_BP,neuron migration,0.9950572647178118,0.9999844633139112,1/380
Pooled_OUD_vs_Control,GO_BP,generation of neurons,0.9962625614870146,0.9999844633139112,31/380
Pooled_OUD_vs_Control,GO_BP,neuron differentiation,0.9965060290013281,0.9999844633139112,29/380
Male_OUD_vs_Control,GO_CC,glutamatergic synapse,0.9464228983104719,0.9999868775619866,2/100
Male_OUD_vs_Control,GO_CC,postsynapse,0.9480110164300865,0.9999868775619866,3/100
Male_OUD_vs_Control,GO_CC,asymmetric synapse,0.9505531166044539,0.9999868775619866,1/100
Male_OUD_vs_Control,GO_CC,neuron to neuron synapse,0.9652970997866093,0.9999868775619866,1/100
Male_OUD_vs_Control,GO_CC,neuronal cell body,0.9857592204207233,0.9999868775619866,1/100
Male_OUD_vs_Control,GO_CC,presynapse,0.9957579882482932,0.9999868775619866,1/100
Male_OUD_vs_Control,GO_CC,axon,0.9959624850385009,0.9999868775619866,1/100
Male_OUD_vs_Control,GO_CC,synapse,0.9974380241473637,0.9999868775619866,5/100
Male_OUD_vs_Control,GO_CC,neuron projection,0.9999868775619866,0.9999868775619866,1/100
Control_DLPFC_vs_NAC,Reactome,Neuronal System,0.0030487962810311266,0.9999892145483157,205/3031
Control_DLPFC_vs_NAC,Reactome,Transmission across Chemical Synapses,0.020799556226805082,0.9999892145483157,128/3031
Control_DLPFC_vs_NAC,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.037795716385358016,0.9999892145483157,15/3031
Control_DLPFC_vs_NAC,Reactome,Neurotransmitter release cycle,0.04873557683715793,0.9999892145483157,28/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of steroid hormones,0.07285538252663047,0.9999892145483157,12/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of amine-derived hormones,0.09065911507784014,0.9999892145483157,11/3031
Control_DLPFC_vs_NAC,Reactome,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.09065911507784014,0.9999892145483157,11/3031
Control_DLPFC_vs_NAC,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,0.11546973035704185,0.9999892145483157,93/3031
Control_DLPFC_vs_NAC,Reactome,Opioid Signalling,0.15744244260551654,0.9999892145483157,46/3031
Control_DLPFC_vs_NAC,Reactome,Na+/Cl- dependent neurotransmitter transporters,0.17461906047942818,0.9999892145483157,8/3031
Control_DLPFC_vs_NAC,Reactome,Glycogen metabolism,0.17461906047942818,0.9999892145483157,8/3031
Control_DLPFC_vs_NAC,Reactome,Arachidonate metabolism,0.1956079667399376,0.9999892145483157,24/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,0.2055236299557395,0.9999892145483157,94/3031
Control_DLPFC_vs_NAC,Reactome,Glutamate and glutamine metabolism,0.2172344264297648,0.9999892145483157,7/3031
Control_DLPFC_vs_NAC,Reactome,Serine metabolism,0.2172344264297648,0.9999892145483157,7/3031
Control_DLPFC_vs_NAC,Reactome,Integration of energy metabolism,0.22275418724798865,0.9999892145483157,47/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of nucleotides,0.24026546305661828,0.9999892145483157,32/3031
Control_DLPFC_vs_NAC,Reactome,Pyruvate metabolism,0.24459008246164227,0.9999892145483157,12/3031
Control_DLPFC_vs_NAC,Reactome,Heparan sulfate/heparin (HS-GAG) metabolism,0.2453229558530789,0.9999892145483157,27/3031
Control_DLPFC_vs_NAC,Reactome,Glucose metabolism,0.2491303223659993,0.9999892145483157,22/3031
Control_DLPFC_vs_NAC,Reactome,Activation of kainate receptors upon glutamate binding,0.2502070583286493,0.9999892145483157,17/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of non-coding RNA,0.2702324451752745,0.9999892145483157,6/3031
Control_DLPFC_vs_NAC,Reactome,Glyoxylate metabolism and glycine degradation,0.2702324451752745,0.9999892145483157,6/3031
Control_DLPFC_vs_NAC,Reactome,Phospholipid metabolism,0.28279012227228784,0.9999892145483157,71/3031
Control_DLPFC_vs_NAC,Reactome,"Unblocking of NMDA receptors, glutamate binding and activation",0.28650017314114695,0.9999892145483157,11/3031
Control_DLPFC_vs_NAC,Reactome,Glycosphingolipid metabolism,0.3243452302563201,0.9999892145483157,15/3031
Control_DLPFC_vs_NAC,Reactome,Glutamate Neurotransmitter Release Cycle,0.3243452302563201,0.9999892145483157,15/3031
Control_DLPFC_vs_NAC,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.33427735281432036,0.9999892145483157,10/3031
Control_DLPFC_vs_NAC,Reactome,p75NTR regulates axonogenesis,0.3361384413878823,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.3361384413878823,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,Diseases of carbohydrate metabolism,0.3361384413878823,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF),0.3361384413878823,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,Inositol phosphate metabolism,0.349350538268879,0.9999892145483157,19/3031
Control_DLPFC_vs_NAC,Reactome,Peptide hormone metabolism,0.36328872547770125,0.9999892145483157,32/3031
Control_DLPFC_vs_NAC,Reactome,Dopamine Neurotransmitter Release Cycle,0.3670599290876674,0.9999892145483157,14/3031
Control_DLPFC_vs_NAC,Reactome,Serotonin Neurotransmitter Release Cycle,0.4135376400302757,0.9999892145483157,13/3031
Control_DLPFC_vs_NAC,Reactome,"Cell death signalling via NRAGE, NRIF and NADE",0.4150919147425318,0.9999892145483157,26/3031
Control_DLPFC_vs_NAC,Reactome,Axon guidance,0.41689042268433424,0.9999892145483157,190/3031
Control_DLPFC_vs_NAC,Reactome,Diseases associated with glycosaminoglycan metabolism,0.42950391750406725,0.9999892145483157,17/3031
Control_DLPFC_vs_NAC,Reactome,Regulation of pyruvate metabolism,0.44873523518576797,0.9999892145483157,8/3031
Control_DLPFC_vs_NAC,Reactome,Acetylcholine Neurotransmitter Release Cycle,0.4636249813004796,0.9999892145483157,12/3031
Control_DLPFC_vs_NAC,Reactome,Sema3A PAK dependent Axon repulsion,0.5155419880821216,0.9999892145483157,7/3031
Control_DLPFC_vs_NAC,Reactome,Diseases of the neuronal system,0.5155419880821216,0.9999892145483157,7/3031
Control_DLPFC_vs_NAC,Reactome,Norepinephrine Neurotransmitter Release Cycle,0.5170056718784215,0.9999892145483157,11/3031
Control_DLPFC_vs_NAC,Reactome,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.5189786869337363,0.9999892145483157,15/3031
Control_DLPFC_vs_NAC,Reactome,Diseases of Immune System,0.5189786869337363,0.9999892145483157,15/3031
Control_DLPFC_vs_NAC,Reactome,Retinoid metabolism and transport,0.5209414328072108,0.9999892145483157,19/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of steroids,0.5583402183170066,0.9999892145483157,46/3031
Control_DLPFC_vs_NAC,Reactome,Sphingolipid metabolism,0.5586229614812581,0.9999892145483157,30/3031
Control_DLPFC_vs_NAC,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.5593516266435119,0.9999892145483157,26/3031
Control_DLPFC_vs_NAC,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.5606157228505959,0.9999892145483157,22/3031
Control_DLPFC_vs_NAC,Reactome,Keratan sulfate/keratin metabolism,0.5663951903006241,0.9999892145483157,14/3031
Control_DLPFC_vs_NAC,Reactome,Triglyceride metabolism,0.5663951903006241,0.9999892145483157,14/3031
Control_DLPFC_vs_NAC,Reactome,Surfactant metabolism,0.5731632511801876,0.9999892145483157,10/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of polyamines,0.5882205576483318,0.9999892145483157,6/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of lipids,0.5952992440859171,0.9999892145483157,217/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of fat-soluble vitamins,0.5989126803069544,0.9999892145483157,21/3031
Control_DLPFC_vs_NAC,Reactome,Initial triggering of complement,0.6313432714307763,0.9999892145483157,9/3031
Control_DLPFC_vs_NAC,Reactome,Sialic acid metabolism,0.6313432714307763,0.9999892145483157,9/3031
Control_DLPFC_vs_NAC,Reactome,Negative regulation of NMDA receptor-mediated neuronal transmission,0.6313432714307763,0.9999892145483157,9/3031
Control_DLPFC_vs_NAC,Reactome,Adaptive Immune System,0.6313866780612645,0.9999892145483157,214/3031
Control_DLPFC_vs_NAC,Reactome,Protein-protein interactions at synapses,0.6447393660556678,0.9999892145483157,35/3031
Control_DLPFC_vs_NAC,Reactome,Response of endothelial cells to shear stress,0.6447393660556678,0.9999892145483157,35/3031
Control_DLPFC_vs_NAC,Reactome,Regulation of lipid metabolism by PPARalpha,0.6564484361852975,0.9999892145483157,27/3031
Control_DLPFC_vs_NAC,Reactome,RUNX3 Regulates Immune Response and Cell Migration,0.6656684224509241,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,Sulfur amino acid metabolism,0.6905188238595913,0.9999892145483157,8/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of cofactors,0.6905188238595913,0.9999892145483157,8/3031
Control_DLPFC_vs_NAC,Reactome,MECP2 regulates neuronal receptors and channels,0.6905188238595913,0.9999892145483157,8/3031
Control_DLPFC_vs_NAC,Reactome,Glycosaminoglycan metabolism,0.697152263625887,0.9999892145483157,52/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism,0.7064743058611658,0.9999892145483157,596/3031
Control_DLPFC_vs_NAC,Reactome,Cellular response to chemical stress,0.713063290810581,0.9999892145483157,40/3031
Control_DLPFC_vs_NAC,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.7132280230226858,0.9999892145483157,18/3031
Control_DLPFC_vs_NAC,Reactome,Bile acid and bile salt metabolism,0.7323529520847321,0.9999892145483157,14/3031
Control_DLPFC_vs_NAC,Reactome,Vitamin D (calciferol) metabolism,0.745900862504925,0.9999892145483157,4/3031
Control_DLPFC_vs_NAC,Reactome,FOXO-mediated transcription of cell death genes,0.745900862504925,0.9999892145483157,4/3031
Control_DLPFC_vs_NAC,Reactome,Hyaluronan metabolism,0.749365623219358,0.9999892145483157,7/3031
Control_DLPFC_vs_NAC,Reactome,Aspartate and asparagine metabolism,0.749365623219358,0.9999892145483157,7/3031
Control_DLPFC_vs_NAC,Reactome,Cellular response to heat stress,0.7498257736834142,0.9999892145483157,17/3031
Control_DLPFC_vs_NAC,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.7927889773279724,0.9999892145483157,26/3031
Control_DLPFC_vs_NAC,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,0.7966878708002406,0.9999892145483157,19/3031
Control_DLPFC_vs_NAC,Reactome,Cytokine Signaling in Immune system,0.8158438411855068,0.9999892145483157,243/3031
Control_DLPFC_vs_NAC,Reactome,PI Metabolism,0.8181083725658101,0.9999892145483157,25/3031
Control_DLPFC_vs_NAC,Reactome,Fatty acid metabolism,0.8183817902759589,0.9999892145483157,46/3031
Control_DLPFC_vs_NAC,Reactome,Diseases of metabolism,0.837985989712978,0.9999892145483157,70/3031
Control_DLPFC_vs_NAC,Reactome,Innate Immune System,0.8387874158187522,0.9999892145483157,306/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of amino acids and derivatives,0.8573932263956097,0.9999892145483157,83/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of porphyrins,0.8592880844574038,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,Class C/3 (Metabotropic glutamate/pheromone receptors),0.8592880844574038,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,Oxidative Stress Induced Senescence,0.8637856629614201,0.9999892145483157,33/3031
Control_DLPFC_vs_NAC,Reactome,Chemokine receptors bind chemokines,0.8786947686716786,0.9999892145483157,16/3031
Control_DLPFC_vs_NAC,Reactome,"Sensory perception of sweet, bitter, and umami (glutamate) taste",0.8794059609907351,0.9999892145483157,10/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of Angiotensinogen to Angiotensins,0.906365742612927,0.9999892145483157,4/3031
Control_DLPFC_vs_NAC,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.906365742612927,0.9999892145483157,4/3031
Control_DLPFC_vs_NAC,Reactome,Regulation of commissural axon pathfinding by SLIT and ROBO,0.906365742612927,0.9999892145483157,4/3031
Control_DLPFC_vs_NAC,Reactome,Drug ADME,0.9242552247301301,0.9999892145483157,29/3031
Control_DLPFC_vs_NAC,Reactome,Regulation of Complement cascade,0.9391780830735451,0.9999892145483157,13/3031
Control_DLPFC_vs_NAC,Reactome,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.9453690952415565,0.9999892145483157,3/3031
Control_DLPFC_vs_NAC,Reactome,Linoleic acid (LA) metabolism,0.9453690952415565,0.9999892145483157,3/3031
Control_DLPFC_vs_NAC,Reactome,alpha-linolenic acid (ALA) metabolism,0.9453690952415565,0.9999892145483157,3/3031
Control_DLPFC_vs_NAC,Reactome,Peroxisomal lipid metabolism,0.9476744479748045,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,Complement cascade,0.950185563920947,0.9999892145483157,15/3031
Control_DLPFC_vs_NAC,Reactome,Activation of ATR in response to replication stress,0.9537952399896457,0.9999892145483157,7/3031
Control_DLPFC_vs_NAC,Reactome,Nicotinate metabolism,0.9603699453055403,0.9999892145483157,9/3031
Control_DLPFC_vs_NAC,Reactome,Diseases of programmed cell death,0.963703607095975,0.9999892145483157,28/3031
Control_DLPFC_vs_NAC,Reactome,Intrinsic Pathway for Apoptosis,0.9685223101135255,0.9999892145483157,16/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of nitric oxide: NOS3 activation and regulation,0.9691359534869584,0.9999892145483157,4/3031
Control_DLPFC_vs_NAC,Reactome,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.9691359534869584,0.9999892145483157,4/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of proteins,0.9691441872665155,0.9999892145483157,444/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of vitamins and cofactors,0.9692801466739865,0.9999892145483157,55/3031
Control_DLPFC_vs_NAC,Reactome,Immune System,0.9723749591601183,0.9999892145483157,592/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of RNA,0.9771669379265109,0.9999892145483157,53/3031
Control_DLPFC_vs_NAC,Reactome,Programmed Cell Death,0.9801076618412758,0.9999892145483157,49/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of folate and pterines,0.9822205671905926,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,Defective Intrinsic Pathway for Apoptosis,0.9822205671905926,0.9999892145483157,5/3031
Control_DLPFC_vs_NAC,Reactome,Apoptosis,0.9828914338397533,0.9999892145483157,39/3031
Control_DLPFC_vs_NAC,Reactome,IL-6-type cytokine receptor ligand interactions,0.9843724478701859,0.9999892145483157,3/3031
Control_DLPFC_vs_NAC,Reactome,Cellular responses to stress,0.9909311592992138,0.9999892145483157,162/3031
Control_DLPFC_vs_NAC,Reactome,Metabolism of water-soluble vitamins and cofactors,0.9919374280151487,0.9999892145483157,27/3031
Control_DLPFC_vs_NAC,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.9925066658846786,0.9999892145483157,14/3031
Control_DLPFC_vs_NAC,Reactome,Vitamin B5 (pantothenate) metabolism,0.9938367807133824,0.9999892145483157,2/3031
Control_DLPFC_vs_NAC,Reactome,Selenoamino acid metabolism,0.9987203024466184,0.9999892145483157,12/3031
Control_DLPFC_vs_NAC,Reactome,Regulation of necroptotic cell death,0.9989482756360869,0.9999892145483157,6/3031
NAC_OUD_vs_Control,GO_CC,dopaminergic synapse,0.11361486381527007,0.9999901426110656,2/549
NAC_OUD_vs_Control,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.14325969139077865,0.9999901426110656,2/549
NAC_OUD_vs_Control,GO_CC,excitatory synapse,0.35188831594626,0.9999901426110656,5/549
NAC_OUD_vs_Control,GO_CC,glycinergic synapse,0.35848824835553383,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,stress fiber,0.4255389667505758,0.9999901426110656,4/549
NAC_OUD_vs_Control,GO_CC,axon terminus,0.42725118385764915,0.9999901426110656,7/549
NAC_OUD_vs_Control,GO_CC,neuron to neuron synapse,0.43810043323796355,0.9999901426110656,19/549
NAC_OUD_vs_Control,GO_CC,asymmetric synapse,0.44826143927113427,0.9999901426110656,17/549
NAC_OUD_vs_Control,GO_CC,Schaffer collateral - CA1 synapse,0.4557369632920384,0.9999901426110656,5/549
NAC_OUD_vs_Control,GO_CC,symmetric synapse,0.4629153230398304,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,ribbon synapse,0.4629153230398304,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,astrocyte projection,0.5085804132754099,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,cholinergic synapse,0.5085804132754099,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,immunological synapse,0.5162814508487532,0.9999901426110656,2/549
NAC_OUD_vs_Control,GO_CC,glutamatergic synapse,0.5293853206568491,0.9999901426110656,25/549
NAC_OUD_vs_Control,GO_CC,neuronal dense core vesicle,0.5430454243820042,0.9999901426110656,2/549
NAC_OUD_vs_Control,GO_CC,neuron projection terminus,0.5522963340345222,0.9999901426110656,7/549
NAC_OUD_vs_Control,GO_CC,cytoplasmic stress granule,0.568761768841053,0.9999901426110656,2/549
NAC_OUD_vs_Control,GO_CC,neuronal cell body,0.5936386859628289,0.9999901426110656,22/549
NAC_OUD_vs_Control,GO_CC,distal axon,0.648719613657585,0.9999901426110656,12/549
NAC_OUD_vs_Control,GO_CC,dendrite cytoplasm,0.6849299247936755,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,synapse,0.6954663645744985,0.9999901426110656,67/549
NAC_OUD_vs_Control,GO_CC,postsynapse,0.698800742376914,0.9999901426110656,31/549
NAC_OUD_vs_Control,GO_CC,dendrite membrane,0.7008241763709095,0.9999901426110656,2/549
NAC_OUD_vs_Control,GO_CC,hippocampal mossy fiber to CA3 synapse,0.7532193965833222,0.9999901426110656,2/549
NAC_OUD_vs_Control,GO_CC,neuron spine,0.7789541934722242,0.9999901426110656,6/549
NAC_OUD_vs_Control,GO_CC,AMPA glutamate receptor complex,0.779271596569139,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,parallel fiber to Purkinje cell synapse,0.8152662924105365,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,axonal growth cone,0.831002336703262,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,neuron projection membrane,0.8558354250770428,0.9999901426110656,2/549
NAC_OUD_vs_Control,GO_CC,neuron projection cytoplasm,0.8558354250770428,0.9999901426110656,2/549
NAC_OUD_vs_Control,GO_CC,presynapse,0.8634981599313518,0.9999901426110656,24/549
NAC_OUD_vs_Control,GO_CC,GABA-ergic synapse,0.8738509548922984,0.9999901426110656,3/549
NAC_OUD_vs_Control,GO_CC,neuron projection,0.8910732623155158,0.9999901426110656,50/549
NAC_OUD_vs_Control,GO_CC,ionotropic glutamate receptor complex,0.9009724208583352,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,dendrite,0.9025230353290687,0.9999901426110656,22/549
NAC_OUD_vs_Control,GO_CC,axon,0.9127231952099433,0.9999901426110656,23/549
NAC_OUD_vs_Control,GO_CC,neurotransmitter receptor complex,0.917142650539601,0.9999901426110656,1/549
NAC_OUD_vs_Control,GO_CC,main axon,0.9762507688737581,0.9999901426110656,1/549
Control_DLPFC_vs_NAC,KEGG,Carbon metabolism,0.043750754030942876,0.9999907231367143,35/2345
Control_DLPFC_vs_NAC,KEGG,Morphine addiction,0.08340830749445387,0.9999907231367143,47/2345
Control_DLPFC_vs_NAC,KEGG,Glutamatergic synapse,0.09693786679093647,0.9999907231367143,56/2345
Control_DLPFC_vs_NAC,KEGG,Nitrogen metabolism,0.11347539032767849,0.9999907231367143,10/2345
Control_DLPFC_vs_NAC,KEGG,Choline metabolism in cancer,0.12782627993737203,0.9999907231367143,38/2345
Control_DLPFC_vs_NAC,KEGG,Cholinergic synapse,0.1298376849706268,0.9999907231367143,58/2345
Control_DLPFC_vs_NAC,KEGG,Cholesterol metabolism,0.1531932517237948,0.9999907231367143,26/2345
Control_DLPFC_vs_NAC,KEGG,Drug metabolism - other enzymes,0.16649336318860936,0.9999907231367143,20/2345
Control_DLPFC_vs_NAC,KEGG,Amphetamine addiction,0.19775749374937987,0.9999907231367143,34/2345
Control_DLPFC_vs_NAC,KEGG,Retinol metabolism,0.22010889907748335,0.9999907231367143,18/2345
Control_DLPFC_vs_NAC,KEGG,Nicotine addiction,0.22284154976336998,0.9999907231367143,23/2345
Control_DLPFC_vs_NAC,KEGG,Purine metabolism,0.2573060061376438,0.9999907231367143,50/2345
Control_DLPFC_vs_NAC,KEGG,GABAergic synapse,0.29856177820642044,0.9999907231367143,39/2345
Control_DLPFC_vs_NAC,KEGG,Glycerophospholipid metabolism,0.3100657539923366,0.9999907231367143,34/2345
Control_DLPFC_vs_NAC,KEGG,Nucleotide metabolism,0.3225525585615183,0.9999907231367143,29/2345
Control_DLPFC_vs_NAC,KEGG,Sphingolipid metabolism,0.32619993069481223,0.9999907231367143,15/2345
Control_DLPFC_vs_NAC,KEGG,Drug metabolism - cytochrome P450,0.32619993069481223,0.9999907231367143,15/2345
Control_DLPFC_vs_NAC,KEGG,Thiamine metabolism,0.3372131097969896,0.9999907231367143,5/2345
Control_DLPFC_vs_NAC,KEGG,Metabolism of xenobiotics by cytochrome P450,0.3515344500201401,0.9999907231367143,19/2345
Control_DLPFC_vs_NAC,KEGG,"Glycine, serine and threonine metabolism",0.3689881521296034,0.9999907231367143,14/2345
Control_DLPFC_vs_NAC,KEGG,Tyrosine metabolism,0.3689881521296034,0.9999907231367143,14/2345
Control_DLPFC_vs_NAC,KEGG,Serotonergic synapse,0.38628529953718754,0.9999907231367143,53/2345
Control_DLPFC_vs_NAC,KEGG,Cysteine and methionine metabolism,0.3904048615485668,0.9999907231367143,18/2345
Control_DLPFC_vs_NAC,KEGG,Arachidonic acid metabolism,0.4058967623059162,0.9999907231367143,22/2345
Control_DLPFC_vs_NAC,KEGG,Starch and sucrose metabolism,0.4155148384517614,0.9999907231367143,13/2345
Control_DLPFC_vs_NAC,KEGG,Amino sugar and nucleotide sugar metabolism,0.4155148384517614,0.9999907231367143,13/2345
Control_DLPFC_vs_NAC,KEGG,Arginine and proline metabolism,0.43180843318028206,0.9999907231367143,17/2345
Control_DLPFC_vs_NAC,KEGG,Glyoxylate and dicarboxylate metabolism,0.4503380575125612,0.9999907231367143,8/2345
Control_DLPFC_vs_NAC,KEGG,Butanoate metabolism,0.4503380575125612,0.9999907231367143,8/2345
Control_DLPFC_vs_NAC,KEGG,Fructose and mannose metabolism,0.46562060291591745,0.9999907231367143,12/2345
Control_DLPFC_vs_NAC,KEGG,Pyrimidine metabolism,0.47553906686721037,0.9999907231367143,16/2345
Control_DLPFC_vs_NAC,KEGG,Cocaine addiction,0.48867099629413047,0.9999907231367143,24/2345
Control_DLPFC_vs_NAC,KEGG,Galactose metabolism,0.5171143577949289,0.9999907231367143,7/2345
Control_DLPFC_vs_NAC,KEGG,Inositol phosphate metabolism,0.5277036436418563,0.9999907231367143,27/2345
Control_DLPFC_vs_NAC,KEGG,Central carbon metabolism in cancer,0.5277036436418563,0.9999907231367143,27/2345
Control_DLPFC_vs_NAC,KEGG,"Alanine, aspartate and glutamate metabolism",0.5686665188252952,0.9999907231367143,14/2345
Control_DLPFC_vs_NAC,KEGG,Glycerolipid metabolism,0.6017122779602915,0.9999907231367143,21/2345
Control_DLPFC_vs_NAC,KEGG,Phenylalanine metabolism,0.633156755288697,0.9999907231367143,9/2345
Control_DLPFC_vs_NAC,KEGG,Linoleic acid metabolism,0.633156755288697,0.9999907231367143,9/2345
Control_DLPFC_vs_NAC,KEGG,Cortisol synthesis and secretion,0.6595976397637574,0.9999907231367143,27/2345
Control_DLPFC_vs_NAC,KEGG,Propanoate metabolism,0.6670072993371872,0.9999907231367143,5/2345
Control_DLPFC_vs_NAC,KEGG,Porphyrin metabolism,0.6670072993371872,0.9999907231367143,5/2345
Control_DLPFC_vs_NAC,KEGG,Glutathione metabolism,0.7521100698562598,0.9999907231367143,17/2345
Control_DLPFC_vs_NAC,KEGG,Ether lipid metabolism,0.7521100698562598,0.9999907231367143,17/2345
Control_DLPFC_vs_NAC,KEGG,Folate transport and metabolism,0.7746383503375105,0.9999907231367143,13/2345
Control_DLPFC_vs_NAC,KEGG,Histidine metabolism,0.8073826904157482,0.9999907231367143,9/2345
Control_DLPFC_vs_NAC,KEGG,Taurine and hypotaurine metabolism,0.8074870598778562,0.9999907231367143,6/2345
Control_DLPFC_vs_NAC,KEGG,alpha-Linolenic acid metabolism,0.8074870598778562,0.9999907231367143,6/2345
Control_DLPFC_vs_NAC,KEGG,Adipocytokine signaling pathway,0.8100914959852356,0.9999907231367143,22/2345
Control_DLPFC_vs_NAC,KEGG,Tryptophan metabolism,0.8127832055468399,0.9999907231367143,12/2345
Control_DLPFC_vs_NAC,KEGG,Platinum drug resistance,0.8605667065409769,0.9999907231367143,20/2345
Control_DLPFC_vs_NAC,KEGG,Nicotinate and nicotinamide metabolism,0.879081781642807,0.9999907231367143,13/2345
Control_DLPFC_vs_NAC,KEGG,beta-Alanine metabolism,0.8806462926054833,0.9999907231367143,10/2345
Control_DLPFC_vs_NAC,KEGG,Pyruvate metabolism,0.8876825976751552,0.9999907231367143,7/2345
Control_DLPFC_vs_NAC,KEGG,Chemokine signaling pathway,0.8952746700432997,0.9999907231367143,62/2345
Control_DLPFC_vs_NAC,KEGG,Intestinal immune network for IgA production,0.903232446008521,0.9999907231367143,18/2345
Control_DLPFC_vs_NAC,KEGG,Fatty acid metabolism,0.9264529128955672,0.9999907231367143,11/2345
Control_DLPFC_vs_NAC,KEGG,Apoptosis - multiple species,0.9339704686980475,0.9999907231367143,8/2345
Control_DLPFC_vs_NAC,KEGG,Autoimmune thyroid disease,0.9339704686980475,0.9999907231367143,8/2345
Control_DLPFC_vs_NAC,KEGG,Ascorbate and aldarate metabolism,0.9458075692109946,0.9999907231367143,3/2345
Control_DLPFC_vs_NAC,KEGG,Cytokine-cytokine receptor interaction,0.9577219697085055,0.9999907231367143,95/2345
Control_DLPFC_vs_NAC,KEGG,Oxidative phosphorylation,0.9838859930144235,0.9999907231367143,19/2345
Control_DLPFC_vs_NAC,KEGG,Fluid shear stress and atherosclerosis,0.9887203096463085,0.9999907231367143,46/2345
Control_DLPFC_vs_NAC,KEGG,2-Oxocarboxylic acid metabolism,0.990734437674615,0.9999907231367143,4/2345
Control_DLPFC_vs_NAC,KEGG,Complement and coagulation cascades,0.9940330552844737,0.9999907231367143,26/2345
Control_DLPFC_vs_NAC,KEGG,Viral protein interaction with cytokine and cytokine receptor,0.9992218056924728,0.9999907231367143,22/2345
Control_DLPFC_vs_NAC,KEGG,Apoptosis,0.9999907231367143,0.9999907231367143,31/2345
OUD_DLPFC_vs_NAC,GO_MF,postsynaptic neurotransmitter receptor activity,0.12853239685030884,0.9999928389785339,38/5162
OUD_DLPFC_vs_NAC,GO_MF,neurotransmitter receptor activity,0.15318150782414605,0.9999928389785339,54/5162
OUD_DLPFC_vs_NAC,GO_MF,structural constituent of synapse,0.15828403680017533,0.9999928389785339,17/5162
OUD_DLPFC_vs_NAC,GO_MF,L-glutamate transmembrane transporter activity,0.22080259256849444,0.9999928389785339,8/5162
OUD_DLPFC_vs_NAC,GO_MF,G protein-coupled neurotransmitter receptor activity,0.26671925197362095,0.9999928389785339,7/5162
OUD_DLPFC_vs_NAC,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.3067609733022117,0.9999928389785339,29/5162
OUD_DLPFC_vs_NAC,GO_MF,structural constituent of postsynapse,0.31801176332598863,0.9999928389785339,12/5162
OUD_DLPFC_vs_NAC,GO_MF,toxic substance binding,0.38914482478815493,0.9999928389785339,5/5162
OUD_DLPFC_vs_NAC,GO_MF,glutamate-gated calcium ion channel activity,0.38914482478815493,0.9999928389785339,5/5162
OUD_DLPFC_vs_NAC,GO_MF,dopamine binding,0.38914482478815493,0.9999928389785339,5/5162
OUD_DLPFC_vs_NAC,GO_MF,neurotransmitter transmembrane transporter activity,0.4660785613428816,0.9999928389785339,9/5162
OUD_DLPFC_vs_NAC,GO_MF,axon guidance receptor activity,0.5249469924829506,0.9999928389785339,8/5162
OUD_DLPFC_vs_NAC,GO_MF,glutamate receptor activity,0.5578657398356894,0.9999928389785339,12/5162
OUD_DLPFC_vs_NAC,GO_MF,ionotropic glutamate receptor binding,0.6076898040689218,0.9999928389785339,11/5162
OUD_DLPFC_vs_NAC,GO_MF,glutamate receptor binding,0.6523026936603826,0.9999928389785339,23/5162
OUD_DLPFC_vs_NAC,GO_MF,glutamate-gated receptor activity,0.7098188361628665,0.9999928389785339,9/5162
OUD_DLPFC_vs_NAC,GO_MF,G protein-coupled glutamate receptor binding,0.72400054173542,0.9999928389785339,5/5162
OUD_DLPFC_vs_NAC,GO_MF,CXCR chemokine receptor binding,0.72400054173542,0.9999928389785339,5/5162
OUD_DLPFC_vs_NAC,GO_MF,opioid receptor binding,0.7935295205742181,0.9999928389785339,4/5162
OUD_DLPFC_vs_NAC,GO_MF,type 5 metabotropic glutamate receptor binding,0.7935295205742181,0.9999928389785339,4/5162
OUD_DLPFC_vs_NAC,GO_MF,complement binding,0.923341431740607,0.9999928389785339,7/5162
OUD_DLPFC_vs_NAC,GO_MF,complement receptor activity,0.9469864221998872,0.9999928389785339,6/5162
OUD_DLPFC_vs_NAC,GO_MF,chemokine activity,0.9591040462141674,0.9999928389785339,8/5162
OUD_DLPFC_vs_NAC,GO_MF,neurotransmitter receptor regulator activity,0.9660142892555422,0.9999928389785339,5/5162
OUD_DLPFC_vs_NAC,GO_MF,chemokine receptor activity,0.9686112061648976,0.9999928389785339,10/5162
OUD_DLPFC_vs_NAC,GO_MF,CCR chemokine receptor binding,0.9803691143195821,0.9999928389785339,4/5162
OUD_DLPFC_vs_NAC,GO_MF,chemokine receptor binding,0.9827930299315121,0.9999928389785339,11/5162
OUD_DLPFC_vs_NAC,GO_MF,cytokine activity,0.985979030649453,0.9999928389785339,70/5162
OUD_DLPFC_vs_NAC,GO_MF,cytokine receptor activity,0.9893693840260726,0.9999928389785339,40/5162
OUD_DLPFC_vs_NAC,GO_MF,lipopolysaccharide immune receptor activity,0.990269980564289,0.9999928389785339,3/5162
OUD_DLPFC_vs_NAC,GO_MF,C-C chemokine receptor activity,0.990799707346564,0.9999928389785339,7/5162
OUD_DLPFC_vs_NAC,GO_MF,C-C chemokine binding,0.9971410470282812,0.9999928389785339,7/5162
OUD_DLPFC_vs_NAC,GO_MF,chemokine binding,0.997740000239036,0.9999928389785339,11/5162
OUD_DLPFC_vs_NAC,GO_MF,immune receptor activity,0.9981952711682947,0.9999928389785339,54/5162
OUD_DLPFC_vs_NAC,GO_MF,cytokine binding,0.999361167742157,0.9999928389785339,46/5162
OUD_DLPFC_vs_NAC,GO_MF,cytokine receptor binding,0.9999928389785339,0.9999928389785339,67/5162
DLPFC_OUD_vs_Control,GO_CC,neuron spine,0.703883522654912,0.9999947162860467,3/261
DLPFC_OUD_vs_Control,GO_CC,stress fiber,0.8005593946438591,0.9999947162860467,1/261
DLPFC_OUD_vs_Control,GO_CC,neuron projection cytoplasm,0.8005593946438591,0.9999947162860467,1/261
DLPFC_OUD_vs_Control,GO_CC,main axon,0.8238942691022233,0.9999947162860467,1/261
DLPFC_OUD_vs_Control,GO_CC,postsynapse,0.9285622722343457,0.9999947162860467,11/261
DLPFC_OUD_vs_Control,GO_CC,axon terminus,0.9514884511167276,0.9999947162860467,1/261
DLPFC_OUD_vs_Control,GO_CC,asymmetric synapse,0.952821638761044,0.9999947162860467,4/261
DLPFC_OUD_vs_Control,GO_CC,glutamatergic synapse,0.9574849861067479,0.9999947162860467,7/261
DLPFC_OUD_vs_Control,GO_CC,neuron projection terminus,0.9666753344041095,0.9999947162860467,1/261
DLPFC_OUD_vs_Control,GO_CC,presynapse,0.9700675518509871,0.9999947162860467,8/261
DLPFC_OUD_vs_Control,GO_CC,neuron to neuron synapse,0.9750706339122241,0.9999947162860467,4/261
DLPFC_OUD_vs_Control,GO_CC,neuronal cell body,0.9855915781943931,0.9999947162860467,5/261
DLPFC_OUD_vs_Control,GO_CC,axoneme,0.9861537461585981,0.9999947162860467,1/261
DLPFC_OUD_vs_Control,GO_CC,dendrite,0.9927460554559915,0.9999947162860467,6/261
DLPFC_OUD_vs_Control,GO_CC,synapse,0.995139462116138,0.9999947162860467,21/261
DLPFC_OUD_vs_Control,GO_CC,axon,0.9955681364993241,0.9999947162860467,6/261
DLPFC_OUD_vs_Control,GO_CC,distal axon,0.998236820678036,0.9999947162860467,1/261
DLPFC_OUD_vs_Control,GO_CC,neuron projection,0.999866371459648,0.9999947162860467,12/261
Control_DLPFC_vs_NAC,GO_MF,L-glutamate transmembrane transporter activity,0.1780263987240097,0.999995756203279,8/5025
Control_DLPFC_vs_NAC,GO_MF,G protein-coupled glutamate receptor binding,0.2741347072782753,0.999995756203279,6/5025
Control_DLPFC_vs_NAC,GO_MF,toxic substance binding,0.3401563927562501,0.999995756203279,5/5025
Control_DLPFC_vs_NAC,GO_MF,opioid receptor binding,0.3401563927562501,0.999995756203279,5/5025
Control_DLPFC_vs_NAC,GO_MF,type 5 metabotropic glutamate receptor binding,0.3401563927562501,0.999995756203279,5/5025
Control_DLPFC_vs_NAC,GO_MF,neurotransmitter receptor activity,0.34266687668623796,0.999995756203279,51/5025
Control_DLPFC_vs_NAC,GO_MF,glutamate receptor binding,0.3432790558369697,0.999995756203279,24/5025
Control_DLPFC_vs_NAC,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.36048990792728314,0.999995756203279,28/5025
Control_DLPFC_vs_NAC,GO_MF,axon guidance receptor activity,0.4545878070854972,0.999995756203279,8/5025
Control_DLPFC_vs_NAC,GO_MF,structural constituent of postsynapse,0.5240596224585135,0.999995756203279,11/5025
Control_DLPFC_vs_NAC,GO_MF,structural constituent of synapse,0.5272174422098956,0.999995756203279,15/5025
Control_DLPFC_vs_NAC,GO_MF,postsynaptic neurotransmitter receptor activity,0.5705204985044654,0.999995756203279,34/5025
Control_DLPFC_vs_NAC,GO_MF,chemokine receptor binding,0.5743104254970424,0.999995756203279,14/5025
Control_DLPFC_vs_NAC,GO_MF,CCR chemokine receptor binding,0.5934303345417001,0.999995756203279,6/5025
Control_DLPFC_vs_NAC,GO_MF,glutamate-gated receptor activity,0.6375522974041259,0.999995756203279,9/5025
Control_DLPFC_vs_NAC,GO_MF,lipopolysaccharide immune receptor activity,0.6702648201461258,0.999995756203279,5/5025
Control_DLPFC_vs_NAC,GO_MF,neurotransmitter transmembrane transporter activity,0.6960958899534563,0.999995756203279,8/5025
Control_DLPFC_vs_NAC,GO_MF,chemokine binding,0.6980545121316317,0.999995756203279,15/5025
Control_DLPFC_vs_NAC,GO_MF,cytokine receptor activity,0.7189671365269086,0.999995756203279,44/5025
Control_DLPFC_vs_NAC,GO_MF,glutamate receptor activity,0.7190061240713597,0.999995756203279,11/5025
Control_DLPFC_vs_NAC,GO_MF,dopamine binding,0.7496854495599814,0.999995756203279,4/5025
Control_DLPFC_vs_NAC,GO_MF,ionotropic glutamate receptor binding,0.7658865788959042,0.999995756203279,10/5025
Control_DLPFC_vs_NAC,GO_MF,chemokine activity,0.810611660091999,0.999995756203279,9/5025
Control_DLPFC_vs_NAC,GO_MF,cytokine binding,0.8465511580636877,0.999995756203279,52/5025
Control_DLPFC_vs_NAC,GO_MF,complement binding,0.8897323028813336,0.999995756203279,7/5025
Control_DLPFC_vs_NAC,GO_MF,immune receptor activity,0.9043904117912676,0.999995756203279,58/5025
Control_DLPFC_vs_NAC,GO_MF,CXCR chemokine receptor binding,0.9085267083876926,0.999995756203279,4/5025
Control_DLPFC_vs_NAC,GO_MF,C-C chemokine binding,0.9112430927832114,0.999995756203279,9/5025
Control_DLPFC_vs_NAC,GO_MF,C-C chemokine receptor activity,0.9354130900710154,0.999995756203279,8/5025
Control_DLPFC_vs_NAC,GO_MF,cytokine activity,0.9464196545332628,0.999995756203279,70/5025
Control_DLPFC_vs_NAC,GO_MF,chemokine receptor activity,0.9466627378937672,0.999995756203279,10/5025
Control_DLPFC_vs_NAC,GO_MF,glutamate-gated calcium ion channel activity,0.9467030125304738,0.999995756203279,3/5025
Control_DLPFC_vs_NAC,GO_MF,neurotransmitter receptor regulator activity,0.9492273481756834,0.999995756203279,5/5025
Control_DLPFC_vs_NAC,GO_MF,G protein-coupled neurotransmitter receptor activity,0.970094274028363,0.999995756203279,4/5025
Control_DLPFC_vs_NAC,GO_MF,cytokine receptor binding,0.9707173061120405,0.999995756203279,75/5025
Control_DLPFC_vs_NAC,GO_MF,complement receptor activity,0.9974230426442878,0.999995756203279,4/5025
Pooled_OUD_vs_Control,Reactome,Phospholipid metabolism,0.9862318213584376,0.9999964013467268,2/267
Pooled_OUD_vs_Control,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,0.9864970919351939,0.9999964013467268,3/267
Pooled_OUD_vs_Control,Reactome,Axon guidance,0.9886904967383949,0.9999964013467268,9/267
Pooled_OUD_vs_Control,Reactome,Transmission across Chemical Synapses,0.9986899317485064,0.9999964013467268,3/267
Pooled_OUD_vs_Control,Reactome,Metabolism of amino acids and derivatives,0.9996823604445841,0.9999964013467268,1/267
Pooled_OUD_vs_Control,Reactome,Metabolism,0.9999625197568762,0.9999964013467268,30/267
Pooled_OUD_vs_Control,Reactome,Neuronal System,0.9999964013467268,0.9999964013467268,3/267
Control_DLPFC_vs_NAC,WikiPathways,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.015417838650271755,0.999997399575947,27/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_DOPAMINERGIC_NEUROGENESIS,0.022547031883204945,0.999997399575947,17/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.035308607112875014,0.999997399575947,69/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.04409794283869423,0.999997399575947,14/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.08618814375174011,0.999997399575947,11/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.10774341947397265,0.999997399575947,10/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.123033749577891,0.999997399575947,27/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.13467927434246568,0.999997399575947,9/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_RETINOL_METABOLISM,0.13467927434246568,0.999997399575947,9/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.18061898679946226,0.999997399575947,34/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.18279917573100402,0.999997399575947,29/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_AMINO_ACID_METABOLISM,0.18299303527361885,0.999997399575947,24/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_ONECARBON_METABOLISM,0.19867710234523514,0.999997399575947,13/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.2103881341245597,0.999997399575947,7/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.2103881341245597,0.999997399575947,7/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_NEUROTRANSMITTER_DISORDERS,0.2103881341245597,0.999997399575947,7/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.23454781704238198,0.999997399575947,12/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.23454781704238198,0.999997399575947,12/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.2629249190491348,0.999997399575947,6/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.2725015781599395,0.999997399575947,16/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.2759181027939732,0.999997399575947,11/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.2759181027939732,0.999997399575947,11/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_OPIOID_RECEPTOR_PATHWAYS,0.29790681547484227,0.999997399575947,20/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.29790681547484227,0.999997399575947,20/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.30902667811067314,0.999997399575947,42/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.31094024082257066,0.999997399575947,15/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENT_ACTIVATION,0.32329617669629757,0.999997399575947,10/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_ALANINE_AND_ASPARTATE_METABOLISM,0.3285557957888814,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.3285557957888814,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,0.3285557957888814,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_DOPAMINE_METABOLISM,0.3285557957888814,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_GABA_METABOLISM_AKA_GHB,0.3285557957888814,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.35331309242512393,0.999997399575947,14/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.3720924825173904,0.999997399575947,18/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.3720924825173904,0.999997399575947,18/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_AXON_GUIDANCE,0.40299962986139454,0.999997399575947,30/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.4125555507592334,0.999997399575947,63/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.43759184934428264,0.999997399575947,8/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_ENERGY_METABOLISM,0.457092028112961,0.999997399575947,16/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_PYRIMIDINE_METABOLISM,0.46212851306214586,0.999997399575947,20/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.47121479308938796,0.999997399575947,32/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,0.5034546744277257,0.999997399575947,11/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.5047514831533604,0.999997399575947,7/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.5047514831533604,0.999997399575947,7/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.5413864445449614,0.999997399575947,22/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.5510530665703743,0.999997399575947,14/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.5510530665703743,0.999997399575947,14/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.5601865462079202,0.999997399575947,10/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.5601865462079202,0.999997399575947,10/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.5601865462079202,0.999997399575947,10/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.5781456285965851,0.999997399575947,6/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_ESTROGEN_METABOLISM_WP697,0.5781456285965851,0.999997399575947,6/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_GLYCOSPHINGOLIPID_METABOLISM,0.5781456285965851,0.999997399575947,6/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,0.619228029740633,0.999997399575947,9/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.6321839970906394,0.999997399575947,16/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.6503404873113622,0.999997399575947,12/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.6567101794876105,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.6567101794876105,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_ESTROGEN_METABOLISM_WP5276,0.6567101794876105,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.6567101794876105,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_TAMOXIFEN_METABOLISM,0.6567101794876105,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.6795513740857948,0.999997399575947,8/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_TRYPTOPHAN_METABOLISM,0.6795513740857948,0.999997399575947,8/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.7353492864005978,0.999997399575947,17/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.7384670709623412,0.999997399575947,4/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_GLYOXYLATE_METABOLISM,0.7384670709623412,0.999997399575947,4/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_NAD_METABOLISM,0.7384670709623412,0.999997399575947,4/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_NEUROINFLAMMATION,0.7384670709623412,0.999997399575947,4/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_PURINE_METABOLISM,0.7384670709623412,0.999997399575947,4/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.7398102014851323,0.999997399575947,7/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.7398102014851323,0.999997399575947,7/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENT_SYSTEM,0.7399662814285394,0.999997399575947,38/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.7492927854752329,0.999997399575947,10/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.7963524803387727,0.999997399575947,9/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.7983280649262607,0.999997399575947,6/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.7983280649262607,0.999997399575947,6/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.8089521093581511,0.999997399575947,35/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CHEMOKINE_SIGNALING,0.8101005120420153,0.999997399575947,56/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.8426186968969053,0.999997399575947,17/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_PHOSPHOINOSITIDES_METABOLISM,0.8426186968969053,0.999997399575947,17/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_GLUTATHIONE_METABOLISM,0.8531215567151722,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.8531215567151722,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,0.8531215567151722,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.8804141320835867,0.999997399575947,7/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.8859993749973056,0.999997399575947,82/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.8934410360793751,0.999997399575947,15/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.9019808539118035,0.999997399575947,4/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.9019808539118035,0.999997399575947,4/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.9153637918085173,0.999997399575947,6/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.9153637918085173,0.999997399575947,6/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.9197184595741602,0.999997399575947,11/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_BENZOAPYRENE_METABOLISM,0.9426410318229588,0.999997399575947,3/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.9426410318229588,0.999997399575947,3/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.9426410318229588,0.999997399575947,3/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.9444440430300247,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.9444440430300247,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.9444440430300247,0.999997399575947,5/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.9504150183023033,0.999997399575947,7/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.9570269008603078,0.999997399575947,9/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_FOLATE_METABOLISM,0.9622490791936344,0.999997399575947,19/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.9833012097341141,0.999997399575947,3/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.9833012097341141,0.999997399575947,3/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.9895499564331086,0.999997399575947,17/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.9898091239845986,0.999997399575947,4/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.9934471380481981,0.999997399575947,18/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.9934471380481981,0.999997399575947,18/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.9954321794042159,0.999997399575947,3/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.9954321794042159,0.999997399575947,3/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.9961279562121137,0.999997399575947,12/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.9978064654732652,0.999997399575947,15/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_NANOMATERIAL_INDUCED_APOPTOSIS,0.9984383289602838,0.999997399575947,2/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_APOPTOSIS,0.9985826381840135,0.999997399575947,23/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_OXIDATIVE_PHOSPHORYLATION,0.9988075606601227,0.999997399575947,6/2625
Control_DLPFC_vs_NAC,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.999997399575947,0.999997399575947,23/2625
OUD_DLPFC_vs_NAC,KEGG,Apoptosis - multiple species,0.3495606962025296,0.9999974882398853,11/2402
OUD_DLPFC_vs_NAC,KEGG,Ascorbate and aldarate metabolism,0.38027627790350005,0.9999974882398853,5/2402
OUD_DLPFC_vs_NAC,KEGG,Thiamine metabolism,0.38027627790350005,0.9999974882398853,5/2402
OUD_DLPFC_vs_NAC,KEGG,Phenylalanine metabolism,0.3988373763665142,0.9999974882398853,10/2402
OUD_DLPFC_vs_NAC,KEGG,Linoleic acid metabolism,0.3988373763665142,0.9999974882398853,10/2402
OUD_DLPFC_vs_NAC,KEGG,"Alanine, aspartate and glutamate metabolism",0.4039480758858395,0.9999974882398853,15/2402
OUD_DLPFC_vs_NAC,KEGG,Drug metabolism - cytochrome P450,0.4039480758858395,0.9999974882398853,15/2402
OUD_DLPFC_vs_NAC,KEGG,Folate transport and metabolism,0.4039480758858395,0.9999974882398853,15/2402
OUD_DLPFC_vs_NAC,KEGG,Cortisol synthesis and secretion,0.4336933605656579,0.9999974882398853,29/2402
OUD_DLPFC_vs_NAC,KEGG,Glutathione metabolism,0.4426084644541227,0.9999974882398853,19/2402
OUD_DLPFC_vs_NAC,KEGG,Tryptophan metabolism,0.4475961663714082,0.9999974882398853,14/2402
OUD_DLPFC_vs_NAC,KEGG,Fatty acid metabolism,0.4475961663714082,0.9999974882398853,14/2402
OUD_DLPFC_vs_NAC,KEGG,Axon guidance,0.4521817845444993,0.9999974882398853,81/2402
OUD_DLPFC_vs_NAC,KEGG,Nitrogen metabolism,0.4531815630154701,0.9999974882398853,9/2402
OUD_DLPFC_vs_NAC,KEGG,Central carbon metabolism in cancer,0.4650940346061607,0.9999974882398853,28/2402
OUD_DLPFC_vs_NAC,KEGG,Glyoxylate and dicarboxylate metabolism,0.5125107051314735,0.9999974882398853,8/2402
OUD_DLPFC_vs_NAC,KEGG,Fructose and mannose metabolism,0.542628694285749,0.9999974882398853,12/2402
OUD_DLPFC_vs_NAC,KEGG,alpha-Linolenic acid metabolism,0.5764777319362016,0.9999974882398853,7/2402
OUD_DLPFC_vs_NAC,KEGG,Adipocytokine signaling pathway,0.598143428865471,0.9999974882398853,24/2402
OUD_DLPFC_vs_NAC,KEGG,Histidine metabolism,0.6452207771864371,0.9999974882398853,10/2402
OUD_DLPFC_vs_NAC,KEGG,Carbon metabolism,0.6526247688444676,0.9999974882398853,31/2402
OUD_DLPFC_vs_NAC,KEGG,Metabolism of xenobiotics by cytochrome P450,0.6586409680337016,0.9999974882398853,18/2402
OUD_DLPFC_vs_NAC,KEGG,Arachidonic acid metabolism,0.6998519867507297,0.9999974882398853,21/2402
OUD_DLPFC_vs_NAC,KEGG,Propanoate metabolism,0.7149298603830326,0.9999974882398853,5/2402
OUD_DLPFC_vs_NAC,KEGG,Chemokine signaling pathway,0.7370646095009872,0.9999974882398853,66/2402
OUD_DLPFC_vs_NAC,KEGG,Pyrimidine metabolism,0.7690840035407579,0.9999974882398853,15/2402
OUD_DLPFC_vs_NAC,KEGG,Butanoate metabolism,0.8003623257527501,0.9999974882398853,7/2402
OUD_DLPFC_vs_NAC,KEGG,Ether lipid metabolism,0.8242930613445332,0.9999974882398853,17/2402
OUD_DLPFC_vs_NAC,KEGG,Taurine and hypotaurine metabolism,0.8480172267738018,0.9999974882398853,6/2402
OUD_DLPFC_vs_NAC,KEGG,2-Oxocarboxylic acid metabolism,0.8480172267738018,0.9999974882398853,6/2402
OUD_DLPFC_vs_NAC,KEGG,Intestinal immune network for IgA production,0.8656511059234052,0.9999974882398853,19/2402
OUD_DLPFC_vs_NAC,KEGG,Retinol metabolism,0.8766089468621947,0.9999974882398853,15/2402
OUD_DLPFC_vs_NAC,KEGG,Cholesterol metabolism,0.878328775801241,0.9999974882398853,22/2402
OUD_DLPFC_vs_NAC,KEGG,Nicotinate and nicotinamide metabolism,0.9198217492339562,0.9999974882398853,13/2402
OUD_DLPFC_vs_NAC,KEGG,Glycerophospholipid metabolism,0.9216128889481876,0.9999974882398853,30/2402
OUD_DLPFC_vs_NAC,KEGG,Complement and coagulation cascades,0.9632096193397334,0.9999974882398853,29/2402
OUD_DLPFC_vs_NAC,KEGG,Galactose metabolism,0.9635659479812911,0.9999974882398853,5/2402
OUD_DLPFC_vs_NAC,KEGG,Amino sugar and nucleotide sugar metabolism,0.9656249911989612,0.9999974882398853,10/2402
OUD_DLPFC_vs_NAC,KEGG,Apoptosis,0.9768440731119367,0.9999974882398853,40/2402
OUD_DLPFC_vs_NAC,KEGG,Autoimmune thyroid disease,0.9898381367249269,0.9999974882398853,7/2402
OUD_DLPFC_vs_NAC,KEGG,Starch and sucrose metabolism,0.991283217689994,0.9999974882398853,9/2402
OUD_DLPFC_vs_NAC,KEGG,Fluid shear stress and atherosclerosis,0.9986995513289734,0.9999974882398853,45/2402
OUD_DLPFC_vs_NAC,KEGG,Cytokine-cytokine receptor interaction,0.9999342763482397,0.9999974882398853,88/2402
OUD_DLPFC_vs_NAC,KEGG,Viral protein interaction with cytokine and cytokine receptor,0.9999974882398853,0.9999974882398853,19/2402
OUD_DLPFC_vs_NAC,GO_CC,neurotransmitter receptor complex,0.46404206491329647,0.9999975504940561,24/5358
OUD_DLPFC_vs_NAC,GO_CC,cytoplasmic stress granule,0.4657454982588106,0.9999975504940561,19/5358
OUD_DLPFC_vs_NAC,GO_CC,axonemal A tubule inner sheath,0.5047087423420168,0.9999975504940561,18/5358
OUD_DLPFC_vs_NAC,GO_CC,ionotropic glutamate receptor complex,0.5338698598605405,0.9999975504940561,22/5358
OUD_DLPFC_vs_NAC,GO_CC,axonal growth cone,0.5449965720627379,0.9999975504940561,17/5358
OUD_DLPFC_vs_NAC,GO_CC,astrocyte projection,0.5908062014824329,0.9999975504940561,7/5358
OUD_DLPFC_vs_NAC,GO_CC,inhibitory synapse,0.657316152249562,0.9999975504940561,6/5358
OUD_DLPFC_vs_NAC,GO_CC,ribbon synapse,0.657316152249562,0.9999975504940561,6/5358
OUD_DLPFC_vs_NAC,GO_CC,dopaminergic synapse,0.657316152249562,0.9999975504940561,6/5358
OUD_DLPFC_vs_NAC,GO_CC,synapse-associated extracellular matrix,0.657316152249562,0.9999975504940561,6/5358
OUD_DLPFC_vs_NAC,GO_CC,apical dendrite,0.7125938689221238,0.9999975504940561,9/5358
OUD_DLPFC_vs_NAC,GO_CC,NMDA selective glutamate receptor complex,0.7260820915791799,0.9999975504940561,5/5358
OUD_DLPFC_vs_NAC,GO_CC,perineuronal net,0.7952033772519905,0.9999975504940561,4/5358
OUD_DLPFC_vs_NAC,GO_CC,glycinergic synapse,0.7952033772519905,0.9999975504940561,4/5358
OUD_DLPFC_vs_NAC,GO_CC,paranode region of axon,0.8113522092306825,0.9999975504940561,7/5358
OUD_DLPFC_vs_NAC,GO_CC,cholinergic synapse,0.8568460045509492,0.9999975504940561,6/5358
OUD_DLPFC_vs_NAC,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.8568460045509492,0.9999975504940561,6/5358
OUD_DLPFC_vs_NAC,GO_CC,symmetric synapse,0.897996939903225,0.9999975504940561,5/5358
OUD_DLPFC_vs_NAC,GO_CC,dendrite terminus,0.897996939903225,0.9999975504940561,5/5358
OUD_DLPFC_vs_NAC,GO_CC,immunological synapse,0.986975462181489,0.9999975504940561,13/5358
OUD_DLPFC_vs_NAC,GO_CC,stress fiber,0.9897611657924023,0.9999975504940561,27/5358
DLPFC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.9556140563323807,0.9999981970777737,1/286
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.9633199558260523,0.9999981970777737,3/286
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,0.9730611198666771,0.9999981970777737,2/286
DLPFC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.9839893657894941,0.9999981970777737,1/286
DLPFC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.9953923840977921,0.9999981970777737,3/286
OUD_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.05557559198130202,0.9999983903329541,42/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_OPIOID_RECEPTOR_PATHWAYS,0.05671776435068515,0.9999983903329541,22/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.05746764526294488,0.9999983903329541,14/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.07918679658769955,0.9999983903329541,20/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENT_ACTIVATION,0.10611024735868417,0.9999983903329541,11/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.12397687959108207,0.9999983903329541,68/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.15121582833226627,0.9999983903329541,16/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.15121582833226627,0.9999983903329541,16/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.19580337357946065,0.9999983903329541,8/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.19580337357946065,0.9999983903329541,8/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_AMINO_ACID_METABOLISM,0.23937377926767747,0.9999983903329541,24/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_GLYCOSPHINGOLIPID_METABOLISM,0.24013067404497548,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.24013067404497548,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_NEUROTRANSMITTER_DISORDERS,0.24013067404497548,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.24941306644985872,0.9999983903329541,34/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,0.2784002635870187,0.9999983903329541,12/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.2944727224238314,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.2944727224238314,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_NANOMATERIAL_INDUCED_APOPTOSIS,0.2944727224238314,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.2944727224238314,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.32183744547713494,0.9999983903329541,11/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.32183744547713494,0.9999983903329541,11/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.3610875255489233,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,0.3610875255489233,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_DOPAMINE_METABOLISM,0.3610875255489233,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_GABA_METABOLISM_AKA_GHB,0.3610875255489233,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.3610875255489233,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_PURINE_METABOLISM,0.3610875255489233,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.36465001538036873,0.9999983903329541,20/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,0.37064926553920846,0.9999983903329541,10/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.39226336327584016,0.9999983903329541,24/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.4110945780183094,0.9999983903329541,42/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_TRYPTOPHAN_METABOLISM,0.4250436691274432,0.9999983903329541,9/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.42685376689759724,0.9999983903329541,23/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.44117261187880596,0.9999983903329541,18/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.48504883403068455,0.9999983903329541,8/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.48504883403068455,0.9999983903329541,8/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_AXON_GUIDANCE,0.4955328143093556,0.9999983903329541,30/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.5150881473599171,0.9999983903329541,25/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.5504217773035813,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.5504217773035813,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.5607419458727756,0.9999983903329541,11/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.5689079035943032,0.9999983903329541,32/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.6147083658495767,0.9999983903329541,10/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_DOPAMINERGIC_NEUROGENESIS,0.6154379148149964,0.9999983903329541,14/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.6205250126969644,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.6205250126969644,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.6205250126969644,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,0.6205250126969644,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CHEMOKINE_SIGNALING,0.6364069988569608,0.9999983903329541,59/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.6582279614776618,0.9999983903329541,17/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.6698184852744987,0.9999983903329541,9/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.6698184852744987,0.9999983903329541,9/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.6941615411743802,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.6941615411743802,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.6941615411743802,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.6941615411743802,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.72506949364365,0.9999983903329541,8/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_APOPTOSIS,0.7445160826367703,0.9999983903329541,30/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_ONECARBON_METABOLISM,0.7515631971583726,0.9999983903329541,11/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_ALANINE_AND_ASPARTATE_METABOLISM,0.769355712429397,0.9999983903329541,4/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_BENZOAPYRENE_METABOLISM,0.769355712429397,0.9999983903329541,4/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.769355712429397,0.9999983903329541,4/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.769355712429397,0.9999983903329541,4/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_GLYOXYLATE_METABOLISM,0.769355712429397,0.9999983903329541,4/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_NEUROINFLAMMATION,0.769355712429397,0.9999983903329541,4/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.7792270787587194,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.7792270787587194,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.7792270787587194,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.7792270787587194,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_OXIDATIVE_PHOSPHORYLATION,0.7945964324389143,0.9999983903329541,10/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.8308347188771134,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.8308347188771134,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.8351488435492638,0.9999983903329541,9/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.8436845037627823,0.9999983903329541,12/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.8533252478237368,0.9999983903329541,15/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.8745011763556936,0.9999983903329541,11/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.8782528623679182,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_ESTROGEN_METABOLISM_WP697,0.8782528623679182,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_GLUTATHIONE_METABOLISM,0.8782528623679182,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.8857868833688348,0.9999983903329541,17/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.9021795206402686,0.9999983903329541,10/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.9055947773605479,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_ESTROGEN_METABOLISM_WP5276,0.9197440549394309,0.9999983903329541,4/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.9197440549394309,0.9999983903329541,4/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_TAMOXIFEN_METABOLISM,0.9197440549394309,0.9999983903329541,4/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.9241950678204134,0.9999983903329541,12/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.9295746899090513,0.9999983903329541,21/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.9295746899090513,0.9999983903329541,21/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_RETINOL_METABOLISM,0.9340499991139009,0.9999983903329541,6/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.9429716638068277,0.9999983903329541,33/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.9469188607856347,0.9999983903329541,8/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_NAD_METABOLISM,0.9536264584540419,0.9999983903329541,3/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.9572831015192601,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.9572831015192601,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.9654960839117153,0.9999983903329541,57/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_FOLATE_METABOLISM,0.977366285965162,0.9999983903329541,19/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.9797622083665702,0.9999983903329541,8/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.9797622083665702,0.9999983903329541,8/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.9871359584419003,0.9999983903329541,7/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.9883508124876071,0.9999983903329541,14/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.9918081778689327,0.9999983903329541,13/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_PYRIMIDINE_METABOLISM,0.9931845201338858,0.9999983903329541,15/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.9947057624773272,0.9999983903329541,78/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.9959161273079884,0.9999983903329541,5/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.9959546271536648,0.9999983903329541,9/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.9960153391880266,0.9999983903329541,16/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_COMPLEMENT_SYSTEM,0.9993801056415275,0.9999983903329541,31/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.9995597512002294,0.9999983903329541,9/2675
OUD_DLPFC_vs_NAC,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.9999930064483654,0.9999983903329541,1/2675
Control_DLPFC_vs_NAC,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.03449868727955618,0.9999988261919683,89/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.06790686522355499,0.9999988261919683,87/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.07785259848527801,0.9999988261919683,70/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.18899169514389028,0.9999988261919683,55/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.2208539480177714,0.9999988261919683,72/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.23635482960262338,0.9999988261919683,71/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.3059829835335519,0.9999988261919683,76/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.3149664433543733,0.9999988261919683,71/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.35031399440443883,0.9999988261919683,78/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.3553447670064092,0.9999988261919683,60/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.37284056422594025,0.9999988261919683,68/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.5101375397249619,0.9999988261919683,70/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.5215089235981936,0.9999988261919683,82/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.5239695366781685,0.9999988261919683,61/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.5347165284700455,0.9999988261919683,73/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.5739106331695041,0.9999988261919683,67/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.5861164351169026,0.9999988261919683,42/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.6135476814930743,0.9999988261919683,49/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.7484181530990124,0.9999988261919683,70/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.7603463453787571,0.9999988261919683,77/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.7648787732589092,0.9999988261919683,50/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.7929046660932608,0.9999988261919683,56/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.8060038917332474,0.9999988261919683,74/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.8098623448523136,0.9999988261919683,55/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.8275763133747162,0.9999988261919683,65/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.8509707831466411,0.9999988261919683,56/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.8550198222549366,0.9999988261919683,63/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.896076731982641,0.9999988261919683,56/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.8962987639449018,0.9999988261919683,42/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.8972164899341223,0.9999988261919683,63/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.9028926564611135,0.9999988261919683,66/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.9291428264536138,0.9999988261919683,70/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.9394324655709723,0.9999988261919683,48/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.9456408833122261,0.9999988261919683,78/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,0.9500634051709481,0.9999988261919683,60/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.9547225616590045,0.9999988261919683,66/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.958826937155434,0.9999988261919683,42/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.9748589394290974,0.9999988261919683,39/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,0.9801878238670925,0.9999988261919683,63/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.9881827693590312,0.9999988261919683,41/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.9904769271414235,0.9999988261919683,52/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.9926839739528805,0.9999988261919683,66/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.996489198907612,0.9999988261919683,41/5771
Control_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.997423627928683,0.9999988261919683,57/5771
Female_OUD_vs_Control,Reactome,Metabolism of amino acids and derivatives,0.9978893199152769,0.9999991978187497,1/206
Female_OUD_vs_Control,Reactome,Neuronal System,0.9998579658016324,0.9999991978187497,3/206
Female_OUD_vs_Control,Reactome,Metabolism,0.9999991978187497,0.9999991978187497,17/206
Female_OUD_vs_Control,GO_CC,parallel fiber to Purkinje cell synapse,0.6013440849256868,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,neuronal dense core vesicle,0.6381856700704132,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,cytoplasmic stress granule,0.6553133079143562,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,neuronal cell body membrane,0.6553133079143562,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,dendrite membrane,0.7423758057936531,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,hippocampal mossy fiber to CA3 synapse,0.7772988728228748,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,neuron projection membrane,0.8490372149908012,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,neuron projection cytoplasm,0.8490372149908012,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,axon terminus,0.8660275270592923,0.9999996478554936,2/305
Female_OUD_vs_Control,GO_CC,excitatory synapse,0.8926141302331005,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,neuron projection terminus,0.9052863165146088,0.9999996478554936,2/305
Female_OUD_vs_Control,GO_CC,Schaffer collateral - CA1 synapse,0.919827659125797,0.9999996478554936,1/305
Female_OUD_vs_Control,GO_CC,distal axon,0.994861016424347,0.9999996478554936,2/305
Female_OUD_vs_Control,GO_CC,neuron to neuron synapse,0.997901994277508,0.9999996478554936,3/305
Female_OUD_vs_Control,GO_CC,dendrite,0.998583589608119,0.9999996478554936,6/305
Female_OUD_vs_Control,GO_CC,glutamatergic synapse,0.9986103757857331,0.9999996478554936,5/305
Female_OUD_vs_Control,GO_CC,neuronal cell body,0.9989856598478413,0.9999996478554936,4/305
Female_OUD_vs_Control,GO_CC,asymmetric synapse,0.999044166948766,0.9999996478554936,2/305
Female_OUD_vs_Control,GO_CC,presynapse,0.999771880922219,0.9999996478554936,5/305
Female_OUD_vs_Control,GO_CC,postsynapse,0.9998794422043396,0.9999996478554936,6/305
Female_OUD_vs_Control,GO_CC,synapse,0.9999978828240522,0.9999996478554936,16/305
Female_OUD_vs_Control,GO_CC,axon,0.999999283869978,0.9999996478554936,2/305
Female_OUD_vs_Control,GO_CC,neuron projection,0.9999996478554936,0.9999996478554936,10/305
Female_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.95272845096446,0.9999996591539513,4/334
Female_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.9657675425634605,0.9999996591539513,1/334
Female_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.966958757809678,0.9999996591539513,3/334
Female_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.9901438400246848,0.9999996591539513,4/334
Female_OUD_vs_Control,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.9909628263535146,0.9999996591539513,1/334
Female_OUD_vs_Control,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.9997185699670261,0.9999996591539513,1/334
Female_OUD_vs_Control,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.9999844426541251,0.9999996591539513,1/334
Control_DLPFC_vs_NAC,GO_CC,hippocampal mossy fiber to CA3 synapse,0.4270535100422318,0.9999999006138397,26/5212
Control_DLPFC_vs_NAC,GO_CC,neuron spine,0.43128967230212834,0.9999999006138397,73/5212
Control_DLPFC_vs_NAC,GO_CC,Schaffer collateral - CA1 synapse,0.43391680622284606,0.9999999006138397,43/5212
Control_DLPFC_vs_NAC,GO_CC,paranode region of axon,0.4553601229379658,0.9999999006138397,8/5212
Control_DLPFC_vs_NAC,GO_CC,neuron projection terminus,0.46834290028825876,0.9999999006138397,67/5212
Control_DLPFC_vs_NAC,GO_CC,neuron projection cytoplasm,0.5079555444095756,0.9999999006138397,32/5212
Control_DLPFC_vs_NAC,GO_CC,astrocyte projection,0.5219088195084294,0.9999999006138397,7/5212
Control_DLPFC_vs_NAC,GO_CC,dendrite cytoplasm,0.5249922378524257,0.9999999006138397,11/5212
Control_DLPFC_vs_NAC,GO_CC,ribbon synapse,0.5941204189948971,0.9999999006138397,6/5212
Control_DLPFC_vs_NAC,GO_CC,axon cytoplasm,0.6475986735016341,0.9999999006138397,20/5212
Control_DLPFC_vs_NAC,GO_CC,NMDA selective glutamate receptor complex,0.6708748371491601,0.9999999006138397,5/5212
Control_DLPFC_vs_NAC,GO_CC,dynein axonemal particle,0.6968375583247496,0.9999999006138397,8/5212
Control_DLPFC_vs_NAC,GO_CC,perineuronal net,0.7501887184279988,0.9999999006138397,4/5212
Control_DLPFC_vs_NAC,GO_CC,glycinergic synapse,0.7501887184279988,0.9999999006138397,4/5212
Control_DLPFC_vs_NAC,GO_CC,neuronal dense core vesicle,0.7922676446575626,0.9999999006138397,16/5212
Control_DLPFC_vs_NAC,GO_CC,cholinergic synapse,0.8107552174542999,0.9999999006138397,6/5212
Control_DLPFC_vs_NAC,GO_CC,juxtaparanode region of axon,0.8627608825348176,0.9999999006138397,5/5212
Control_DLPFC_vs_NAC,GO_CC,dendrite terminus,0.8627608825348176,0.9999999006138397,5/5212
Control_DLPFC_vs_NAC,GO_CC,inhibitory synapse,0.8627608825348176,0.9999999006138397,5/5212
Control_DLPFC_vs_NAC,GO_CC,synapse-associated extracellular matrix,0.8627608825348176,0.9999999006138397,5/5212
Control_DLPFC_vs_NAC,GO_CC,stress fiber,0.8820044112554847,0.9999999006138397,29/5212
Control_DLPFC_vs_NAC,GO_CC,excitatory synapse,0.9067830157453303,0.9999999006138397,34/5212
Control_DLPFC_vs_NAC,GO_CC,axonal growth cone,0.9251507891542241,0.9999999006138397,14/5212
Control_DLPFC_vs_NAC,GO_CC,immunological synapse,0.9733068516507946,0.9999999006138397,13/5212
Control_DLPFC_vs_NAC,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.9910109001712955,0.9999999006138397,4/5212
Control_DLPFC_vs_NAC,GO_CC,symmetric synapse,0.995991149609081,0.9999999006138397,3/5212
OUD_DLPFC_vs_NAC,Reactome,Axon guidance,0.0020856737228266953,0.9999999296440789,209/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism,0.0031637666277268108,0.9999999296440789,642/3111
OUD_DLPFC_vs_NAC,Reactome,PI Metabolism,0.013906140980165226,0.9999999296440789,32/3111
OUD_DLPFC_vs_NAC,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,0.021777527816476808,0.9999999296440789,98/3111
OUD_DLPFC_vs_NAC,Reactome,Neurotransmitter release cycle,0.0228598859545489,0.9999999296440789,29/3111
OUD_DLPFC_vs_NAC,Reactome,Integration of energy metabolism,0.025591856256627517,0.9999999296440789,51/3111
OUD_DLPFC_vs_NAC,Reactome,Bile acid and bile salt metabolism,0.03136086683942039,0.9999999296440789,18/3111
OUD_DLPFC_vs_NAC,Reactome,Protein-protein interactions at synapses,0.03756248298516027,0.9999999296440789,41/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of amino acids and derivatives,0.04562359532094756,0.9999999296440789,96/3111
OUD_DLPFC_vs_NAC,Reactome,Dopamine Neurotransmitter Release Cycle,0.046115666504223586,0.9999999296440789,16/3111
OUD_DLPFC_vs_NAC,Reactome,Serotonin Neurotransmitter Release Cycle,0.055916735160482955,0.9999999296440789,15/3111
OUD_DLPFC_vs_NAC,Reactome,Acetylcholine Neurotransmitter Release Cycle,0.06779701018004956,0.9999999296440789,14/3111
OUD_DLPFC_vs_NAC,Reactome,"Sensory perception of sweet, bitter, and umami (glutamate) taste",0.06779701018004956,0.9999999296440789,14/3111
OUD_DLPFC_vs_NAC,Reactome,Opioid Signalling,0.0789119068752925,0.9999999296440789,48/3111
OUD_DLPFC_vs_NAC,Reactome,Norepinephrine Neurotransmitter Release Cycle,0.08219676250363654,0.9999999296440789,13/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of proteins,0.08581791152751003,0.9999999296440789,484/3111
OUD_DLPFC_vs_NAC,Reactome,Sphingolipid metabolism,0.09152444299184802,0.9999999296440789,34/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of steroids,0.10807866552198768,0.9999999296440789,51/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of amine-derived hormones,0.12080068946454313,0.9999999296440789,11/3111
OUD_DLPFC_vs_NAC,Reactome,Sialic acid metabolism,0.12080068946454313,0.9999999296440789,11/3111
OUD_DLPFC_vs_NAC,Reactome,Drug ADME,0.14758406403873495,0.9999999296440789,36/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,0.1523045886607859,0.9999999296440789,97/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of lipids,0.16738088238877874,0.9999999296440789,230/3111
OUD_DLPFC_vs_NAC,Reactome,Glycosphingolipid metabolism,0.17548037126214142,0.9999999296440789,16/3111
OUD_DLPFC_vs_NAC,Reactome,Glutamate Neurotransmitter Release Cycle,0.17548037126214142,0.9999999296440789,16/3111
OUD_DLPFC_vs_NAC,Reactome,Triglyceride metabolism,0.17548037126214142,0.9999999296440789,16/3111
OUD_DLPFC_vs_NAC,Reactome,Hyaluronan metabolism,0.17749495927891012,0.9999999296440789,9/3111
OUD_DLPFC_vs_NAC,Reactome,Selenoamino acid metabolism,0.2339287146420197,0.9999999296440789,20/3111
OUD_DLPFC_vs_NAC,Reactome,Phospholipid metabolism,0.25487007443195314,0.9999999296440789,73/3111
OUD_DLPFC_vs_NAC,Reactome,Glycosaminoglycan metabolism,0.26062664370553784,0.9999999296440789,57/3111
OUD_DLPFC_vs_NAC,Reactome,Class C/3 (Metabotropic glutamate/pheromone receptors),0.2607381984046142,0.9999999296440789,7/3111
OUD_DLPFC_vs_NAC,Reactome,Glutamate and glutamine metabolism,0.2607381984046142,0.9999999296440789,7/3111
OUD_DLPFC_vs_NAC,Reactome,Regulation of commissural axon pathfinding by SLIT and ROBO,0.31599286331612364,0.9999999296440789,6/3111
OUD_DLPFC_vs_NAC,Reactome,Regulation of Complement cascade,0.33014440574847764,0.9999999296440789,17/3111
OUD_DLPFC_vs_NAC,Reactome,Oxidative Stress Induced Senescence,0.3310379495249858,0.9999999296440789,38/3111
OUD_DLPFC_vs_NAC,Reactome,Heparan sulfate/heparin (HS-GAG) metabolism,0.34868698547629445,0.9999999296440789,27/3111
OUD_DLPFC_vs_NAC,Reactome,"Cell death signalling via NRAGE, NRIF and NADE",0.34868698547629445,0.9999999296440789,27/3111
OUD_DLPFC_vs_NAC,Reactome,Surfactant metabolism,0.3534657747078542,0.9999999296440789,11/3111
OUD_DLPFC_vs_NAC,Reactome,Intrinsic Pathway for Apoptosis,0.37523090886720895,0.9999999296440789,21/3111
OUD_DLPFC_vs_NAC,Reactome,p75NTR regulates axonogenesis,0.3829353308183804,0.9999999296440789,5/3111
OUD_DLPFC_vs_NAC,Reactome,"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.3829353308183804,0.9999999296440789,5/3111
OUD_DLPFC_vs_NAC,Reactome,Vitamin D (calciferol) metabolism,0.3829353308183804,0.9999999296440789,5/3111
OUD_DLPFC_vs_NAC,Reactome,Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF),0.3829353308183804,0.9999999296440789,5/3111
OUD_DLPFC_vs_NAC,Reactome,Initial triggering of complement,0.4027598608106784,0.9999999296440789,10/3111
OUD_DLPFC_vs_NAC,Reactome,Negative regulation of NMDA receptor-mediated neuronal transmission,0.4027598608106784,0.9999999296440789,10/3111
OUD_DLPFC_vs_NAC,Reactome,Keratan sulfate/keratin metabolism,0.4088257180711191,0.9999999296440789,15/3111
OUD_DLPFC_vs_NAC,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.4107954825202452,0.9999999296440789,20/3111
OUD_DLPFC_vs_NAC,Reactome,Inositol phosphate metabolism,0.44826240779846016,0.9999999296440789,19/3111
OUD_DLPFC_vs_NAC,Reactome,Complement cascade,0.44826240779846016,0.9999999296440789,19/3111
OUD_DLPFC_vs_NAC,Reactome,Cellular response to heat stress,0.44826240779846016,0.9999999296440789,19/3111
OUD_DLPFC_vs_NAC,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.4986659773761275,0.9999999296440789,13/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of fat-soluble vitamins,0.5147288081956882,0.9999999296440789,22/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of folate and pterines,0.5162397703809757,0.9999999296440789,8/3111
OUD_DLPFC_vs_NAC,Reactome,Aspartate and asparagine metabolism,0.5162397703809757,0.9999999296440789,8/3111
OUD_DLPFC_vs_NAC,Reactome,Regulation of pyruvate metabolism,0.5162397703809757,0.9999999296440789,8/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of nucleotides,0.5258194516707494,0.9999999296440789,31/3111
OUD_DLPFC_vs_NAC,Reactome,Nicotinate metabolism,0.5471986386025882,0.9999999296440789,12/3111
OUD_DLPFC_vs_NAC,Reactome,Glucose metabolism,0.5513538949738079,0.9999999296440789,21/3111
OUD_DLPFC_vs_NAC,Reactome,Activation of kainate receptors upon glutamate binding,0.5700712883203787,0.9999999296440789,16/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of water-soluble vitamins and cofactors,0.5733036513287858,0.9999999296440789,34/3111
OUD_DLPFC_vs_NAC,Reactome,Sema3A PAK dependent Axon repulsion,0.5799726858718274,0.9999999296440789,7/3111
OUD_DLPFC_vs_NAC,Reactome,Na+/Cl- dependent neurotransmitter transporters,0.5799726858718274,0.9999999296440789,7/3111
OUD_DLPFC_vs_NAC,Reactome,Pyruvate metabolism,0.5975876182077575,0.9999999296440789,11/3111
OUD_DLPFC_vs_NAC,Reactome,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.6128163197591371,0.9999999296440789,15/3111
OUD_DLPFC_vs_NAC,Reactome,Retinoid metabolism and transport,0.6262303028699772,0.9999999296440789,19/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of porphyrins,0.6475208527851796,0.9999999296440789,6/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of polyamines,0.6475208527851796,0.9999999296440789,6/3111
OUD_DLPFC_vs_NAC,Reactome,Serine metabolism,0.6475208527851796,0.9999999296440789,6/3111
OUD_DLPFC_vs_NAC,Reactome,"Unblocking of NMDA receptors, glutamate binding and activation",0.6492302913247956,0.9999999296440789,10/3111
OUD_DLPFC_vs_NAC,Reactome,Peptide hormone metabolism,0.6594102694489641,0.9999999296440789,31/3111
OUD_DLPFC_vs_NAC,Reactome,Adaptive Immune System,0.679041127896951,0.9999999296440789,219/3111
OUD_DLPFC_vs_NAC,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.6799166945172578,0.9999999296440789,26/3111
OUD_DLPFC_vs_NAC,Reactome,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.7013529871395152,0.9999999296440789,9/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of non-coding RNA,0.7176476683296644,0.9999999296440789,5/3111
OUD_DLPFC_vs_NAC,Reactome,Glyoxylate metabolism and glycine degradation,0.7176476683296644,0.9999999296440789,5/3111
OUD_DLPFC_vs_NAC,Reactome,RUNX3 Regulates Immune Response and Cell Migration,0.7176476683296644,0.9999999296440789,5/3111
OUD_DLPFC_vs_NAC,Reactome,Diseases associated with glycosaminoglycan metabolism,0.7377002036106137,0.9999999296440789,16/3111
OUD_DLPFC_vs_NAC,Reactome,Diseases of programmed cell death,0.7458566834259445,0.9999999296440789,32/3111
OUD_DLPFC_vs_NAC,Reactome,Sulfur amino acid metabolism,0.753000771332099,0.9999999296440789,8/3111
OUD_DLPFC_vs_NAC,Reactome,Regulation of lipid metabolism by PPARalpha,0.7685661014576697,0.9999999296440789,27/3111
OUD_DLPFC_vs_NAC,Reactome,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.7884252691487544,0.9999999296440789,4/3111
OUD_DLPFC_vs_NAC,Reactome,Linoleic acid (LA) metabolism,0.7884252691487544,0.9999999296440789,4/3111
OUD_DLPFC_vs_NAC,Reactome,alpha-linolenic acid (ALA) metabolism,0.7884252691487544,0.9999999296440789,4/3111
OUD_DLPFC_vs_NAC,Reactome,FOXO-mediated transcription of cell death genes,0.7884252691487544,0.9999999296440789,4/3111
OUD_DLPFC_vs_NAC,Reactome,Cellular responses to stress,0.7945496541503791,0.9999999296440789,176/3111
OUD_DLPFC_vs_NAC,Reactome,Arachidonate metabolism,0.8214695363115971,0.9999999296440789,21/3111
OUD_DLPFC_vs_NAC,Reactome,Cellular response to chemical stress,0.8337037058870125,0.9999999296440789,40/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of vitamins and cofactors,0.8386211919703064,0.9999999296440789,60/3111
OUD_DLPFC_vs_NAC,Reactome,Fatty acid metabolism,0.850046252175666,0.9999999296440789,47/3111
OUD_DLPFC_vs_NAC,Reactome,Peroxisomal lipid metabolism,0.8501653535252363,0.9999999296440789,6/3111
OUD_DLPFC_vs_NAC,Reactome,Glycogen metabolism,0.8501653535252363,0.9999999296440789,6/3111
OUD_DLPFC_vs_NAC,Reactome,Diseases of the neuronal system,0.8501653535252363,0.9999999296440789,6/3111
OUD_DLPFC_vs_NAC,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,0.8688409521959146,0.9999999296440789,19/3111
OUD_DLPFC_vs_NAC,Reactome,Activation of ATR in response to replication stress,0.890728195845655,0.9999999296440789,8/3111
OUD_DLPFC_vs_NAC,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.890728195845655,0.9999999296440789,8/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of nitric oxide: NOS3 activation and regulation,0.8929647071908761,0.9999999296440789,5/3111
OUD_DLPFC_vs_NAC,Reactome,Diseases of metabolism,0.8986909540715007,0.9999999296440789,71/3111
OUD_DLPFC_vs_NAC,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.9160840408184132,0.9999999296440789,20/3111
OUD_DLPFC_vs_NAC,Reactome,MECP2 regulates neuronal receptors and channels,0.9197911671911378,0.9999999296440789,7/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of Angiotensinogen to Angiotensins,0.9299804707869349,0.9999999296440789,4/3111
OUD_DLPFC_vs_NAC,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.9299804707869349,0.9999999296440789,4/3111
OUD_DLPFC_vs_NAC,Reactome,Response of endothelial cells to shear stress,0.9309336195900546,0.9999999296440789,33/3111
OUD_DLPFC_vs_NAC,Reactome,Regulation of necroptotic cell death,0.9395052885383656,0.9999999296440789,9/3111
OUD_DLPFC_vs_NAC,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.9406538478377025,0.9999999296440789,25/3111
OUD_DLPFC_vs_NAC,Reactome,Defective Intrinsic Pathway for Apoptosis,0.9444202803960879,0.9999999296440789,6/3111
OUD_DLPFC_vs_NAC,Reactome,Apoptosis,0.9476682555840932,0.9999999296440789,42/3111
OUD_DLPFC_vs_NAC,Reactome,Vitamin B5 (pantothenate) metabolism,0.9598582739641056,0.9999999296440789,3/3111
OUD_DLPFC_vs_NAC,Reactome,Diseases of Immune System,0.9741077392237871,0.9999999296440789,12/3111
OUD_DLPFC_vs_NAC,Reactome,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.9793348222483469,0.9999999296440789,4/3111
OUD_DLPFC_vs_NAC,Reactome,Programmed Cell Death,0.9882668925295841,0.9999999296440789,50/3111
OUD_DLPFC_vs_NAC,Reactome,IL-6-type cytokine receptor ligand interactions,0.9897360771412762,0.9999999296440789,3/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of steroid hormones,0.9901238671922983,0.9999999296440789,7/3111
OUD_DLPFC_vs_NAC,Reactome,Chemokine receptors bind chemokines,0.9918116024160779,0.9999999296440789,14/3111
OUD_DLPFC_vs_NAC,Reactome,Diseases of carbohydrate metabolism,0.9960306931210275,0.9999999296440789,2/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of cofactors,0.9969216836575088,0.9999999296440789,5/3111
OUD_DLPFC_vs_NAC,Reactome,Metabolism of RNA,0.9972637686174818,0.9999999296440789,52/3111
OUD_DLPFC_vs_NAC,Reactome,Innate Immune System,0.998451294091827,0.9999999296440789,300/3111
OUD_DLPFC_vs_NAC,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.9998495147065258,0.9999999296440789,12/3111
OUD_DLPFC_vs_NAC,Reactome,Immune System,0.9999991458027523,0.9999999296440789,581/3111
OUD_DLPFC_vs_NAC,Reactome,Cytokine Signaling in Immune system,0.9999996408098302,0.9999999296440789,222/3111
OUD_DLPFC_vs_NAC,DO,withdrawal disorder,0.00934617833795117,0.9999999634777519,25/2440
OUD_DLPFC_vs_NAC,DO,cocaine dependence,0.05051301838576272,0.9999999634777519,16/2440
OUD_DLPFC_vs_NAC,DO,drug dependence,0.05678406177016569,0.9999999634777519,39/2440
OUD_DLPFC_vs_NAC,DO,heroin dependence,0.06715067272261133,0.9999999634777519,23/2440
OUD_DLPFC_vs_NAC,DO,alcohol dependence,0.0723200151323022,0.9999999634777519,30/2440
OUD_DLPFC_vs_NAC,DO,substance dependence,0.09611358779765743,0.9999999634777519,60/2440
OUD_DLPFC_vs_NAC,DO,opiate dependence,0.10380706343400957,0.9999999634777519,34/2440
OUD_DLPFC_vs_NAC,DO,substance-related disorder,0.16844257015636804,0.9999999634777519,158/2440
OUD_DLPFC_vs_NAC,DO,complement deficiency,0.22525486011532855,0.9999999634777519,8/2440
OUD_DLPFC_vs_NAC,DO,substance abuse,0.24006318282860895,0.9999999634777519,119/2440
OUD_DLPFC_vs_NAC,DO,metal metabolism disorder,0.27487320702097884,0.9999999634777519,25/2440
OUD_DLPFC_vs_NAC,DO,combined oxidative phosphorylation deficiency,0.32710525127381523,0.9999999634777519,6/2440
OUD_DLPFC_vs_NAC,DO,substance-induced psychosis,0.32710525127381523,0.9999999634777519,6/2440
OUD_DLPFC_vs_NAC,DO,glucose intolerance,0.3941383191939942,0.9999999634777519,5/2440
OUD_DLPFC_vs_NAC,DO,opioid abuse,0.4192665666363099,0.9999999634777519,10/2440
OUD_DLPFC_vs_NAC,DO,morphine dependence,0.4192665666363099,0.9999999634777519,10/2440
OUD_DLPFC_vs_NAC,DO,nicotine dependence,0.4346363327354008,0.9999999634777519,20/2440
OUD_DLPFC_vs_NAC,DO,mitochondrial metabolism disease,0.5056254081538296,0.9999999634777519,23/2440
OUD_DLPFC_vs_NAC,DO,autoimmune disease of skin and connective tissue,0.5948468870698679,0.9999999634777519,7/2440
OUD_DLPFC_vs_NAC,DO,glycogen metabolism disorder,0.6610135780088322,0.9999999634777519,6/2440
OUD_DLPFC_vs_NAC,DO,neuronal ceroid lipofuscinosis,0.6610135780088322,0.9999999634777519,6/2440
OUD_DLPFC_vs_NAC,DO,autoimmune disease of the nervous system,0.7175468892266726,0.9999999634777519,13/2440
OUD_DLPFC_vs_NAC,DO,autoimmune disease of peripheral nervous system,0.7293036587948853,0.9999999634777519,5/2440
OUD_DLPFC_vs_NAC,DO,autoimmune hepatitis,0.7293036587948853,0.9999999634777519,5/2440
OUD_DLPFC_vs_NAC,DO,autoimmune disease of central nervous system,0.7978226814226532,0.9999999634777519,4/2440
OUD_DLPFC_vs_NAC,DO,plasma protein metabolism disease,0.7978226814226532,0.9999999634777519,4/2440
OUD_DLPFC_vs_NAC,DO,autoimmune thyroiditis,0.7978226814226532,0.9999999634777519,4/2440
OUD_DLPFC_vs_NAC,DO,lipid metabolism disorder,0.8240202522928335,0.9999999634777519,42/2440
OUD_DLPFC_vs_NAC,DO,motor neuron disease,0.8271576426934346,0.9999999634777519,46/2440
OUD_DLPFC_vs_NAC,DO,calcium metabolism disease,0.8994224400489093,0.9999999634777519,8/2440
OUD_DLPFC_vs_NAC,DO,post-traumatic stress disorder,0.9000288607600165,0.9999999634777519,5/2440
OUD_DLPFC_vs_NAC,DO,mineral metabolism disease,0.9048266969782951,0.9999999634777519,11/2440
OUD_DLPFC_vs_NAC,DO,adult respiratory distress syndrome,0.9195241790389631,0.9999999634777519,17/2440
OUD_DLPFC_vs_NAC,DO,newborn respiratory distress syndrome,0.9348607266781899,0.9999999634777519,4/2440
OUD_DLPFC_vs_NAC,DO,autoimmune disease of endocrine system,0.9483543160836982,0.9999999634777519,15/2440
OUD_DLPFC_vs_NAC,DO,disease of metabolism,0.9496175137926643,0.9999999634777519,527/2440
OUD_DLPFC_vs_NAC,DO,glucose metabolism disease,0.9677090817428604,0.9999999634777519,251/2440
OUD_DLPFC_vs_NAC,DO,autoimmune disease of gastrointestinal tract,0.9738289859506666,0.9999999634777519,7/2440
OUD_DLPFC_vs_NAC,DO,autoimmune disease of blood,0.9794597070671716,0.9999999634777519,9/2440
OUD_DLPFC_vs_NAC,DO,autoimmune thrombocytopenic purpura,0.9794597070671716,0.9999999634777519,9/2440
OUD_DLPFC_vs_NAC,DO,autoimmune disease,0.9813741429828109,0.9999999634777519,105/2440
OUD_DLPFC_vs_NAC,DO,"autoimmune disease of eyes, ear, nose and throat",0.9904082355878455,0.9999999634777519,5/2440
OUD_DLPFC_vs_NAC,DO,autosomal dominant distal hereditary motor neuronopathy,0.9907556043901322,0.9999999634777519,3/2440
OUD_DLPFC_vs_NAC,DO,immune system disease,0.9999868575523416,0.9999999634777519,186/2440
OUD_DLPFC_vs_NAC,DO,bone inflammation disease,0.9999997150363247,0.9999999634777519,78/2440
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.778253916365375,0.9999999714102767,11/581
NAC_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.7909925011207124,0.9999999714102767,2/581
NAC_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.8032362384182343,0.9999999714102767,2/581
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.8295571325700773,0.9999999714102767,1/581
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.8373824757641403,0.9999999714102767,6/581
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_STOMACH_ENS_NEURONS,0.8724220443779258,0.9999999714102767,2/581
NAC_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.8781598946544913,0.9999999714102767,6/581
NAC_OUD_vs_Control,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.9324975379581427,0.9999999714102767,3/581
NAC_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.979594157366713,0.9999999714102767,6/581
NAC_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.9815283125408923,0.9999999714102767,2/581
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.9831447603688621,0.9999999714102767,4/581
NAC_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.992079255769271,0.9999999714102767,1/581
NAC_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.9979798163321073,0.9999999714102767,5/581
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.8116487728805176,0.9999999883117905,1/435
Pooled_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.8693945638882498,0.9999999883117905,2/435
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.8725186328729517,0.9999999883117905,7/435
Pooled_OUD_vs_Control,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.8765212446125501,0.9999999883117905,6/435
Pooled_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.8968467726983328,0.9999999883117905,2/435
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,0.9494941422767005,0.9999999883117905,1/435
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.9768395334351814,0.9999999883117905,1/435
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.9916553816732734,0.9999999883117905,4/435
Pooled_OUD_vs_Control,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.9916621895034008,0.9999999883117905,1/435
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.992578547955159,0.9999999883117905,2/435
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,0.9979467163888751,0.9999999883117905,2/435
Pooled_OUD_vs_Control,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.9982604513983269,0.9999999883117905,1/435
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.9983631757471728,0.9999999883117905,3/435
Pooled_OUD_vs_Control,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.9999351464391502,0.9999999883117905,3/435
Pooled_OUD_vs_Control,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.999976236098487,0.9999999883117905,2/435
OUD_DLPFC_vs_NAC,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.42077307391010677,0.9999999980582318,60/1389
OUD_DLPFC_vs_NAC,Hallmark,HALLMARK_COMPLEMENT,0.6901415058739607,0.9999999980582318,68/1389
OUD_DLPFC_vs_NAC,Hallmark,HALLMARK_APOPTOSIS,0.9489847028821967,0.9999999980582318,56/1389
Pooled_OUD_vs_Control,GO_CC,cholinergic synapse,0.39791476213886257,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,axonal growth cone,0.7190585081974596,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,neuronal dense core vesicle,0.7363666665223523,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,cytoplasmic stress granule,0.7526110299230394,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,neuronal cell body membrane,0.7526110299230394,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,neuron spine,0.8053001937658207,0.9999999992076681,4/397
Pooled_OUD_vs_Control,GO_CC,dendrite membrane,0.8311242116632515,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,axon terminus,0.8349538072259108,0.9999999992076681,3/397
Pooled_OUD_vs_Control,GO_CC,hippocampal mossy fiber to CA3 synapse,0.8604913743639466,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,neuron projection terminus,0.887698569086486,0.9999999992076681,3/397
Pooled_OUD_vs_Control,GO_CC,neuron projection membrane,0.9162158110968969,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,neuron projection cytoplasm,0.9162158110968969,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,excitatory synapse,0.9463994433722464,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,distal axon,0.9863492946675978,0.9999999992076681,4/397
Pooled_OUD_vs_Control,GO_CC,neuron to neuron synapse,0.9973349786851111,0.9999999992076681,5/397
Pooled_OUD_vs_Control,GO_CC,neuronal cell body,0.9978863674872671,0.9999999992076681,7/397
Pooled_OUD_vs_Control,GO_CC,axoneme,0.9986153724038571,0.9999999992076681,1/397
Pooled_OUD_vs_Control,GO_CC,postsynapse,0.999435365524181,0.9999999992076681,11/397
Pooled_OUD_vs_Control,GO_CC,asymmetric synapse,0.9995330024537856,0.9999999992076681,3/397
Pooled_OUD_vs_Control,GO_CC,dendrite,0.9998692475645596,0.9999999992076681,7/397
Pooled_OUD_vs_Control,GO_CC,presynapse,0.999933984971848,0.9999999992076681,7/397
Pooled_OUD_vs_Control,GO_CC,glutamatergic synapse,0.9999918902106586,0.9999999992076681,4/397
Pooled_OUD_vs_Control,GO_CC,axon,0.9999971548474202,0.9999999992076681,5/397
Pooled_OUD_vs_Control,GO_CC,neuron projection,0.9999999982350655,0.9999999992076681,12/397
Pooled_OUD_vs_Control,GO_CC,synapse,0.9999999992076681,0.9999999992076681,17/397
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.03234781928327178,0.9999999994780191,85/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.06312948291423803,0.9999999994780191,90/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.09425798934751634,0.9999999994780191,79/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.11636667761561094,0.9999999994780191,88/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.14313386956316962,0.9999999994780191,50/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.16034950588581537,0.9999999994780191,72/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.19265949398980328,0.9999999994780191,75/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.20572650821916855,0.9999999994780191,74/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.22416683799565143,0.9999999994780191,56/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.3152737185136076,0.9999999994780191,51/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.40551661279135626,0.9999999994780191,52/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.41361279965140474,0.9999999994780191,72/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.45215244137205146,0.9999999994780191,70/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.4905724224767841,0.9999999994780191,73/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.511995869600483,0.9999999994780191,67/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.5461869965447435,0.9999999994780191,75/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.6593623213527299,0.9999999994780191,83/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.6708636084315365,0.9999999994780191,50/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.6993645888830917,0.9999999994780191,76/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.733901883182427,0.9999999994780191,47/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.7407261167775083,0.9999999994780191,60/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.8307629639919683,0.9999999994780191,76/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.8350927221638222,0.9999999994780191,67/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.8409558002975432,0.9999999994780191,58/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.8442182514527452,0.9999999994780191,41/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.8577533119372023,0.9999999994780191,78/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.8598932317132587,0.9999999994780191,65/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.8752346312287762,0.9999999994780191,43/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.876170941590183,0.9999999994780191,72/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.8806333105227333,0.9999999994780191,59/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.9008053259694409,0.9999999994780191,82/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.9036666500072807,0.9999999994780191,65/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.9202961206535154,0.9999999994780191,55/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.9493419139549841,0.9999999994780191,55/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.9493419139549841,0.9999999994780191,55/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.9616512282693722,0.9999999994780191,49/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.9664226947660914,0.9999999994780191,71/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,0.9919365544094485,0.9999999994780191,64/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.9949779472809758,0.9999999994780191,61/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.9966994504941908,0.9999999994780191,45/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.9988463279341886,0.9999999994780191,63/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,0.9994490365276347,0.9999999994780191,56/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.9999629961165108,0.9999999994780191,48/5936
OUD_DLPFC_vs_NAC,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.9999828213985469,0.9999999994780191,54/5936
OUD_DLPFC_vs_NAC,GO_BP,central nervous system neuron development,0.014128365706599219,0.9999999999999711,49/5050
OUD_DLPFC_vs_NAC,GO_BP,neuronal action potential,0.015493754012013172,0.9999999999999711,22/5050
OUD_DLPFC_vs_NAC,GO_BP,dendrite development,0.016006209004340227,0.9999999999999711,103/5050
OUD_DLPFC_vs_NAC,GO_BP,axon development,0.01682789858231907,0.9999999999999711,245/5050
OUD_DLPFC_vs_NAC,GO_BP,dendrite morphogenesis,0.01766782521515469,0.9999999999999711,62/5050
OUD_DLPFC_vs_NAC,GO_BP,central nervous system neuron axonogenesis,0.018731760666740947,0.9999999999999711,21/5050
OUD_DLPFC_vs_NAC,GO_BP,synapse assembly,0.021168934934221915,0.9999999999999711,131/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter transport,0.022236325637656488,0.9999999999999711,53/5050
OUD_DLPFC_vs_NAC,GO_BP,axonogenesis,0.023788320666455993,0.9999999999999711,217/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of dendrite morphogenesis,0.02898334890425896,0.9999999999999711,28/5050
OUD_DLPFC_vs_NAC,GO_BP,vesicle-mediated transport in synapse,0.029446509633462736,0.9999999999999711,127/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of synapse assembly,0.03241477162889095,0.9999999999999711,83/5050
OUD_DLPFC_vs_NAC,GO_BP,central nervous system projection neuron axonogenesis,0.040005267256176764,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neuron differentiation,0.04091426574022871,0.9999999999999711,99/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.04487688426245672,0.9999999999999711,54/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neuronal synaptic plasticity,0.04510153998727298,0.9999999999999711,33/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of synapse assembly,0.05299986880701914,0.9999999999999711,39/5050
OUD_DLPFC_vs_NAC,GO_BP,axonal fasciculation,0.0584516830312896,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron projection fasciculation,0.0584516830312896,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron recognition,0.059504627714207274,0.9999999999999711,31/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor localization to postsynaptic specialization membrane,0.07065039607058377,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron projection arborization,0.07065039607058377,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron migration,0.08137652136931348,0.9999999999999711,73/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of dendrite development,0.08247708457462019,0.9999999999999711,42/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of dendrite morphogenesis,0.085392021297938,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of synapse structure or activity,0.0904641043053662,0.9999999999999711,140/5050
OUD_DLPFC_vs_NAC,GO_BP,postsynapse organization,0.1000312837588243,0.9999999999999711,105/5050
OUD_DLPFC_vs_NAC,GO_BP,glutamate secretion,0.10092434310722571,0.9999999999999711,20/5050
OUD_DLPFC_vs_NAC,GO_BP,central nervous system neuron differentiation,0.10258078420319142,0.9999999999999711,99/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of neurotransmitter secretion,0.10320603765048522,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,neutrophil activation involved in immune response,0.10320603765048522,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of sensory perception of pain,0.10320603765048522,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of synapse organization,0.1086852366714203,0.9999999999999711,137/5050
OUD_DLPFC_vs_NAC,GO_BP,forebrain neuron development,0.11726156879605203,0.9999999999999711,19/5050
OUD_DLPFC_vs_NAC,GO_BP,response to morphine,0.12473204391574828,0.9999999999999711,11/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of short-term neuronal synaptic plasticity,0.12473204391574828,0.9999999999999711,11/5050
OUD_DLPFC_vs_NAC,GO_BP,calcium ion-regulated exocytosis of neurotransmitter,0.12473204391574828,0.9999999999999711,11/5050
OUD_DLPFC_vs_NAC,GO_BP,interneuron migration,0.12473204391574828,0.9999999999999711,11/5050
OUD_DLPFC_vs_NAC,GO_BP,response to oxidative stress,0.13071778302269074,0.9999999999999711,123/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of dopamine secretion,0.13601739867344959,0.9999999999999711,18/5050
OUD_DLPFC_vs_NAC,GO_BP,axonal transport,0.1496259548171738,0.9999999999999711,24/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron projection guidance,0.1505259733752415,0.9999999999999711,126/5050
OUD_DLPFC_vs_NAC,GO_BP,peripheral nervous system axon ensheathment,0.15074263481960765,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,sperm axoneme assembly,0.157489506254551,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,axon guidance,0.15926526974163535,0.9999999999999711,125/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of neuron differentiation,0.1686955258000008,0.9999999999999711,47/5050
OUD_DLPFC_vs_NAC,GO_BP,"synaptic transmission, dopaminergic",0.18199456206470066,0.9999999999999711,16/5050
OUD_DLPFC_vs_NAC,GO_BP,adenylate cyclase-activating dopamine receptor signaling pathway,0.1821710238684883,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,cerebral cortex GABAergic interneuron differentiation,0.1821710238684883,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of dopamine metabolic process,0.1821710238684883,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,peripheral nervous system neuron differentiation,0.1821710238684883,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of neuron apoptotic process,0.1933147615089316,0.9999999999999711,28/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neuron projection development,0.19348226800960358,0.9999999999999711,179/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of neuron apoptotic process,0.19628579257039191,0.9999999999999711,62/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron apoptotic process,0.2025257575091196,0.9999999999999711,110/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neuron apoptotic process,0.2030281321300464,0.9999999999999711,94/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron projection extension,0.209356137890869,0.9999999999999711,72/5050
OUD_DLPFC_vs_NAC,GO_BP,retinal ganglion cell axon guidance,0.20986324776810839,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,L-glutamate import,0.21592524736522822,0.9999999999999711,21/5050
OUD_DLPFC_vs_NAC,GO_BP,protein localization to postsynapse,0.21592524736522822,0.9999999999999711,21/5050
OUD_DLPFC_vs_NAC,GO_BP,stress granule assembly,0.22014439675341116,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,peripheral nervous system neuron development,0.22014439675341116,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of synapse assembly,0.22014439675341116,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of axon guidance,0.22014439675341116,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,receptor localization to synapse,0.2323511944249962,0.9999999999999711,32/5050
OUD_DLPFC_vs_NAC,GO_BP,execution phase of apoptosis,0.23865110927866154,0.9999999999999711,26/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of neurotransmitter transport,0.24143237862070202,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,sensory perception of pain,0.2561865993287364,0.9999999999999711,42/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to oxidative stress,0.2624367149262585,0.9999999999999711,79/5050
OUD_DLPFC_vs_NAC,GO_BP,cortisol metabolic process,0.26602418279105455,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,dopamine biosynthetic process,0.26602418279105455,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,neuronal ion channel clustering,0.26602418279105455,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,"glutamate secretion, neurotransmission",0.26602418279105455,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,neuronal dense core vesicle exocytosis,0.26602418279105455,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,dendrite arborization,0.26602418279105455,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,response to L-glutamate,0.26602418279105455,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,ensheathment of neurons,0.2700899589921472,0.9999999999999711,68/5050
OUD_DLPFC_vs_NAC,GO_BP,axon ensheathment,0.2700899589921472,0.9999999999999711,68/5050
OUD_DLPFC_vs_NAC,GO_BP,G protein-coupled dopamine receptor signaling pathway,0.2724652128399016,0.9999999999999711,19/5050
OUD_DLPFC_vs_NAC,GO_BP,anterograde axonal transport,0.2724652128399016,0.9999999999999711,19/5050
OUD_DLPFC_vs_NAC,GO_BP,dopamine secretion,0.2724652128399016,0.9999999999999711,19/5050
OUD_DLPFC_vs_NAC,GO_BP,"complement activation, classical pathway",0.2770331492535439,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of glutamate secretion,0.2770331492535439,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.2770331492535439,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of dendrite extension,0.2770331492535439,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,"synaptic transmission, glutamatergic",0.2776617126502705,0.9999999999999711,57/5050
OUD_DLPFC_vs_NAC,GO_BP,response to endoplasmic reticulum stress,0.2826505947720937,0.9999999999999711,62/5050
OUD_DLPFC_vs_NAC,GO_BP,postsynaptic neurotransmitter receptor internalization,0.30481986757002805,0.9999999999999711,18/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of response to endoplasmic reticulum stress,0.30481986757002805,0.9999999999999711,18/5050
OUD_DLPFC_vs_NAC,GO_BP,multicellular organismal response to stress,0.3112271808696179,0.9999999999999711,50/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of neuron differentiation,0.3147878141223971,0.9999999999999711,34/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of immune response to tumor cell,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,hydrogen peroxide-mediated programmed cell death,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,axonal transport of mitochondrion,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,interneuron migration from the subpallium to the cortex,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,substrate-independent telencephalic tangential interneuron migration,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,cerebral cortex GABAergic interneuron development,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,cortisol biosynthetic process,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of dopamine receptor signaling pathway,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,motor neuron apoptotic process,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,programmed cell death in response to reactive oxygen species,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,protein localization to axon,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,midbrain dopaminergic neuron differentiation,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of chemokine (C-X-C motif) ligand 2 production,0.32145467765889724,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,oxidative phosphorylation,0.3214931289065597,0.9999999999999711,23/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor internalization,0.3214931289065597,0.9999999999999711,23/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of axonogenesis,0.32246220190980146,0.9999999999999711,65/5050
OUD_DLPFC_vs_NAC,GO_BP,cerebral cortex neuron differentiation,0.3400024206939128,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of postsynapse assembly,0.3400024206939128,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,dendrite self-avoidance,0.36151811283364055,0.9999999999999711,11/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of dendrite extension,0.36151811283364055,0.9999999999999711,11/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to dopamine,0.3616245315069484,0.9999999999999711,27/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of axonogenesis,0.3673882066471665,0.9999999999999711,32/5050
OUD_DLPFC_vs_NAC,GO_BP,motor neuron axon guidance,0.37803500854589744,0.9999999999999711,16/5050
OUD_DLPFC_vs_NAC,GO_BP,dendrite extension,0.37803500854589744,0.9999999999999711,16/5050
OUD_DLPFC_vs_NAC,GO_BP,ventral spinal cord interneuron specification,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,branchiomotor neuron axon guidance,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,cerebral cortex GABAergic interneuron migration,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,forebrain neuron fate commitment,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,olfactory bulb interneuron development,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,"regulation of synaptic transmission, dopaminergic",0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of translation in response to stress,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,autophagic cell death,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,"negative regulation of synaptic transmission, glutamatergic",0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,spontaneous neurotransmitter secretion,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,sympathetic neuron projection extension,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of hydrogen peroxide-mediated programmed cell death,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,"regulation of glutamate secretion, neurotransmission",0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,axonemal central apparatus assembly,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of cortisol biosynthetic process,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of motor neuron apoptotic process,0.38842174727624135,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,presynapse organization,0.3921743368803432,0.9999999999999711,26/5050
OUD_DLPFC_vs_NAC,GO_BP,forebrain generation of neurons,0.3990979123335944,0.9999999999999711,41/5050
OUD_DLPFC_vs_NAC,GO_BP,retrograde axonal transport,0.4108485438582017,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,axon extension involved in axon guidance,0.4108485438582017,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,detection of mechanical stimulus involved in sensory perception of pain,0.4108485438582017,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron projection extension involved in neuron projection guidance,0.4108485438582017,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of receptor localization to synapse,0.4108485438582017,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.4108485438582017,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,axon ensheathment in central nervous system,0.4188783905436678,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,inhibitory synapse assembly,0.4188783905436678,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,protein localization to synapse,0.4248598401215934,0.9999999999999711,35/5050
OUD_DLPFC_vs_NAC,GO_BP,L-glutamate transmembrane transport,0.46241629458885525,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of cellular response to oxidative stress,0.4650265253084144,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of response to endoplasmic reticulum stress,0.4650265253084144,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,forebrain neuron differentiation,0.477479454875988,0.9999999999999711,38/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of postsynapse organization,0.48270118104042103,0.9999999999999711,62/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of neuron projection development,0.4863410824540627,0.9999999999999711,57/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron fate commitment,0.4863708654330944,0.9999999999999711,28/5050
OUD_DLPFC_vs_NAC,GO_BP,dopamine transport,0.49197404924608923,0.9999999999999711,23/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter uptake,0.49894779595078875,0.9999999999999711,18/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter receptor activity,0.49894779595078875,0.9999999999999711,18/5050
OUD_DLPFC_vs_NAC,GO_BP,"regulation of synaptic transmission, glutamatergic",0.504808298397444,0.9999999999999711,37/5050
OUD_DLPFC_vs_NAC,GO_BP,glutamate metabolic process,0.5084381583670152,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron fate specification,0.5084381583670152,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to chemical stress,0.5103608239337474,0.9999999999999711,99/5050
OUD_DLPFC_vs_NAC,GO_BP,response to dopamine,0.5183938523660567,0.9999999999999711,27/5050
OUD_DLPFC_vs_NAC,GO_BP,cytokinesis,0.5191768387019937,0.9999999999999711,46/5050
OUD_DLPFC_vs_NAC,GO_BP,microglia differentiation,0.5239313798327943,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of long-term neuronal synaptic plasticity,0.5239313798327943,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.5239313798327943,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of protein localization to synapse,0.5239313798327943,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron maturation,0.527473954495788,0.9999999999999711,22/5050
OUD_DLPFC_vs_NAC,GO_BP,microglial cell activation,0.5393702217292589,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,complement activation,0.5393702217292589,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.5393702217292589,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron projection organization,0.5517220600845913,0.9999999999999711,40/5050
OUD_DLPFC_vs_NAC,GO_BP,GABAergic neuron differentiation,0.5566207416461008,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of response to oxidative stress,0.5566207416461008,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of oxidative phosphorylation,0.5871826850545575,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron cell-cell adhesion,0.5871826850545575,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of glutamate secretion,0.5871826850545575,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,olfactory bulb interneuron differentiation,0.5871826850545575,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of axon extension involved in axon guidance,0.5871826850545575,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter-gated ion channel clustering,0.5871826850545575,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of neuron migration,0.5871826850545575,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,cytoskeleton-dependent cytokinesis,0.5889075706183963,0.9999999999999711,34/5050
OUD_DLPFC_vs_NAC,GO_BP,presynapse assembly,0.600578979742014,0.9999999999999711,20/5050
OUD_DLPFC_vs_NAC,GO_BP,postsynapse assembly,0.6047288184366651,0.9999999999999711,38/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of innate immune response,0.617216385242404,0.9999999999999711,33/5050
OUD_DLPFC_vs_NAC,GO_BP,glutamate receptor signaling pathway,0.6173874618528938,0.9999999999999711,24/5050
OUD_DLPFC_vs_NAC,GO_BP,axon extension,0.6190616881989719,0.9999999999999711,42/5050
OUD_DLPFC_vs_NAC,GO_BP,response to toxic substance,0.6225468768209232,0.9999999999999711,97/5050
OUD_DLPFC_vs_NAC,GO_BP,mitochondrial outer membrane permeabilization involved in programmed cell death,0.6230953005325215,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to toxic substance,0.6321845024897323,0.9999999999999711,46/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neuron migration,0.637640558246225,0.9999999999999711,19/5050
OUD_DLPFC_vs_NAC,GO_BP,peripheral nervous system axon regeneration,0.6540376468659529,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.6540376468659529,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,G protein-coupled opioid receptor signaling pathway,0.6540376468659529,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of astrocyte differentiation,0.6540376468659529,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter loading into synaptic vesicle,0.6540376468659529,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of execution phase of apoptosis,0.6540376468659529,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of microglial cell activation,0.6540376468659529,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.6575006989810063,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,spinal cord motor neuron differentiation,0.6575006989810063,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,cytokinetic process,0.6575006989810063,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,response to arsenic-containing substance,0.6575006989810063,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,synapse pruning,0.6575006989810063,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of synapse organization,0.6575006989810063,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of presynapse organization,0.6655931801330615,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of presynapse assembly,0.6655931801330615,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of axon extension,0.6733813800553115,0.9999999999999711,31/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of neuron projection development,0.6767422592238802,0.9999999999999711,53/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of response to cytokine stimulus,0.6924710387977207,0.9999999999999711,26/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of axon extension,0.7078662347390428,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,ionotropic glutamate receptor signaling pathway,0.7078662347390428,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,dopaminergic neuron differentiation,0.7078662347390428,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter reuptake,0.7078662347390428,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,maintenance of synapse structure,0.7078662347390428,0.9999999999999711,13/5050
OUD_DLPFC_vs_NAC,GO_BP,natural killer cell activation involved in immune response,0.708827441834373,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,immune response to tumor cell,0.708827441834373,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular component disassembly involved in execution phase of apoptosis,0.708827441834373,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neurotransmitter uptake,0.708827441834373,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,neuronal stem cell population maintenance,0.708827441834373,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,macrophage cytokine production,0.7111655312877545,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of macrophage cytokine production,0.7111655312877545,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of immune system process,0.7131235896692396,0.9999999999999711,196/5050
OUD_DLPFC_vs_NAC,GO_BP,assembly of actomyosin apparatus involved in cytokinesis,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,natural killer cell mediated immune response to tumor cell,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,"complement activation, alternative pathway",0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,G protein-coupled glutamate receptor signaling pathway,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neuron maturation,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of dendrite morphogenesis,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,dopamine uptake involved in synaptic transmission,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of dopamine uptake involved in synaptic transmission,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,axonogenesis involved in innervation,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to salt stress,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,commissural neuron axon guidance,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,"neurotransmitter receptor transport, postsynaptic endosome to lysosome",0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,anterograde axonal protein transport,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of execution phase of apoptosis,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of response to oxidative stress,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of response to drug,0.7232570953629616,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron cellular homeostasis,0.7278985693515632,0.9999999999999711,29/5050
OUD_DLPFC_vs_NAC,GO_BP,synapse maturation,0.7468964985320421,0.9999999999999711,16/5050
OUD_DLPFC_vs_NAC,GO_BP,detection of stimulus involved in sensory perception of pain,0.7468964985320421,0.9999999999999711,16/5050
OUD_DLPFC_vs_NAC,GO_BP,response to pain,0.7478543865187924,0.9999999999999711,20/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of axonogenesis,0.7478543865187924,0.9999999999999711,20/5050
OUD_DLPFC_vs_NAC,GO_BP,response to immobilization stress,0.7493510747624417,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of macrophage cytokine production,0.7493510747624417,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor transport,0.7493510747624417,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.7505321680764225,0.9999999999999711,24/5050
OUD_DLPFC_vs_NAC,GO_BP,mast cell activation involved in immune response,0.7505321680764225,0.9999999999999711,24/5050
OUD_DLPFC_vs_NAC,GO_BP,immunological synapse formation,0.7595507979303132,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,tolerance induction,0.7595507979303132,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of immune response to tumor cell,0.7595507979303132,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.7784745565622254,0.9999999999999711,19/5050
OUD_DLPFC_vs_NAC,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.7784745565622254,0.9999999999999711,19/5050
OUD_DLPFC_vs_NAC,GO_BP,antiviral innate immune response,0.78141963844267,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,myeloid cell activation involved in immune response,0.791118468717418,0.9999999999999711,43/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of dendritic cell cytokine production,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of natural killer cell mediated immune response to tumor cell,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,noradrenergic neuron differentiation,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,phospholipase C-activating dopamine receptor signaling pathway,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,stress-induced premature senescence,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,AMPA glutamate receptor clustering,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,motor neuron migration,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,glutamate receptor clustering,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,antibacterial innate immune response,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of synapse pruning,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron projection maintenance,0.7929315138114467,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of cytokinesis,0.807749668294844,0.9999999999999711,18/5050
OUD_DLPFC_vs_NAC,GO_BP,ventral spinal cord interneuron differentiation,0.8085622533307293,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,astrocyte activation,0.8085622533307293,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of axon regeneration,0.8085622533307293,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of programmed necrotic cell death,0.8085622533307293,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of neuron projection regeneration,0.8085622533307293,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,dopamine uptake,0.8085622533307293,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.8085622533307293,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor diffusion trapping,0.8085622533307293,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,response to fluid shear stress,0.8143357587349503,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of axon extension,0.8143357587349503,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.8143357587349503,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of excitatory synapse assembly,0.8143357587349503,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,response to axon injury,0.825548745548772,0.9999999999999711,33/5050
OUD_DLPFC_vs_NAC,GO_BP,behavioral response to pain,0.8274715386747633,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of cytokine production involved in inflammatory response,0.8274715386747633,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,excitatory synapse assembly,0.829871874767952,0.9999999999999711,21/5050
OUD_DLPFC_vs_NAC,GO_BP,response to osmotic stress,0.8445610924960801,0.9999999999999711,32/5050
OUD_DLPFC_vs_NAC,GO_BP,dendritic cell cytokine production,0.854602532300139,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of dendritic cell cytokine production,0.854602532300139,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron remodeling,0.854602532300139,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,response to laminar fluid shear stress,0.854602532300139,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,ventral spinal cord interneuron fate commitment,0.854602532300139,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor transport to plasma membrane,0.854602532300139,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,neurotransmitter receptor transport to postsynaptic membrane,0.854602532300139,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of dendrite development,0.854602532300139,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,somatic diversification of immune receptors,0.861235593713763,0.9999999999999711,16/5050
OUD_DLPFC_vs_NAC,GO_BP,complement receptor mediated signaling pathway,0.8628076703944735,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of cytokinesis,0.8628076703944735,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of programmed necrotic cell death,0.8628076703944735,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,mitotic cytokinesis,0.8691512405168899,0.9999999999999711,23/5050
OUD_DLPFC_vs_NAC,GO_BP,myeloid leukocyte cytokine production,0.8754384283664289,0.9999999999999711,19/5050
OUD_DLPFC_vs_NAC,GO_BP,somatic diversification of immune receptors via germline recombination within a single locus,0.8849890581745535,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,macrophage activation involved in immune response,0.8948130808528201,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,mucosal immune response,0.8948130808528201,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,response to salt stress,0.8948130808528201,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,programmed cell death involved in cell development,0.8948130808528201,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to fluid shear stress,0.8948130808528201,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,chemokine (C-X-C motif) ligand 2 production,0.8948130808528201,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of synapse maturation,0.8948130808528201,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of chemokine (C-X-C motif) ligand 2 production,0.8948130808528201,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of programmed cell death,0.8951607004688902,0.9999999999999711,284/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of stress fiber assembly,0.8955750034926995,0.9999999999999711,18/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of humoral immune response,0.8963057166054832,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of complement activation,0.8963057166054832,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,L-glutamate import across plasma membrane,0.8963057166054832,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of dopaminergic neuron differentiation,0.8963057166054832,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,protein localization to presynapse,0.8963057166054832,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.8996646705447837,0.9999999999999711,11/5050
OUD_DLPFC_vs_NAC,GO_BP,immunoglobulin production involved in immunoglobulin-mediated immune response,0.9065008955533365,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of humoral immune response,0.9065008955533365,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,programmed necrotic cell death,0.9065008955533365,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,immune response-regulating cell surface receptor signaling pathway,0.9104334227539744,0.9999999999999711,133/5050
OUD_DLPFC_vs_NAC,GO_BP,immune response-activating cell surface receptor signaling pathway,0.9186951531432771,0.9999999999999711,119/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of stress fiber assembly,0.9225636346006729,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.9225636346006729,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.9229223159316994,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,muscle hypertrophy in response to stress,0.9229223159316994,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,cardiac muscle hypertrophy in response to stress,0.9229223159316994,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.9229223159316994,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of programmed cell death,0.9234474069920906,0.9999999999999711,186/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of chemokine production,0.9295371431506987,0.9999999999999711,30/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of stress fiber assembly,0.9295371431506987,0.9999999999999711,30/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of response to cytokine stimulus,0.9317769021182423,0.9999999999999711,64/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of type 2 immune response,0.9322803507084172,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.9322803507084172,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of macrophage cytokine production,0.9322803507084172,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,spinal cord association neuron differentiation,0.9322803507084172,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,pyramidal neuron differentiation,0.9322803507084172,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,T-helper 2 cell cytokine production,0.9322803507084172,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of synapse structural plasticity,0.9322803507084172,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of T-helper 2 cell cytokine production,0.9322803507084172,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of neuron migration,0.9322803507084172,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of cytokine-mediated signaling pathway,0.9323303538348297,0.9999999999999711,60/5050
OUD_DLPFC_vs_NAC,GO_BP,astrocyte differentiation,0.9361046294109021,0.9999999999999711,33/5050
OUD_DLPFC_vs_NAC,GO_BP,T cell differentiation involved in immune response,0.9399646699154593,0.9999999999999711,29/5050
OUD_DLPFC_vs_NAC,GO_BP,somatic recombination of immunoglobulin genes involved in immune response,0.942330233130616,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,somatic diversification of immunoglobulins involved in immune response,0.942330233130616,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of immunoglobulin mediated immune response,0.942330233130616,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of astrocyte differentiation,0.942330233130616,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,astrocyte development,0.9443727193265298,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.9447699801162542,0.9999999999999711,25/5050
OUD_DLPFC_vs_NAC,GO_BP,glutamatergic neuron differentiation,0.9466830902389589,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,axon regeneration,0.9473547681031094,0.9999999999999711,18/5050
OUD_DLPFC_vs_NAC,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.9501943908784618,0.9999999999999711,35/5050
OUD_DLPFC_vs_NAC,GO_BP,stress fiber assembly,0.9501943908784618,0.9999999999999711,35/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of immune effector process,0.9529636403938215,0.9999999999999711,92/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.9542146367890642,0.9999999999999711,24/5050
OUD_DLPFC_vs_NAC,GO_BP,integrated stress response signaling,0.9566951827704964,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,alpha-beta T cell activation involved in immune response,0.957648593879224,0.9999999999999711,27/5050
OUD_DLPFC_vs_NAC,GO_BP,alpha-beta T cell differentiation involved in immune response,0.957648593879224,0.9999999999999711,27/5050
OUD_DLPFC_vs_NAC,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.957648593879224,0.9999999999999711,27/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of response to cytokine stimulus,0.957648593879224,0.9999999999999711,27/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to osmotic stress,0.9580954941617756,0.9999999999999711,17/5050
OUD_DLPFC_vs_NAC,GO_BP,lymphocyte activation involved in immune response,0.9585037625534262,0.9999999999999711,75/5050
OUD_DLPFC_vs_NAC,GO_BP,organ or tissue specific immune response,0.9588239017695142,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of humoral immune response,0.9588239017695142,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of cytokine production involved in immune response,0.9609490685070678,0.9999999999999711,30/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of tolerance induction,0.961243483243571,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,astrocyte cell migration,0.961243483243571,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,mitotic cytokinetic process,0.961243483243571,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of T-helper 17 type immune response,0.961243483243571,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of T-helper 17 type immune response,0.961243483243571,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to stress,0.963714594554258,0.9999999999999711,482/5050
OUD_DLPFC_vs_NAC,GO_BP,innate immune response in mucosa,0.9658110237810567,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of immunoglobulin mediated immune response,0.9658110237810567,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,ectopic germ cell programmed cell death,0.9658110237810567,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,immune system development,0.9675873148730338,0.9999999999999711,43/5050
OUD_DLPFC_vs_NAC,GO_BP,activation of immune response,0.9696997051723028,0.9999999999999711,193/5050
OUD_DLPFC_vs_NAC,GO_BP,chemokine production,0.9697222273634576,0.9999999999999711,39/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of chemokine production,0.9697222273634576,0.9999999999999711,39/5050
OUD_DLPFC_vs_NAC,GO_BP,leukocyte activation involved in immune response,0.9704420232861333,0.9999999999999711,111/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of immune response,0.9720153401942571,0.9999999999999711,64/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of type 2 immune response,0.9721134773197379,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of cellular response to stress,0.9730486876475035,0.9999999999999711,114/5050
OUD_DLPFC_vs_NAC,GO_BP,stress-activated protein kinase signaling cascade,0.9749924196080175,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,stress-activated MAPK cascade,0.9749924196080175,0.9999999999999711,15/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of type 2 immune response,0.9757102769125199,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,cytokine production involved in inflammatory response,0.975860573527881,0.9999999999999711,21/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of cytokine production involved in inflammatory response,0.975860573527881,0.9999999999999711,21/5050
OUD_DLPFC_vs_NAC,GO_BP,cell activation involved in immune response,0.9799001655359374,0.9999999999999711,111/5050
OUD_DLPFC_vs_NAC,GO_BP,T cell activation involved in immune response,0.9800592422480416,0.9999999999999711,47/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of cellular response to osmotic stress,0.9802465295123292,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.9802465295123292,0.9999999999999711,4/5050
OUD_DLPFC_vs_NAC,GO_BP,neuron projection regeneration,0.9810662625480815,0.9999999999999711,20/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of production of molecular mediator of immune response,0.9813401096584293,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,immunoglobulin mediated immune response,0.9815788531876086,0.9999999999999711,43/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of stress-activated MAPK cascade,0.9823242516998482,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of stress-activated protein kinase signaling cascade,0.9823242516998482,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of innate immune response,0.9828420943674868,0.9999999999999711,149/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,0.9830195657745129,0.9999999999999711,46/5050
OUD_DLPFC_vs_NAC,GO_BP,B cell activation involved in immune response,0.9831791106168,0.9999999999999711,29/5050
OUD_DLPFC_vs_NAC,GO_BP,immune response-activating signaling pathway,0.9832531137031066,0.9999999999999711,177/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.9850845159537274,0.9999999999999711,35/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of T-helper 17 type immune response,0.9852397977786236,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,type 2 immune response,0.9856484755978792,0.9999999999999711,16/5050
OUD_DLPFC_vs_NAC,GO_BP,immune response-regulating signaling pathway,0.9861008971322418,0.9999999999999711,191/5050
OUD_DLPFC_vs_NAC,GO_BP,activation of innate immune response,0.9872982099414849,0.9999999999999711,99/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of immune response,0.9873361638853346,0.9999999999999711,323/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of innate immune response,0.9874593806997038,0.9999999999999711,122/5050
OUD_DLPFC_vs_NAC,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.9880397720473679,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of production of molecular mediator of immune response,0.9887837869197286,0.9999999999999711,47/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of immunoglobulin mediated immune response,0.9889477610825026,0.9999999999999711,18/5050
OUD_DLPFC_vs_NAC,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,0.9891798991463556,0.9999999999999711,27/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of response to osmotic stress,0.9897209407086789,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.990206615778725,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of astrocyte differentiation,0.990206615778725,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of mitotic cytokinesis,0.990206615778725,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of immune response,0.9903429497466916,0.9999999999999711,252/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of axon regeneration,0.9907188830900511,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of neuron projection regeneration,0.9907188830900511,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of adaptive immune response,0.9913904123275765,0.9999999999999711,23/5050
OUD_DLPFC_vs_NAC,GO_BP,chemokine-mediated signaling pathway,0.9914776405884823,0.9999999999999711,20/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of cytokine production involved in immune response,0.9921190675750386,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,innate immune response-activating signaling pathway,0.9921280844003941,0.9999999999999711,95/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of adaptive immune response,0.9923153839300458,0.9999999999999711,35/5050
OUD_DLPFC_vs_NAC,GO_BP,response to chemokine,0.9934204891948173,0.9999999999999711,22/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to chemokine,0.9934204891948173,0.9999999999999711,22/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of programmed cell death,0.9934373878962999,0.9999999999999711,466/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of cytokine production involved in immune response,0.9934914857488841,0.9999999999999711,44/5050
OUD_DLPFC_vs_NAC,GO_BP,mature B cell differentiation involved in immune response,0.9935108219055064,0.9999999999999711,11/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of cytokine production,0.9940053995266664,0.9999999999999711,104/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.9950534853412238,0.9999999999999711,21/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of immune system process,0.9954428972013307,0.9999999999999711,546/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of immune effector process,0.9956218680279031,0.9999999999999711,42/5050
OUD_DLPFC_vs_NAC,GO_BP,T cell cytokine production,0.995764144862952,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of T cell cytokine production,0.995764144862952,0.9999999999999711,10/5050
OUD_DLPFC_vs_NAC,GO_BP,production of molecular mediator of immune response,0.9960066850695073,0.9999999999999711,72/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of T-helper 1 type immune response,0.9962195640546445,0.9999999999999711,2/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of stress-activated protein kinase signaling cascade,0.9962195640546445,0.9999999999999711,2/5050
OUD_DLPFC_vs_NAC,GO_BP,chemokine (C-C motif) ligand 5 production,0.9962195640546445,0.9999999999999711,2/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of chemokine (C-C motif) ligand 5 production,0.9962195640546445,0.9999999999999711,2/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.9962195640546445,0.9999999999999711,2/5050
OUD_DLPFC_vs_NAC,GO_BP,T-helper 17 type immune response,0.9964672148238524,0.9999999999999711,12/5050
OUD_DLPFC_vs_NAC,GO_BP,cytokine production involved in immune response,0.9966067439369394,0.9999999999999711,44/5050
OUD_DLPFC_vs_NAC,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",0.9971176297175096,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,antifungal innate immune response,0.9971176297175096,0.9999999999999711,5/5050
OUD_DLPFC_vs_NAC,GO_BP,immune effector process,0.9971310114190317,0.9999999999999711,229/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of production of molecular mediator of immune response,0.9973592729662384,0.9999999999999711,66/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.997363876110615,0.9999999999999711,9/5050
OUD_DLPFC_vs_NAC,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.9975857296000146,0.9999999999999711,108/5050
OUD_DLPFC_vs_NAC,GO_BP,stress response to copper ion,0.9976766804785219,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.997778940286728,0.9999999999999711,65/5050
OUD_DLPFC_vs_NAC,GO_BP,tumor necrosis factor superfamily cytokine production,0.9982606607757312,0.9999999999999711,67/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,0.9982606607757312,0.9999999999999711,67/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of T cell cytokine production,0.9984354788219099,0.9999999999999711,6/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of stress-activated MAPK cascade,0.9984498697859705,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,humoral immune response,0.9987269687472418,0.9999999999999711,72/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of adaptive immune response,0.9988625825197412,0.9999999999999711,68/5050
OUD_DLPFC_vs_NAC,GO_BP,T-helper 1 type immune response,0.9989445462223998,0.9999999999999711,14/5050
OUD_DLPFC_vs_NAC,GO_BP,negative regulation of chemokine production,0.9991488566332929,0.9999999999999711,7/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of immune effector process,0.9992288398421483,0.9999999999999711,136/5050
OUD_DLPFC_vs_NAC,GO_BP,cell death,0.9992918519558758,0.9999999999999711,614/5050
OUD_DLPFC_vs_NAC,GO_BP,innate immune response,0.999377520219502,0.9999999999999711,308/5050
OUD_DLPFC_vs_NAC,GO_BP,programmed cell death,0.999415519450098,0.9999999999999711,611/5050
OUD_DLPFC_vs_NAC,GO_BP,adaptive immune response,0.999464059942607,0.9999999999999711,159/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of T-helper 1 type immune response,0.9994734676194741,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,stress response to metal ion,0.9994734676194741,0.9999999999999711,3/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of T-helper 1 type immune response,0.9995358634613258,0.9999999999999711,8/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of cytokine production,0.9997768373786589,0.9999999999999711,178/5050
OUD_DLPFC_vs_NAC,GO_BP,positive regulation of immune system process,0.999792753699428,0.9999999999999711,368/5050
OUD_DLPFC_vs_NAC,GO_BP,cytokine-mediated signaling pathway,0.9998977302040607,0.9999999999999711,183/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of response to stress,0.9999376423987809,0.9999999999999711,415/5050
OUD_DLPFC_vs_NAC,GO_BP,regulation of cytokine production,0.9999491136465171,0.9999999999999711,275/5050
OUD_DLPFC_vs_NAC,GO_BP,cytokine production,0.99997605240286,0.9999999999999711,276/5050
OUD_DLPFC_vs_NAC,GO_BP,response to cytokine,0.9999784518295913,0.9999999999999711,325/5050
OUD_DLPFC_vs_NAC,GO_BP,cellular response to cytokine stimulus,0.9999924152662302,0.9999999999999711,289/5050
OUD_DLPFC_vs_NAC,GO_BP,immune response,0.9999957335676394,0.9999999999999711,584/5050
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.3970718611869036,0.9999999999999833,196/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.4177344556757355,0.9999999999999833,70/6081
Control_DLPFC_vs_NAC,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.445818037112649,0.9999999999999833,30/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.47995730418866034,0.9999999999999833,181/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.5108414078921666,0.9999999999999833,208/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.5244614438645396,0.9999999999999833,65/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.5259972801345416,0.9999999999999833,7/6081
Control_DLPFC_vs_NAC,C8_CellType,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.6335841178070338,0.9999999999999833,416/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.6558503969044484,0.9999999999999833,59/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,0.6714922673797965,0.9999999999999833,264/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.67422735044317506,0.9999999999999833,5/6081
Control_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.7279437013953501,0.9999999999999833,29/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.746656963876526,0.9999999999999833,47/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.7529537138122336,0.9999999999999833,4/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C1_DLX5_POS_INTERNEURON,0.7529537138122336,0.9999999999999833,4/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,0.8288650390296889,0.9999999999999833,15/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.855597407488608,0.9999999999999833,8/6081
Control_DLPFC_vs_NAC,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,0.8781131533256163,0.9999999999999833,231/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.8923969950261113,0.9999999999999833,7/6081
Control_DLPFC_vs_NAC,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.9003612552940994,0.9999999999999833,289/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.9166505224821353,0.9999999999999833,137/6081
Control_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.9373587682803992,0.9999999999999833,8/6081
Control_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.9373587682803992,0.9999999999999833,8/6081
Control_DLPFC_vs_NAC,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.9853247172411437,0.9999999999999833,3/6081
OUD_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.20235073708381293,1,34/6250
OUD_DLPFC_vs_NAC,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.20243502007739214,1,57/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.2224269589667929,1,33/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.2521130662826476,1,20/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.2521130662826476,1,20/6250
OUD_DLPFC_vs_NAC,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.25282886065020954,1,97/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.28832783854755695,1,52/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.3270989595527737,1,6/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.3698366901810975,1,11/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.3698366901810975,1,11/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.3823745114053695,1,144/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,0.39409008353483954,1,5/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.39409008353483954,1,5/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C1_DLX5_POS_INTERNEURON,0.39409008353483954,1,5/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.39409008353483954,1,5/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,0.4192026057408377,1,10/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.4192026057408377,1,10/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.4292573669143369,1,15/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,0.4727166399904149,1,14/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.47326342833309687,1,9/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.47326342833309687,1,9/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,0.5509291256544875,1,17/6250
OUD_DLPFC_vs_NAC,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.5864183516296997,1,30/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.5946248973554201,1,7/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_1,0.6049729508972732,1,34/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,0.6542046498210843,1,92/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.6755265810121143,1,14/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.7165371299982665,1,9/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.7290457034451658,1,5/6250
OUD_DLPFC_vs_NAC,C8_CellType,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.7861019032896608,1,424/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.7975812913807081,1,4/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.8591788176099354,1,6/6250
OUD_DLPFC_vs_NAC,C8_CellType,HU_FETAL_RETINA_MICROGLIA,0.9294786832783288,1,179/6250
OUD_DLPFC_vs_NAC,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.9346524672517927,1,4/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,0.9450181053508185,1,75/6250
OUD_DLPFC_vs_NAC,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.9804392639355304,1,292/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,0.990084023300873,1,337/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.9946359522717664,1,171/6250
OUD_DLPFC_vs_NAC,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.9951547774591714,1,198/6250
OUD_DLPFC_vs_NAC,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,0.9997748241758291,1,250/6250
OUD_DLPFC_vs_NAC,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.9999096514673969,1,57/6250
OUD_DLPFC_vs_NAC,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,0.9999998203205972,1,211/6250
